User Image Cart Icon 0 Search Image

Insulin & Obesity

  1. A better parameter in predictingย insulinย resistance:ย obesityย plus elevated alanine aminotransferase
  2. A case of familial Bardet-Biedl syndrome (obesity, slight mental retardation, polydactyly, retinitis pigmentosum and renal failure) withย insulin-resistant diabetes mellitus
  3. A case ofย insulinย autoimmune syndrome that developed after topiramate anti-obesityย medication
  4. A central role for JNK inย obesityย andย insulinย resistance
  5. A clinically confirmed family history for early myocardial infarction is associated with increased risk ofย obesity,ย insulinย resistance and metabolic syndrome
  6. A combination of circulating chemokines as biomarkers ofย obesityโ€inducedย insulinย resistance at puberty
  7. A comparison of the relative effects ofย obesityย and non-insulin-dependent diabetes mellitus on in vivoย insulin-stimulated glucose utilization
  8. A CONNECTION BETWEENย insulinย RESISTANCE AND ANDROGENS, INDEPENDENT OFย obesity?
  9. A cross-sectional study of the phenotypes ofย obesityย andย insulinย resistance in adults with down syndrome.
  10. A Distinct Population of Lipid Sensing iNKT Cells are Enriched in Fat and Protect Against Diet-Inducedย obesityย andย insulinย Resistance (176.26)
  11. A free-choice high-fat high-sugar diet induces glucose intolerance andย insulinย unresponsiveness to a glucose load not explained byย obesity
  12. A functional GNAQ promoter haplotype is associated with altered Gq expression and withย insulinย resistance andย obesityย in women with polycystic ovary syndrome
  13. A haplotype at the adiponectin locus is associated withย obesityย and other features of theย insulinย resistance syndrome
  14. A high alanine aminotransferase/aspartate aminotransferase ratio determinesย insulinย resistance and metabolically healthy/unhealthyย obesityย in a general adult โ€ฆ
  15. A high omega-6 PUFA diet impairs hepatocyteย insulinย signalling during diet-inducedย obesity
  16. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improvesย obesity-linked inflammation andย insulinย resistance through suppressing activation of TLR4 in SD โ€ฆ
  17. A high-sugar diet producesย obesityย andย insulinย resistance in wild-type Drosophila
  18. A ketogenic diet reduces centralย obesityย and serumย insulinย in women with ovarian or endometrial cancer
  19. A lower duodenal immune response is associated with an increase ofย insulinย resistance in patients with morbidย obesity
  20. A major locus for fastingย insulinย concentrations andย insulinย resistance on chromosome 6q with strong pleiotropic effects onย obesity-related phenotypes in โ€ฆ
  21. A major role ofย insulinย in promotingย obesity-associated adipose tissue inflammation
  22. A major role ofย insulinย in promotingย obesity-associated adipose tissue inflammation
  23. A Meta-analysis of Effects of Aerobic Exercise on Glucose andย insulinย in Overweight/obesityย Children and Adolescent [J]
  24. A Meta-Analysis of the Impact ofย obesity, Metabolic Syndrome,ย insulinย Resistance, and Microbiome on the Diagnosis of Barrettโ€™s Esophagus
  25. A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes toย obesity-inducedย insulinย resistance in skeletal muscle
  26. A mitochondrially encoded hormone amelioratesย obesityย andย insulinย resistance
  27. A mouse model of diet-inducedย obesityย andย insulinย resistance
  28. A multidisciplinary intervention in childhoodย obesityย acutely improvesย insulinย resistance and inflammatory markers independent from body composition
  29. A Multiplatform Non-targeted Metabolomics Approach to Investigateย insulinย Resistance Associated toย obesityย in Childhood
  30. A muscle-specific UBE2O/AMPKฮฑ2 axis promotesย insulinย resistance and metabolic syndrome inย obesity
  31. A new endoscopically implantable device (SatiSphere) for treatment ofย obesityโ€”efficacy, safety, and metabolic effects on glucose,ย insulin, and GLP-1 levels
  32. A new link between skeleton,ย obesityย andย insulinย resistance: relationships between osteocalcin, leptin andย insulinย resistance in obese children before and after weight โ€ฆ
  33. A new paradigm for diabetes andย obesity: the hepaticย insulinย sensitizing substance (HISS) hypothesis
  34. A new tumor necrosis factor (TNF)-ฮฑ regulator, lipopolysaccharides-induced TNF-ฮฑ factor, is associated withย obesityย andย insulinย resistance
  35. A non-invasive marker ofย insulinย resistance in patients withย obesity
  36. A novel approach to childhoodย obesity: circulating chemokines and growth factors as biomarkers ofย insulinย resistance
  37. A novel GPCR messenger mediating cholinergic stimulation of synaptotagmin-dependentย insulinย exocytosis andย obesity
  38. A novel IKKฮฒ inhibitor stimulates adiponectin levels and amelioratesย obesity-linkedย insulinย resistance
  39. A novel role forย insulinย resistance in the connection betweenย obesityย and postmenopausal breast cancer
  40. A pharmacologic sympathectomy prevents the development ofย obesityย andย insulinย resistance in the high fat fed rat
  41. A polymorphic variant of theย insulin-like growth factor type I receptor gene modifies risk ofย obesityย for esophageal adenocarcinoma
  42. A polyphenol-rich cranberry extract protects from diet-inducedย obesity,ย insulinย resistance and intestinal inflammation in association with increased Akkermansia spp โ€ฆ
  43. A post-weaning obesogenic diet exacerbates the detrimental effects of maternalย obesityย on offspringย insulinย signaling in adipose tissue
  44. A post-weaning obesogenic diet exacerbates the detrimental effects of maternalย obesityย on offspringย insulinย signaling in adipose tissue
  45. A Potential New Treatment Option for Asthma in the Setting ofย obesityย orย insulinย Resistance?
  46. A potential role forย insulinย treatment during pregnancy in reducing postpartum psychological distress in maternalย obesity: An administrative population health โ€ฆ
  47. A preliminary study ofย insulinย resistance in essential hypertension, simpleย obesityย and acromegaly
  48. A preliminary study of mechanism of periodontitis and periodontal therapy influence inย insulinย resistance forย obesityย rats
  49. A prospective observational study ofย obesity, body composition, andย insulinย resistance in 18 women with bipolar disorder and 17 matched control subjects
  50. A randomized control trial of the impact of LCPUFAโ€ฯ‰3 supplementation on body weight andย insulinย resistance in pubertal children withย obesity
  51. A review ofย obesity,ย insulinย resistance, and the role of exercise in breast cancer patients
  52. A review of the carbohydrateโ€“insulinย model ofย obesity
  53. A role for 5-lipoxygenase products inย obesity-associated inflammation andย insulinย resistance
  54. A role for EP3 and its associated G protein, Gz, in negatively regulating beta-cell function and mass in the context ofย insulinย resistance andย obesity
  55. A role of lipin in humanย obesityย andย insulinย resistance: relation to adipocyte glucose transport and GLUT4 expression
  56. A simple and effective model to studyย insulinย resistance inย obesityย and diabetes and the processes and mechanisms of in vitro aging using lymphocyte culture
  57. A simplified method using somatostatin to assess in vivoย insulinย resistance over a range ofย obesity
  58. A study of association of sex hormones withย insulinย resistance andย obesityย for diabetes mellitus risk in adult women
  59. A Study onย insulinย Resistance andย obesityย Among Women at High Risk for Breast Cancer Using Cluster Analysis.
  60. A study on relation ofย obesityย to serum lipid, leptin andย insulinย concentration in elementary schoolchildren
  61. A study on the genetics ofย obesity: influence of polymorphisms of the beta-3-adrenergic receptor andย insulinย receptor substrate 1 in relation to weight loss, waist to hip โ€ฆ
  62. A study on the relationship between neck circumference andย obesityย related indexes and metabolic disorders associated withย insulinย resistance
  63. A Submaximal Exercise Patterns Intervention on the Plasmatic Leptin Level andย insulinย Resistance for Overweight/obesityย Boys Adolescences
  64. A three-year follow-up study on risk factors forย obesityย and non-insulinย dependent diabetes mellitus in aging populations in China
  65. A twenty-first century cancer epidemic caused byย obesity: the involvement ofย insulin, diabetes, andย insulin-like growth factors
  66. A Uniform. Approach in the Use of U-500 Regularย insulinย in the Management Of Paiients withย obesityย and Insu] in Resistance: The Cliniciaโ€™s View.
  67. A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediatesย obesityย andย insulinย resistance
  68. AB0025 Is Abatacept Successful in Improvingย insulinย Resistance in A High Fat Diet Model ofย obesity?
  69. AB0092 Effect of methotrexate, leflunomide and hydroxychloroquine on theย insulinย resistance andย obesityย associated with rheumatoid arthritis: obese mouse models โ€ฆ
  70. AB1098ย obesityย andย insulinย resistance in fibromyalgia patients
  71. ABCA1 and metabolic syndrome; a review of the ABCA1 role in HDL-VLDL production,ย insulin-glucose homeostasis, inflammation andย obesity
  72. Abdominalย obesityย andย insulinย resistance after an episode of acute pancreatitis
  73. Abdominalย obesityย andย insulinย resistance in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project
  74. Abdominalย obesityย andย insulinย resistance in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project.
  75. Abdominalย obesityย andย insulinย resistance in people exposed to moderate-to-high levels of dioxin
  76. Abdominalย obesityย and low physical activity are associated withย insulinย resistance in overweight adolescents: a cross-sectional study
  77. Abdominalย obesityย as a mediator of the influence of physical activity onย insulinย resistance in Spanish adults
  78. Abdominalย obesityย as important component ofย insulin-resistance syndrome.
  79. Abdominalย obesityย associated with elevated serum Butyrylcholinesterase activity,ย insulinย resistance and reduced high density lipoprotein-cholesterol levels
  80. Abdominalย obesityย in BTBR male mice is associated with peripheral but not hepaticย insulinย resistance
  81. Abdominalย obesityย in older women: potential role for disrupted fatty acid reesterification inย insulinย resistance
  82. Abdominalย obesityย is associated withย insulinย resistance and reduced glycogen synthase activity in skeletal muscle
  83. Abdominalย obesityย is associated withย insulinย resistance.
  84. Abdominalย obesityย Predicts Decliningย insulinย Sensitivity in Non-Obese Normoglycemics
  85. Abdominalย obesityย predicts decliningย insulinย sensitivity in nonโ€obese normoglycaemics: theย insulinย Resistance Atherosclerosis Study (IRAS)
  86. ABDOMINALย obesity, DYSLIPIDEMIA,ย insulinย RESISTANCE, TYPE 2 DIABETES AND ATHEROSCLEROSIS: WHO IS THE RIGHT PATIENT TO BE โ€ฆ
  87. Abdominalย obesity, fatty acids andย insulinย resistance
  88. Abdominalย obesity, impaired nonesterified fatty acid suppression, andย insulin-mediated glucose disposal are early metabolic abnormalities in families with premature โ€ฆ
  89. Abdominalย obesity,ย insulinย resistance and hypertension: impact on left ventricular mass and function in women
  90. Abdominalย obesity,ย insulinย resistance, and alterations in hemostasis
  91. Abdominalย obesity,ย insulinย resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
  92. Abdominalย obesity,ย insulinย resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression
  93. Abdominalย obesity,ย insulinย resistance, and metabolic syndrome in a southern European population
  94. Abdominalย obesity,ย insulinย resistance, and the metabolic syndrome: contribution of physical activity/exercise
  95. Abdominalย obesity,ย insulinย resistance, and the risk of colonic adenoma
  96. Abdominalย obesity,ย insulinย resistance, metabolic syndrome and cholesterol homeostasis
  97. ABDOMINALย obesity, METABOLIC SYNDROME ANDย insulinย RESISTANCE: PP. 26.340
  98. Abdominalย obesity, muscle composition, andย insulinย resistance in premenopausal women
  99. Abdominal subcutaneous adipose tissue gene expression in relation to tissue-specificย insulinย resistance in humanย obesity
  100. Aberrant expression of miR-214 is associated withย obesity-inducedย insulinย resistance as a biomarker and therapeutic
  101. Aberrant hepatic expression of PPARฮณ2 stimulates hepatic lipogenesis in a mouse model ofย obesity,ย insulinย resistance, dyslipidemia, and hepatic steatosis
  102. Ablation ofย insulin-producing cells preventsย obesityย but not premature mortality caused by a high-sugar diet in Drosophila
  103. Ablation of MARK4, an AMPK-related Kinase, Leads toย insulinย Hypersensitivity and Resistance to Diet-inducedย obesity
  104. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-inducedย obesityย andย insulinย resistance
  105. Abnormal liver function andย insulinย resistance inย obesity
  106. Abnormal mitochondrial metabolism inย obesityย andย insulinย resistance
  107. Abnormalities of Glucose andย insulinย Metabolism in Exogenousย obesity.
  108. Abnormalities of islet B-cell function,ย insulinย action, and fat distribution in women with histories of gestational diabetes: relationship toย obesity
  109. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominalย obesityย and relations withย insulinย resistance: evidence for a central โ€ฆ
  110. Abrogation of toll-like receptor 4 mitigatesย obesity-induced oxidative stress, proinflammation, andย insulinย resistance through metabolic reprogramming of mitochondria โ€ฆ
  111. Absence of GIP secretion alleviates age-relatedย obesityย andย insulinย resistance
  112. ABSENCE OF GUT MICROBIOTA PROTECTS AGAINST DIET-INDUCEDย obesityย ANDย insulin-RESISTANCE BUT PREDISPOSES TO LIVER DAMAGE
  113. Absence of S6K1 protects against age-and diet-inducedย obesityย while enhancingย insulinย sensitivity
  114. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but notย obesityย orย insulinย resistance in Lepob/Lepob mice
  115. Absence of the ROS Scavenger DJ-1 Paradoxically Protects Mice fromย obesityย andย insulinย Resistance
  116. Absence of tollโ€like receptorโ€2 (Tlr2) attenuates diet inducedย obesityย and adipose tissue inflammation andย insulinย resistance
  117. Abstract CN13-04:ย obesity,ย insulinย resistance, hyperglycemia, and cancer: A novel role for metformin as an anticancer drug
  118. Abstract KN01: Keynote Lecture: PI 3-kinase linksย obesity,ย insulinย resistance, and cancer
  119. Abstract MP55: DNA methylation mediates the effects ofย obesityย onย insulinย resistance in african american youth and young adults
  120. Abstract P034: Association betweenย obesityย Indices andย insulinย Resistance among Healthy Korean Adolescents
  121. Abstract P088:ย obesity, Hypertension andย insulinย Resistance in a Primary Pediatric Setting in Southern Italy
  122. Abstract P438: Staying Active improvesย insulinย Resistance independent of the Metabolic Syndrome andย obesity
  123. Abstract P636:ย insulinย Resistance inย obesityย Results in Postprandial Salt and Water Loss
  124. Abstract WP132: Relationship Of Neck Circumference Andย insulinย Resistance On The Cerebrovascular Reactivity In Subjects Withย obesity.
  125. Acanthosis nigricans andย obesity: acquired and intrinsic defects inย insulinย action
  126. Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association withย obesityย andย insulinย resistance in Mexican American โ€ฆ
  127. Acanthosis nigricans in obese children and adolescents in relation to severity ofย obesityย andย insulinย resistance.
  128. Acanthosis nigricans with severeย obesity,ย insulinย resistance and hypothyroidism: improvement by diet control
  129. ACANTHOSIS NIGRICANS,ย obesity,ย insulinย RESISTANCE AND HYPERANDROGENEMIA: NATURAL HISTORY AND PEDIATRIC PERSPECTIVE
  130. Acanthosis nigricans: A valid clinical marker ofย insulinย resistance inย obesity
  131. Acetylsalicylic acid modulates inflammation andย insulinย resistance in a mouse model of diet-inducedย obesity
  132. Acquiredย obesityย Changes Adipose Tissue MRNA Expression, Increases Abdominal and Liver Fat, and Causesย insulinย Resistance in Monozygotic Twins
  133. Acquiredย obesityย is associated with increased liver fat, intra-abdominal fat, andย insulinย resistance in young adult monozygotic twins
  134. ACSL1 multiโ€tissue knockout mice are resistant to dietโ€and ageโ€inducedย obesityย andย insulinย resistance
  135. Activated glucose-6-phosphate dehydrogenase is associated withย insulinย resistance by upregulating pentose and pentosidine in diet-inducedย obesityย of rats
  136. Activating transcriptional factor 4 correlated withย obesityย andย insulinย resistance in polycystic ovary syndrome
  137. Activation and regulation of the pattern recognition receptors inย obesity-induced adipose tissue inflammation andย insulinย resistance
  138. Activation of calcium/calmodulin-dependent protein kinase II inย obesityย mediates suppression of hepaticย insulinย signaling
  139. Activation of malonylโ€CoA/fatty acid synthase axis is an early event in the effects ofย insulinย in human skeletal muscle myotubes: Implication forย obesityย linkedย insulinย โ€ฆ
  140. Activation of placentalย insulinย and mTOR signaling in a mouse model of maternalย obesityย associated with fetal overgrowth
  141. Activation of the Cblย insulinย signaling pathway in cardiac muscle; dysregulation inย obesityย and diabetes
  142. Activation of the cholinergic antiinflammatory pathway amelioratesย obesity-induced inflammation andย insulinย resistance
  143. Activation of vascular protein kinase C-ฮฒ inhibits Akt-dependent endothelial nitric oxide synthase function inย obesity-associatedย insulinย resistance
  144. Activation of ฮฑ7nAChR via vagus nerve preventsย obesity-inducedย insulinย resistance via suppressing endoplasmic reticulum stress-induced inflammation in Kupffer โ€ฆ
  145. Activity of tamarindus indica pulp water extract in high carbohydrate diet rats as a treatment forย obesityย andย insulinย resistance
  146. Acupuncture for Treatment ofย obesityย andย insulinย Resistance
  147. Acupuncture targeting SIRT1 in the hypothalamic arcuate nucleus can improveย obesityย in high-fat-diet-induced rats withย insulinย resistance via an anorectic effect
  148. Acuteย insulinย infusion decreases plasma ghrelin levels in uncomplicatedย obesity
  149. Acute regulation ofย insulinย release by the pituitary gland in relation to hyperinsulinaemia andย obesity
  150. Acylcarnitine kinetics in a fasting-andย obesity-inducedย insulinย resistant mouse model
  151. Adapter proteins regulateย insulinย resistance and lipid metabolism inย obesity
  152. Adapting toย insulinย resistance inย obesity: role ofย insulinย secretion and clearance
  153. Adaptive immunity and antigen-specific activation inย obesity-associatedย insulinย resistance
  154. Adaptive immunity inย obesityย andย insulinย resistance
  155. ADAR1 deficiency protects against high-fat diet-inducedย obesityย andย insulinย resistance in mice
  156. Added impact ofย obesityย andย insulinย resistance in nocturnal blood pressure elevation in children and adolescents
  157. Additive effects ofย obesity, hypertension, and type 2 diabetes onย insulinย resistance.
  158. Adenosine Triphosphate-Sensitive Potassium (KATp) Channel Activity Is Coupled withย insulinย Resistance inย obesityย and
  159. Adenovirus-36 seropositivity enhances effects of nutritional intervention onย obesity, bright liver, andย insulinย resistance
  160. Adenylyl cyclase 3 haploinsufficiency confers susceptibility to diet-inducedย obesityย andย insulinย resistance in mice
  161. Adenylyl cyclase type 5 deficiency protects against diet-inducedย obesityย andย insulinย resistance
  162. Adipocyte apoptosis, a link betweenย obesity,ย insulinย resistance, and hepatic steatosis
  163. Adipocyte CD1d determines adipose inflammation andย insulinย resistance inย obesity
  164. Adipocyte CREB promotesย insulinย resistance inย obesity
  165. Adipocyte DIO2 expression increases in humanย obesityย but is not related to systemicย insulinย sensitivity
  166. Adipocyte dysfunction, inflammation, andย insulinย resistance inย obesity
  167. Adipocyte dysfunctions linkingย obesityย toย insulinย resistance and type 2 diabetes
  168. Adipocyte fatty acid-binding protein is associated with markers ofย obesity, but is an unlikely link betweenย obesity,ย insulinย resistance, and hyperandrogenism in โ€ฆ
  169. Adipocyteย insulinย resistance: effects of aging,ย obesity, exercise, and food restriction
  170. Adipocyte protein carbonylation and oxidative stress inย obesity-linked mitochondrial dysfunction andย insulinย resistance.
  171. Adipocyte SIRT1 knockout promotes PPARฮณ activity, adipogenesis andย insulinย sensitivity in chronic-HFD andย obesity
  172. Adipocyte-specific CD1d-deficiency mitigates diet-inducedย obesityย andย insulinย resistance in mice
  173. Adipocyte-specific deficiency of NADPH oxidase 4 delays the onset ofย insulinย resistance and attenuates adipose tissue inflammation inย obesity
  174. Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-inducedย obesity, but results inย insulinย resistance
  175. Adipocyteโ€specific enhancement of angiotensin II type 1 receptorโ€associated protein ameliorates dietโ€induced visceralย obesityย andย insulinย resistance
  176. Adipocytes secrete leukotrienes: contribution toย obesity-associated inflammation andย insulinย resistance in mice
  177. Adipocytokine profile andย insulinย resistance in childhoodย obesity
  178. Adipocytokines andย insulinย levels in young obese subjects at risk for type II diabetesโ€“the STYrian Juvenileย obesityย Study (STYJOBS)
  179. Adipocytokines,ย insulinย resistance andย obesityย coherence in women with previously diagnosed gestational diabetes
  180. Adipocytokines,ย obesity, andย insulinย resistance during combined androgen blockade for prostate cancer
  181. Adipocytokines: a bridge connectingย obesityย andย insulinย resistance
  182. Adipogenesis andย insulinย sensitivity inย obesityย are regulated by retinoidโ€related orphan receptor gamma
  183. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARฮณ ofย insulinย resistance induced by high-fat diet-associatedย obesity
  184. ADIPOKINE PROFILES OFinsulinย SENSITIVEย obesityANDย insulinย RESISTANCEย obesityย AMONG CHINESE CHILDREN: THE BCAMS STUDY
  185. Adipokines as Novel Links betweenย obesityย andย insulinย Resistance
  186. Adipokines, Ghrelin andย obesityโ€Associatedย insulinย Resistance in Nondiabetic Patients with Acute Coronary Syndrome
  187. Adipokines, inflammation, andย insulinย resistance inย obesity
  188. Adipokines, systemic inflammation and inflamed adipose tissue inย obesityย andย insulinย resistance
  189. Adipokines: the missing link betweenย insulinย resistance andย obesity
  190. Adiponectin and adiponectin receptors inย obesity-linkedย insulinย resistance
  191. Adiponectin andย insulinย resistance in childhoodย obesity
  192. Adiponectin andย insulinย resistance inย obesity-related diseases
  193. Adiponectin andย insulinย resistance responses to aerobic training in males with abdominalย obesity
  194. Adiponectin and its potential in the treatment ofย obesity, diabetes andย insulinย resistance.
  195. Adiponectin and its role in theย obesity-inducedย insulinย resistance and related complications
  196. Adiponectin and its role in the pathogenesis ofย obesity, diabetes mellitus andย insulinย resistance
  197. Adiponectin as novel biomarker of endothelial dysfunction inย insulinย resistance andย obesityโ€“a narrative review
  198. Adiponectin expression from human adipose tissue: relation toย obesity,ย insulinย resistance, and tumor necrosis factor-ฮฑ expression
  199. Adiponectin expression in visceral adiposity is an important determinant ofย insulinย resistance in morbidย obesity
  200. Adiponectin Gene Variation-4522C/T Is Associated with Type 2 Diabeticย obesityย andย insulinย Resistance in Chinese
  201. Adiponectin gene variationโˆ’ 4522C/T is associated with type 2 diabeticย obesityย andย insulinย resistance in Chinese
  202. Adiponectin, anthropometric measurements andย insulinย resistance in adolescence withย obesity.
  203. Adiponectin, the missing link inย insulinย resistance andย obesity
  204. Adiponectin: a biomarker ofย obesity-inducedย insulinย resistance in adipose tissue and beyond
  205. Adiponectin: A Mediator ofย obesity,ย insulinย Resistance, Diabetes, and the Metabolic Syndrome
  206. Adiponectin: a new link betweenย obesity,ย insulinย resistance and cardiovascular disease
  207. ADIPOSE AND INTESTINAL IMMUNOPATHOLOGY INย obesityย RELATEDย insulinย RESISTANCE.
  208. Adipose cell and lipid turnovers inย obesityย andย insulinย resistance
  209. Adipose dipeptidyl peptidase-4 andย obesity: correlation withย insulinย resistance and depot-specific release from adipose tissue in vivo and in vitro
  210. Adipose DPP4 andย obesity: correlation withย insulinย resistance and depot-specific release from adipose tissue in vivo and in vitro
  211. Adipose Estrogen and Increased Breast Cancer Risk inย obesity: Regulation by Leptin andย insulin
  212. Adipose Expression and Regulation of Selenoprotein P inย obesityย andย insulinย Resistance
  213. Adipose expression of tumor necrosis factor-alpha: direct role inย obesity-linkedย insulinย resistance
  214. Adipose extracellular matrix remodelling inย obesityย andย insulinย resistance
  215. Adipose HuR protects against diet-inducedย obesityย andย insulinย resistance
  216. Adipose HuR protects against diet-inducedย obesityย andย insulinย resistance in mice
  217. Adipose hypothermia inย obesityย and its association with period homolog 1,ย insulinย sensitivity, and inflammation in fat
  218. Adipose inflammation: cause or consequence ofย obesity-relatedย insulinย resistance
  219. Adipose natural killer cells regulate adipose tissue macrophages to promoteย insulinย resistance inย obesity
  220. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-inducedย insulinย resistance andย obesity
  221. Adipose tissue adiponectin production and adiponectin serum concentration in humanย obesityย andย insulinย resistance
  222. Adipose tissue andย insulinย secretion in the pathophysiology ofย obesityย and its complications
  223. Adipose tissue as a source of proinflammatory factors inย obesity: The importance in the development ofย insulinย resistance and diabetes
  224. Adipose tissue dendritic cells are independent contributors toย obesity-induced inflammation andย insulinย resistance
  225. Adipose tissue extracellular matrix and vascular abnormalities inย obesityย andย insulinย resistance
  226. Adipose tissue fatty acid chain length and mono-unsaturation increases withย obesityย andย insulinย resistance
  227. Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers inย obesity: implications for metabolic inflammation andย insulinย resistance
  228. Adipose tissue inย obesity-related inflammation andย insulinย resistance: cells, cytokines, and chemokines
  229. Adipose tissue inflammation and systemicย insulinย resistance in mice with diet-inducedย obesityย is possibly associated with disruption of PFKFB3 in hematopoietic cells
  230. Adipose tissue inflammation is directly linked toย obesity-inducedย insulinย resistance, while gut dysbiosis and mitochondrial dysfunction are not required
  231. Adipose tissue inflammation: a cause or consequence ofย obesity-relatedย insulinย resistance?
  232. Adipose tissueย insulinย resistance due to loss of PI3K p110ฮฑ leads to decreased energy expenditure andย obesity
  233. Adipose tissue lymphocytes and macrophages inย obesityย andย insulinย resistance: makers or markers, and which comes first?
  234. Adipose tissue macrophage phenotypes and characteristics: the key toย insulinย resistance inย obesityย and metabolic disorders
  235. Adipose tissue macrophage-derived exosomal miR-29a regulatesย obesity-associatedย insulinย resistance
  236. Adipose tissue macrophages in the development ofย obesity-induced inflammation,ย insulinย resistance and type 2 diabetes
  237. Adipose tissue macrophages, low grade inflammation andย insulinย resistance in humanย obesity
  238. Adipose tissue monomethyl branchedโ€chain fatty acids andย insulinย sensitivity: Effects ofย obesityย and weight loss
  239. Adipose tissue mRNA expression of HDAC1, HDAC3 and HDAC9 in obese women in relation toย obesityย indices andย insulinย resistance
  240. Adipose tissue NAD+ biology inย obesityย andย insulinย resistance: From mechanism to therapy
  241. Adipose tissue natriuretic peptide receptor expression is related toย insulinย sensitivity inย obesityย and diabetes
  242. Adipose Tissue Overexpression of a Constitutively Active Isoform of Chrebp Protects Againstย obesityย andย insulinย Resistance in Mice
  243. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-inducedย obesityย andย insulinย resistance
  244. Adipose Tissue Secretory Changes and Low-Grade Inflammation Combine Withย insulinย Resistance and Vascular Dysfunction in Humanย obesity
  245. Adipose tissue selectiveย insulinย receptor knockout protects againstย obesityย andย obesity-related glucose intolerance
  246. Adipose tissue transplantation protects ob/ob mice fromย obesity, normalizesย insulinย sensitivity and restores fertility
  247. Adipose tissue tumor necrosis factor and interleukin-6 expression in humanย obesityย andย insulinย resistance
  248. Adipose Tissue VEGFโ€D Overexpression Increases Lymphatic Vessel Density and Protects Against Inflammation andย insulinย Resistance inย obesity
  249. Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased inย obesityย and related toย insulinย sensitivity
  250. Adipose TNF and IL-6 expression in humanย obesity-associatedย insulinย resistance
  251. Adipose-resident group 1 innate lymphoid cells promoteย obesity-associatedย insulinย resistance
  252. Adipose-specific deficiency of fumarate hydratase in mice protects againstย obesity, hepatic steatosis, andย insulinย resistance
  253. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice againstย obesityย andย insulinย resistance
  254. Adipose-specific knockdown of Sirt1 results inย obesityย andย insulinย resistance by promoting exosomes release
  255. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-inducedย obesity,ย insulinย resistance, and hepatic steatosis
  256. Adiposeโ€specific deletion of Kif5b exacerbatesย obesityย andย insulinย resistance in a mouse model of dietโ€inducedย obesity
  257. Adiposity in childhood predictsย obesityย andย insulinย resistance in young adulthood
  258. Adolescent Metabolic/Bariatric Surgery: Effects onย obesity, Comorbidities, andย insulinย Resistance
  259. Adolescentย obesityย andย insulinย resistance: roles of ectopic fat accumulation and adipose inflammation
  260. Adrenocortical dysregulation as a major player inย insulinย resistance and onset ofย obesity
  261. Adrenomedullin 2 improves earlyย obesity-induced adiposeย insulinย resistance by inhibiting the class II MHC in adipocytes
  262. Adult-onsetย obesityย reveals prenatal programming of glucose-insulinย sensitivity in male sheep nutrient restricted during late gestation
  263. Adverse effects ofย obesityย on lipid and lipoprotein levels inย insulin-dependent and non-insulin-dependent diabetes
  264. Adverse effects ofย obesityย on lipid and lipoprotein levels in the patients with non-insulinย dependent diabetes in the young
  265. Adverse Effects ofย obesity, Hyperglycemia, andย insulinย Resistance on Cardiac Mechanics
  266. Aerobic Exercise Training Preventsย obesityย andย insulinย Resistance Independent of Changes in the Skeletal Muscle ACE2/Ang 1โ€7/Mas Axis.
  267. Aerobic exercise training preventsย obesityย andย insulinย resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose โ€ฆ
  268. Age-associated increase in abdominalย obesityย andย insulinย resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular โ€ฆ
  269. Aging enhances theย insulinย resistance inย obesityย through both receptor and postreceptor alterations
  270. AKAP1 Deficiency Attenuates Dietโ€Inducedย obesityย andย insulinย Resistance by Promoting Fatty Acid Oxidation and Thermogenesis in Brown Adipocytes
  271. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-ฮณ2 gene is associated withย obesityย andย insulinย resistance in Asian โ€ฆ
  272. Ala54Thr polymorphism of fatty acid binding protein 2, role onย insulinย resistance and cardiovascular risk factors in presurgical morbidย obesityย patients
  273. Alanine aminotransferase levels and fatty liver in childhoodย obesity: associations withย insulinย resistance, adiponectin, and visceral fat
  274. Alcohol intake,ย insulinย resistance, and abdominalย obesityย in elderly men
  275. All-trans-retinoic acid repressesย obesityย andย insulinย resistance by activating both peroxisome proliferation-activated receptor ฮฒ/ฮด and retinoic acid receptor
  276. Allelic Variant Gly1057 Asp of IRS-2 Gene Has Distinctive Effects onย insulinย Secretion and Sensitivity inย obesityย and Type 2 Diabetes
  277. Allicin amelioratesย obesityย comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy,ย insulinย resistance and NOX โ€ฆ
  278. Allograft Inflammatory Factor-1 Deficiency Preventsย obesityย andย insulinย Resistance by Promoting Brown and Beige Adipocyte Thermogenic Programs
  279. ALOX5AP expression, but not gene haplotypes, is associated withย obesityย andย insulinย resistance
  280. ALOX5AP overexpression in adipose tissue leads to LXA4 production and protection against diet-inducedย obesityย andย insulinย resistance
  281. Alstrรถm syndrome: an ultra-rare monogenic disorder as a model forย insulinย resistance, type 2 diabetes mellitus andย obesity
  282. Alstrรถm syndrome: renal findings in correlation withย obesity,ย insulinย resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH โ€ฆ
  283. Alteration of gut microbiota by vancomycin and bacitracin improvesย insulinย resistance via glucagonโ€like peptide 1 in dietโ€inducedย obesity
  284. Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis andย obesity-associatedย insulinย resistance in mice
  285. Alteration of lipid metabolism andย insulinย secretion in ventromedial hypothalamicย obesityย rats
  286. Alteration of local adipose tissue trace element homeostasis as a possible mechanism ofย obesity-relatedย insulinย resistance
  287. Alterations in hepatic mitochondrial compartment in a model ofย obesityย andย insulinย resistance
  288. Alterations in Novel Signals in the Gutโ€“Adipose Axisโ€“A Pilot Study inย insulin-Resistant Children withย obesityย and Biopsy-Proven Nonalcoholic Steatohepatitis
  289. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression inย insulin-resistant humanย obesityย and diabetes.
  290. Alterations in the hepaticย insulinย receptor kinase in genetic and acquiredย obesityย in rats
  291. Alterations in the liver of intrauterine growth retarded piglets may predispose to development ofย insulinย resistance andย obesityย in later life
  292. Alterations in vitamin A/retinoic acid homeostasis in diet-inducedย obesityย andย insulinย resistance
  293. Alterations of carbohydrate and lipoprotein metabolism in childhoodย obesityโ€“impact ofย insulinย resistance and acanthosis nigricans.
  294. Alterations of mitochondrial function andย insulinย sensitivity in humanย obesityย and diabetes mellitus
  295. Alterations of Serum Trueย insulinย in Patients with Simpleย obesityย and Analyses of Factors Affectingย insulinย Resistance [J]
  296. Alterations of the classic pathway of complement in adipose tissue ofย obesityย andย insulinย resistance
  297. Altered adrenocorticotropin and cortisol secretion in abdominalย obesity: implications for theย insulinย resistance syndrome
  298. Altered amino acid concentrations in NAFLD: impact ofย obesityย andย insulinย resistance
  299. Altered amino acid concentrations in NAFLD: Impact ofย obesityย andย insulinย resistance
  300. Altered circulating levels of retinol binding protein 4 and transthyretin in relation toย insulinย resistance,ย obesity, and glucose intolerance in Asian Indians
  301. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated Withย obesityย and TNFฮฑ-Inducedย insulinย Resistance
  302. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated Withย obesityย and TNFฮฑ-Inducedย insulinย Resistance
  303. Altered hypothalamic leptin,ย insulin, and melanocortin binding associated with moderate-fat diet and predisposition toย obesity
  304. Alteredย insulinย response to an acute bout of exercise in pediatricย obesity
  305. Alteredย insulin-Dependent Brain Glucose Metabolism Duringย obesityย Depends On Specific Brain Areas
  306. Altered interleukin-10 signaling in skeletal muscle regulatesย obesity-mediated inflammation andย insulinย resistance
  307. Altered lipid metabolism associated withย insulinย resistance andย obesityย is a major contributor to the onset and progression of type 2 diabetes
  308. Altered plasmaย insulinย and glucose afterย obesity-producing bipiperidyl brain lesions
  309. Altered temporal changes in Ser312-phosphofetuin-A concentrations in response to a glucose challenge in a mouse model of diet-inducedย obesityย andย insulinย โ€ฆ
  310. Altering adipocyte metabolism as a way to counteractย obesityย andย insulinย Resistance
  311. Alternative M2 activation of Kupffer cells by PPARฮด amelioratesย obesity-inducedย insulinย resistance
  312. Alzheimerโ€™s disease risk,ย obesityย and tau: isย insulinย resistance guilty?
  313. Ambient air pollution exaggerates adipose inflammation andย insulinย resistance in a mouse model of diet-inducedย obesity
  314. Amelioration ofย insulinย requirement in patients undergoing duodenal bypass for reasons other thanย obesityย implicates foregut factors in the pathophysiology of type II โ€ฆ
  315. Amelioration ofย obesity-associated inflammation andย insulinย resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation
  316. Ameliorative effect of low-dose spironolactone onย obesityย andย insulinย resistance is through replenishment of estrogen in ovariectomized rats
  317. Aminotransferase activity in morbid and uncomplicatedย obesity: predictive role of fastingย insulin
  318. Aminotransferase and gamma-glutamyl transpeptidase levels inย obesityย are associated withย insulinย resistance and the metabolic syndrome
  319. Amniotic fluidย insulinย concentration as a predictor ofย obesity.
  320. AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguishย insulinย sensitive fromย insulinย resistantย obesity?
  321. AMP-activated protein kinase ฮฑ1 protects against diet-inducedย insulinย resistance andย obesity
  322. AMP-activated protein kinase ฮฑ1 protects against diet-inducedย insulinย resistance andย obesity. Diabetes 2012; 61: 3114โ€“3125
  323. AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and amelioratesย insulinย resistance inย obesity
  324. AMPK ฮฒ1 deletion reduces appetite, preventingย obesityย and hepaticย insulinย resistance
  325. An 8-week high-fat diet inducesย obesityย andย insulinย resistance with small changes in the muscle transcriptome of C57BL/6J mice
  326. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistentย obesity
  327. An Analysis of the Relationships Amongย obesity, Plasmaย insulin, and Hepatic Lipogenic Enzymes in
  328. An animal model of gestationalย obesityย and prediabetes: HISS-dependentย insulinย resistance induced by a high sucrose diet in Sprague Dawley rats.
  329. An anti-inflammatory sterol decreasesย obesity-related inflammation-inducedย insulinย resistance and metabolic dysregulation
  330. An evaluation of acylated ghrelin and obestatin levels in childhoodย obesityย and their association withย insulinย resistance, metabolic syndrome, and oxidative stress
  331. An Exploration of relationships between three main characteristics of Equine Metabolic Syndrome,ย obesity,ย insulinย resistance, and laminitis
  332. An extract of Urtica dioica L. mitigatesย obesityย inducedย insulinย resistance in mice skeletal muscle via protein phosphatase 2A (PP2A)
  333. An In Vivo Screen for Genes Involved in Central Nervous System Control ofย obesityย Identifies Diacylglycerol Kinase as a Regulator ofย insulinย Secretion
  334. An in vivo screen for neuronal genes involved inย obesityย identifies Diacylglycerol kinase as a regulator ofย insulinย secretion
  335. An individual participant data meta-analysis on metabolomics profiles forย obesityย andย insulinย resistance in European children
  336. An insertional polymorphism of the proopiomelanocortin gene is associated with fastingย insulinย levels in childhoodย obesity
  337. An investigation into the effects of aspalathin on myocardial glucose transport using cardiomyocytes from control andย obesity-inducedย insulinย resistant rats, and โ€ฆ
  338. An investigation of the association betweenย obesity, acanthosis nigricans, and fasting serumย insulinย level in 6-9 year old children living on the El Paso-Juarez United โ€ฆ
  339. Anย obesityย genetic risk score predicts risk ofย insulinย resistance among Chinese children
  340. Anย obesityย risk SNP (rs17782313) near the MC4R gene is associated with cerebrocorticalย insulinย resistance in humans
  341. An update on immune dysregulation inย obesityโ€relatedย insulinย resistance
  342. An Update to the WISP-1/CCN4 Role inย obesity,ย insulinย Resistance and Diabetes
  343. Analysis of data onย insulinย resistance from the European group for the study ofย insulinย resistance: focus onย obesityย and hypertension
  344. Analysis of FTO gene variants withย obesityย and glucose homeostasis measures in the multiethnicย insulinย Resistance Atherosclerosis Study cohort
  345. Analysis of metabolic profiles underlying surrogates forย obesityย andย insulinย resistance in young adults from the Western Australian Pregnancy Cohort (Raine) Study
  346. Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes andย obesity
  347. ANALYSIS OF THE IMPACT OFย obesityย ONย insulin-SENSITIVITY AND METABOLIC ABNOMALITY IN TYPE 2 DIABETES MELLITUS [J]
  348. Analysis of three glucose transporter genes in a Caucasian population: no associations with nonโ€insulinโ€dependent diabetes andย obesity
  349. Androgen receptor roles inย insulinย resistance andย obesityย in males: the linkage of androgen-deprivation therapy to metabolic syndrome
  350. Androgenicity andย obesityย are independently associated withย insulinย sensitivity in postmenopausal women
  351. ANDROLOGY:ย obesity,ย insulinย RESISTANCE AND THEIR CORRELATION WITH TESTOSTERONE LEVELS IN MALE PATIENTS
  352. Angiogenesis and vascular functions in modulation ofย obesity, adipose metabolism, andย insulinย sensitivity
  353. Angiogenesis modulatesย obesityย andย insulinย sensitivity
  354. Angiogenic Potential, Circulating Angiogenic Factors andย insulinย Resistance in Subjects withย obesity
  355. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation andย obesity-related systemicย insulinย resistance
  356. Angiopoietin-related growth factor antagonizesย obesityย andย insulinย resistance
  357. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-inducedย obesity,ย insulinย resistance and fatty liver in mice
  358. Angiotensin-converting enzyme inhibition reverses diet-inducedย obesity,ย insulinย resistance and inflammation in C57BL/6J mice
  359. Angiotensinogen gene polymorphism (Met235Thr) influences visceralย obesityย andย insulinย resistance in obese Japanese women
  360. Anhydroicaritin improves diet-inducedย obesityย and hyperlipidemia and alleviatesย insulinย resistance by suppressing SREBPs activation
  361. Anorexigenic lipopeptides ameliorate centralย insulinย signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-inducedย obesity
  362. Anthocyaninโ€rich Black Elderberry Extract improves Inflammatory Markers andย insulinย Resistance in a Highโ€Fat Dietโ€Inducedย obesityย Model of Mice
  363. Anthropometric measures ofย obesityย andย insulinย resistance in Turkish patients with type 2 diabetes
  364. Anti-diabetic and anti-obesityย effects of the allosteric PTP1B inhibitor KY-226 viaย insulinย and leptin signal enhancement
  365. Anti-inflammatory effects of yerba matรฉ extract (Ilex paraguariensis) ameliorateย insulinย resistance in mice with high fat diet-inducedย obesity
  366. Anti-obesityย and anti-insulinย resistance effects of tomato vinegar beverage in diet-induced obese mice
  367. Anti-obesityย andย insulin-sensitising effects of a glycosaminoglycan mix
  368. Anti-obesityย effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulinย dependent diabetic KK mice
  369. Anti-obesityย effects of DHA and EPA in high fat-inducedย insulinย resistant mice
  370. Antiโ€obesityย action of gingerol: effect on lipid profile,ย insulin, leptin, amylase and lipase in male obese rats induced by a highโ€fat diet
  371. Antiโ€obesityย and antiโ€diabetic effects of carteolol in nonโ€insulinโ€dependent diabetic mice
  372. Antihypertensive drugs andย insulinย resistance inย obesity
  373. Antioxidant supplementation andย obesityย have independent effects on hepatic oxylipin profiles inย insulin-resistant,ย obesity-prone rats
  374. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducibleย insulinย resistance andย obesity
  375. Antipsychotic drug-inducedย obesityย in rats: correlation between leptin,ย insulinย and body weight during sulpiride treatment
  376. Anxa2 gene silencing attenuatesย obesity-inducedย insulinย resistance by suppressing the NF-ฮบB signaling pathway
  377. Apelin, a newly identified adipokine up-regulated byย insulinย andย obesity
  378. Apolipoprotein C3 deficiency results in diet-inducedย obesityย and aggravatedย insulinย resistance in mice
  379. Apolipoprotein C3-deficiency results in diet-inducedย obesityย andย insulinย resistance in mice
  380. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals withย obesityย andย insulinย resistance syndromes: the โ€ฆ
  381. Appearance of acanthosis nigricans may precedeย obesity: an involvement of theย insulin/IGF receptor signaling pathway
  382. Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence ofย obesity,ย insulinย Resistance, and Sex
  383. Appetite, hunger andย obesityย as a function of dietary sugar intake: Can these effects be mediated byย insulin-induced hypoglycemia? A reply to commentaries
  384. APPL1 counteractsย obesity-induced vascularย insulinย resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 โ€ฆ
  385. Application of nuclear techniques in the prevention of degenerative diseases (obesityย and non-insulinย dependent diseases) in ageing
  386. Appropriate use of stimulation tests andย insulin-like growth factor-I inย obesity.
  387. Areย insulinย Hypersecretion and Food Additives a Cause ofย obesityย and Diabetes?
  388. Areย obesity-relatedย insulinย resistance and type 2 diabetes autoimmune diseases?
  389. Areย obesity-related metabolic risk factors modulated by the degree ofย insulinย resistance in adolescents?
  390. Are racial differences inย obesityย andย insulinย resistance related to aggressive breast cancer?
  391. Are racial differences inย obesityย andย insulinย resistance related to aggressive breast cancer?
  392. Are racial differences inย obesityย andย insulinย resistance related to aggressive breast cancer?
  393. Arsenic methylation capacity andย obesityย are associated withย insulinย resistance in obese children and adolescents
  394. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-inducedย obesityย mice by enhancing hepaticย insulinย and AMPK signaling independently of โ€ฆ
  395. Arterialย insulinย resistance in Yucatan micropigs with diet-inducedย obesityย and metabolic syndrome
  396. Arterial stiffening,ย insulinย resistance and acanthosis nigricans in a community sample of adolescents withย obesity
  397. Aryl hydrocarbon receptor agonist indigo protects againstย obesity-relatedย insulinย resistance through modulation of intestinal and metabolic tissue immunity
  398. Assess the relationship betweenย insulinย fasting levels and healthyย obesityย in adults in the province of Babylon, Iraq
  399. Assessing associations of cardiorespiratory fitness (CRF) and degree ofย obesityย withย insulin-resistance.
  400. ASSESSINGย obesityย ANDย insulinย MOLECULAR PATHWAYS INVOLVED IN WEIGHT LOSS INDUCED BY ROUX-EN-Y GASTRIC BYPASS
  401. Assessing risk factors forย obesityย between childhood and adolescence: I. Birth weight, childhood adiposity, parentalย obesity,ย insulin, and leptin
  402. Assessing risk factors forย obesityย between childhood and adolescence. I. Birth weight, childhood adiposity, parentalย obesity,ย insulin, and leptin.
  403. Assessing the Mediating Effect ofย obesity-Linked SNPs in Nuclear Mitochondrial Genes on Exercise-Enhancedย insulinย Sensitivity
  404. Assessment of different bariatric surgeries in the treatment ofย obesityย andย insulinย resistance in mice
  405. Assessment of different bariatric surgeries in the treatment ofย obesityย andย insulinย resistance in mice
  406. Assessment of different bariatric surgeries in the treatment ofย obesityย andย insulinย resistance in mice.
  407. Assessment ofย obesity, dyslipidemia, andย insulinย resistance in idiopathic hirsutism: a caseโ€“control study
  408. Assessment of the relationship of hepatic enzymes withย obesityย andย insulinย resistance in adults in Saudi Arabia
  409. Assisted reproductive technologies predispose toย insulinย resistance andย obesityย in male mice challenged with a high-fat diet
  410. Association between 14 bp insertion/deletion HLAโ€G functional polymorphism andย insulinย resistance in a cohort of Italian children withย obesity
  411. Association Between Anthropometric Measures ofย obesityย andย insulinย Resistance in a Self-Selected Group of Indigenous Australians
  412. Association between caries,ย obesityย andย insulinย resistance in Mexican adolescents
  413. Association between Caries,ย obesityย andย insulinย Resistance in Mexican Adolescents.
  414. Association between complement component C3 and body composition: a possibleย obesityย inflammatory biomarker forย insulinย resistance
  415. Association between cortisol,ย insulinย resistance and zinc inย obesity: A mini-review
  416. Association between dietaryย insulinย index and load withย obesityย in adults
  417. Association between duration ofย obesityย and risk of non-insulin-dependent diabetes mellitus: the Sotetsu Study
  418. Association Between Expanded Normal Weightย obesityย andย insulinย Resistance Among US Adults in the National Health and Nutrition Examination Survey
  419. Association between four adipokines andย insulinย sensitivity in patients withย obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population
  420. Association between G-protein beta3 subunit (GNB (3)) gene C825T polymorphism, hypertension,ย insulinย resistance andย obesity
  421. Association between muscle mass andย insulinย sensitivity independent of detrimental adipose depots in young adults with overweight/obesity
  422. Association betweenย obesityย andย insulinย resistance with UCP2โ€“UCP3 gene variants in Spanish children and adolescents
  423. Association betweenย obesityย history and hand grip strength in older adultsโ€”exploring the roles of inflammation andย insulinย resistance as mediating factors
  424. Association betweenย obesityย indices andย insulinย resistance among healthy Korean adolescents: the JS high school study
  425. Association betweenย obesityย phenotypes ofย insulinย resistance and risk of type 2 diabetes in African Americans: The Jackson Heart Study
  426. Association between polymorphisms ofย insulinย andย insulinย receptor gene with childhoodย obesityย in Malay population
  427. Association between Serum Lipid Profile andย insulinย Resistance in Type 2 Diabetic Patients withย obesityย [J]
  428. Association between Transcription Factor AP-2B genotype,ย obesity,ย insulinย resistance and dietary intake in a longitudinal birth cohort study
  429. Association of abdominalย obesity,ย insulinย resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome
  430. #VALUE!
  431. Association of adipocytokines withย obesityย andย insulinย resistance in Korean-Chinese and Han nationality pupils of Yanbian area
  432. Association of adipocytokines withย obesityย andย insulinย resistance in Korean-Chinese and Han nationality pupils of Yanbian area
  433. Association of adipokines andย insulin, which have a role inย obesity, with colorectal cancer
  434. Association of Adipokines andย insulin, Which Have a Role inย obesity, with Colorectal Cancer
  435. Association of ADRB1 and UCP3 gene polymorphisms withย insulinย sensitivity but notย obesity
  436. Association of angiopoietin-2, C-reactive protein and markers ofย obesityย andย insulinย resistance with survival outcome in colorectal cancer
  437. Association of centralย obesityย andย insulinย resistance with high prevalence of diabetes and cardiovascular disease in an elderly population with low fat intake and lower โ€ฆ
  438. Association of extracellular heat shock protein 70 andย insulinย resistance in type 2 diabetes; independent ofย obesityย and C-reactive protein
  439. Association of fasting blood sugar level,ย insulinย level, andย obesityย with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study
  440. Association of free fatty acids with theย insulin-resistant state but not with centralย obesityย in individuals from Venezuela.
  441. Association of gene polymorphism of the fat-mass andย obesity-associated gene withย insulinย resistance in Japanese
  442. Association of gene polymorphism of the fat-mass andย obesity-associated gene withย insulinย resistance in Japanese
  443. Association of gut microbiome with fasting triglycerides, fastingย insulinย andย obesityย status in Mexican children
  444. Association of hepatitis C withย insulinย resistance and type 2 diabetes in US general population: the impact of the epidemic ofย obesity
  445. Association ofย insulinย Actions with Blood Pressure in Rodent Models ofย obesityย and Diabetes
  446. Association ofย insulinย actions with blood pressure in rodent models ofย obesityย and diabetes.
  447. Association ofย insulinย resistance and GLP-2 secretion inย obesity: a pilot study
  448. Association ofย insulinย resistance andย obesityย with impaired immune response to ะฝepatitis B vaccination in health care workers
  449. ASSOCIATION OFย insulinย RESISTANCE ANDย obesityย WITH IMPAIRED IMMUNE RESPONSE TO ะะ•ะ ะTITIS B VACCINATION IN HEALTH CARE WORKERS
  450. Association ofย insulinย resistance withย obesityย in children
  451. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures ofย obesity,ย insulinย sensitivity and glucose โ€ฆ
  452. Association of leisure time physical activity and abdominalย obesityย with fasting serumย insulinย and 2โ€h postchallenge plasma glucose levels
  453. Association of leptin andย insulinย with childhoodย obesityย and retinal vessel diameters
  454. Association of Leptin Gene G2548A Polymorphism and Leptin Resistance withย insulinย Resistance andย obesityย among Egyptians
  455. Association of Leptin Withย obesityย andย insulinย Resistance
  456. Association of Markers ofย obesityย withย insulinย Resistance and Type 2 Diabetes Mellitus in a Rural Female Population
  457. Association of miR-34a and mir-149 withย obesityย andย insulinย Resistance in Obese Children and Adolescents
  458. Association of MMPโ€8 withย obesity, smoking andย insulinย resistance
  459. Association of monocyte CCR2 expression withย obesityย andย insulinย resistance in postmenopausal women
  460. Association of nerve conduction impairment andย insulinย resistance in children withย obesity
  461. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of centralย obesityย andย insulinย resistance
  462. Association of nonalcoholic fatty liver disease withย obesityย andย insulinย resistance
  463. Association ofย obesityย and hyperandrogenemia withย insulinย resistance in women with polycystic ovary syndrome
  464. Association ofย obesityย andย insulinย resistance with asthma and aeroallergen sensitization
  465. Association ofย obesityย andย insulinย resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
  466. Association ofย obesityย andย insulinย resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
  467. Association ofย obesityย andย insulinย resistance with serum testosterone, sex hormone binding globulin and estradiol in older males
  468. #VALUE!
  469. Association ofย obesityย and overweight with the prevalence ofย insulinย resistance, pre-diabetes and clinicalโ€“biochemical characteristics among infertile Mexican women โ€ฆ
  470. Association ofย obesityย indexes of waist circumference, body mass index and WHR withย insulinย resistance in non-diabetic subjects
  471. Association ofย obesityย risk SNPs in PCSK1 withย insulinย sensitivity and proinsulinย conversion
  472. Association ofย obesity-mediatedย insulinย resistance and hypothalamic volumes: Possible sex differences
  473. Association ofย obesity, diabetes, serum lipids and blood pressure regulatesย insulinย action
  474. Association of osteocalcin withย obesity,ย insulinย resistance, and cardiovascular risk factors in young adults
  475. Association of osteoprotegerin withย obesity,ย insulinย resistance and non-alcoholic fatty liver disease in children
  476. Association of osteosarcopenicย obesityย and its components: osteoporosis, sarcopenia andย obesityย withย insulinย resistance
  477. #VALUE!
  478. Association of Peptic Ulcer Disease withย obesity, Serumย insulinย Level and Lipid Profile
  479. Association of perilipin andย insulinย receptor substrate-1 genes polymorphism with lipid profiles, centralย obesity, and type 2 diabetes in a sample of an Iranian โ€ฆ
  480. Association of plasminogen activator inhibitor-1 withย insulinย resistance in Japan whereย obesityย is rare
  481. Association of Polymorphism in the Glucocorticoid Recepter Gene and Plasm Glucose,ย insulin, Lipids in Abdominalย obesity
  482. Association of Resistin Gene 3โ€ฒ-Untranslated Region EX4-44Gโ€“> A Polymorphism withย obesity-andย insulin-Related Phenotypes in Turkish Type 2 Diabetes โ€ฆ
  483. Association of resistin gene 3โ€ฒ-untranslated region EX4-44Gโ€“> A polymorphism withย obesity-andย insulin-related phenotypes in Turkish type 2 diabetes patients.
  484. Association of serum ferritin and abdominalย obesityย andย insulinย resistance
  485. Association of serum ferritin withย insulinย resistance, abdominalย obesity, and metabolic syndrome in Korean adolescent and adults: The Korean National โ€ฆ
  486. #VALUE!
  487. Association of serum leptin and adiponectin with anthropomorphic indices ofย obesity, blood lipids andย insulinย resistance in a Sub-Saharan African population
  488. Association of serum leptin levels with homeostasis model assessmentโ€“estimatedย insulinย resistance and metabolic syndrome: the key role of centralย obesity
  489. Association of single nucleotide polymorphism at position 45 in adiponectin gene with plasma adiponectin level andย insulinย resistance inย obesity
  490. Association of sleep apnea severity andย obesityย withย insulinย resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea
  491. Association of sleep disturbances withย obesity,ย insulinย resistance and the metabolic syndrome
  492. Association of SNP45 in adiponectin gene withย obesityย andย insulinย resistance
  493. Association of TCF7L2 and GCG gene variants withย insulinย secretion,ย insulinย resistance, andย obesityย in new-onset diabetes
  494. Association of the C825T polymorphism of the G-protein ฮฒ3 subunit gene with hypertension,ย obesity, hyperlipidemia,ย insulinย resistance, diabetes, diabetic โ€ฆ
  495. Association of the polycystic ovary syndrome with genomic variants related toย insulinย resistance, type 2 diabetes mellitus, andย obesity
  496. Association of the TG polymorphism in adiponectin (exon 2) withย obesityย andย insulinย sensitivity: interaction with family history of type 2 diabetes
  497. Association of the TNFโ€ฮฑโˆ’308 G/A Promoter Polymorphism withย insulinย Resistance inย obesity
  498. Association of theโˆ’ 243A> G,+ 61450C> A Polymorphisms of the Glutamate Decarboxylase 2 (GAD2) Gene withย obesityย andย insulinย Level in North Indian โ€ฆ
  499. #VALUE!
  500. Association of Trp64Arg polymorphism of beta3-adrenergic receptor withย insulinย resistance in Polish children withย obesity.
  501. Association of vitamin B12 withย obesity, overweight,ย insulinย resistance and metabolic syndrome, and body fat composition; primary care-based study
  502. Association of ฮฒ2-adrenergic receptor andย insulinย receptor substrate-1 polymorphisms withย obesityย in a Northern Indian population
  503. Associations between Body Fat Measurement by Dual-Energy X-Ray Absorptiometry and Abdominalย obesityย andย insulinย Resistance in Korean Populations: Cross โ€ฆ
  504. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links toย obesityย andย insulinย resistance
  505. Associations betweenย insulinย sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicatedย obesity
  506. Associations between long self-reported sleep,ย obesityย andย insulinย resistance in a cohort of premenopausal Black and White South African women
  507. Associations between sleep duration andย insulinย resistance in European children and adolescents considering the mediating role of abdominalย obesity
  508. Associations of 25-hydroxyvitamin D with markers of inflammation,ย insulinย resistance andย obesityย in black and white community-dwelling adults
  509. Associations of C-reactive protein with measures ofย obesity,ย insulinย resistance, and subclinical atherosclerosis in healthy, middle-aged women
  510. Associations of cardiac structure withย obesity, blood pressure, inflammation, andย insulinย resistance in African-American adolescents
  511. Associations of chronic inflammation,ย insulinย resistance, and severeย obesityย with mortality, myocardial infarction, cancer, and chronic pulmonary disease
  512. Associations of fibroblast growth factor-23 with markers of inflammation,ย insulinย resistance andย obesityย in adults
  513. Associations ofย obesityย and circulatingย insulinย and glucose with breast cancer risk: a Mendelian randomization analysis
  514. Associations ofย obesityย markers,ย insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals
  515. Associations ofย obesity-metabolic Status Withย insulinย Resistance and Chronic Inflammation Level: Results From the CNTR Study
  516. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, andย insulinย resistance in children with overweight/obesity
  517. Associations of sarcopenicย obesityย with the metabolic syndrome andย insulinย resistance over five years in older men: The Concord Health and Ageing in Men Project
  518. Associations of Serum Fatty Acid Proportions withย obesity,ย insulinย Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study
  519. Associations of the PTENโˆ’ 9C> G polymorphism withย insulinย sensitivity and centralย obesityย in Chinese
  520. Associations of vitamin D withย insulinย resistance,ย obesity, type 2 diabetes, and metabolic syndrome
  521. Astaxanthin restricts weight gain, promotesย insulinย sensitivity and curtails fatty liver disease in mice fed aย obesity-promoting diet
  522. AT1 receptor blockade attenuatesย insulinย resistance and myocardial remodeling in rats with diet-inducedย obesity
  523. ATF7 ablation prevents diet-inducedย obesityย andย insulinย resistance
  524. Atorvastatin improvesย insulinย sensitivity in mice withย obesityย induced by monosodium glutamate
  525. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation withย insulinย Resistance inย obesityย [Corrigendum]
  526. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation withย insulinย Resistance inย obesityย [Corrigendum]
  527. ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation withย insulinย resistance inย obesity
  528. Attenuatedย insulinย induced dilation in coronary arteries fromย obesityย resistant andย obesityย prone high fat fed rats (1071.6)
  529. Attenuated secretion of glucose-dependentย insulinotropic polypeptide (GIP) does not alleviate hyperphagicย obesityย andย insulinย resistance in ob/ob mice
  530. Attenuated secretion of glucose-dependentย insulinotropic polypeptide (GIP) does not alleviate hyperphagicย obesityย andย insulinย resistance in ob/ob mice
  531. Attenuation of Diet-Inducedย obesity, Hypertension andย insulinย Resistance in Vascular Endothelial Endothelin-1 Knockout Mice
  532. Attenuation ofย obesityย andย insulinย resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet
  533. Attenuation ofย obesity-inducedย insulinย resistance in mice with heterozygous deletion of ROCK2
  534. Attenuation ofย obesity,ย insulinย resistance, and inflammation in TLR4 deficient 10ScN mice in response to a diet high in saturated fat
  535. Atypical PKC: a target for treatingย insulin-resistant disorders ofย obesity, the metabolic syndrome and type 2 diabetes mellitus
  536. Augmentation of alimentaryย insulinย secretion despite similar gastric inhibitory peptide (GIP) responses in juvenileย obesity
  537. Augmentedย insulinย and leptin resistance of high fat diet-fed APPswe/PS1dE9 transgenic mice exacerbateย obesityย and glycemic dysregulation
  538. Aurantioโ€obtusin improvesย obesityย andย insulinย resistance induced by highโ€fat diet in obese mice
  539. Authorsโ€™ response: Associations ofย obesityย and circulatingย insulinย and glucose with breast cancer risk
  540. Autoimmune activation of the GnRH receptor inducesย insulinย resistance independent ofย obesityย in a female rat model
  541. Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduceย insulinย resistance and fatty liver in dietโ€inducedย obesityย rats
  542. Autonomic Blockade Improvesย obesity-Associatedย insulinย Resistance
  543. Autonomic neuropathy in nonโ€insulinย dependent (type II) diabetes mellitus. Possible influence ofย obesity
  544. Autophagy deficiency leads to protection fromย obesityย andย insulinย resistance by inducing Fgf21 as a mitokine
  545. Autophagy: a potential link betweenย obesityย andย insulinย resistance
  546. AUTOTAXIN IS NUTRITIONALLY REGULATED AND ALTERS MITOCHONDRIAL FUNCTION INย obesity-INDUCEDย insulinย RESISTANCE
  547. Autotaxin-LPA signaling contributes toย obesity-inducedย insulinย resistance in muscle and impairs mitochondrial metabolism
  548. Avocatin B Protects Against Lipotoxicity and Improvesย insulinย Sensitivity in Dietโ€Inducedย obesity
  549. B Cell Activation inย insulinย Resistance andย obesity
  550. B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related toย obesityย but not toย insulinย resistance
  551. B lymphocyte stimulator (BLyS) is expressed in human adipocytes in vivo and is related toย obesityย but not toย insulinย resistance
  552. B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related toย obesityย but not toย insulinย resistance
  553. B Lymphocytes inย obesity-related adipose tissue inflammation andย insulinย resistance
  554. b3-adrenergic-receptor polymorphism: a genetic marker for visceral fatย obesityย and theย insulinย resistance syndrome
  555. B64 EFFECTS OFย obesityย ON LUNG FUNCTION:ย insulinย Excess Leads To Lung Remodeling And Features Of Asthma
  556. Baccharis dracunculifolia methanol extract enhances glucose-stimulatedย insulinย secretion in pancreatic islets of monosodium glutamate induced-obesityย model rats
  557. Bacterial endotoxin activity in human serum is associated with dyslipidemia,ย insulinย resistance,ย obesity, and chronic inflammation
  558. Baicalin againstย obesityย andย insulinย resistance through activation of AKT/AS160/GLUT4 pathway
  559. Basalย insulinย andย obesity
  560. Basis of Impaired Coronary Metabolic Dilation inย obesityย andย insulinย Resistance
  561. Bax inhibitor-1 deficiency leads toย obesityย by increasing Ca2+-dependentย insulinย secretion
  562. Behavior of C-peptide and immunoreactiveย insulinย in essentialย obesity
  563. Beneficial effect of oral administration of Lactobacillus casei strain Shirota onย insulinย resistance in dietโ€inducedย obesityย mice
  564. Beneficial effects of ethanol consumption onย insulinย resistance are only applicable to subjects withoutย obesityย orย insulinย resistance; drinking is not necessarily a โ€ฆ
  565. Beneficial effects of exercise on offspringย obesityย andย insulinย resistance are reduced by maternal high-fat diet
  566. Beneficial effects of exercise on offspringย obesityย andย insulinย resistance are reduced by maternal high-fat diet
  567. Beneficial effects of IKKฮต-deficiency on body weight andย insulinย sensitivity are lost in high fat diet-inducedย obesityย in mice
  568. Beneficial effects of murtilla extract and madecassic acid onย insulinย sensitivity and endothelial function in a model of diet-inducedย obesity
  569. Beneficial Effects of vitamin D onย insulinย sensitivity, blood pressure, abdominal subcutaneous fat thickness, and weight loss in refractoryย obesity
  570. Beneficial Effects of Vitamin D onย insulinย Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractoryย obesity
  571. Beneficial metabolic effects of selected probiotics on dietโ€inducedย obesityย andย insulinย resistance in mice are associated with improvement of dysbiotic gut microbiota
  572. Beta-endorphin,ย insulin, ACTH and cortisol plasma levels during oral glucose tolerance test inย obesityย after weight loss
  573. Biallelic mutations in GPD1 gene in a Chinese boy mainly presented withย obesity,ย insulinย resistance, fatty liver, and short stature
  574. Bif-1 deficiency impairs lipid homeostasis and causesย obesityย accompanied byย insulinย resistance
  575. Bile acid alterations in nonalcoholic fatty liver disease,ย obesity,ย insulinย resistance and type 2 diabetes: what do the human studies tell?
  576. Bilirubin reduces visceralย obesityย andย insulinย resistance by suppression of inflammatory cytokines
  577. Binding and molecular weight properties of theย insulinย receptor from omental and subcutaneous adipocytes in humanย obesity
  578. Bioactiveย insulin-like growth factor-I inย obesity
  579. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships withย obesityย andย insulinย resistance
  580. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: relationships withย obesityย andย insulinย resistance
  581. Bioavailableย insulin-like growth factor-I as mediator of racial disparity inย obesity-relevant breast and colorectal cancer risk among postmenopausal women
  582. Biochemical characteristics and risk factors forย insulinย resistance at different levels ofย obesity
  583. Biochemical Effects of Anti-Diabetic Therapies onย obesityย andย insulinย Resistance Induced by Monosodium Glutamate in Male Rats
  584. Biochemical studies of cutaneous damage in mouse models ofย insulinย resistance andย obesity
  585. #VALUE!
  586. Biocompounds attenuating the development ofย obesityย andย insulinย resistance produced by a high-fat sucrose diet
  587. Biomarkers of Alzheimer disease,ย insulinย resistance, andย obesityย in childhood
  588. Bisphenol A and diabetes,ย insulinย resistance, cardiovascular disease andย obesity: controversy in a (plastic) cup?
  589. Bisphenol-A plasma levels are related to inflammatory markers, visceralย obesityย andย insulin-resistance: a cross-sectional study on adult male population
  590. BITC and S-carvone restrain high-fat diet-inducedย obesityย and ameliorate hepatic steatosis andย insulinย resistance
  591. Black yeast beta glucan forย insulinย Resistance Prevention through IL-33, ST2 and Leptin Level: An In vivo Study of anย obesityย model using Sprague dawley Rats
  592. Blockade of class IB phosphoinositide-3 kinase amelioratesย obesity-induced inflammation andย insulinย resistance
  593. Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of counteringย insulinย resistance in the treatment ofย obesity-diabetes
  594. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-ฮฑ signaling protected Wistar rats from diet-inducedย obesityย andย insulinย resistance
  595. Blocking CD40-TRAF6 Signaling is a Novel Therapeutic Target inย obesity-Associatedย insulinย Resistance
  596. Blocking CD40-TRAF6 signaling is a therapeutic target inย obesity-associatedย insulinย resistance
  597. Blocking CD40-TRAF6 signaling is a therapeutic target inย obesity-associatedย insulinย resistance (Proceedings of the National Academy of Sciences of the United States โ€ฆ
  598. Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuatesย insulinย resistance and inflammation inย obesity
  599. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improvesย insulinย sensitivity in diet-inducedย obesity
  600. Blocking high-fat diet-inducedย obesity,ย insulinย resistance and fatty liver by overexpression of Il-13 gene in mice
  601. Blood coagulation and aortic wall integrity in rats withย obesity-inducedย insulinย resistance
  602. Blood glucose level andย insulinย resistance in patients with type 2 diabetic mellitus, diabetic retinopathy andย obesity
  603. Bloodย insulinย levels during oral glucose tolerance tests in the obese child. Influence of age, sex, degree and duration ofย obesity
  604. Blood pressure in 15 inbred mouse strains and its lack of relation withย obesityย andย insulinย resistance in the progeny of an NZO/HILtJร— C3H/HeJ intercross
  605. Blood pressure in relation toย obesity,ย insulinย and the hypothalamic-pituitary-adrenal axis in Swedish men
  606. Blood sugar and immunoreactiveย insulinย in women with hypothalamic, maternal and simpleย obesity. Part I.
  607. Blood viscosity in humanย obesity: relation to glucose tolerance andย insulinย status.
  608. Blueberries Improve Wholeโ€Bodyย insulinย Action and Alter the Development ofย obesityย in Highโ€Fat Fed Mice
  609. Body Composition and its Association withย insulinย Resistance in Korea Older Population: A Focus on Sarcopenicย obesity
  610. Body fat distribution andย insulinย resistance: beyondย obesityย in nonalcoholic fatty liver disease among overweight men
  611. Body mass index-independent inflammation in omental adipose tissue associated withย insulinย resistance in morbidย obesity
  612. Bothย insulinย signaling defects in the liver andย obesityย contribute toย insulinย resistance and cause diabetes in irs2โ€“/โ€“mice
  613. Botryosphaeran reducesย obesity, hepatic steatosis, dyslipidaemia,ย insulinย resistance and glucose intolerance in diet-induced obese rats
  614. Brain and behavioral correlates ofย insulinย resistance in youth with depression andย obesity
  615. Brainย insulinย andย obesity: From Man to C. elegans
  616. #VALUE!
  617. Brain PPAR-ฮณ promotesย obesityย and is required for theย insulinโ€“sensitizing effect of thiazolidinediones
  618. Brain-Specific Disruption of the Maternal (but not Paternal) Allele of the Imprinted G [sub s] ฮฑ Gene Leads toย obesityย andย insulinย Resistance.
  619. Breastmilk with a high omegaโ€6 to omegaโ€3 fatty acid ratio induced cellular events similar toย insulinย resistance andย obesityย in 3T3โ€L1 adipocytes
  620. Bromocriptine inhibits the seasonally occurringย obesity, hyperinsulinemia,ย insulinย resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus โ€ฆ
  621. Brown adipose tissue activity as a target for the treatment ofย obesity/insulinย resistance
  622. Brown adipose tissue triglyceride content is associated with decreasedย insulinย sensitivity, independently of age andย obesity
  623. Bypassing the duodenum does not improveย insulinย resistance associated with dietโ€inducedย obesityย in rodents
  624. c-Abl inhibition mitigates diet-inducedย obesityย through improvingย insulinย sensitivity of subcutaneous fat in mice
  625. C-peptide andย insulinย secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range ofย insulinย concentrations and inย obesity
  626. C-reactive protein in healthy subjects: associations withย obesity,ย insulinย resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose โ€ฆ
  627. C-reactive protein,ย insulinย resistance, centralย obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
  628. C-reactive protein,ย obesity, andย insulinย resistance in postmenopausal women in urban slums of North India
  629. C1q/TNF-related protein 6 (CTRP6) linksย obesityย to adipose tissue inflammation andย insulinย resistance
  630. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improvesย insulinย sensitivity and glycemic control in mouse models ofย obesityย and diabetes
  631. C825T Polymorphism of the G Protein ฮฒ3 Subunit Is Associated withย obesityย but Not withย insulinย Sensitivity
  632. Ca2+ mishandling and cardiac dysfunction inย obesityย andย insulinย resistance: Role of oxidative stress
  633. Cafeteria diet inducesย obesityย andย insulinย resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon โ€ฆ
  634. Cafeteria diet-inducedย obesityย is associated with a low spontaneous growth hormone secretion and normal plasmaย insulin-like growth factor-I concentrations
  635. Calanus oil in the treatment ofย obesity-related low-grade inflammation,ย insulinย resistance, and atherosclerosis
  636. Caloric restriction in pregnant diabetic women: a review of maternalย obesity, glucose andย insulinย relationships as investigated at the University of California, San Diego โ€ฆ
  637. Calorie restriction reduced blood pressure inย obesityย hypertensives by improvement of autonomic nerve activity andย insulinย sensitivity
  638. Canย obesityย Alone Increase Fasting Serumย insulin, Fasting Serum C-Peptide andย insulinย Resistance?
  639. Can prokineticin preventย obesityย andย insulinย resistance?
  640. Canagliflozin improvesย obesityย andย insulinย resistance in a diabetic patient with Cushingโ€™s disease undergoing postoperative steroid therapy: A case report
  641. Cannabinoid CB2 receptor potentiatesย obesity-associated inflammation,ย insulinย resistance and hepatic steatosis
  642. Cannabinoid receptor type 1 mediates high-fat diet-inducedย insulinย resistance by increasing forkhead box O1 activity in a mouse model ofย obesity
  643. Cannabis use in relation toย obesityย andย insulinย resistance in the inuit population
  644. Carbohydrate intake affectsย insulinย binding to human erythrocytes in normal weight subjects but not in subjects with familyย obesity
  645. Carbohydrates,ย insulin, andย obesity
  646. Carbonylation of adipose proteins inย obesityย andย insulinย resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4 โ€ฆ
  647. CARD3 deficiency exacerbates diet-inducedย obesity, hepatosteatosis, andย insulinย resistance in male mice
  648. Cardiac ischemia-reperfusion injury underย insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-inducedย obesity
  649. Cardiac ischemiaโ€“reperfusion injury underย insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-inducedย obesity
  650. Cardiac natriuretic peptides,ย obesity, andย insulinย resistance: evidence from two community-based studies
  651. #VALUE!
  652. Cardiomyopathy inย obesity,ย insulinย resistance and diabetes
  653. Cardiorespiratory fitness,ย insulinย sensitivity, and perceptions ofย obesityย treatment in obese children and adolescents
  654. Cardiovascular and renal complications inย obesityย andย obesity-related medical conditions: role of sympathetic nervous activity andย insulinย resistance
  655. Cardiovascular and renal complications of type 2 diabetes inย obesity: role of sympathetic nerve activity andย insulinย resistance
  656. Cardiovascular and Renal Integration: Microvascularย insulinย resistance in skeletal muscle and brain occurs early in the development of juvenileย obesityย in pigs
  657. Cardiovascular Consequences ofย obesityย and Type 2 Diabetes: Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the โ€ฆ
  658. Cardiovascular risk factors in adolescents: Role ofย insulinย resistance andย obesity
  659. Carotid Intima-media thickness in childhood and adolescentย obesityย relations to abdominalย obesity, high triglyceride level andย insulinย resistance
  660. Carvedilol improves glucose tolerance andย insulinย sensitivity in treatment of adrenergic overdrive in high fat diet-inducedย obesityย in mice
  661. Case problem: Dietary recommendations to combatย obesity,ย insulinย resistance, and other concerns related to polycystic ovary syndrome/Response
  662. Cashew apple extract inhibition of fat storage andย insulinย resistance in the diet-inducedย obesityย mouse model
  663. Casitas B-Lineage Lymphoma RING Domain Inhibitors Protect Mice against High-Fat Diet-Inducedย obesityย andย insulinย Resistance
  664. Casitas b-lineage lymphomaโ€“deficient mice are protected against high-fat dietโ€“inducedย obesityย andย insulinย resistance
  665. Caspase-12, but not caspase-11, inhibitsย obesityย andย insulinย resistance
  666. CATECHOL-O-METHYLTRANFERASE GENOTYPE MODULATION OFย insulinย RESISTANCE INย obesity, IS INDEPENDENT OF BLOOD PRESSURE LEVEL: 9B โ€ฆ
  667. CATECHOLAMINES,ย obesityย ANDย insulinโ€”RESISTANT DIABETES: EXPERIMENTAL INSIGHTS
  668. Catestatin inhibitsย obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improvedย insulinย โ€ฆ
  669. Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotesย insulinย resistance duringย obesity
  670. Causal Effects of Overall and Abdominalย obesityย onย insulinย Resistance and the Risk of Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization โ€ฆ
  671. Causal Relationship of Non-alcoholic Fatty Liver Disease withย obesityย andย insulinย Resistance.
  672. Cbl-b is a critical regulator of macrophage activation associated withย obesity-inducedย insulinย resistance in mice
  673. CC motif chemokine receptor 9 regulatesย obesity-inducedย insulinย resistance via inflammation of the small intestine in mice
  674. CCL2 and CCL3 chemokine gene expression and their receptors in human visceral and subcutaneous adipose tissue is associated withย obesityย andย insulinย โ€ฆ
  675. CCR5 plays a critical role inย obesity-induced adipose tissue inflammation andย insulinย resistance by regulating both macrophage recruitment and M1/M2 status
  676. Ccrl2 deficiency deterioratesย obesityย andย insulinย resistance through increasing adipose tissue macrophages infiltration
  677. CD11b regulatesย obesity-inducedย insulinย resistance via limiting alternative activation and proliferation of adipose tissue macrophages
  678. CD40 deficiency aggravates diet-inducedย obesity, adipose tissue inflammation, andย insulinย resistance in mice
  679. CD40 deficiency in mice exacerbatesย obesity-induced adipose tissue inflammation, hepatic steatosis, andย insulinย resistance
  680. CD47 deficiency protects mice from diet-inducedย obesityย and improves whole body glucose tolerance andย insulinย sensitivity
  681. CEACAM1 loss links inflammation toย insulinย resistance inย obesityย and non-alcoholic steatohepatitis (NASH)
  682. Cellular alterations responsible forย insulinย resistance inย obesityย and type II diabetes mellitus
  683. Cellular and molecular players in adipose tissue inflammation in the development ofย obesity-inducedย insulinย resistance
  684. Cellular inflammatory responses: novel insights forย obesityย andย insulinย resistance
  685. Cellular ions in hypertension,ย insulinย resistance,ย obesity, and diabetes: a unifying theme.
  686. Cellular mechanisms in selected states ofย insulinย resistance: humanย obesity, glucocorticoid excess, and chronic renal failure
  687. Central and peripheralย insulinย resistance in a large animal model ofย obesity
  688. Central arterial stiffness and diastolic dysfunction are associated withย insulinย resistance and abdominalย obesityย in young women but polycystic ovary syndrome does โ€ฆ
  689. Central arterial stiffness and diastolic dysfunction are not increased in young women with PCOS but are associated withย insulinย resistance and abdominalย obesity
  690. Centralย obesityย and altered peripheral adipose tissue gene expression characterize the NAFLD patient withย insulinย resistance: Role of nutrition andย insulinย challenge
  691. Centralย obesityย and hyperinsulinaemia in women are associated with polymorphism in the 5 โ€˜flanking region of the humanย insulinย gene
  692. Centralย obesityย and hypertension: relationship between fasting serumย insulin, plasma renin activity, and diastolic blood pressure in young obese subjects
  693. Centralย obesityย andย insulinย resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function
  694. Centralย obesityย and theย insulinย resistance syndrome: new elements in the etiology of non-communicable diseases
  695. Centralย obesityย in rhesus monkeys: association with hyperinsulinemia,ย insulinย resistance and hypertriglyceridemia?
  696. Centralย obesityย increases the risk of gestational diabetes partially through increasingย insulinย resistance
  697. Centralย obesityย is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort โ€ฆ
  698. Centralย obesityย withย insulinย Resistance and Type 2 Diabetes
  699. Centralย obesity,ย insulinย resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
  700. Centralย obesity, type 2 diabetes andย insulin: exploring a pathway full of thorns
  701. Central serotonin and dopamine transporters in overeating,ย obesityย andย insulinย resistance
  702. Cephalic phaseย insulinย response as a predictor of body weight gain andย obesityย induced by a palatable cafeteria diet.
  703. Ceramide kinase deficiency improves diet-inducedย obesityย andย insulinย resistance
  704. Ceramides, mitochondrial fission, and reactive oxygen species a novel mechanism ofย obesityโ€inducedย insulinย resistance (LB167)
  705. CerS1-derived C18: 0 ceramide in skeletal muscle promotesย obesity-inducedย insulinย resistance
  706. Changes in DNA Methylation and Gene Expression ofย insulinย andย obesity-Related Gene PIK3R1 after Roux-en-Y Gastric Bypass
  707. Changes inย insulinย responses and binding in adipocytes from monkeys withย obesityย progressing to diabetes.
  708. Changes inย insulinย sensitivity after weight loss in hypertensive patients withย obesity
  709. Changes inย insulin, somatostatin, and glucagon secretion during the development ofย obesityย in ventromedial hypothalamic-lesioned rats
  710. Changes in plasma immunoreactiveย insulinย during thyroid treatment ofย obesity.
  711. Changes induced by metabolic surgery on the main components of glucose/insulinย system in patients with diabetes andย obesity
  712. Changes ofย insulinย Resistance and ฮฒ-Cell Secrete Function in Children with Simpleย obesityย [J]
  713. Changes of serum leptin, adiponection andย insulinย levels in females with simpleย obesity
  714. chapter 6โ€“metabolic and vascularย insulinย sensitivity inย obesityย and hypertension
  715. Characterisation of betatrophin concentrations in childhood and adolescentย obesityย andย insulinย resistance
  716. Characteristics of adipose tissue macrophages and macrophage-derivedย insulin-like growth factor-1 in virus-inducedย obesity
  717. Characterization of gut microbiota and adipose tissues in the regulation ofย obesity-inducedย insulinย resistance
  718. Characterization of inflammation andย insulinย resistance in highโ€fat dietโ€induced male C57BL/6J mouse model ofย obesity
  719. CHARACTERIZATION OF SERUMย insulinย IN STUDIES OFย obesityย OF CUINO PIGS
  720. Characterization of theย insulin-like growth factor axis in term pregnancies complicated by maternalย obesity
  721. Characterizing the Effects of Diabetes andย obesityย onย insulinย and Leptin Levels amongst Pregnant Women
  722. CHDH-PNPLA3 Geneโ€“Gene Interactions Predictย insulinย Resistance in Children withย obesity
  723. Chemerin Serum Level andย insulinย Resistancein Hypertensive Patients withย obesity
  724. Chemical gastric inhibitory polypeptide receptor antagonism protects againstย obesity,ย insulinย resistance, glucose intolerance and associated disturbances in โ€ฆ
  725. Chemical inducers ofย obesity-associated metabolic stress activate inflammation and reduceย insulinย sensitivity in 3T3-L1 adipocytes
  726. Chemokine systems linkย obesityย toย insulinย resistance
  727. Childhhoodย obesity,ย insulinย resistance and increased cardiovascular risk
  728. Childhoodย obesityย andย insulinย resistance
  729. Childhoodย obesityย andย insulinย resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development
  730. Childhoodย obesityย andย insulinย resistance: how should it be managed?
  731. Childhoodย obesityย andย insulin-resistant syndrome
  732. Childhoodย obesityย in Asian Indians: a burgeoning cause ofย insulinย resistance, diabetes and sub-clinical inflammation.
  733. Childhoodย obesity,ย insulinย Resistance, and Magnesium Metabolism
  734. Childhoodย obesity, thyroid function, andย insulinย resistanceโ€“is there a link? A longitudinal study
  735. Childhoodย obesity: serum lipoproteins, glucose andย insulinย concentrations after an oral glucose load.
  736. Childhood social preference and adolescentย insulinย resistance: Accounting for the indirect effects ofย obesity
  737. Chlorogenic acid/chromium supplement rescues diet-inducedย insulinย resistance andย obesityย in mice
  738. Cholecystectomy versus centralย obesityย orย insulinย resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition โ€ฆ
  739. Chromogranin A regulation ofย obesityย and peripheralย insulinย sensitivity
  740. Chronic adipose tissue inflammation linkingย obesityย toย insulinย resistance and type 2 diabetes
  741. Chronic consumption of farmed salmon containing persistent organic pollutants causesย insulinย resistance andย obesityย in mice
  742. Chronic Exposure to Environmental Level Phenanthrene Induces Non-obesity-Dependentย insulinย Resistance in Male Mice
  743. Chronic exposure to PCBs (Aroclor 1254) exacerbatesย obesity-inducedย insulinย resistance and hyperinsulinemia in mice
  744. Chronic inflammation in fat plays a crucial role in the development ofย obesity-relatedย insulinย resistance
  745. Chronic intestinal electrical stimulation improves glucose intolerance andย insulinย resistance in dietโ€inducedย obesityย rats
  746. Chronic kidney disease andย obesityย bias surrogate estimates ofย insulinย sensitivity compared with the hyperinsulinemic euglycemic clamp
  747. Chronic reduction of GIP secretion alleviatesย obesityย andย insulinย resistance under high-fat diet conditions
  748. Chronic stress, glucocorticoids,ย insulinย andย obesity
  749. Chronically increased glucose uptake by adipose tissue leads to lactate production and improvedย insulinย sensitivity rather thanย obesityย in the mouse
  750. Cideb regulates diet-inducedย obesity, liver steatosis, andย insulinย sensitivity by controlling lipogenesis and fatty acid oxidation
  751. Cinnamon extract improvesย insulinย sensitivity in the brain and lowers liver fat in mouse models ofย obesity
  752. Circadian disruption leads toย insulinย resistance andย obesity
  753. Circadian rhythms of cortisol andย insulinย in nutritionalย obesityย in children
  754. Circulating adhesion molecule serum concentrations in individuals withย insulinย sensitiveย obesity
  755. Circulating adiponectin levels associate with inflammatory markers,ย insulinย resistance and metabolic syndrome independent ofย obesity
  756. Circulating branchedโ€chain amino acid concentrations are associated withย obesityย and futureย insulinย resistance in children and adolescents
  757. Circulating follistatin and activin A and their regulation byย insulinย inย obesityย and type 2 diabetes
  758. Circulating High Molecular Weight Adiponectin Levels Are Related toย obesityย hut not toย insulinย Sensitivity in Healthy and Glucose Tolerant Caucasians.
  759. Circulating immune complexes andย insulinย antibodies inย obesityย in children
  760. Circulating levels ofย insulin-like growth factor-II/mannose-6-phosphate receptor inย obesityย and type 2 diabetes
  761. Circulating lipopolysaccharide-binding protein (LBP) as a marker ofย obesity-relatedย insulinย resistance
  762. Circulating microRNA profile inย insulinย Resistant Childhoodย obesity
  763. Circulating miRNA Signatures Associated withย insulinย Resistance in Adolescents withย obesity
  764. Circulating mitochondrial DNA is decreased in children and adolescents withย obesityย and/orย insulinย resistance
  765. Circulating sDPP-4 is increased inย obesityย andย insulinย resistance but is not related to systemic metabolic inflammation
  766. Circulating soluble IL-6 receptor concentration and visceral adipocyte size are related toย insulinย resistance in Taiwanese adults with morbidย obesity
  767. Circulating zonulin, a marker of intestinal permeability, is increased in association withย obesity-associatedย insulinย resistance
  768. CK2 modulates adipocyteย insulin-signaling and is up-regulated in humanย obesity
  769. Clinacal Application of Determination ofย insulinย Receptor in NIDDM Patients withย obesity
  770. Clinical application of relativeย insulinย sensitivity index in children withย obesityย and diabetes mellitus
  771. Clinical assessment ofย obesityย andย insulinย resistance in type 1 diabetes subjects seen at a center in Kolkata
  772. Clinical case of the month. Natural history of morbidย obesity: towardsย insulin-requiring type 2 diabetes and reversal after bariatric surgery
  773. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree ofย obesityย at diagnosis of diabetes
  774. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree ofย obesityย at diagnosis of diabetes
  775. Clinical Research of Integrated Chinese and Western Medicine Therapy for Patients withย obesityย Hypertension Relatedย insulinย Resistance
  776. Clinical significance of changes of plasma leptin and serumย insulin/testosterone levels before and after treatment in patients with womanย obesityย of infertile
  777. Clinical use of continuous subcutaneousย insulinย infusion for type 2 diabetic patients withย obesityย [J]
  778. Clinical value of selected markers of angiogenesis, inflammation,ย insulinย resistance andย obesityย in type 1 endometrial cancer
  779. Clinico pathological study of Acanthosis Nigricans and its correlation withย obesityย andย insulinย resistance
  780. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fastingย insulinย and central and overallย obesityย in a general population
  781. Cme instructions: Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women withย obesityย andย insulinย resistance
  782. CNS Vitamin D Improves Glucose Tolerance, Hepaticย insulinย Sensitivity, and Reverses Diet-Inducedย obesity
  783. CNTF reversesย obesity-inducedย insulinย resistance by activating skeletal muscle AMPK
  784. Cocoa polyphenols suppress adipogenesis in vitro andย obesityย in vivo by targetingย insulinย receptor
  785. Coconut oil aggravates pressure overload-induced cardiomyopathy without inducingย obesity, systemicย insulinย resistance, or cardiac steatosis
  786. Codon 972 polymorphism in theย insulinย receptor substrate-1 gene,ย obesity, and risk of noninsulin-dependent diabetes mellitus.
  787. Coffee intake mitigated inflammation andย obesity-inducedย insulinย resistance in skeletal muscle of high-fat diet-induced obese mice
  788. Colesevelam improvesย insulinย resistance in a diet-inducedย obesityย (F-DIO) rat model by increasing the release of GLP-1
  789. Combination therapy with metformin and fenofibrate forย insulinย resistance inย obesity
  790. Combined effect of abdominalย obesityย and both hepatic lipase gene polymorphism and angiotensin genepolymorphism on lipid and lipoprotein levels andย insulinย โ€ฆ
  791. #VALUE!
  792. Combined effects ofย insulinย treatment and adipose tissue-specific agouti expression on the development ofย obesity
  793. Combined hyperlipidemia in relation to race/ethnicity,ย obesity, andย insulinย resistance in the Multi-Ethnic Study of Atherosclerosis
  794. Combined influence ofย insulinย resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes
  795. Combined Influence ofย insulinย Resistance, Overweight/obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes
  796. #VALUE!
  797. Combining metabolic profiling of plasma and faeces as a fingerprint ofย insulinย resistance inย obesity
  798. Comment on Francรฉs et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis,ย obesity, andย insulinย Resistance. Diabetes 2015; 64: 1522 โ€ฆ
  799. Comment on: Cani et al.(2007) Metabolic Endotoxemia Initiatesย obesityย andย insulinย Resistance: Diabetes
  800. Comment on: Cani et al.(2007) Metabolic endotoxemia initiatesย obesityย andย insulinย resistance: Diabetes 56: 1761โ€“1772
  801. Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia,ย insulinย Resistance,ย obesity, and Chronic Inflammation โ€ฆ
  802. Commentary on the Impact ofย obesityย and Puberty onย insulinย Sensitivity
  803. Commentary: FGF21 holds promises for treatingย obesity-relatedย insulinย resistance and hepatosteatosis
  804. Comments on: Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships toย insulinย resistance andย obesity.
  805. Common familial influences on clustering of metabolic syndrome traits with centralย obesityย andย insulinย resistance: the Kielย obesityย prevention study
  806. Common genetic variants highlight the role ofย insulinย resistance and body fat distribution in type 2 diabetes, independent ofย obesity
  807. Common genetic variation in the SERPINF1 locus determines overall adiposity,ย obesity-relatedย insulinย resistance, and circulating leptin levels
  808. Common Genetic Variation in the SERPINF1 Locus Determines Overall Adiposity,ย obesity-Relatedย insulinย Resistance, and Circulating Leptin Levels
  809. Common STAT3 Variants Are Not Associated Withย obesityย orย insulinย Resistance in Female Twins
  810. Common variants in SOCS7 gene predictย obesity, disturbances in lipid metabolism andย insulinย resistance
  811. Common variants in the regulatory region of theย insulinย gene are associated with fasting plasmaย insulinย levels in juvenileย obesity
  812. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination onย obesity,ย insulinย resistance, and liver and pancreas remodelling in C57BL/6 โ€ฆ
  813. Comparing Different Markers ofย insulinย Resistance in Pediatricย obesity
  814. Comparison of Abdominalย obesityย and Fatty Liver and Their Association withย insulinย Resistance and Metabolic Syndrome in Chinese Adults
  815. Comparison of Cardiometabolic Syndrome Parameters,ย obesity,ย insulinย Resistance, and Elevated Alanine Aminotransferase in Current Professional Baseball and โ€ฆ
  816. Comparison of Lipoprotein Basedย insulinย Resistance Score and Traditional Risk Factors in Adolescents withย obesity
  817. Comparison of Predictive Value ofย obesityย and Lipid Related Variables for Metabolic Syndrome andย insulinย Resistance in Obese Adults
  818. Comparison of surrogate and direct measurement ofย insulinย resistance in chronic hepatitis C virus infection: impact ofย obesityย and ethnicity
  819. Comparison of the association with sleep apnoea ofย obesityย versusย insulinย resistance
  820. Comparison of the effects of captopril and nicardipine onย insulinย sensitivity and thrombotic profile in patients with hypertension and androidย obesity
  821. Comparison of therapeutic effects of electroacupuncture and acupoint catgut embedding in redu-cing serum leptin andย insulinย levels in simpleย obesityย patients
  822. Comparison of ฮฒ-cell dysfunction andย insulinย resistance correlatingย obesityย with type 2 diabetes: a cross-sectional study
  823. Compensation forย obesity-inducedย insulinย resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis
  824. Complement 3 serum levels as a pro-inflammatory biomarker forย insulinย resistance inย obesity
  825. Complement activation inย obesity,ย insulinย resistance, and type 2 diabetes mellitus
  826. Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced byย obesityย andย insulinย sensitivity
  827. Complement component C3: relationship withย obesity,ย insulinย resistance and cardiovascular risk markers.
  828. Complement factor C3 methylation and mRNA expression is associated to BMI andย insulinย resistance inย obesity
  829. Complete failure ofย insulin-transmitted signaling, but notย obesity-inducedย insulinย resistance, impairs respiratory chain function in muscle
  830. Complex Interactions Between Diet, Exercise, and the HPA Axis on the Development ofย obesity,ย insulinย Resistance, and Type 2 Diabetes
  831. Composition of dietary fat affects blood pressure andย insulinย responses to dietaryย obesityย in the dog
  832. CONCISE REVIEW biological: Periodontal inflammation andย insulinย resistanceโ€”lessons fromย obesity
  833. Conditional disruption of IฮบB kinase 2 fails to preventย obesity-inducedย insulinย resistance
  834. Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated withย obesityย andย insulinย resistance
  835. Conjugated linoleic acid,ย obesity, andย insulinย resistance: waiting for the day of liberation from chronic disease
  836. Constitutiveย insulinย sensitivity andย obesityย my be caused by PTEN mutations
  837. Consumption of added sugars from liquid but not solid sources predicts impaired glucose homeostasis andย insulinย resistance among youth at risk ofย obesity
  838. Consumption of nutrients andย insulinย resistance suppress markers of bone turnover in subjects with abdominalย obesity
  839. Continuous glucose monitoring, oral glucose tolerance, andย insulin-glucose parameters in adolescents with simpleย obesity.
  840. Contribution of 24ย obesity-associated genetic variants toย insulinย resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population
  841. Contribution of abdominal visceralย obesityย andย insulinย resistance to the cardiovascular risk profile of postmenopausal women
  842. Contribution of B cells toย obesityย andย insulinย resistance
  843. Contribution of genetic, biochemical and environmental factors onย insulinย resistance andย obesityย in Mexican young adults
  844. Contribution ofย insulinย resistance to decreased baroreceptor sensitivity & cardiometabolic risks in pre-obesityย &ย obesity
  845. Contribution of leptin in the development ofย insulinย resistance in pregnant women withย obesity
  846. Contribution of lipid-reactive natural killer T cells toย obesity-associated inflammation andย insulinย resistance
  847. Contribution ofย obesityย toย insulinย resistance in noninsulin-dependent diabetes mellitus
  848. Contribution of the lean body mass toย insulinย resistance in postmenopausal women with visceralย obesity: a Monet study
  849. Contribution of TNF-ฮฑ toย obesity-Associatedย insulinย Resistance
  850. Contribution of visceralย obesityย to theย insulinย resistance syndrome
  851. Contributions of dysglycaemia,ย obesity, andย insulinย resistance to impaired endotheliumโ€dependent vasodilation in humans
  852. Convergence of leptin andย insulinย signaling networks inย obesity
  853. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects ofย obesityย and non-insulin-dependent diabetes mellitus
  854. Copeptin and Nesfatin-1 Are Interrelated Biomarkers with Roles in the Pathogenesis ofย insulinย Resistance in Chinese Children withย obesity
  855. Copeptin and Obestatin Levels in Polycystic Ovary women and their Relation toย obesity,ย insulinย metabolism and Cardiovascular diseases
  856. Copeptin as a Novel Biomarker ofย obesity-Inducedย insulinย Resistance and Metabolic Syndrome
  857. Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-inducedย obesityย andย insulinย resistance
  858. Coronavirus andย obesity: couldย insulinย resistance mediate the severity of Covid-19 infection?
  859. Correction: Beneficial effects of exercise on offspringย obesityย andย insulinย resistance are reduced by maternal high-fat diet
  860. Correction:ย insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting inย obesity
  861. Correction: Methionine-Restricted C57BL/6J Mice Are Resistant to Diet-Inducedย obesityย andย insulinย Resistance but Have Low Bone Density
  862. Correction:ย obesityย Resistance and Enhancedย insulinย Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy โ€ฆ
  863. Correction: Percentage fractions of urinary di (2-ethylhexyl) phthalate metabolites: Association withย obesityย andย insulinย resistance in Korean girls
  864. Correlation analysis of serum obestatin expression withย insulinย resistance in childhoodย obesity
  865. Correlation Analysis onย obesityย Complicated with Hyperlipidemia And Lipid, Fatty-insulinย Axis, Autonomic Nerve Function
  866. Correlation betweenย insulinย resistance and liver histology in patients with nonalcoholic steatohepatitis with and withoutย obesity
  867. Correlation Betweenย insulinย Resistance andย obesityย in Normoglycemic Obese Syrian Subjects
  868. Correlation betweenย insulinย resistance surrogates and echocardiographic findings in asymptomatic patients with morbidย obesity: a cross-sectional study
  869. Correlation betweenย insulin-like growth factor-I andย obesityย index during inpatient treatment in anorexia nervosa in childhood and adolescence
  870. Correlation between Mid-thigh Low Density Muscle andย insulinย Resistance inย obesity
  871. Correlation between myostatin andย obesityย orย insulinย resistance of patients with polycystic ovary syndrome
  872. Correlation Betweenย obesity, BMI andย insulinย Resistance in Bulgarian Children
  873. Correlation Betweenย obesity, Body Mass Index andย insulinย Resistance in Bulgarian Children
  874. Correlation between plasma fibroblast growth factor 21 level,ย obesityย andย insulinย resistance in nonalcoholic fatty liver disease patients [J]
  875. Correlation between plasma fibroblast growth factor 21 level,ย obesityย andย insulinย resistance in nonalcoholic fatty liver disease patients.
  876. Correlation between the various measurements ofย obesityย and the degree of resistance toย insulin
  877. Correlation of body mass index with serum leptin,ย insulinย and sex hormones level in preschoolย obesityย children
  878. Correlation of childhoodย obesityย and relatedย insulinย resistance with leptin and retinol binding protein 4
  879. Correlation of Childhoodย obesityย and Relatedย insulinย Resistance with Leptin and Retinol Binding Protein 4: Correspondence
  880. Correlation ofย obesityย and the novel adipocytokines, leptin and adiponectin withย insulinย resistance in type 2 diabetes
  881. Correlation ofย obesityย Status with Zinc Serum Levels andย insulinย Resistance in Perimenopause Obese Women
  882. Correlation ofย obesityย with C-reactive protein, leptin andย insulinย sensitive index in children
  883. Correlation ofย obesity,ย insulinย resistance and lipid profile in women with PCOS in Kims Hospital Bangalore
  884. Correlation of Plasma Angiopoietin-2 and Inflammation Marker withย insulinย Resistence in Patients with Centralย obesity
  885. Correlation of plasma resistin withย obesityย andย insulinย resistance in type 2 diabetic patients
  886. Correlation of serum cytokines withย insulinย sensitivity and RAS system activity in patients withย obesity-related hypertension
  887. Correlation of serumย insulin-like growth factor-I andย insulin-like growth factor binding protein-3 level with other hormones in preschoolย obesityย children
  888. Correlation of serum leptin andย insulinย levels of pregnant protein-restricted rats with predictiveย obesityย variables
  889. CORRELATION OF TUMOUR NECROSIS FACTOR-รŽยฑWITHย obesityย INDUCEDย insulinย RESISTANCE IN TYPE 2 DIABETES MELLITUS
  890. Correlations between plasmaย insulinย and body weight inย obesity, anorexia nervosa and diabetes mellitus
  891. Correlations of Xinjiang Kazakย obesityย andย insulinย resistance to cardiovascular risk factors
  892. Corrigendum to โ€˜Weight-adjusted lean body mass and calf circumference are protective againstย obesity-associatedย insulinย resistance and metabolic abnormalitiesโ€™
  893. Corrigendum: IL-37 protects againstย obesity-induced inflammation andย insulinย resistance
  894. Corticostriatal dopamine networks mediate impulsivity inย obesityย andย insulinย resistance
  895. Corylin reducesย obesityย andย insulinย resistance and promotes adipose tissue browning through SIRT-1 and ฮฒ3-AR activation
  896. Cost-effectiveness of exenatide versusย insulinย glargine in Spanish patients withย obesityย and type 2 diabetes mellitus
  897. Could SCGF-Beta Levels Be Associated with Inflammation Markers andย insulinย Resistance in Male Patients Suffering fromย obesity-Related NAFLD?
  898. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-inducedย obesityย andย insulinย resistance in C57BL/6J mice
  899. COXโ€2โ€mediated inflammation in fat is crucial forย obesityโ€linkedย insulinย resistance and fatty liver
  900. CREBH improves diet-inducedย obesity,ย insulinย resistance, and metabolic disturbances by FGF21-dependent and FGF21-independent mechanisms
  901. CREG1 heterozygous mice are susceptible to high fat diet-inducedย obesityย andย insulinย resistance
  902. Cross-sectional and longitudinal relationship of sodium-lithium countertransport toย insulin,ย obesityย and blood pressure in healthy perimenopausal women.
  903. Crucial role of a long-chain fatty acid elongase, Elovl6, inย obesity-inducedย insulinย resistance
  904. Crucial roles of N ox2โ€derived oxidative stress in deteriorating the function ofย insulinย receptors and endothelium in dietaryย obesityย of middleโ€aged mice
  905. CTLA-4Ig immunotherapy ofย obesity-inducedย insulinย resistance by manipulation of macrophage polarization in adipose tissues
  906. Cudrania tricuspidata water extract improvedย obesity-induced hepaticย insulinย resistance in db/db mice by suppressing ER stress and inflammation
  907. Cudrania tricuspidata water extract improvesย obesity-induced hepaticย insulinย resistance through suppression of ER stress and inflammation in db/db mice
  908. Cumulative inflammatory burden andย obesityย as determinants ofย insulinย resistance in patients with established rheumatoid arthritis: cross-sectional study
  909. Curcumin prevents high fat diet inducedย insulinย resistance andย obesityย via attenuating lipogenesis in liver and inflammatory pathway in adipocytes
  910. Curcumin rescues high fat diet-inducedย obesityย andย insulinย sensitivity in mice through regulating SREBP pathway
  911. Current role of the NLRP3 inflammasome onย obesityย andย insulinย resistance: A systematic review
  912. Cx30. 2 deletion causes imbalances in testicular Cx43, Cx46, and Cx50 andย insulinย receptors. Reciprocally, diabetes/obesityย alters Cx30. 2 in mouse testis
  913. CXC ligand 5 is an adipose-tissue derived factor that linksย obesityย toย insulinย resistance
  914. CXC ligand 5 is an adipose-tissue derived factor that linksย obesityย toย insulinย resistance
  915. CXCL14 enhancesย insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-inducedย obesity
  916. CXCL5 is an adipose tissue derived factor that linksย obesityย toย insulinย resistance
  917. CXCR3 modulatesย obesityโ€induced visceral adipose inflammation and systemicย insulinย resistance
  918. Cyanidin 3-glucoside attenuatesย obesity-associatedย insulinย resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1
  919. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking toย obesity, andย insulinย resistance
  920. Cyclocarya paliurus (Batal.) Ijinskaja aqueous extract (CPAE) amelioratesย obesityย by improvingย insulinย signaling in the hypothalamus of a metabolic syndrome โ€ฆ
  921. Cystathionine beta synthase-hydrogen sulfide system in paraventricular nucleus reduced high fatty diet inducedย obesityย andย insulinย resistance by brain โ€ฆ
  922. Cystathionine ฮณโ€lyase deficiency aggravatesย obesityโ€relatedย insulinย resistance via FoxO1โ€dependent hepatic gluconeogenesis
  923. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-inducedย obesityย andย insulinย resistance
  924. d-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction inย obesity-inducedย insulin-resistant rats
  925. Daily branchedโ€chain amino acid intake and risks ofย obesityย andย insulinย resistance in children: A crossโ€sectional study
  926. Dairy consumption,ย obesity, and theย insulinย resistance syndrome in young adults: the CARDIA Study
  927. Daniel Porte Jr.: a leader in our understanding of the role of defectiveย insulinย secretion and action inย obesityย and type 2 diabetes
  928. DBZ is a putative PPARรŽยณ agonist that prevents high fat diet-inducedย obesity,ย insulinย resistance and gut dysbiosis
  929. DBZ is a putative PPARฮณ agonist that prevents high fat diet-inducedย obesity,ย insulinย resistance and gut dysbiosis
  930. De novo 19p13. 2 microdeletion encompassing theย insulinย receptor and resistin genes in a patient withย obesityย and learning disability
  931. Debating the relevance of resistin: hormone linksย obesityย andย insulinย resistance in mice, but doubts persist about impact on type 2 diabetes research.(Hot Papers)
  932. Decaffeinated green coffee bean extract attenuates diet-inducedย obesityย andย insulinย resistance in mice
  933. Decline in physical fitness from childhood to adulthood associated with increasedย obesityย andย insulinย resistance in adults
  934. Decrease of miR-146b-5p in monocytes duringย obesityย is associated with loss of the anti-inflammatory but notย insulinย signaling action of adiponectin
  935. #VALUE!
  936. Decreased adipose tissue oxygenation associates withย insulinย resistance in individuals withย obesity
  937. Decreased apolipoprotein A5 is implicated inย insulinย resistance-related hypertriglyceridemia inย obesity
  938. Decreased basalย insulinย secretion from pancreatic islets of pups in a rat model of maternalย obesity
  939. Decreased hepaticย insulinย extraction in upper bodyย obesity: relationship to unbound androgens and sex hormone binding globulin
  940. Decreasedย insulinย removal contributes to hyperinsulinemia inย obesity
  941. Decreased jaw bone density and osteoblasticย insulinย signaling in a model ofย obesity
  942. Decreased number ofย insulinย receptors inย obesity: studies in the obese hyperglycemic mouse (authorโ€™s transl)
  943. Decreased serum CA 19โ€9 is associated with improvement ofย insulinย resistance and metabolic control in patients withย obesityย and type 2 diabetes after Rouxโ€enโ€Y โ€ฆ
  944. Decreased sex hormone binding globulin (SHBG) andย insulinโ€like growth factor binding protein (IGFBPโ€1) in extremeย obesity
  945. Decrement in resting andย insulinโ€stimulated soleus muscle mitochondrial respiration is an early event in dietโ€inducedย obesityย in mice
  946. Dectin-1 activation exacerbatesย obesityย andย insulinย resistance in the absence of MyD88
  947. Defective Activation of Protein Kinase Cz in Muscle byย insulinย and Phosphatidylinositol-3,4,5,-(PO4)3 inย obesityย and Polycystic Ovary Syndrome
  948. Defective autophagy causes a maladaptive cardiac phenotype to exercise that leads to premature death and FGF21โ€mediated protection againstย obesityย andย insulinย โ€ฆ
  949. Defective FXR-SHP regulation inย obesityย aberrantly increases miR-802 expression, promotingย insulinย resistance and fatty liver
  950. Defective hepatic autophagy inย obesityย promotes ER stress and causesย insulinย resistance
  951. Defectiveย insulinย receptor tyrosine kinase in human skeletal muscle inย obesityย and type 2 (non-insulin-dependent) diabetes mellitus
  952. Defectiveย insulinย signalling, mediated by inflammation, connectsย obesityย to Alzheimer disease; relevant pharmacological therapies and preventive dietary โ€ฆ
  953. Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading toย obesityย andย insulinย resistance
  954. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-inducedย obesityย andย insulinย resistance in mice
  955. Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice fromย insulinย resistance without affectingย obesity
  956. Deficiency in the shortโ€chain acylโ€CoA dehydrogenase protects mice against dietโ€inducedย obesityย andย insulinย resistance
  957. Deficiency of CB2 cannabinoid receptor in mice improvesย insulinย sensitivity but increases food intake andย obesityย with age
  958. Deficiency of interleukin-18 in mice leads to hyperphagia,ย obesityย andย insulinย resistance
  959. Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-inducedย obesityย andย insulinย resistance
  960. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemicย insulinย resistance in diet-inducedย obesity
  961. Deficiency of Tyk2 kinase in mice leads toย obesityย andย insulinย resistance
  962. Deficient hippocampalย insulinย signaling and augmented Tau phosphorylation is related toย obesity-and age-induced peripheralย insulinย resistance: a study in โ€ฆ
  963. Dehydroepiandrosterone in relation toย obesity,ย insulinย resistance and lipid spectra in Czech non-diabetic population
  964. Delayedย insulinย absorption correlates with alterations in subcutaneous depot kinetics in rats with dietโ€inducedย obesity
  965. Deletion of ALMS1 (Alstrom Syndrome 1) enhances saltโ€sensitive hypertension, and inducesย insulinย resistance andย obesityย in rats.
  966. Deletion of Apolipoprotein D Prevents Diet-Inducedย obesityย andย insulinย Resistance.
  967. Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociatesย obesityย fromย insulinย resistance
  968. Deletion of CD1d in adipocytes aggravates adipose tissue inflammation andย insulinย resistance inย obesity
  969. Deletion of class A scavenger receptor deterioratesย obesity-inducedย insulinย resistance in adipose tissue
  970. Deletion of EHD2 Attenuated Adipocyte Hypertrophic Expansion and Ameliorated Diet-Inducedย obesityย andย insulinย Resistance
  971. Deletion of G0/G1 Switch Gene 2 preventsย obesityย andย insulinย resistance and promotes browning of white adipose tissue
  972. Deletion of Gpr21 protects againstย obesity-associated inflammation andย insulinย resistance
  973. Deletion of PPARฮณ in adipose tissues of mice protects against high fat diet-inducedย obesityย andย insulinย resistance
  974. Deletion of skeletal muscle SOCS3 preventsย insulinย resistance inย obesity
  975. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-inducedย obesityย andย insulinย resistance
  976. Deletion of the nuclear receptor RORฮฑ in macrophages does not modify the development ofย obesity,ย insulinย resistance and NASH
  977. Deletion of the nuclear receptor RORฮฑ in macrophages does not modify the development ofย obesity,ย insulinย resistance and NASH
  978. Dependence of Hypothalamicย obesityย onย insulin, the Pituitary and the Adrenal Gland1
  979. Depot-specific expression of caveolin-1 in human adipose tissue and their relationship withย obesityย andย insulinย resistance
  980. Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship withย obesityย andย insulinย resistance
  981. Depressed levels in plasmaย insulin-growth factor-1 (IGF-1) and binding protein-1 (IGFBP-1) in adolescenceย obesity. 372
  982. Detection and Analysis of Leptin,ย insulinย and Sexual Hormone in Serum of Simpleย obesityย Boys
  983. Detection ofย insulinย sensitivity and antibody againstย insulinย inย obesityย induced by antipsychotics
  984. Determinants and correlates of adipose tissueย insulinย resistance index in Japanese women without diabetes andย obesity
  985. Determination ofย insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbidย obesityย and anorexia nervosa after therapeutic intervention
  986. Determination of Optimal Cut-off Points forย obesity-related Measures of Metabolic Syndrome Based onย insulinย Resistance
  987. Detrimental effects of diet-inducedย obesityย on ฯ„ pathology are independent ofย insulinย resistance in ฯ„ transgenic mice
  988. Development and validation of a cell based model ofย insulinย resistance and investigation into the intracellular molecular defects induced by diabetes andย obesity
  989. Development of a new modified western diet to induce NASH withย obesityย andย insulinย resistance in mice
  990. Development ofย insulinย resistance andย obesityย in mice overexpressing cellular glutathione peroxidase
  991. Development ofย obesityย andย insulinย resistance in the Israeli sand rat (Psammomys obesus). Does leptin play a role?
  992. Development ofย obesityย in Zucker rats: earlyย insulinย resistance in muscles but normal sensitivity in white adipose tissue
  993. Development ofย obesity-induced inflammation andย insulinย resistance: The role of adipose tissue, fatty acids, and toll-like receptors
  994. Development of VMHย obesity: in vivoย insulinย secretion and tissueย insulinย sensitivity
  995. Development of Yak-Sun for Excess Syndromeย obesityย (1) Effects of Weight, Serum Glucose,ย insulinย and Lipid Profiles of Oriental Medicinal Herbs with Removal of โ€ฆ
  996. Developmental programming ofย obesityย andย insulinย resistance: does mitochondrial dysfunction in oocytes play a role?
  997. DHEA protects against visceralย obesityย and muscleย insulinย resistance in rats fed a high-fat diet
  998. Diabetes andย insulinย resistance in pediatricย obesity
  999. Diabetes andย obesityย during pregnancy alterย insulinย signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose โ€ฆ
  1000. Diabetes andย obesityโ€”Cumulative or Complementary Effects On Adipokines, Inflammation, andย insulinย Resistance
  1001. Diabetes in pregnancy:ย insulinย resistance,ย obesityย and placental dysfunction
  1002. Diabetes mellitus in dogs: relationship ofย obesityย to glucose tolerance andย insulinย response.
  1003. Diabetes-related risk factors and cognitive aging: focus onย obesity,ย insulinย resistance, and the metabolic syndrome
  1004. Diabetes,ย obesityย and hypertension: role ofย insulinย and the sympathetic nervous system
  1005. Diabetes,ย obesity,ย insulinย resistance: different pathways to cancer?
  1006. Diabetes: Have We Got It All Wrong?:ย insulinย hypersecretion and food additives: cause ofย obesityย and diabetes?
  1007. Diagnosingย obesity, diabetes mellitus, andย insulinย resistance syndrome
  1008. Diagnostic accuracy of triglyceride/glucose and triglyceride/HDL index as predictors forย insulinย resistance in children with and withoutย obesity
  1009. Diet and exercise in the treatment ofย obesity: effects of 3 interventions onย insulinย resistance
  1010. Diet in the Prevention and Control ofย obesity,ย insulinย Resistance, and Type II Diabetes
  1011. Diet-andย obesity-independent improvements inย insulinย sensitivity in mice genetically deficient in tumor necrosis factor-ฮฑ (TNF-ฮฑ KO).
  1012. Diet-genotype interactions in the early development ofย obesityย andย insulinย resistance in mice with a genetic deficiency in tumor necrosis factorโ€“ฮฑ
  1013. Diet-induced maternalย obesityย altersย insulinย signalling in male mice offspring rechallenged with a high-fat diet in adulthood
  1014. Diet-inducedย obesityย andย insulinย resistance spur tumor growth and cancer cachexia in rats bearing the yoshida sarcoma
  1015. Diet-inducedย obesityย and weight loss alter bile acid concentrations and bile acidโ€“sensitive gene expression inย insulinย target tissues of C57BL/6J mice
  1016. Diet-inducedย obesityย impairsย insulin-induced vasodilation in mouse mesenteric arteries via a mechanism involving ET-1
  1017. Diet-inducedย obesityย in female mice leads to offspring hyperphagia, adiposity, hypertension, andย insulinย resistance: a novel murine model of developmental โ€ฆ
  1018. Diet-inducedย obesityย in young mice interferes with the pancreatic intrinsic nervous system maturation and alters its control ofย insulinย secretion
  1019. Diet-inducedย obesityย induces endoplasmic reticulum stress andย insulinย resistance in the amygdala of rats
  1020. Diet-inducedย obesityย obstructsย insulinย signaling in the heart
  1021. Diet-inducedย obesityย prevents interstitial dispersion ofย insulinย in skeletal muscle
  1022. Dietโ€induced centralย obesityย andย insulinย resistance in rabbits
  1023. Dietโ€induced DNA methylation within the hypothalamic arcuate nucleus and dysregulated leptin andย insulinย signaling in the pathophysiology ofย obesity
  1024. Dietโ€inducedย obesityย and impairedย insulinย and glucose tolerance in sterol regulatory element binding proteinโ€1a knockโ€out mice
  1025. Dietโ€inducedย obesityย andย insulinย resistance are associated with brown fat degeneration in SIRT 1โ€deficient mice
  1026. Dietโ€inducedย obesityย causesย insulinย resistance in mouse brown adipose tissue
  1027. Dietโ€Inducedย obesityย Causes Selectiveย insulinย Resistance
  1028. Dietโ€inducedย obesityย in rats decreasesย insulinย sensitivity and baroreflex gain
  1029. Dietโ€inducedย obesityย in young mice: Consequences on the pancreatic intrinsic nervous system control ofย insulinย secretion
  1030. Diet,ย insulinย resistance, andย obesity: zoning in on data for Atkins dieters living in South Beach
  1031. Diet,ย obesityย and hypertension: an hypothesis involvingย insulin, the sympathetic nervous system, and adaptive thermogenesis
  1032. Diet,ย obesity, and metabolic control in girls withย insulinย dependent diabetes mellitus.
  1033. Dietary 1, 3-diacylglycerol protects against diet-inducedย obesityย andย insulinย resistance
  1034. Dietary aloe improvesย insulinย sensitivity via the suppression ofย obesity-induced inflammation in obese mice
  1035. Dietary aloe QDM complex reducesย obesity-inducedย insulinย resistance and adipogenesis in obese mice fed a high-fat diet
  1036. Dietary anthocyanin-rich extract of aรงai protects from diet-inducedย obesity, liver steatosis andย insulinย resistance with modulation of gut microbiota in mice
  1037. Dietary blueberry attenuatesย obesityโ€associatedย insulinย resistance by reducing adipocyte death and macrophage proโ€inflammatory activation in adipose tissue of high โ€ฆ
  1038. Dietary capsaicin reducesย obesityโ€inducedย insulinย resistance and hepatic steatosis in obese mice fed a highโ€fat diet
  1039. Dietary effects on A2AR expression in liver and adipose tissues: A role for A2AR in protecting against inflammation andย insulinย resistance inย obesity
  1040. Dietary fat andย insulinย sensitivity in a triethnic population: the role ofย obesity. Theย insulinย Resistance Atherosclerosis Study (IRAS)
  1041. Dietary fat versus carbohydrate inย obesityย andย insulinย resistance
  1042. Dietary fiber, plasmaย insulin, andย obesity
  1043. Dietary guar gum supplementation does not modifyย insulinย resistance in grossย obesity
  1044. Dietary iron overload induces visceral adipose tissueย insulinย resistance and hyper-resistinemia, and synergizes withย obesityย and fatty liver in inducing systemicย insulinย โ€ฆ
  1045. Dietary iron overload induces visceral adipose tissueย insulinย resistance associated with hyper-resistinemia, and synergizes withย obesityย in inducing systemicย insulinย โ€ฆ
  1046. DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUEย insulinย RESISTANCE: SYNERGY WITHย obesityย IN INDUCING SYSTEMICย insulinย โ€ฆ
  1047. Dietary isoliquiritigenin at a low dose amelioratesย insulinย resistance and NAFLD in diet-inducedย obesityย in C57BL/6J mice
  1048. Dietary management ofย obesityย andย insulinย resistance: countering risk for laminitis
  1049. Dietary n-6/n-3 FA Ratio, but Not Total Content of n-3 PUFA, Regulates Diet-inducedย obesity,ย insulinย Resistance, and Metabolic Dysfunction (OR19-01-19)
  1050. Dietaryย obesityย in the rat induces endothelial dysfunction without causingย insulinย resistance: a possible role for triacylglycerols
  1051. Dietary Phaseolus vulgaris extract alleviated diet-inducedย obesity,ย insulinย resistance and hepatic steatosis and alters gut microbiota composition in mice
  1052. Dietary regulation ofย insulinย receptors inย obesity
  1053. Dietary supplementation with Agaricus blazei murill extract prevents dietโ€inducedย obesityย andย insulinย resistance in rats
  1054. Dietary supplementation with evodiamine preventsย obesityย and improvesย insulinย resistance in ageing mice
  1055. Dietary supplementation with inulin-propionate ester or inulin improvesย insulinย sensitivity in adults with overweight andย obesityย with distinct effects on the gut โ€ฆ
  1056. Dietary-fat-inducedย obesityย in mice results in beta cell hyperplasia but not increasedย insulinย release: evidence for specificity of impaired beta cell adaptation
  1057. Dietary-inducedย obesityย in Mice results in Metabolic and Vascularย insulin-like Growth Factor 1 Resistance
  1058. Differences in gene expression between young and adult mice may play a protective role againstย insulinย resistance in the setting of high fat diet-inducedย obesity.
  1059. DIFFERENCES OF HOMEOSTASIS MODEL ASSESMENT-insulinย RESISTANCE (HOMA-IR) LEVELS BETWEENย obesityย PREGNANT WOMEN WITH THE โ€ฆ
  1060. Different Expression of Duodenal Genes Related toย insulinย Resistance Between Nonobese Women and Those with Severeย obesity
  1061. Different genes forย obesityย are associated withย insulinย loss of regulation of the membrane (Ca2++ Mg2+)-ATPase in theย obesityย syndrome. Lessons from animal โ€ฆ
  1062. Differential association between S100A4 levels andย insulinย resistance in prepubertal children and adult subjects with clinically severeย obesity
  1063. Differential effects of exposure to maternalย obesityย or maternal weight loss during the periconceptional period in the sheep onย insulinย signalling molecules in โ€ฆ
  1064. Differential effects ofย insulinย resistance on leucine and glucose kinetics inย obesity
  1065. Differential effects of maternalย obesityย and weight loss in the periconceptional period on the epigenetic regulation of hepaticย insulinโ€signaling pathways in the offspring
  1066. Differential expression ofย insulinย receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-inducedย obesity
  1067. Differential hepatic distribution ofย insulinย receptor substrates causes selectiveย insulinย resistance in diabetes andย obesity
  1068. Differential impact ofย insulinย andย obesityย on cardiovascular risk factors in non-diabetic subjects.
  1069. Differential impact of simple childhoodย obesityย on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis
  1070. Differential regulation of the p80 tumor necrosis factor receptor in humanย obesityย andย insulinย resistance
  1071. Differentiation betweenย obesityย andย insulinย resistance in the association with C-reactive protein
  1072. Difficult Intubation Rates in Relation to Diabetes,ย insulinย Dependency, andย obesity
  1073. Diminished anabolic signaling response toย insulinย induced by intramuscular lipid accumulation is associated with inflammation in aging but notย obesity
  1074. Diminished hepaticย insulinย removal inย obesity
  1075. Discordant effects on centralย obesity, hepaticย insulinย resistance, and alanine aminotransferase of lowโ€dose metformin and thiazolidinedione combination therapy in โ€ฆ
  1076. Discovery of a potent SCAP degrader that ameliorates HFD-inducedย obesity, hyperlipidemia andย insulinย resistance via an autophagy-independent lysosomal pathway
  1077. Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restoreย insulinย Sensitivity in the Diet-Inducedย obesityย in Vivo Mouse Model
  1078. Discrimination betweenย obesityย andย insulinย resistance in the relationship with adiponectin
  1079. Disruption of CXC motif chemokine ligand-14 in mice amelioratesย obesity-inducedย insulinย resistance
  1080. Disruption of GIP/GIPR axis in human adipose tissue is linked toย obesityย andย insulinย resistance
  1081. Disruption of TBP-2 amelioratesย insulinย sensitivity and secretion without affectingย obesity
  1082. Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat dietโ€“inducedย obesityย andย insulinย resistance in mice
  1083. Dissecting the relationship betweenย obesityย and hyperinsulinemia: role ofย insulinย secretion andย insulinย clearance
  1084. Dissociation between high fat diet-inducedย obesityย (DIO) andย insulinย resistance: lessons from AHNAK knockout mice
  1085. Dissociation ofย obesityย andย insulinย resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1
  1086. Distinct gene signatures predictย insulinย resistance in young mice with high fat diet-inducedย obesity
  1087. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development ofย obesityย andย insulinย resistance
  1088. Distribution of subcutaneous fat predictsย insulinย action inย obesityย in sexโ€specific manner
  1089. Diurnal GIP, PP andย insulinย levels in morbidย obesityย before and after stapled gastric partitioning with gastro-gastrostomy.
  1090. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon andย insulinย in human morbidย obesity.
  1091. Diurnal variation in vascular and metabolic function in diet-inducedย obesity: divergence ofย insulinย resistance and loss of clock rhythm
  1092. DNA methylation of FKBP5 in South African women: associations withย obesityย andย insulinย resistance
  1093. DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence ofย obesityย andย insulinย resistance
  1094. DNA methylation of the LY86 gene is associated withย obesity,ย insulinย resistance, and inflammation
  1095. DNA polymorphism of theย insulinย gene, diabetes, and severeย obesity
  1096. Do Cardiorespiratory Fitness and Abdominalย obesityย Mediate the Exercise-Induced Change inย insulinย Sensitivity in Older Adults?
  1097. Do flavanols-rich natural products relieveย obesity-relatedย insulinย resistance?
  1098. Do nutrientโ€“gutโ€“microbiota interactions play a role in humanย obesity,ย insulinย resistance and type 2 diabetes?
  1099. Doย obesityย and non-insulinย dependent diabetes mellitus aggravate exercise-induced microproteinuria?
  1100. Doย obesityย and physical inactivity underlie theย insulinย resistance of aging?
  1101. Does aging intensify theย insulinย resistance of humanย obesity?
  1102. Does cardiorespiratory fitness attenuate the adverse effects of severe/morbidย obesityย on cardiometabolic risk andย insulinย resistance in children? A pooled analysis
  1103. Does inflammation mediate the association betweenย obesityย andย insulinย resistance?
  1104. Doesย insulinย concentration modify the outcome of dietary intervention in young adults withย obesity?
  1105. Doesย insulinย explain the relation between maternalย obesityย and poor lactation outcomes? An overview of the literature
  1106. Does Leptin Affect Directly Blood Pressure in Obese Hypertensive Women-Influence ofย insulinย and Different Methods ofย obesityย Assessment
  1107. Does microvascular dysfunction linkย obesityย withย insulinย resistance and hypertension?
  1108. Doesย obesityย change the effect of aromatase inhibitors (AIs) on estradiol, leptin,ย insulin, and IGF-1 serum levels in breast cancer patients?
  1109. Doesย obesityย play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, andย insulinย resistance?
  1110. Dose-dependent effect of octreotide onย insulinย secretion after OGTT inย obesity
  1111. Double Incretin Receptor Knockout Mice Are Protected from Diet-Inducedย obesityย andย insulinย Resistance.
  1112. Double-stranded RNA-activated protein kinase is a key modulator ofย insulinย sensitivity in physiological conditions and inย obesityย in mice
  1113. Down-regulation of adipose 11 [beta] HSD1 mediates theย insulinย sensitising effects of salicylate inย obesity
  1114. Down-regulation of MicroRNA-592 inย obesityย contributes to hyperglycemia andย insulinย resistance
  1115. DPP-4 inhibition by linagliptin attenuatesย obesity-related inflammation andย insulinย resistance by regulating M1/M2 macrophage polarization
  1116. DPP-4 inhibition by linagliptin attenuatesย obesity-related inflammation andย insulinย resistance by regulating M1/M2 macrophage polarization
  1117. DPP-4 inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renalย insulinย resistance inย obesityย and diabetes
  1118. DPP4 deletion in adipose tissue improves hepaticย insulinย sensitivity in diet-inducedย obesity
  1119. DsbA-L preventsย obesity-induced inflammation andย insulinย resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway
  1120. Dual CCR2/5 antagonist attenuatesย obesityโ€inducedย insulinย resistance by regulating macrophage recruitment and M1/M2 status
  1121. Duration ofย obesityย and risk of non-insulin-dependent diabetes mellitus
  1122. Duration ofย obesityย is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia
  1123. Dynamic changes inย insulinย and glucagon during disease progression in rhesus monkeys withย obesityโ€related type 2 diabetes mellitus
  1124. Dynamics ofย insulinย secretion and the clinical implications forย obesityย and diabetes
  1125. Dynamics ofย insulinย secretion inย obesityย and diabetes
  1126. Dyslipidemia,ย obesity,ย insulinย Resistance and Atherosclerosis in LDL-Receptor Deficient Rats
  1127. Dysregulation of glucose,ย insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominalย obesity
  1128. Dysregulation of Glycogen Synthase COOH- and NH2-Terminal Phosphorylation byย insulinย inย obesityย and Type 2 Diabetes Mellitus
  1129. Dysregulation ofย insulinย receptor substrate 2 in ฮฒ cells and brain causesย obesityย and diabetes
  1130. Dysregulation of microRNA-125a contributes toย obesity-associatedย insulinย resistance and dysregulates lipid metabolism in mice
  1131. E. The Influence ofย obesityย onย insulinย Signaling at
  1132. E028: Leptin,ย obesity,ย insulinย resistance and intraerythrocyte sodium content in hypertensive syndrome
  1133. Early changes in postprandialย insulinย secretion, not inย insulinย sensitivity, characterize juvenileย obesity
  1134. Early Clinical Indicators of Metabolic Syndrome andย insulinย Resistance in A Cohort of Greek Children withย obesity
  1135. Early diet,ย insulin-like growth factor-1, growth and laterย obesity
  1136. Early effects of roflumilast onย insulinย sensitivity in adults with prediabetes and overweight/obesityย involve age-associated fat mass lossโ€“results of an โ€ฆ
  1137. Early intervention of N-acetylcysteine better improvesย insulinย resistance in diet-inducedย obesityย mice
  1138. Early kinetic abnormalities of apoB-containing lipoproteins inย insulin-resistant women with abdominalย obesity
  1139. Early mitochondrial adaptations in skeletal muscle to diet-inducedย obesityย are strain dependent and determine oxidative stress and energy expenditure but notย insulinย โ€ฆ
  1140. Early response of plasmaย insulinย to small doses of intravenous glucose: Effect ofย obesity
  1141. Early-life stress and the development ofย obesityย andย insulinย resistance in juvenile bonnet macaques
  1142. Early-onsetย obesityย dysregulates pulmonary adipocytokine/insulinย signaling and induces asthma-like disease in mice
  1143. Eating competence is associated with lower prevalence ofย obesityย and betterย insulinย sensitivity in finnish adults with increased risk for type 2 diabetes: The stopdia โ€ฆ
  1144. Eating habits of preschool children and the risk ofย obesity,ย insulinย resistance and metabolic syndrome in adults
  1145. Ecscr regulatesย insulinย sensitivity and predisposition toย obesityย by modulating endothelial cell functions
  1146. Ectopic UCP1 overexpression in white adipose tissue improvesย insulinย sensitivity in Lou/C rats, a model ofย obesityย resistance
  1147. Editorial (Thematic Issue: Vascular Dysfunction inย obesityย andย insulinย Resistance)
  1148. Editorial [Hot Topic: New Insight inย obesityย andย insulinย Resistance (Guest Editor: Geltrude Mingrone)]
  1149. Effect of 3-month L-arginine supplementation onย insulinย resistance and tumor necrosis factor activity in patients with visceralย obesity
  1150. Effect of 7 days of exercise on exogenous carbohydrate oxidation andย insulinย resistance in children withย obesity
  1151. EFFECT OF 8 WEEKS OF AEROBIC INTERVAL TRAINING ON LEVELS OF LIPOCALIN-2, GLUCOSE,ย insulinย ANDย insulinย RESISTANCE INย obesityย WOMEN
  1152. Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids andย insulinย sensitivity in adults with mild abdominalย obesity
  1153. Effect of a high protein/low glycaemic index diet onย insulinย resistance in adolescents with overweight/obesityโ€”A PREVIEW randomized clinical trial
  1154. Effect of a long term very low calorie diet on glucose/insulinย metabolism inย obesity. Influence of fat distribution on hepaticย insulinย extraction.
  1155. Effect of abdominalย obesityย onย insulinย resistance and the components of the metabolic syndrome: evidence supportingย obesityย as the central feature
  1156. Effect of acetylsalicylic acid on inflamed adipose tissue.ย insulinย resistance and hepatic steatosis in a mouse model of diet-inducedย obesity
  1157. Effect of acupoint catgut embedding on TNF-alpha andย insulinย resistance in simpleย obesityย patients
  1158. Effect of Acupoint Catgut Embedding on TNF-ฮฑ andย insulinย Resistance in Simpleย obesityย Patients [J]
  1159. Effect of acupoint thread embedding on blood lipids andย insulinย in simpleย obesity
  1160. Effect of acupoint thread embedding on the peripheral serum leptin andย insulinย levels in simpleย obesityย patients
  1161. Effect of acupuncture on blood serum leptin andย insulinย in a rat model ofย obesityย [J]
  1162. Effect of acupuncture on serumย insulinย level in the patient of simpleย obesity
  1163. EFFECT OF AEROBIC TRAINING PROGRAM ONย obesityย ANDย insulinย RESISTANCE IN YOUNG WOMEN WITH POLYCYSTIC OVERY SYDROME
  1164. Effect of age andย obesityย on fasting levels of glucose,ย insulin, glucagon, and growth hormone in man
  1165. Effect of aging andย obesityย onย insulinย responsiveness and glut-4 glucose transporter content in skeletal muscle of Fischer 344ร— Brown Norway rats
  1166. Effect of an alcohol-free beer enriched with isomaltulose and a resistant dextrin onย insulinย resistance in diabetic patients with overweight orย obesity
  1167. Effect of antioxidant treatment on some indicators ofย obesity-induced changes inย insulinย sensitivity and beta-cell function in New Zealand white rabbits.
  1168. Effect of ARHGAP21 reduction upon glucose-insulinย homeostasis and body composition of diet-inducedย obesityย in C57BL/6 mice
  1169. Effect of avocado soybean unsaponifiables onย insulinย secretion andย insulinย sensitivity in patients withย obesity
  1170. Effect of Bloodletting Cupping on the Serumย insulinย Level in Simpleย obesity
  1171. Effect of bromocriptine onย insulin, growth hormone and prolactin responses to arginine inย obesity
  1172. Effect of Cabergoline on Body Weight, Glycemic Control andย insulinย Resistance in Patient withย obesityย and Prediabetes
  1173. Effect of combination of irbesartan with amlodipine on serum leptin level andย insulinย sensitivity in youngย obesity-associated hypertensive patients [J]
  1174. Effect of common genetic variants of growth arrest-specific 6 gene onย insulinย resistance,ย obesityย and type 2 diabetes in an Asian population
  1175. Effect of Comprehensive Intervention Therapy of Losing Weight on Blood Leptin, Blood Lipid, Blood Glucose,ย insulinย in Adolescent Girl Students with Simpleย obesity
  1176. Effect of Curcuma longa L. on theย obesityย andย insulinย resistance in Sprague-Dawley rats and db/db mice
  1177. #VALUE!
  1178. Effect of diet-inducedย obesityย and experimental hyperinsulinemia onย insulinย uptake into CSF of the rat
  1179. Effect of diet-inducedย obesityย on glucose andย insulinย tolerance of a rodent with a lowย insulinย response (Acomys cahirinus)
  1180. Effect of doxazosin onย insulinย resistance in hypertensive patients withย obesity
  1181. Effect of electroacupuncture and diet adjusting onย insulinย resistance in rats with nutritionย obesity
  1182. Effect of Endogenousย insulinย Levels on Serum Testosterone, Glycemic, andย obesityย Parameters in Premenopausal Women with Type 2 Diabetes Mellitus
  1183. Effect of endostatin andย insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction withย obesityย under the influence of zofenopril
  1184. Effect of experimental reducing fat on leptin resistance andย insulinย resistance in adolecent girl students with simpleย obesity
  1185. Effect of high-fat-diet on serum glucose, triglyceride, leptin andย insulinย sensitivity inย obesity-susceptible andย obesity-resistant rats.[J]
  1186. Effect ofย insulinย on oxidative and nonoxidative pathways of free fatty acid metabolism in humanย obesity
  1187. Effect ofย insulinย on postradiationย obesityย of bone marrow
  1188. Effect ofย insulinย on stimulated lipolysis inย obesityย with normal carbohydrate tolerance and unimpaired thyroid function.
  1189. Effect ofย insulinย therapy andย obesityย on colon adenoma and advanced adenoma among type II diabetes mellitus population
  1190. Effect ofย insulinโ€“glucose metabolism compared withย obesityย on adipose omentin gene expression in different models of diabetic C57BL/6 mice
  1191. Effect of inulin-type carbohydrates onย insulinย resistance in patients with type 2 diabetes andย obesity: a systematic review and meta-analysis
  1192. Effect of irbesartan and hydrochlorothiazide onย insulinย resistance and lipid in hypertensive patients withย obesity
  1193. Effect of long term tolbutamide treatment on glucose tolerance andย insulinย secretion in maturity-onset diabetes withoutย obesity
  1194. Effect of maternalย obesityย onย insulinย action in male adult offspring rats
  1195. Effect of meridian tuina on serumย insulinย and triglyceride of 50 simpleย obesityย patients
  1196. Effect of naloxone on beta-endorphin andย insulinย concentrations during glucose tolerance testing in patients with simpleย obesity
  1197. Effect of naltrexone treatment onย insulinย secretion,ย insulinย action and postprandial thermogenesis inย obesity
  1198. Effect ofย obesityย and body fat distribution on sex hormones andย insulinย in men
  1199. Effect ofย obesityย and glycemic control on serum lipocalins andย insulin-like growth factor axis in type 2 diabetic patients
  1200. Effect ofย obesityย andย insulinย on immunity in non-insulin-dependent diabetes mellitus
  1201. Effect ofย obesityย andย insulinย Resistance Factor on Lipid Metabolism in Women with Polycystic Ovary Syndrome
  1202. Effect ofย obesityย andย insulinย resistance on diabetic control
  1203. Effect ofย obesityย andย insulinย resistance on myocardial substrate metabolism and efficiency in young women
  1204. Effect ofย obesityย andย insulinย resistance on resting and glucose-induced thermogenesis in man
  1205. Effect ofย obesityย andย insulinย sensitivity on adiponectin isoform distribution
  1206. Effect ofย obesityย andย insulinย Sensitivity on Adiponectin Isoform Distribution.
  1207. Effect ofย obesityย and of starvation onย insulinย activity
  1208. Effect ofย obesityย and type 2 diabetes on protein anabolic response toย insulinย in elderly women
  1209. Effect ofย obesityย and weight loss on the arginine vasopressin response toย insulinโ€induced hypoglycaemia
  1210. Effect ofย obesityย Intervention Programs on Adipokines,ย insulinย Resistance, Lipid Profile and Low Grade Inflammation in 3-to 5-Year-Old Children
  1211. Effect ofย obesityย intervention programs on adipokines,ย insulinย resistance, lipid profile, and low-grade inflammation in 3-to 5-y-old children
  1212. Effect ofย obesityย on ambient plasma glucose, free fatty acid,ย insulin, growth hormone, and glucagon concentrations
  1213. Effect ofย obesityย onย insulinย resistance in normal subjects and patients with NIDDM
  1214. Effect ofย obesityย onย insulinย Secretion in Response to a 48-Hour Physiological Increase in Plasma FFA in Mexican-American Subjects Genetically Predisposed Type 2 โ€ฆ
  1215. Effect ofย obesityย onย insulinย sensitivity of human adipose tissue
  1216. Effect ofย obesityย onย insulinย signaling through JAK2 in rat aorta
  1217. Effect ofย obesityย on Left Ventricular Functions in Patients With Nonย insulinย Dependent Diabetes Mellitus
  1218. Effect ofย obesityย on plasmaย insulin-like growth factor-I in cancer patients.
  1219. Effect ofย obesityย on susceptibility to fatty acidโ€“induced peripheral tissueย insulinย resistance
  1220. Effect ofย obesityย on the response toย insulinย therapy in noninsulin-dependent diabetes mellitus
  1221. Effect ofย obesityย on Tissue Expression of Growth Hormone (GH) Receptor andย insulin-like Growth Factor-I RNA
  1222. Effect ofย obesityย on total and freeย insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3,ย insulin, and growth hormone
  1223. #VALUE!
  1224. Effect of oral inulin administration on lipid profile andย insulinย sensitivity in subjects withย obesityย and dyslipidemia
  1225. Effect of pharmacological suppression ofย insulinย secretion on tissue sensitivity toย insulinย in subjects with moderateย obesity.
  1226. Effect of physical training onย insulinย action inย obesity
  1227. Effect of piperine inย obesityย inducedย insulinย resistance and type-II diabetes mellitus in rats.
  1228. Effect of pomegranate juice onย insulinย secretion and sensitivity in patients withย obesity
  1229. Effect of prolonged fasting glucose andย insulinย metabolism in exogenousย obesity
  1230. Effect of rosiglitazone on the differential expression ofย obesityย andย insulinย resistance associated proteins in lep/lep mice
  1231. Effect of Roux-en-Y bariatric surgery on lipoproteins,ย insulinย resistance, and systemic and vascular inflammation inย obesityย and diabetes
  1232. Effect of seyoeum onย obesity,ย insulinย resistance, and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice
  1233. Effect of tea polyphones on serum leptin,ย insulinย and blood lipids in rats withย obesityย [J]
  1234. Effect of the intake of dietary protein onย insulinย resistance in subjects withย obesity: a randomized controlled clinical trial
  1235. Effect of ursolic acid onย insulinย resistance and hyperinsulinemia in rats with diet-inducedย obesity: role of adipokines expression
  1236. Effect of ursolic acid onย obesity-inducedย insulinย resistance in rat liver
  1237. Effect of Vitamin D Supplementation onย obesityโ€Inducedย insulinย Resistance: A Doubleโ€Blind, Randomized, Placeboโ€Controlled Trial
  1238. Effect of Weight Loss and Triiodothyronine on Plasma Growth Hormone andย insulinย inย obesity.
  1239. Effect of weight reduction on metabolic products of carbohydrate and fat metabolism and on the behaviour of serumย insulinย inย obesity.
  1240. Effects of 12-week circuit exercise program onย obesityย index, appetite regulating hormones, andย insulinย resistance in middle-aged obese females
  1241. Effects of 12-week circuit exercise program onย obesityย index, appetite regulating hormones, andย insulinย resistance in middle-aged obese females
  1242. Effects of 14-day infusions of growth hormone and/orย insulin-like growth factor I on theย obesityย of growing Zucker rats
  1243. Effects of a Eucaloric Low Glycemic Index Diet onย insulinย Sensitivity and Intramyocellular Lipid Content in Adults with Abdominalย obesity
  1244. Effects of acute exercise onย insulinย binding to monocytes inย obesity
  1245. Effects of Age andย obesityย onย insulinย Binding to Isolated Adipocytes12
  1246. Effects of age, diet andย obesityย onย insulinย secretion from isolated perfused rat pancreas: Response to glucose, arginine and glucagon-like peptide 1 (7-37)
  1247. Effects of aging andย obesityย onย insulinย secretion and sensitivity
  1248. Effects of astragalus polysaccharides onย insulinย sensitivity inย obesityย rats fed with high-fat diet
  1249. Effects of bariatric surgery on preclinical myocardial alterations in severeย obesityย and the related role ofย insulinย resistance
  1250. Effects of caloric restriction and exercise ofย insulinย receptors inย obesity: Association with changes in membrane lipids
  1251. Effects of castration-induced visceralย obesityย and antioxidant treatment on lipid profile andย insulinย sensitivity in New Zealand white rabbits
  1252. Effects of changes in body weight andย insulinย resistance on inflammation and endothelial function in morbidย obesityย after bariatric surgery
  1253. Effects of childhood malnutrition on the increase of risk factors forย obesity, non-insulinย dependent diabetes mellitus and coronary heart disease
  1254. Effects of cholinergic blockade by pirenzepine onย insulinย and glucose response to oral and intravenous glucose and to arginine load inย obesity
  1255. Effects of Curcumin onย insulinย Resistance in Simpleย obesityย Rats
  1256. Effects of diet-inducedย obesityย on protein expression inย insulinย signaling pathways of skeletal muscle in male Wistar rats
  1257. Effects of Dietโ€inducedย obesityย on Protein Expressions ofย insulinย Signalling Pathways in the Skeletal Muscle of Male Wistar Rats
  1258. Effects of dietary fat energy restriction and fish oil feeding on hepatic metabolic abnormalities andย insulinย resistance in KK mice with high-fat diet-inducedย obesity
  1259. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, andย insulinย kinetics in children withย obesity
  1260. Effects of Difference Chinese Medicinal Herbs for Tonifying Spleen onย obesityย Degree andย insulinย Resistance in Diet-inducedย obesityย Rats
  1261. Effects of different diets used in diet-inducedย obesityย models onย insulinย resistance and vascular dysfunction in C57BL/6 mice
  1262. Effects of different intensity exercise on blood glucose, adolescentย obesityย ratsย insulinย sensitivity and RBP4
  1263. Effects of electroacupuncture onย insulinย resistance and hypothalamicย insulinย signal molecule in rats with diet-inducedย obesity
  1264. Effects of electroacupuncture onย insulinย resistance and hypothalamicย insulinย signal molecule in rats with diet-inducedย obesity
  1265. Effects of estrogen on high-fat diet-inducedย obesityย andย insulinย resistance in ovariectomized rats
  1266. Effects of exercise modality onย insulinย resistance and ectopic fat in adolescents with overweight andย obesity: a randomized clinical trial
  1267. Effects of fasting onย insulinย secretion and glucose tolerance inย obesity.
  1268. Effects of free fatty acids onย insulinย secretion inย obesity
  1269. Effects of FTOSNPrs9939609 on Body Composition andย insulinย Resistance in Overweight andย obesityย Male College students
  1270. Effects of glucose load and/or arginine onย insulinย and growth hormone secretion in hyperprolactinemia andย obesity
  1271. Effects ofย insulinย and exercise training on FGF21, its receptors and target genes inย obesityย and type 2 diabetes
  1272. Effects ofย insulinย gene dosage on murineย obesityย and lifespan
  1273. Effects ofย insulinย Level on Dyslipidemia in Children with Simpleย obesity
  1274. Effects ofย insulinย resistance andย obesityย on lipoproteins and sensitivity to egg feeding
  1275. Effects of Inula helenium on Inflammation andย insulinย Resistance inย obesity-inducedย insulinย Resistance Mouse by High Fat Diet
  1276. Effects of Longโ€Term Soy vs Casein Protein Intake andย obesityย on Serumย insulinโ€Like Growth Factor 1 (IGFโ€1) and IGFBPโ€3 Levels using Obese Female Zucker Rat โ€ฆ
  1277. Effects of losartan on whole body, skeletal muscle and vascularย insulinย responses inย obesity/insulinย resistance without hypertension
  1278. Effects of maresin 1 on adipose tissue inflammation andย insulinย resistance onย obesity: characterization of mechanisms involved
  1279. Effects of massiveย obesityย onย insulinย sensitivity andย insulinย clearance and the metabolic response toย insulinย as assessed by the euglycemic clamp technique
  1280. Effects of mazindol on carbohydrate andย insulinย metabolism inย obesity
  1281. Effects of metformin and rosiglitazone on peripheralย insulinย resistance and ฮฒ-cell function inย obesity: A double-blind, randomized, controlled study
  1282. Effects of metformin and rosiglitazone on peripheralย insulinย resistance and ฮฒ-cell function in patients with simpleย obesityย [J]
  1283. Effects of Momordica charantia onย insulinย resistance and visceralย obesityย in mice on high-fat diet
  1284. Effects of monosodium glutamateโ€inducedย obesityย in mice on carbohydrate metabolism inย insulinย secretion
  1285. Effects of morbidย obesityย onย insulinย clearance andย insulinย sensitivity in several aspects of metabolism as assessed by low-doseย insulinย infusion
  1286. Effects of murine norovirus infection on a mouse model of diet-inducedย obesityย andย insulinย resistance
  1287. Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol inย obesityโ€“insulinย resistance โ€ฆ
  1288. Effects of naloxone-induced opiate receptors blockade onย insulinย secretion inย obesity
  1289. Effects ofย obesityย and exercise training on mitochondrial function andย insulinย resistance in aging skeletal muscle
  1290. Effects ofย obesityย and exercise training on mitochondrial function andย insulinย resistance in aging skeletal muscle
  1291. Effects ofย obesityย and Gender onย insulinย Receptor Expression in Liver of SHHF/Mccโ€FACP Rats
  1292. Effects ofย obesityย and inheritance on the development of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima fatty rats
  1293. Effects ofย obesityย Andย insulinย on Tissue-Specific Recycling Between Cortisol And Cortisone in Men
  1294. Effects ofย obesityย and ovarian steroids onย insulinย secretion and removal in sheep
  1295. Effects ofย obesityย and shortโ€term dietary manipulations on serumย insulinย and leptin levels in female Zucker rats following DMBA treatment
  1296. Effects ofย obesityย and weight reduction on serumย insulinย levels
  1297. Effects ofย obesityย onย insulinย and glucose metabolism in cyclic heifers
  1298. Effects ofย obesityย onย insulinย resistance in patients with hypertension
  1299. Effects ofย obesityย onย insulinย resistance, ฮฒ-cell function and serum high-sensitivity C-reactive protein level in first-degree relatives of type 2 diabetic patients
  1300. Effects ofย obesityย onย insulinย sensitivity and responsiveness in sheep
  1301. Effects ofย obesityย onย insulin:ย insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
  1302. Effects ofย obesityย on metabolic and cardiovascular outcomes followingย insulinย initiation in patients with type 2 diabetes
  1303. Effects ofย obesityย on pancreatic ฮฒ cell function andย insulinย function
  1304. Effects ofย obesityย on Serumย insulinโ€Like Growth Factor 1 (IGFโ€1) Levels Using DMBAโ€Induced Ovariectomized Zucker Rat Model.
  1305. Effects ofย obesityย surgery on nonโ€“insulin-dependent diabetes mellitus
  1306. Effects ofย obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone andย insulinย secretion: evidence for the existence of a growth hormone โ€ฆ
  1307. Effects ofย obesity, hyperinsulinemia, and glucose intolerance onย insulinย action in adipose tissue of sixty-year-old men
  1308. Effects ofย obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, andย insulinย resistance in the National Health and Nutrition Survey โ€ฆ
  1309. Effects of Omega-3 Fatty Acids onย insulinย Resistance in an Ovariectomized Mouse Model of Diet-Inducedย obesityย Treated with Chemotherapy
  1310. Effects of physical activity onย insulinย action and glucose tolerance inย obesity.
  1311. Effects of Physical Activity on The Inflammatory Process Related toย insulinย Resistance andย obesity
  1312. Effects of physical exercise in molecular parameters of the route ofย obesityย andย insulinย signaling
  1313. Effects of pioglitazone and metformin on body weight and theย insulinย resistance parameters in young patients withย obesity
  1314. Effects of pioglitazone on adipose tissue remodeling within the setting ofย obesityย andย insulinย resistance
  1315. Effects of potassium supplementation onย insulinย binding andย insulinย action in humanย obesity: proteinโ€modified fast and refeeding
  1316. Effects of probiotics and synbiotics onย obesity,ย insulinย resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials
  1317. Effects of recombinant humanย insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone inย obesity
  1318. Effects of starvation andย obesityย on somatostatin,ย insulin, and glucagon release from an isolated perfused organ system
  1319. Effects of sucrose vs starch diets on in vivoย insulinย action, thermogenesis, andย obesityย in rats
  1320. Effects of sucrose vs starch diets on in vivoย insulinย action, thermogenesis, andย obesityย in rats14
  1321. Effects of Tea Pigments on Rat Models withย obesity-inducedย insulinย Resistance [J]
  1322. Effects of telmisartan on body fat, serum lipids andย insulinย resistance in patients withย obesityย hypertension [J]
  1323. Effects of telmisartan onย insulinย resistance and visceral fat distribution in Chinese hypertensive patients withย obesity
  1324. Effects of the 11beta hydroxysteroid dehydrogenase inhibitor carbenoxolone onย insulinย sensitivity in humanย obesity
  1325. Effects of the Magenstrasse and Mill operation forย obesityย on plasma leptin andย insulinย resistance
  1326. Effects of the Magenstrasse and Mill operation forย obesityย on plasma plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrinogen andย insulin
  1327. Effects of various natural sweeteners onย insulinย resistance, inflammation and liver steatosis in a rat model of dietโ€inducedย obesity
  1328. Effects of vitamin D supplementation and circuit training on indices ofย obesityย andย insulinย resistance in T2D and vitamin D deficient elderly women
  1329. Effects of weight loss after bariatric surgery for morbidย obesityย on vascular endothelial growth factor-A, adipocytokines, andย insulin
  1330. Effects of weight loss in massiveย obesityย onย insulinย and C-peptide dynamics: sequential changes inย insulinย production, clearance, and sensitivity
  1331. Effects of weight loss on regional fat distribution andย insulinย sensitivity inย obesity.
  1332. Effects of Zataria oxymel onย obesity,ย insulinย resistance and lipid profile: A randomized, controlled, triple-blind trial
  1333. Efficacy of exenatide combined withย insulinย glargine in newly diagnosed type 2 diabetes patients withย obesity
  1334. Elevated adipose tissue associated IL-2 expression inย obesityย correlates with metabolic inflammation andย insulinย resistance
  1335. Elevated adipose tissue associated IL-2 expression inย obesityย correlates with metabolic inflammation andย insulinย resistance
  1336. Elevated alanine aminotransferase in current national football league players: correlation with cardiometabolic syndrome markers,ย obesity, andย insulinย resistance.
  1337. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker ofย obesityย andย insulinย resistance in prepubertal children
  1338. Elevated circulating microRNA-122 is associated withย obesityย andย insulinย resistance in young adults
  1339. Elevated fastingย insulinย concentrations associate with impairedย insulinย signaling in skeletal muscle of healthy subjects independent ofย obesity
  1340. Elevated fastingย insulinย levels increase the risk of abdominalย obesityย in Korean men
  1341. Elevated interleukin-18 levels are associated with the metabolic syndrome independent ofย obesityย andย insulinย resistance
  1342. ELEVATED INTERLUKIN-6 LEVELS AS A CONSEQUENCE, NOT THE CAUSE OFย obesityย ANDย insulinย RESISTANCE
  1343. Elevated LDL-Cholesterol Level Predicts Diabetes in Centrally Obese Women but Not Men Relative Roles ofย insulinย Resistance and Centralย obesity
  1344. Elevated levels of TWEAK in skeletal muscle promote visceralย obesity,ย insulinย resistance, and metabolic dysfunction
  1345. Elevated sensitivity to diet-inducedย obesityย andย insulinย resistance in mice lacking 4E-BP1 and 4E-BP2
  1346. Elevated serum TNF-ฮฑ is related toย obesityย in type 2 diabetes mellitus and is associated with glycemic control andย insulinย resistance
  1347. Elevated soluble intercellular adhesion molecule-1 levels inย obesity: relationship toย insulinย resistance and tumor necrosis factor-[alpha] system activity
  1348. Elevations of plasma methylarginines inย obesityย and ageing are related toย insulinย sensitivity and rates of protein turnover
  1349. Emerging evidence for beneficial macrophage functions in atherosclerosis andย obesity-inducedย insulinย resistance
  1350. Emerging perspectives on essential amino acid metabolism inย obesityย and theย insulin-resistant state
  1351. Emerging role of adipose tissue hypoxia inย obesityย andย insulinย resistance
  1352. Emerging role of aldosterone in mediating the vicious cycle ofย obesity,ย insulinย resistance and metabolic syndrome
  1353. Emerging role of AMPK in brown and beige adipose tissue (BAT): implications forย obesity,ย insulinย resistance, and type 2 diabetes
  1354. Emerging roles of SGLT2 inhibitors inย obesityย andย insulinย resistance: Focus on fat browning and macrophage polarization
  1355. Empagliflozin reversesย obesityย andย insulinย resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
  1356. Endocrine disturbances in childhoodย obesity: growth-hormone and cortisol response toย insulinย induced hypoglycemia
  1357. Endogenous epinephrine protects againstย obesityย inducedย insulinย resistance
  1358. Endoplasmic reticulum chaperone GRP78 regulates macrophage function andย insulinย resistance in dietโ€inducedย obesity
  1359. Endoplasmic reticulum stress linksย obesity,ย insulinย action, and type 2 diabetes
  1360. Endoplasmic reticulum stress: another link betweenย obesityย andย insulinย resistance/inflammation?
  1361. Endothelial dysfunction and diabetes: roles of hyperglycemia, impairedย insulinย signaling andย obesity
  1362. Endothelial dysfunction inย obesityย andย insulinย resistance: a road to diabetes and heart disease
  1363. Endothelial dysfunction,ย obesityย andย insulinย resistance
  1364. Endothelial nuclear factor ฮบB inย obesityย and aging: is endothelial nuclear factor ฮบB a master regulator of inflammation andย insulinย resistance?
  1365. Endothelinโ€1 in the pathophysiology ofย obesityย andย insulinย resistance
  1366. Endothelium-derived hyperpolarizing factors: a potential therapeutic target for vascular dysfunction inย obesityย andย insulinย resistance
  1367. Endotoxemia-mediated activation of acetyltransferase P300 impairsย insulinย signaling inย obesity
  1368. Endurance training andย obesity: effect on substrate metabolism andย insulinย sensitivity.
  1369. Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impairedย insulin-induced lowering of total rate of appearance inย obesityย and Type II โ€ฆ
  1370. Enhanced fat oxidation through physical activity is associated with improvements inย insulinย sensitivity inย obesity
  1371. Enhanced glucose-induced intracellular signaling promotesย insulinย hypersecretion: pancreatic beta-cell functional adaptations in a model of geneticย obesityย and โ€ฆ
  1372. Enhanced hepatic A-ring reduction of glucocorticoids inย obesity: Regulation by glucocorticoids andย insulin
  1373. Enhanced lipid oxidation and maintenance of muscleย insulinย sensitivity despite glucose intolerance in a diet-inducedย obesityย mouse model
  1374. Enhanced Lymphangiogenesis and Lymphatic Function Protects Dietโ€inducedย obesityย andย insulinย Resistance
  1375. Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-inducedย obesityย andย insulinย resistance
  1376. Enlarged subcutaneous abdominal adipocyte size, but notย obesityย itself, predicts type II diabetes independent ofย insulinย resistance
  1377. ENPP1 Variants and Haplotypes Predispose to Early Onsetย obesityย and Impaired Glucose andย insulinย Metabolism in German Obese Children
  1378. ENPP2 contributes to adipose tissue expansion andย insulinย resistance in diet-inducedย obesity
  1379. Environmental determinants ofย obesityย andย insulin-resistance
  1380. EP3 signaling is decoupled from regulation of glucose-stimulatedย insulinย secretion in ฮฒ-cells compensating forย obesityย andย insulinย resistance
  1381. Epicatechin downregulates adipose tissue CCL19 expression and thereby ameliorates diet-inducedย obesityย andย insulinย resistance
  1382. Epidemiologic study of centralย obesity,ย insulinย resistance and associated disturbances in the urban population of North India.
  1383. Epidemiologic study of diet and coronary risk factors in relation to centralย obesityย andย insulinย levels in rural and urban populations of north India
  1384. Epidemiological Study ofย obesityย and Metabolic Syndrome in Chinese Schoolchildren: Relationship withย insulinย Resistance and Adipocytokins.
  1385. Epidemiology,ย obesity, and non-insulin-dependent diabetes mellitus
  1386. Epigenetic germline inheritance of diet-inducedย obesityย andย insulinย resistance
  1387. Epigenetics: How doesย obesityย lead toย insulinย resistance?
  1388. Equineย obesityย and its role inย insulinย resistance, inflammation and risk for laminitis
  1389. #VALUE!
  1390. #VALUE!
  1391. Erectile dysfunction,ย obesity,ย insulinย resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting
  1392. #VALUE!
  1393. Erratum: Adipose tissue fatty acid chain length and mono-unsaturation increases withย obesityย andย insulinย resistance
  1394. Erratum: Higher glomerular filtration rate is related toย insulinย resistance but not toย obesityย in a predominantly obese non-diabetic cohort
  1395. Erratum: Impact of common polymorphisms in candidate genes forย insulinย resistance andย obesityย on weight loss of morbidly obese subjects after laparoscopic โ€ฆ
  1396. Erratum: Obstructive Sleep Apnea,ย insulinย Resistance, and Steatohepatitis in Severeย obesity
  1397. Erratum. APPL1 Counteractsย obesity-Induced Vascularย insulinย Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and โ€ฆ
  1398. Erratum. Loss of Mbd2 Protects Mice Against High-Fat Dietโ€“Inducedย obesityย andย insulinย Resistance by Regulating the Homeostasis of Energy Storage and โ€ฆ
  1399. Esculentin-2CHa-related peptides modulate islet cell function and improve glucose tolerance in mice with diet-inducedย obesityย andย insulinย resistance
  1400. Essential role of protein tyrosine phosphatase 1B inย obesityโ€induced inflammation and peripheralย insulinย resistance during aging
  1401. Established diet-inducedย obesityย in female rats leads to offspring hyperphagia, adiposity andย insulinย resistance
  1402. Establishment ofย obesityย Rat Animal Model with Leptin Resistance andย insulinย Resistance
  1403. Estimatingย insulinย sensitivity and beta cell function: perspectives from the modern pandemics ofย obesityย and type 2 diabetes
  1404. Estimation of the correlation ofย insulinย resistance and selected adipocytokines in children with simpleย obesityโ€“preliminary study
  1405. Estradiol: THE EMERGING EVIDENCE FOR A PROTECTIVE ROLE AGAINSTย insulinย RESISTANCE ANDย obesity.
  1406. Estrogen modulates adiposity and protects againstย obesity-associated inflammation, oxidative stress, andย insulinย resistance
  1407. Estrogen signaling prevents diet-induced hepaticย insulinย resistance in male mice withย obesity
  1408. Ethanol extract of propolis prevents high-fat diet-inducedย insulinย resistance andย obesityย in association with modulation of gut microbiota in mice
  1409. Ethnic differences in inflammation: Association withย obesityย andย insulinย resistance
  1410. Ethnic differences inย insulinย resistance, adiponectin levels and abdominalย obesity: Haitian Americans and African Americans, with and without type 2 diabetes โ€ฆ
  1411. Ethnic disparity in the relationship betweenย obesityย and plasmaย insulin-like growth factors: the multiethnic cohort
  1412. Ethnicity modifies the effect ofย obesityย onย insulinย resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women
  1413. Ethnicity modifies the relationships ofย insulinย resistance, inflammation, and adiponectin withย obesityย in a multiethnic Asian population
  1414. Etiopathogenesis of nonalcoholic steatohepatitis: role ofย obesity,ย insulinย resistance and mechanisms of hepatotoxicity
  1415. Evaluating a pragmatic estimate ofย insulinย sensitivity in Latino youth withย obesity
  1416. Evaluation of B-cell secretion and peripheralย insulinย resistance during pregnancy and after delivery in gestational diabetes mellitus withย obesity
  1417. Evaluation of existing and candidate measures ofย obesityย for detection ofย insulinย resistance and cardiometabolic risk among Asian Indians: Development of two โ€ฆ
  1418. Evaluation of four mathematical models of glucose andย insulinย dynamics with analysis of effects of age andย obesity
  1419. Evaluation of Ghrelin Levels in Polycystic Ovary Syndrome and the Correlation withย obesity,ย insulinย Resistance and Other Biochemical Features
  1420. #VALUE!
  1421. Evaluation ofย insulinย resistance in children and adolescent with moderate and severeย obesity.
  1422. Evaluation of Mn-superoxide dismutase and catalase gene expression in childhoodย obesity: its association withย insulinย resistance
  1423. Evaluation of neck circumference as a predictor of centralย obesityย andย insulinย resistance in Chinese adults
  1424. Evaluation of ovulation regularity in relation toย insulinย hematic levels, androgens andย obesityย in polycistic ovary syndrome
  1425. Evaluation of TG-HDL Ratio Instead of HOMA Ratio asย insulinย Resistance Marker in Overweight and Children withย obesity.
  1426. EVALUATION OF THE OFย insulinย RESISTANCE EFFECTS ONย obesityย AND RELATED PARAMETERS
  1427. Evaluation of the Relationship betweenย insulin, Vitamin D Levels and Dietary Habits in Adults with Normal Weight andย obesity
  1428. Evaluation of visfatin in patients withย obesity, metabolic syndrome,ย insulinย resistance and impaired glucose tolerance; case-control study
  1429. Evidence for association betweenย insulinย resistance and premature carotid atherosclerosis in childhoodย obesity
  1430. Evidence for recent increases inย obesityย and nonโ€insulinโ€dependent diabetes mellitus in a Navajo community
  1431. Evidence for two types of juvenileย obesityย on the basis of body composition andย insulinย release following small doses of glucose
  1432. Evidence in obese children: contribution of hyperlipidemia,ย obesity-inflammation, andย insulinย sensitivity
  1433. Evidence in obese children: contribution of tri-ponderal mass index or body mass index to dyslipidemia,ย obesity-inflammation, andย insulinย sensitivity
  1434. Evidence of early alterations in adipose tissue biology and function and its association withย obesity-related inflammation andย insulinย resistance in children
  1435. Evidence of increased visceralย obesityย and reduced physical fitness in healthyย insulin-resistant first-degree relatives of type 2 diabetic patients
  1436. Evidence thatย insulinย resistance is responsible for the decreased thermic effect of glucose in humanย obesity.
  1437. Evolution ofย obesityย andย insulinย resistance: relevance to PCOS
  1438. Evolutionary Aspects ofย obesity,ย insulinย Resistance, and Cardiovascular Risk
  1439. Exaggeratedย insulinย response to glucagon in simpleย obesity
  1440. Excessive gestational weight gain andย obesityย contribute to altered expression of maternalย insulin-like growth factor binding protein-3
  1441. Excessive serumย insulinย response to oral glucose inย obesityย and mild diabetes study of 501 patients
  1442. Exenatide therapy inย insulin-treated type 2 diabetes andย obesity
  1443. Exercise alleviates cognitive functions by enhancing hippocampalย insulinย signaling and neuroplasticity in high-fat diet-inducedย obesity
  1444. Exercise and dietary change ameliorate high fat diet inducedย obesityย andย insulinย resistance via mTOR signaling pathway
  1445. Exercise andย obesity-inducedย insulinย resistance in skeletal muscle
  1446. Exercise andย obesity-Inducedย insulinย Resistance in Skeletal Muscle
  1447. Exercise in aging: its important role in mortality,ย obesityย andย insulinย resistance
  1448. Exercise modifies microvascular reactivity toย insulinย in the OLETF rat, a rodent model of hyperphagiaโ€inducedย obesityย and type II diabetes
  1449. Exercise Program Improvesย insulinย Resistance and Functional Limitation in Sedentary Elderly Patients withย obesity
  1450. Exercise Reverses Diet-Inducedย obesityย andย obesity-Associatedย insulinย Resistance through the IKKฮฒ/NF-KB Pathway
  1451. Exercise Training Attenuates Sarcopenicย obesityโ€Inducedย insulinย Resistance and Mitochondrial Dysfunction in the Rat Skeletal Muscle
  1452. Exercise training reducesย insulinย resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of dietโ€inducedย obesityย rats
  1453. Exercise-induced improvement in vasodilatory function accompanies increasedย insulinย sensitivity inย obesityย and type 2 diabetes mellitus
  1454. Exerciseโ€induced reduction inย obesityย andย insulinย resistance in women: a randomized controlled trial
  1455. Exosomal transfer ofย obesityย adipose tissue for decreased miR-141-3p mediateย insulinย resistance of hepatocytes
  1456. Expanded normal weightย obesityย andย insulinย resistance in US adults of the National Health and Nutrition Examination Survey
  1457. Expansive vascular remodeling and increased vascular calcification response to cholecalciferol in a murine model ofย obesityย andย insulinย resistance
  1458. Experimental hypothalamic or geneticย obesityย in the non-insulin-dependent diabetic rat
  1459. Experimentalย obesityย in Man: Hyperaminoacidemia and Diminished Effectiveness ofย insulinย in Regulating Peripheral Amino Acid Release.
  1460. Experimental study on the mechanism of raspberry ketone on simpleย obesityย andย insulinย resistance relevant toย obesity
  1461. Exploring Phytotherapeutic Alternatives forย obesity,ย insulinย Resistance and Diabetes Mellitus
  1462. Exploring the use of adjusted body mass index thresholds based on equivalentย insulinย resistance for defining overweight andย obesityย in UK South Asian โ€ฆ
  1463. Exposure to maternalย obesityย during suckling outweighs in utero exposure in programming for post-weaning adiposity andย insulinย resistance in rats
  1464. Expression of a mutant prohibitin from the aP2 gene promoter leads toย obesity-linked tumor development inย insulinย resistance-dependent manner
  1465. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates withย insulinย sensitivity in humanย obesityย and type 2 diabetes
  1466. Expression of fatty-acid-handling proteins in human adipose tissue in relation toย obesityย andย insulinย resistance
  1467. Expression of FOXC2 in adipose tissues and its correlation withย obesityย andย insulinย resistance
  1468. Expression of S6K1 in human visceral adipose tissue is upregulated inย obesityย and related toย insulinย resistance and inflammation
  1469. Expression of Sirtuin 1 in visceral adipose tissue in Tibetan mini-pigs withย obesityย andย insulinย resistance induced by high fat/cholesterol diet
  1470. Expression of the centralย obesityย and type 2 diabetes mellitus genes is associated withย insulinย resistance in young obese children
  1471. Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) inย obesityย andย insulinย โ€ฆ
  1472. F-DIOย obesity-prone rat isย insulinย resistant beforeย obesityย onset
  1473. FABP4-Cre mediated expression of constitutively active ChREBP protects againstย obesity, fatty liver, andย insulinย resistance
  1474. Factor analysis of the metabolic syndrome:ย obesityย vsย insulinย resistance as the central abnormality
  1475. Factors associated withย insulinย resistance and fasting plasma ghrelin levels in adolescents withย obesityย and family history of type 2 diabetes
  1476. Factors associated withย insulinย resistance in patients with chronic HCV genotype 1 infection withoutย obesityย or type 2 diabetes
  1477. Factors Associated withย insulinย Resistance in Patients with Chronic HCV Genotype 1 Infection withoutย obesityย or Type 2 Diabetes
  1478. Factors Governing Development of Non-Alcoholic Fatty Liver Disease andย insulinย Resistance inย obesity
  1479. Factors governing development of nonalcoholic fatty liver disease andย insulinย resistance inย obesity
  1480. Familial and individual predictors ofย obesityย andย insulinย resistance in urban H ispanic children
  1481. Familial Diabetes Mellitus in Mice, Associated withย insulinย Resistanceย obesity, and Hyperplasia of the Islands of Langerhans
  1482. Familial juvenile autoimmune hypothyroidism, pituitary enlargement,ย obesity, andย insulinย resistance
  1483. Family with Sequence Similarity 13, Member A Protects Againstย obesity-Related Metabolic Disorder by Modulating the Adipocyteย insulinย Signaling
  1484. Family with Sequence Similarity 13, Member A Protects Againstย obesity-Related Metabolic Disorder by Modulating the Adipocyteย insulinย Signaling
  1485. Fanconi anemia links reactive oxygen species toย insulinย resistance andย obesity
  1486. Fas (CD 95) expression in myeloid cells promotesย obesityโ€induced muscleย insulinย resistance
  1487. Fas and FasL Expression in Human Adipose Tissue Is Related toย obesity,ย insulinย Resistance, and Type 2 Diabetes
  1488. Fast food, central nervous systemย insulinย resistance, andย obesity
  1489. Fastingย insulinย andย obesity-related phenotypes are linked to chromosome 2p: the Strong Heart Family Study
  1490. Fastingย insulinย level in obese children: relationship to comorbidities of childhoodย obesity
  1491. Fastingย insulinย resistance affects the prevalence of metabolically healthyย obesityย in Brazilian adolescents
  1492. Fastingย insulin, Glucose, and HbA1c Among Young Adults with Overweight andย obesity
  1493. Fasting serum free glycerol concentration is a potential surrogate marker of visceralย obesityย andย insulinย sensitivity in middle-aged Japanese men
  1494. Fastingโ€based estimates ofย insulinย sensitivity in overweight andย obesity: a critical appraisal
  1495. Fat accumulation in the liver is associated with defects inย insulinย suppression of glucose production and serum free fatty acids independent ofย obesityย in normal men
  1496. Fat feeding causes widespread in vivoย insulinย resistance, decreased energy expenditure, andย obesityย in rats
  1497. Fat metabolism inย obesity, with special emphasis on theย insulinย resistance and elevated lipid mobilization in visceralย obesity
  1498. Fat versus carbohydrate inย insulinย resistance,ย obesity, diabetes and cardiovascular disease
  1499. Fat-depot specific differences in adipose tissue inflammation in the setting ofย obesityย andย insulinย resistance
  1500. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-inducedย obesityย andย insulinย resistance
  1501. Fat-specific Sirt6 ablation sensitizes mice to high-fat dietโ€“inducedย obesityย andย insulinย resistance by inhibiting lipolysis
  1502. FATP1 is anย insulin-sensitive fatty acid transporter involved in diet-inducedย obesity
  1503. Fatty acid binding protein 2 (FABP-2) polymorphism,ย obesityย andย insulinย resistance
  1504. Fatty acid composition of skeletal muscle membrane phospholipids,ย insulinย resistance andย obesity
  1505. Fatty acids,ย obesityย andย insulinย resistance
  1506. Fatty acids,ย obesity, andย insulinย resistance: time for a reevaluation
  1507. Fatty liver,ย insulinย resistance, andย obesity: relationships with increase in coronary artery calcium over time
  1508. Fatty pancreas in relation toย insulinย resistance and metabolic syndrome in children withย obesity
  1509. Fatty-acid binding protein 4 gene variants and childhoodย obesity: potential implications forย insulinย sensitivity and CRP levels
  1510. FDP-E induces adipocyte inflammation and suppressesย insulin-stimulated glucose disposal: effect of inflammation andย obesityย on fibrinogen Bฮฒ mRNA
  1511. Features of some anthropometric indices and indices ofย insulinย resistance in patients with non-alcoholic steatohepatitis on the background ofย obesityย and โ€ฆ
  1512. Febrile neutropenia induces changes inย insulinย sensitivity similar toย obesity
  1513. Fecal microbiota signatures ofย insulinย resistance, inflammation and metabolic syndrome in youth withย obesity. A pilot study.
  1514. Feedback inhibition ofย insulinย and glucagon secretion byย insulinย is altered in abdominalย obesityย with normal or impaired glucose tolerance
  1515. Feedback inhibition ofย insulinย secretion andย insulinย resistance in polycystic ovarian syndrome with and withoutย obesity.
  1516. Feedback inhibition ofย insulinย secretion byย insulin: relation to the hyperinsulinemia ofย obesity
  1517. Feeding high oleic acid Canola oil or olive oil alters inflammation,ย insulinย resistance and lipid metabolism in a rodent model of diet inducedย obesity
  1518. Female 5 [beta]-reductase knockout mice are protected from diet inducedย obesity,ย insulinย resistance, and glucose intolerance
  1519. Femaleย obesity: testosteronemia is positively correlated with peripheralย insulinย resistance
  1520. Female offspring born to obese andย insulin-resistant dams are not at increased risk forย obesityย and metabolic dysfunction during early development
  1521. Fenfluramine in chilhoodย obesity: clinical experience and effects of fenfluramine and weight loss on blood glucose, plasmaย insulinย and plasma growth hormone โ€ฆ
  1522. Fenugreek attenuatesย obesity-induced inflammation and improvesย insulinย resistance through downregulation of iRhom2/TACE
  1523. Ferriman-Gallwey Score correlates withย obesityย andย insulinย level in Polycystic Ovary Syndromeโ€“an observational study
  1524. Fetal growth restriction, catch-up growth and the early origins ofย insulinย resistance and visceralย obesity
  1525. Fetal origins ofย insulinย resistance andย obesity
  1526. Fetuin-null mice are protected againstย obesityย andย insulinย resistance associated with aging
  1527. FGF21 deficiency is associated with childhoodย obesity,ย insulinย resistance and hypoadiponectinaemia: the BCAMS Study
  1528. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models ofย obesityย andย insulin-resistance
  1529. FGF21 gene therapy as treatment forย obesityย andย insulinย resistance
  1530. Fiber intake andย insulinย resistance in 6374 adults: The role of abdominalย obesity
  1531. Fibre, satiety andย insulin-a new approach to overnutrition andย obesity
  1532. Fibrinogen, plasma viscosity and blood viscosity inย obesity. Relationship withย insulinย resistance
  1533. Fibroblast growth factor receptor 4 (FGFR4) deficiency improvesย insulinย resistance and glucose metabolism under diet-inducedย obesityย conditions
  1534. Finding Links betweenย obesityย and Diabetes: Using Diacylglycerol Kinase to Regulateย insulinย Signaling
  1535. Fish oil and argan oil intake differently modulateย insulinย resistance and glucose intolerance in a rat model of dietary-inducedย obesity
  1536. Fish oil in a high lard diet preventsย obesity, hyperlipemia, and adipocyteย insulinย resistance in rats
  1537. Fitness,ย insulinย sensitivity, and frontal lobe integrity in adults with overweight andย obesity
  1538. Five genes influenced byย obesityย may contribute to the development of thyroid cancer through the regulation ofย insulinย levels
  1539. FKBP5 polymorphism is associated withย insulinย resistance in children and adolescents withย obesity
  1540. Flavonoid-rich extract of Paulownia fortunei flowers attenuates diet-induced hyperlipidemia, hepatic steatosis andย insulinย resistance inย obesityย mice by AMPK pathway
  1541. Flow motion dynamics of microvascular blood flow and oxygenation: Evidence of adaptive changes inย obesityย and type 2 diabetes mellitus/insulinย resistance
  1542. FNDC5 attenuates adipose tissue inflammation andย insulinย resistance via AMPK-mediated macrophage polarization inย obesity
  1543. Folate and vitamin B12 status is associated withย insulinย resistance and metabolic syndrome in morbidย obesity
  1544. Food-related sensory stimuli are able to promote pancreatic polypeptide elevation without evident cephalic phaseย insulinย secretion in humanย obesity
  1545. Food,ย obesityย and non-insulin-dependent diabetes: are there molecular links?
  1546. Forearm metabolism inย obesityย and its response to intra-arterialย insulin. Characterization ofย insulinย resistance and evidence for adaptive hyperinsulinism
  1547. Forkhead box O-1 modulation improves endothelialย insulinย resistance in humanย obesity
  1548. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietaryโ€inducedย obesityย andย insulinย โ€ฆ
  1549. FOXC2 and CAPN10 as candidate genes forย obesity,ย insulinย resistance and type 2 diabetes
  1550. FOXC2 is a winged helix gene that counteractsย obesity, hypertriglyceridemia, and diet-inducedย insulinย resistance
  1551. Free fatty acid levels modulate microvascular function: relevance forย obesity-associatedย insulinย resistance, hypertension, and microangiopathy
  1552. Free fatty acid oxidation inย insulinย resistance andย obesity
  1553. Free fatty acids (FFA), a link betweenย obesityย andย insulinย resistance
  1554. Free fatty acids are associated withย obesity,ย insulinย resistance, and atherosclerosis in renal transplant recipients
  1555. Free fatty acids inย insulinโ€resistant individuals are associated with theย insulinโ€resistant state but not with centralย obesity
  1556. Free fatty acids inย obesityย and type 2 diabetes: defining their role in the development ofย insulinย resistance and ฮฒโ€cell dysfunction
  1557. Free fatty acidsโ€”the link betweenย obesityย andย insulinย resistance
  1558. Free Fatty Acids, A Major Link Betweenย obesity,ย insulinย Resistance, Inflammation, and Atherosclerotic Vascular Disease
  1559. Free fatty acids,ย insulinย resistance, and corrected qt intervals in morbidย obesity: effect of weight loss during 6 months with differing dietary interventions
  1560. Freeย insulin-like growth factors in humanย obesity
  1561. Free triiodothyronine is associated with smoking habit, independently ofย obesity, body fat distribution,ย insulin, and metabolic parameters
  1562. Freeze-dried strawberry and blueberry attenuates diet-inducedย obesityย andย insulinย resistance in rats by inhibiting adipogenesis and lipogenesis
  1563. Frequency ofย insulinย resistance in nondiabetic adult Bangladeshi individuals of differentย obesityย phenotypes
  1564. Frequency ofย obesity,ย insulinย resistance, cardio-metabolic risk factors and genetic variation in the genes encoding ADIPOQ and PPAR-[gamma] in urban adults
  1565. From immune senescence andย insulinย resistance toย obesityย and sarcopenia: iNKT cell as bridge?
  1566. Fromย insulinย receptor signalling to Glut 4 translocation abnormalities inย obesityย andย insulinย resistance
  1567. Fromย obesityย to type 2 diabetes: the interplay betweenย insulinย resistance and impairedย insulinย secretion
  1568. From Starvation toย obesity: Howย insulinย Resistance Affects Global Health
  1569. Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity duringย obesityย andย insulinย resistance
  1570. FTโ€“IR Saliva Profiling in Patients withย obesityย andย obesityโ€“Relatedย insulinย Resistance
  1571. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-ฮฑ-mediatedย insulinย resistance in geneticย obesity
  1572. Functional dilator capacity is independently associated withย insulinย sensitivity and age in centralย obesityย and is not improved by high dose statin treatment
  1573. Functional in vivo interactions between JNK1 and JNK2 isoforms inย obesityย andย insulinย resistance
  1574. Further evidence forย insulinย hypersecretion not as an initial event but as a consequence of body growth and maturation in juvenile-onsetย obesity
  1575. G proteinโ€“coupled receptor kinase 2 plays a relevant role inย insulinย resistance andย obesity
  1576. G proteinโ€“coupled receptors targetingย insulinย resistance,ย obesity, and type 2 diabetes mellitus
  1577. G Proteins Regulatingย insulinย Action andย obesity
  1578. GABA type B receptor signaling in proopiomelanocortin neurons protects againstย obesity,ย insulinย resistance, and hypothalamic inflammation in male mice on a high-fat โ€ฆ
  1579. GADD34-deficient mice developย obesity, nonalcoholic fatty liver disease, hepatic carcinoma andย insulinย resistance
  1580. Galacto-oligosaccharides supplementation decreasesย obesityย and improvesย insulinย sensitivity in mice fed a Western-type diet
  1581. Galectin-3 is a potential biomarker toย insulinย resistance andย obesityย in women with polycystic ovary syndrome
  1582. Gamma tocotrienol improves high fat dietโ€inducedย obesityย andย insulinย resistance by inhibiting adipose inflammation and macrophage recruitment (383.4)
  1583. Gamma-tocotrienol attenuates high-fat diet-inducedย obesityย andย insulinย resistance by inhibiting adipose inflammation and M1 macrophage recruitment
  1584. Ganglioside GM3 as a gatekeeper ofย obesity-associatedย insulinย resistance: Evidence and mechanisms
  1585. Ganoderic Acid A improves high fat diet-inducedย obesity, lipid accumulation andย insulinย sensitivity through regulating SREBP pathway
  1586. Gastric Bypass in an Adolescent withย obesity,ย insulinย Resistance, and Type 1 Diabetes
  1587. Gastric inhibitory polypeptide (GIP) andย insulinย inย obesity: II. Reversal of increased response to stimulation by starvation or food restriction
  1588. Gastric inhibitory polypeptide (GIP) andย insulinย inย obesity: increased response to stimulation and defective feedback control of serum levels
  1589. Gastric sleeve surgery alleviatesย obesity-associatedย insulinย resistance and suppresses endoplasmic reticulum stress in adipose tissue of db/db mice
  1590. Gender differences in association of plasma adiponectin withย obesityย reflect resultantย insulinย resistance in nonโ€diabetic Japanese patients with schizophrenia
  1591. GENDER DIFFERENCES OF VITAMIN D LEVELS AND ITS ASSOCIATION WITH SELECTEDย obesityย MARKERS,ย insulinย RESISTANCE IN YOUNG โ€ฆ
  1592. Gender-specific effect of-102G> a polymorphism inย insulinย induced gene 2 onย obesityย in Chinese children
  1593. Gene expression of GLUT4 in skeletal muscle fromย insulin-resistant patients withย obesity, IGT, GDM, and NIDDM
  1594. Genetic ablation of C-reactive protein gene confers resistance toย obesityย andย insulinย resistance in rats
  1595. Genetic ablation of calcium-independent phospholipase A2ฮณ preventsย obesityย andย insulinย resistance during high fat feeding by mitochondrial uncoupling and โ€ฆ
  1596. Genetic Ablation of GIP Producing K Cells Reduces Diet Inducedย obesityย (OB) andย insulinย Resistance (IR) in Mice.
  1597. Genetic Ablation of Liver CPT-1A Gene Protects Mice against High-Fat Dietโ€“Inducedย obesityย andย insulinย Resistance
  1598. Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents dietโ€inducedย obesityย andย insulinย resistance
  1599. Genetic ablation of miR-33 increases food intake, enhances adipose tissue expansion, and promotesย obesityย andย insulinย resistance
  1600. Genetic analysis ofย obesity-induced diabetes associated with a limited capacity to synthesizeย insulinย in C57BL/KS mice: evicence for polygenic control
  1601. Genetic analysis of the IRS: pleiotropic effects of genes influencingย insulinย levels on lipoprotein andย obesityย measures
  1602. Genetic deconstruction of complex traits related to the cardiovascular complications ofย insulinย resistance in multigenicย obesityย mouse models
  1603. Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-inducedย obesityย andย insulinย resistance
  1604. Genetic deletion of mast cell serotonin synthesis prevents the development ofย obesityย andย insulinย resistance
  1605. Genetic determinants of energy expenditure andย insulinย resistance in diet-inducedย obesityย in mice
  1606. Genetic engineering of the skeletal muscle to counteractย insulinย resistance andย obesity
  1607. Genetic evidence that carbohydrate-stimulatedย insulinย secretion leads toย obesity
  1608. Genetic models of humanย obesityย and non-insulinย dependent diabetes in animals: problem of adequacy.
  1609. Genetic Nicotinamide N-Methyltransferase (Nnmt) deficiency in male mice improvesย insulinย sensitivity in diet-inducedย obesityย but does not affect glucose tolerance
  1610. Geneticย obesityย and dietary sucrose decrease hepatic glucagon andย insulinย receptors in LA/N-corpulent rats
  1611. Genetic predisposition toย obesityย is associated withย insulinย secretion in Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study
  1612. Genetic reduction of circulatingย insulin-like growth factor (IGF)-1 inhibitsย obesity-promoted colon tumorigenesis in mice
  1613. Genetic reduction of circulatingย insulin-like growth factor (IGF)-1 inhibitsย obesity-promoted colon tumorigenesis in mice and alters microRNA expression
  1614. Genetic Variants Associated Withย obesityย andย insulin
  1615. Genetic variants associated withย obesityย andย insulinย resistance in Hispanic boys with nonalcoholic fatty liver disease
  1616. Genetic variants of retinol-binding protein 4 in adolescents are associated with liver function and inflammatory markers but not withย obesityย andย insulinย resistance
  1617. Genetic Variation in ฮฒ3-Adrenergic Receptor andย obesity, Type 2 Diabetes,ย insulinย Resistance in Chinese Pedigrees
  1618. Genetics of gene expression of theย insulinย signaling pathway in polygenicย obesity
  1619. Genetics of Paediatric Type 2 Diabetes: ABCC8 Mutation inย obesity-Associatedย insulinย Secretion Defects
  1620. Genotype C/C 13910 of the Lactase Gene as a Risk Factor for the Formation ofย insulin-Resistantย obesityย in Children
  1621. Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association withย obesityย andย insulinย resistance
  1622. Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepaticย insulinย Insensitivity,ย obesity, and Metabolic Syndrome in Adult Female Offspring
  1623. Gestational oxidative stress protects against adultย obesityย andย insulinย resistance
  1624. #VALUE!
  1625. GH receptor deficiency in Ecuadorian adults is associated withย obesityย and enhancedย insulinย sensitivity
  1626. Ginseng-plus-Bai-Hu-Tang ameliorates diet-inducedย obesity, hepatic steatosis, andย insulinย resistance in mice
  1627. #VALUE!
  1628. GIP receptor antagonism reversesย obesity,ย insulinย resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
  1629. Global Tudorโ€SN transgenic mice are protected fromย obesityโ€induced hepatic steatosis andย insulinย resistance
  1630. Glomerular-specific protein kinase C-ฮฒ-inducedย insulinย receptor substrate-1 dysfunction andย insulinย resistance in rat models of diabetes andย obesity
  1631. GLP-1 responses are heritable and blunted in acquiredย obesityย with high liver fat andย insulinย resistance
  1632. Glucocorticoid metabolism in humanย obesity; increased 5 [alpha]-reductase activity is associated withย insulinย resistance in both men and women
  1633. Glucocorticoid Receptor Is Instrumental for the Mechanism of Beta-Cell Compensation forย insulinย Resistance in Dietaryย obesity
  1634. Glucocorticoids exacerbateย obesityย andย insulinย resistance in neuron-specific proopiomelanocortin-deficient mice
  1635. Glucoraphanin amelioratesย obesityย andย insulinย resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice
  1636. Glucoraphanin: a broccoli sprout extract that amelioratesย obesity-induced inflammation andย insulinย resistance
  1637. Glucosamine enhances body weight gain and reducesย insulinย response in mice fed chow diet but mitigatesย obesity,ย insulinย resistance and impaired glucose tolerance โ€ฆ
  1638. Glucose andย insulinย induction of bile acid synthesis: mechanisms and implication in diabetes andย obesity
  1639. Glucose andย insulinย values in an adolescent outpatient population with a high prevalence ofย obesityย and risk factors for diabetes mellitus type 2
  1640. Glucose impairments andย insulinย resistance in prostate cancer: The role ofย obesity, nutrition and exercise
  1641. Glucose intolerance in monosodium glutamateย obesityย is linked to hyperglucagonemia andย insulinย resistance in ฮฑ cells
  1642. Glucose intolerance,ย insulinย resistance and metabolic syndrome in patients with stable angina pectoris.ย obesityย predicts coronary atherosclerosis and โ€ฆ
  1643. Glucose Intolerance,ย insulinย Resistance andย obesityย Risk in Children with Family History of Type II Diabetes
  1644. Glucose metabolism andย insulinย sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment ofย obesityย โ€ฆ
  1645. Glucose metabolism and the response toย insulinย by human adipose tissue in spontaneous and experimentalย obesity: effects of dietary composition and adipose cell โ€ฆ
  1646. Glucose metabolism in incubated human muscle: effect ofย obesityย and non-insulin-dependent diabetes mellitus
  1647. Glucose tolerance andย insulinย sensitivity define adipocyte transcriptional programs in humanย obesity
  1648. Glucose tolerance and serumย insulinย levels in an animal model ofย obesityย induced by sub-acute or chronic administration of antipsychotic drugs.
  1649. Glucose tolerance and serumย insulinย levels in an animal model ofย obesityย induced by the antipsychotic drug, sulpiride
  1650. Glucose tolerance, plasmaย insulin, and plasma glucagon in relation toย obesityย in chickens
  1651. Glucose tolerance, plasmaย insulin, HDL cholesterol andย obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men
  1652. Glucose Tolerance, Plasmaย insulin, HDL Cholesterol andย obesity: 12-year Follow-Up and Development of Coronary Heart Disease in Edinburgh Men
  1653. Glucose uptake of the muscle and adipose tissues in diabetes andย obesityย disease models: evaluation ofย insulinย and ฮฒ3-adrenergic receptor agonist effects by 18 F โ€ฆ
  1654. Glucose-6-phosphate dehydrogenase deficiency improvesย insulinย resistance with reduced adipose tissue inflammation inย obesity
  1655. Glucoseโ€“insulinย homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenicย obesityย versus non-psychiatricย obesity
  1656. Glucose,ย insulinย concentrations andย obesityย in childhood and adolescence as predictors of NIDDM
  1657. GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1 GT/GT, a mouse model forย obesityย andย insulinย resistance
  1658. Glutamate interactions withย obesity,ย insulinย resistance, cognition and gut microbiota composition
  1659. Glutathione depletion prevents dietโ€inducedย obesityย and enhancesย insulinย sensitivity
  1660. Glycaemic control,ย insulinย resistance andย obesity
  1661. Glycated hemoglobin, but notย insulinย sensitivity, is associated with memory in subjects withย obesity
  1662. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect againstย insulinย resistance orย obesity
  1663. Glycerol-3-phosphate dehydrogenase activity in human lymphocytes: effects ofย insulin,ย obesityย and weight loss
  1664. Glycogen Synthase Kinase-3a Contributes to the Development of Cardiac Dysfunction Duringย obesityย andย insulinย Resistance Through Regulation of Peroxisome โ€ฆ
  1665. Goatโ€™s milk intake preventsย obesity, hepatic steatosis andย insulinย resistance in mice fed A high-fat diet by reducing inflammatory markers and increasing energy โ€ฆ
  1666. Gonadal white adipose tissue-derived exosomal MiR-222 promotesย obesity-associatedย insulinย resistance
  1667. Gonadotropins at menopause: the influence ofย obesity,ย insulinย resistance, and estrogens
  1668. Good fats versus bad fats: a comparison of fatty acids in the promotion ofย insulinย resistance, inflammation, andย obesity
  1669. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravatesย obesityย andย insulinย resistance
  1670. GPR105 ablation prevents inflammation and improvesย insulinย sensitivity in mice with diet-inducedย obesity
  1671. GPR43: an emerging target for the potential treatment of type 2 diabetes,ย obesityย andย insulinย resistance.
  1672. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promoteย insulinย sensitivity inย obesity
  1673. Gravidity,ย obesity, and non-insulin-dependent diabetes among Pima Indian women
  1674. Green tea preventsย obesityย by increasing expression ofย insulin-like growth factor binding protein-1 in adipose tissue of high-fat diet-fed mice
  1675. Growth andย obesityย and its association with plasma level of steroid hormones andย insulin-like growth factor-I (IGF-I) in Slovak female students.
  1676. Growth hormone is necessary for the p53-mediated,ย obesity-inducedย insulinย resistance in male C57BL/6Jร— CBA mice
  1677. Growth hormone overexpression in the central nervous system results in hyperphagia-inducedย obesityย associated withย insulinย resistance and dyslipidemia
  1678. Growth hormone receptor deficiency in humans associates toย obesity, increased body fat percentage, a healthy brain and a coordinatedย insulinย sensitivity
  1679. Growth hormone secretion and leptin in morbidย obesityย before and after biliopancreatic diversion: relationships withย insulinย and body composition
  1680. Growth hormone,ย insulin, and prolactin secretion in anorexia nervosa andย obesityย during bromocriptine treatment.
  1681. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-inducedย obesityย andย insulinย resistance
  1682. Guarana supplementation attenuatedย obesity,ย insulinย resistance, and adipokines dysregulation induced by a standardized human Western diet via brown adipose โ€ฆ
  1683. Guenther Boden, MD (1935โ€“2015): A Pioneer in Human Studies of Nutrition andย obesityโ€”And the Mystery ofย insulinย Resistance for Handling Glucose
  1684. Gut commensal Bacteroides acidifaciens preventsย obesityย and improvesย insulinย sensitivity in mice
  1685. Gut inflammation as a contributing factor for the development ofย insulinย resistance inย obesity
  1686. Gut microbiome and its role inย obesityย andย insulinย resistance
  1687. Gut microbiota as a key player in triggeringย obesity, systemic inflammation andย insulinย resistance
  1688. Gut microbiota composition and its effects onย obesityย andย insulinย resistance
  1689. Gut microbiota impairsย insulinย clearance duringย obesity
  1690. Gut microbiota interactions withย obesity,ย insulinย resistance and type 2 diabetes: did gut microbiote co-evolve withย insulinย resistance?
  1691. Gut microbiota interacts with markers of adipose tissue browning,ย insulinย action and plasma acetate in morbidย obesity
  1692. Gut-associated IgA+ immune cells regulateย obesity-relatedย insulinย resistance
  1693. Gut-specific delivery of T-helper 17 cells reducesย obesityย andย insulinย resistance in mice
  1694. Haploinsufficiency of the retinoblastoma protein gene reduces diet-inducedย obesity,ย insulinย resistance, and hepatosteatosis in mice
  1695. Haptoglobin Phenotypes Are Associated with the Postload Glucose andย insulinย Levels in Pediatricย obesity
  1696. Heart Rate,ย insulinย resistance,ย obesityย and blood Pressure in Croatian Rural Population
  1697. Hematopoietic AMPK ฮฒ1 reduces mouse adipose tissue macrophage inflammation andย insulinย resistance inย obesity
  1698. Hematopoietic kit deficiency, rather than lack of mast cells, protects mice fromย obesityย andย insulinย resistance
  1699. Heme oxygenase-1 induction remodels adipose tissue and improvesย insulinย sensitivity inย obesity-induced diabetic rats
  1700. Hemodynamic factors in theย insulinย resistance ofย obesityย and hyperlipidemia
  1701. Hemorheological aspects of the metabolic syndrome: markers ofย insulinย resistance,ย obesityย or hyperinsulinemia?
  1702. Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role inย insulinย resistance andย obesity
  1703. Hepatic Apolipoprotein M Overexpression Increased Total Sphingosine 1-phosphate Mass and Ameliorateย insulinย Resistance in Diet Inducedย obesityย Mice
  1704. Hepatic atypical protein kinase C: an inherited survival-longevity gene that now fuelsย insulin-resistant syndromes ofย obesity, the metabolic syndrome and type โ€ฆ
  1705. Hepatic Bax inhibitor-1 inhibits IRE1ฮฑ and protects fromย obesity-associatedย insulinย resistance and glucose intolerance
  1706. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis,ย obesity, andย insulinย resistance
  1707. Hepaticย insulinย dynamics. Effects of male gender andย obesity: Role of free fatty acids.
  1708. Hepaticย insulinย signaling is required forย obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression
  1709. Hepatic mTORC1 opposes impairedย insulinย action to control mitochondrial metabolism inย obesity
  1710. Hepatic NF-ฮบB essential modulator deficiency preventsย obesity-inducedย insulinย resistance but synergizes with high-fat feeding in tumorigenesis
  1711. Hepatic oncostatin M receptor ฮฒ regulatesย obesity-induced steatosis andย insulinย resistance
  1712. Hepatic oxidative stress promotesย insulin-STAT-5 signaling andย obesityย by inactivating protein tyrosine phosphatase N2
  1713. Hepatic protein tyrosine phosphatase receptor gamma linksย obesity-induced inflammation toย insulinย resistance
  1714. Hepatic Stearoyl-CoA Desaturase-1 Deficiency does not Protect Mice from Diet-Inducedย obesityย andย insulinย Resistance
  1715. Hepatic Steatosis is Common in Adolescents withย obesityย and PCOS and Relates to De Novo Lipogenesis but notย insulinย Resistance
  1716. Hepatic steatosis rather than visceral adiposity is more closely associated withย insulinย resistance in the early stage ofย obesity
  1717. Hepatocyte DACH1 is increased inย obesityย via nuclear exclusion of HDAC4 and promotes hepaticย insulinย resistance
  1718. Hepatocyte growth factor prevented high-fat diet-inducedย obesityย and improvedย insulinย resistance in mice
  1719. Hepatocyte Toll-like receptor 4 regulatesย obesity-induced inflammation andย insulinย resistance
  1720. Hepatocyte TRAF3 promotesย insulinย resistance and type 2 diabetes in mice withย obesity
  1721. Hepatocyte-secreted DPP4 inย obesityย promotes adipose inflammation andย insulinย resistance
  1722. Hepatocyte-specific Ptpn6 deletion protects fromย obesity-linked hepaticย insulinย resistance
  1723. Herbal formula HT048 attenuates diet-inducedย obesityย by improving hepatic lipid metabolism andย insulinย resistance in obese rats
  1724. Hereditary postprandial hypertriglyceridemic rabbit exhibitsย insulinย resistance and centralย obesity: a novel model of metabolic syndrome
  1725. Heritability ofย insulinย sensitivity and lipid profile depend on BMI: evidence for geneโ€“obesityย interaction
  1726. Heterogeneity inย insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people withย obesity
  1727. Heterogeneity of plasmaย insulinย and triglyceride levels inย obesityย demonstrated by family study
  1728. Heterozygous knockout of the IRS-1 gene in mice enhancesย obesity-linkedย insulinย resistance: a possible model for the development of type 2 diabetes
  1729. Heterozygous p53 knockout affects development ofย obesity,ย insulinย resistance and non-alcoholic steatohepatitis in mice fed with a Western type diet
  1730. Hexosamines as mediators of nutrient sensing: relevance toย obesity,ย insulinย resistance, and diabetes
  1731. High density lipoprotein cholesterol,ย insulinย andย obesityย in Samoans
  1732. High Early Childhoodย insulinย Increases Asthma Risk Independent ofย obesity
  1733. High Expression Level of PPARฮณ in CD24 Knockout Mice and Gender-Specific Metabolic Changes: A Model ofย insulin-Sensitiveย obesity
  1734. High fat diet induces centralย obesity,ย insulinย resistance and microvascular dysfunction in hamsters
  1735. High fat-inducedย obesityย associated withย insulin-resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostate
  1736. High incidence ofย obesityย and elevated serum immunoreactiveย insulinย level in patients with paravertebral ligamentous ossification: a relationship to the development of โ€ฆ
  1737. High incidence ofย obesityย andย insulinย resistance in prepubertal children, born too small for their gestational age
  1738. High prevalence of overweight,ย obesity,ย insulinย resistance and metabolic syndrome in rural children and adolescents
  1739. High serum fasting peptide YY (3โ€“36) is associated withย obesity-associatedย insulinย resistance and type 2 diabetes
  1740. High serum selenium levels are associated with increased risk for diabetes mellitus independent of centralย obesityย andย insulinย resistance
  1741. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases inย obesity: relationships with plasmaย insulinย levels
  1742. High-density lipoprotein composition inย obesity: interrelationships with plasmaย insulinย levels and body weight.
  1743. High-fat diet is associated withย obesity-mediatedย insulinย resistance and ฮฒ-cell dysfunction in Mexican Americans
  1744. High-fat diet-inducedย obesityย andย insulinย resistance are characterized by differential beta oscillatory signaling of the limbic cortico-basal ganglia loop
  1745. High-fat diet-inducedย obesityย andย insulinย resistance in CYP4a14 ฯช/ฯช mice is mediated by 20-HETE
  1746. High-fat diet-inducedย obesityย andย insulinย resistance in CYP4a14โˆ’/โˆ’ mice is mediated by 20-HETE
  1747. High-fat diet-inducedย obesityย impairsย insulinย signaling in lungs of allergen-challenged mice: Improvement by resveratrol
  1748. High-fat dietโ€“inducedย obesityย andย insulinย resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice
  1749. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates withย obesityย andย insulinย resistance in mouse
  1750. High-fat feeding promotesย obesityย viaย insulinย receptor/PI3K-dependent inhibition of SF-1 VMH neurons
  1751. High-fructose diet in pregnancy leads to fetal programming of hypertension,ย insulinย resistance, andย obesityย in adult offspring
  1752. High-intensity interval training improves markers of oxidative metabolism in skeletal muscle of individuals withย obesityย andย insulinย resistance
  1753. High-normal TSH values inย obesityย depends on adipose tissue rather thanย insulinย resistance
  1754. Highโ€fat dietย obesityย associated withย insulinย resistance increases cell proliferation, estrogen receptor, and PI3K proteins in rat ventral prostate
  1755. Highโ€fat Dietโ€induced Ultradian Leptin andย insulinย Hypersecretion are Absent inย obesityโ€resistant Rats
  1756. Highโ€normal tsh values inย obesity: Is itย insulinย resistance or adipose tissueโ€™s guilt?
  1757. Higher Concentrations of Glucose orย insulinย Increase the Risk of Various Types of Cancer inย obesityย or Type 2 Diabetes by Decreasing the Expression of โ€ฆ
  1758. Higher glomerular filtration rate is related toย insulinย resistance but not toย obesityย in a predominantly obese non-diabetic cohort
  1759. Higher levels of ANGPTL5 in the circulation of subjects withย obesityย and type 2 diabetes are associated withย insulinย resistance
  1760. Higher PDCD4 expression is associated withย obesity,ย insulinย resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
  1761. Hippocampalย insulinย resistance and altered food decision-making as players onย obesityย risk
  1762. Hippocampalย insulinย resistance links maternalย obesityย with impaired neuronal plasticity in adult offspring
  1763. HIS-388, a novel orally active and long-acting 11ฮฒ-HSD1 inhibitor, amelioratesย insulinย sensitivity and glucose intolerance in diet-inducedย obesityย and non-genetic type โ€ฆ
  1764. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-inducedย obesityย andย insulinย resistance
  1765. HOMA, QUICKI and MF fm to Measureย insulinย Resistance in Morbidย obesity
  1766. Homeostasis model assessment ofย insulinย resistance in a general adult population in Korea: additive association of sarcopenia andย obesityย withย insulinย resistance
  1767. Homeostatic model assessment ofย insulinย resistance as a predictor of metabolic syndrome: consequences ofย obesityย in children and adolescents
  1768. Hormone replacement therapy,ย insulinย sensitivity, and abdominalย obesityย in postmenopausal women
  1769. Hormone resistance in diabetes andย obesity:ย insulin, leptin, and FGF21
  1770. Hormones andย obesity: changes inย insulinย and growth hormone secretion following surgically induced weight loss
  1771. How much variance inย insulinย resistance is explained byย obesity?
  1772. How much variance inย insulinย resistance is explained byย obesity?
  1773. How the association betweenย obesityย and inflammation may lead toย insulinย resistance and cancer
  1774. HSP72 protects againstย obesity-inducedย insulinย resistance
  1775. Huangjinya Black Tea Alleviatesย obesityย andย insulinย Resistance via Modulating Fecal Metabolome in Highโ€Fat Dietโ€Fed Mice
  1776. Human growth gene family chromosomal architecture is affected by maternalย obesity, gestational diabetes andย insulinย treatment
  1777. Human muscle fiber typeโ€“specificย insulinย signaling: Impact ofย obesityย and type 2 diabetes
  1778. Humanย obesityย andย insulinย Resistance
  1779. Humanย obesityย andย insulinย resistance: lessons from experiments of nature
  1780. Humanย obesityย and thinness, hyperlipidemia, hyperglycemia, andย insulinย resistance associated with HIV1 protease inhibitors Prevention by alternating several โ€ฆ
  1781. Humanย obesityย relationship with Ad36 adenovirus andย insulinย resistance
  1782. Human plasma resistin level relate toย insulinย resistance andย obesity
  1783. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase withย obesity, are negatively associated withย insulinย sensitivity and modulate inflammation in vitro
  1784. Huperzine A amelioratesย obesity-related cognitive performance impairments involving neuronalย insulinย signaling pathway in mice
  1785. Hydrodynamic delivery of adiponectin and adiponectin receptor 2 gene blocks high-fat diet-inducedย obesityย andย insulinย resistance
  1786. Hydrodynamic delivery of IL-38 gene alleviatesย obesity-induced inflammation andย insulinย resistance
  1787. Hydroxychloroquine improvesย obesity-associatedย insulinย resistance and hepatic steatosis by regulating lipid metabolism
  1788. Hydroxytyrosol amelioratesย insulinย resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-inducedย obesityย mice
  1789. Hydroxytyrosol improvesย obesityย andย insulinย resistance by modulating gut microbiota in high-fat diet-induced obese mice
  1790. Hyperactivity of the hypothalamoโ€pituitaryโ€adrenal axis inย obesity: a study of ACTH, AVP, ฮฒโ€lipotrophin and Cortisol responses toย insulinโ€induced hypoglycaemia
  1791. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, centralย obesityย andย insulinย resistance compared with their paired โ€ฆ
  1792. Hyperglycemia andย obesityย as Determinants of Glucose,ย insulin, and Glucagon Responses to ฮฒ-Endorphin in Human Diabetes Mellitus
  1793. Hyperglycemia, maturity-onsetย obesity, andย insulinย resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes
  1794. Hyperinsulinaemia inย obesityย is not accompanied by an increase in serum proinsulin/insulinย ratio in groups of human subjects with and without glucose intolerance
  1795. Hyperinsulinemia and its impact onย obesityย andย insulinย resistance.
  1796. Hyperinsulinemia does not compensate for peripheralย insulinย resistance inย obesity
  1797. Hyperinsulinemia drives diet-inducedย obesityย independently of brainย insulinย production
  1798. Hyperinsulinemia due to alteredย insulinย secretion contributes toย insulinย resistance in chronic intermittent hypoxia independently ofย obesity
  1799. Hyperinsulinemia in individuals withย obesity: role ofย insulinย clearance
  1800. Hyperinsulinemia Leads the Elevation of Plasma Aldosterone Concentration Independently withย obesity, Dyslipidemia, andย insulinย Resistance in Patients with Type 2 โ€ฆ
  1801. Hyperinsulinemia ofย obesityย is due to decreased clearance ofย insulin
  1802. Hyperinsulinemia,ย insulinย resistance and free fatty acids. The dog model in diabetes andย obesityย research
  1803. Hyperleptinemia andย insulinย resistance inย obesity-associated sleep apnoea: Sex-dependent effects of CPAP application
  1804. Hyperleptinemia: an early sign of juvenileย obesity. Relations to body fat depots andย insulinย concentrations
  1805. Hypertension and coronary heart disease in patients with type 2 (nonย insulinย dependent) diabetes: influence of overweight andย obesity.
  1806. Hypertension and dyslipidaemia inย obesityย andย insulinย resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy
  1807. Hypertension and Dyslipidemia, but Not Fasting Blood Glucose, Dissociate From Centralย obesityย andย insulinย Resistance With Advancing Age
  1808. Hypertension and Metabolic Disarray: Diabetes Mellitus,ย insulinย Resistance, andย obesityย Hypertension: Kidney, Sodium, and the Renin-Angiotensin System
  1809. Hypertension inย obesityย and NIDDM: role ofย insulinย and sympathetic nervous system
  1810. Hypertension, hyperlipidemia, and abdominalย obesityย and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus
  1811. Hypertension, serumย insulin,ย obesityย and the metabolic syndrome
  1812. Hypoadiponectinemia inย obesityย and type 2 diabetes: close association withย insulinย resistance and hyperinsulinemia
  1813. Hypoadiponectinemia inย obesity: association withย insulinย resistance
  1814. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis viaย insulinย resistance andย obesity.
  1815. Hypomagnesemia andย obesityย in Relation toย insulinย Resistance and Glycemic Control in Type 2 Diabetic Patients
  1816. Hyposialylated IgG activates endothelial IgG receptor FcฮณRIIB to promoteย obesity-inducedย insulinย resistance
  1817. Hypothalamicย insulinย resistance inย obesity: effects on glucose homeostasis
  1818. Hypothalamicย insulin-sensitizing effect of exenatide in dietary induced rat model ofย obesity
  1819. Hypothalamicย obesityย caused by cranial insult in children: altered glucose andย insulinย dynamics and reversal by a somatostatin agonist
  1820. Hypothalamicย obesityย is due toย insulinย Hypersecretion: Reversal With Octreotideโ€ข 455
  1821. Hypothalamic or centralย obesityย is associated with an early rise in plasmaย insulinย concentration
  1822. Hypothesis:ย obesityย and theย insulinย resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled โ€˜hypertensive โ€ฆ
  1823. Hypothesis: postprandial remnant lipoproteins are the causal factors that induce theย insulinย resistance associated withย obesity
  1824. Identification and functional characterization of a missense mutation in resistin in 2 patients with severeย obesityย andย insulinย resistance Running Title: A missense โ€ฆ
  1825. Identification and functional characterization of a missense mutation in resistin in two patients with severeย obesityย andย insulinย resistance
  1826. Identification of adipose tissue dendritic cells correlated withย obesity-associatedย insulin-resistance and inducing Th17 responses in mice and patients
  1827. Identification of anย obesityย quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat andย insulinย on the human homologous region 20q.
  1828. Identification of early transcriptome signatures in placenta exposed toย insulinย andย obesity
  1829. Identification of early transcriptome signatures in placenta exposed toย insulinย andย obesity
  1830. Identification of fatty acid binding protein 4 as an adipokine that regulatesย insulinย secretion duringย obesity
  1831. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-andย obesity-inducedย insulinย resistance
  1832. Identification of novel alleles associated withย insulinย resistance in childhoodย obesityย using pooled-DNA genome-wide association study approach
  1833. Identification of Susceptibility Loci forย obesity,ย insulinย Resistance, and Hyperglycemia in a Backcross Model of New Zealand Obese (NZO) and Lean SJL Mice
  1834. Identifying genetic modifiers ofย obesityย andย insulinย sensitivity
  1835. Identifying the links betweenย obesity,ย insulinย resistance and ฮฒโ€cell function: potential role of adipocyteโ€derived cytokines in the pathogenesis of type 2 diabetes
  1836. IF1 connectsย obesityย andย insulinย resistance through mitochondrial reprogramming in association with ANT2
  1837. IGF-1 levels link estimated glomerular filtration rate toย insulinย resistance inย obesity: a study in obese, but metabolically healthy, subjects and obese,ย insulin-resistant โ€ฆ
  1838. IGF-binding protein-2 protects against the development ofย obesityย andย insulinย resistance
  1839. IGF-Binding Protein-2 Protects Against the Development ofย obesityย andย insulinย Resistance
  1840. IGFBP-1: A vasculoprotective peptide inย obesityย andย insulinย resistance
  1841. IGFBP-3 interacts with the vitamin D receptor inย insulinย signaling associated withย obesityย in visceral adipose tissue
  1842. IKK-ฮฒ links inflammation toย obesity-inducedย insulinย resistance
  1843. IKKฮต is key to induction ofย insulinย resistance in the hypothalamus, and its inhibition reversesย obesity
  1844. IL-14. Small Moleculeย insulinย Mimetics with Potential Utilities as Anti-diabetic and Anti-obesityย Therapies
  1845. IL-29 promotedย obesity-induced inflammation andย insulinย resistance
  1846. IL-33 reverses anย obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation andย insulinย resistance
  1847. IL-34 is associated withย obesity, chronic inflammation, andย insulinย resistance
  1848. IL-37 protects againstย obesity-induced inflammation andย insulinย resistance
  1849. IL-7 receptor deletion ameliorates diet-inducedย obesityย andย insulinย resistance in mice
  1850. Imbalance between neutrophil elastase and its inhibitor ฮฑ1-antitrypsin inย obesityย altersย insulinย sensitivity, inflammation, and energy expenditure
  1851. Imbalancedย insulinย actions inย obesityย and type 2 diabetes: key mouse models ofย insulinย signaling pathway
  1852. Immune and inflammatory processes inย obesity,ย insulinย resistance, diabetes, and related cardiometabolic complications
  1853. Immunity as a link betweenย obesityย andย insulinย resistance
  1854. Immunologic shifts in inhabitants of the Tianโ€™-Shanโ€™lowlands and highlands, suffering fromย obesityย and non-insulin-dependent diabetes mellitus
  1855. Immunoreactiveย insulinย andย obesityย in women.
  1856. Immunoreativeย insulinย inย obesityย of adult women.
  1857. Impact of Aldose Reductase on Endothelial Function and Vascularย insulinย Resistance in Diet-Inducedย obesity
  1858. Impact of alpha-lipoic acid onย insulinย sensitivity in individuals withย obesityย and impaired glucose tolerance [J]
  1859. Impact of android overweight orย obesityย andย insulinย resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities
  1860. Impact of bariatric surgery on heme oxygenase-1, inflammation, andย insulinย resistance in morbidย obesityย with obstructive sleep apnea
  1861. Impact of blood glucose, diabetes,ย insulin, andย obesityย on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT
  1862. Impact of changes inย obesityย parameters on glucose metabolism andย insulinย resistance over a one-year period
  1863. Impact of Chromosome 2ย obesityย Loci on Cardiovascular Complications ofย insulinย Resistance in LDL Receptorโ€“Deficient C57BL/6 Mice
  1864. Impact of common polymorphisms in candidate genes forย insulinย resistance andย obesityย on weight loss of morbidly obese subjects after laparoscopic adjustable โ€ฆ
  1865. Impact of degree ofย obesityย on surrogate estimates ofย insulinย resistance
  1866. Impact of diet-inducedย obesityย on intestinal stem cells: hyperproliferation but impaired intrinsic function that requiresย insulin/IGF1
  1867. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, andย insulinย resistance in diet-inducedย obesity
  1868. Impact ofย insulinย resistance andย obesityย on elevated blood pressure in Chinese children and adolescents: The BCAMS study
  1869. Impact ofย insulinย resistance andย obesityย on intracytoplasmic sperm injection outcomes in young women with polycystฤฑc ovary syndrome
  1870. Impact ofย obesityย andย insulinย resistance on vasomotor tone: nitric oxide and beyond
  1871. Impact ofย obesityย andย insulin-resistance on bone mineral density in Tunisian postmenopausal women
  1872. Impact ofย obesityย andย insulin-resistance on cirrhosis and portal hypertension
  1873. Impact ofย obesityย on IL-12 family gene expression inย insulinย responsive tissues
  1874. Impact ofย obesityย onย insulinย action in NIDDM
  1875. Impact ofย obesityย onย insulinย action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect ofย obesity
  1876. Impact ofย obesityย on maternal and neonatal outcomes inย insulin-resistant pregnancy
  1877. Impact ofย obesityย on MMTV-Wnt-1 Mammary Cancer: Role of Theย insulin-Like Growth Factor-1 (IGF-1)/Akt/mTOR Pathway
  1878. Impact ofย obesityย on MMTV-Wnt-1 mammary cancer: role of theย insulin-like growth factor-1 (IGF-1)/Akt/mTOR pathway
  1879. Impact ofย obesityย on Plasma C1q/TNF-Related Protein 3 andย insulinย Resistance in Newly Diagnosed T_2DM Patients
  1880. Impact ofย obesityย on resting metabolic rate and glucose-induced thermogenesis in non-insulinย dependent diabetes mellitus.
  1881. Impact ofย obesity, hepatic steatosis, andย insulinย resistance on hepatitis C treatment outcomes
  1882. Impact ofย obesity, steatosis andย insulinย resistance on progression and response to therapy of hepatitis C
  1883. Impact of prediagnosis smoking, alcohol,ย obesity, andย insulinย resistance on survival in male cancer patients: National Health Insurance Corporation Study
  1884. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 onย obesityย andย insulinย resistance in Japanese Type 2 diabetic and โ€ฆ
  1885. Impact of proteinase 3 andย insulinย growth factor BP-3 proteolysis inย obesity-induced cardiometabolic risk
  1886. Impact of reduced ATGL-mediated adipocyte lipolysis onย obesity-associatedย insulinย resistance and inflammation in male mice
  1887. Impact of sex on microvascular reactivity in a murine model of diet-inducedย obesityย andย insulinย resistance
  1888. Impact of Uncoupling Protein 3 Deficiency on High-Fat Diet-Inducedย obesityย andย insulinย Resistance
  1889. Impact of weight loss on adipocytokines, C-reactive protein andย insulinย sensitivity in hypertensive women with centralย obesity
  1890. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree ofย obesity
  1891. Impaired autonomic control of heart rate and blood pressure inย obesity: role of age and ofย insulin-resistance
  1892. Impaired fat tolerance as a risk factor ofย insulinย resistance in young patients withย obesity
  1893. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion byย insulinย inย obesityย and glucose intolerance
  1894. IMPAIRED GHRELIN SECRETION INย obesity: THE KEY ROLE OFย insulinย RESISTANCE
  1895. Impaired glucose tolerance inย obesityย is associated with insensitivity toย insulinย in multiple aspects of metabolism as assessed by a low dose incrementalย insulinย โ€ฆ
  1896. Impaired growth hormone response to growth hormone releasing factor andย insulinโ€hypoglycaemia inย obesity
  1897. Impairedย insulinย action in subcutaneous adipocytes from women with visceralย obesity
  1898. Impairedย insulin-induced platelet antiaggregating effect inย obesityย and in obese NIDDM patients
  1899. Impaired macrophage autophagy induces systemicย insulinย resistance inย obesity
  1900. Impaired microvascular function inย obesity: implications forย obesity-associated microangiopathy, hypertension, andย insulinย resistance
  1901. Impaired phagocytosis as a key mechanism underlyingย obesityโ€induced inflammation andย insulinย resistance
  1902. Impaired platelet sensitivity to the anti-aggregating effects of adenosine inย obesityย and obese non-insulin-dependent diabetes mellitus
  1903. Impaired protein metabolism: interlinks betweenย obesity,ย insulinย resistance and inflammation
  1904. Impaired Transient Receptor Potential Vanilloid Type-1 Signaling Promotesย obesityย and Leptin/insulinย Resistance In Mice
  1905. Implication of inflammatory signaling pathways inย obesity-inducedย insulinย resistance
  1906. Implication of MAP kinases inย obesity-induced inflammation andย insulinย resistance
  1907. Implication ofย obesity-induced miR-96 in hepaticย insulinย resistance
  1908. Implications of crosstalk between leptin andย insulinย signaling during the development of diet-inducedย obesity
  1909. Importance of lean muscle maintenance to improveย insulinย resistance by body weight reduction in female patients withย obesity
  1910. Importance of propionate for the repression of hepatic lipogenesis and improvement ofย insulinย sensitivity in highโ€fat dietโ€inducedย obesity
  1911. IMPORTANCE OF SHIP2 GENE INย obesityย INDUCED MUSCLEย insulinย RESISTANCE: FOCUS ON PALMITATE
  1912. Importance of TNF-alpha and leptin inย obesityย andย insulinย resistance: a hypothesis on the impact of physical exercise.
  1913. Imprintedย insulinย predisposes children toย obesity
  1914. Improvedย insulinย sensitivity after exercise training is linked to reduced plasma C 14: 0 ceramide inย obesityย and type 2 diabetes
  1915. Improvedย insulinย sensitivity with angiotensin receptor neprilysin inhibition in individuals withย obesityย and hypertension
  1916. Improvement in hepaticย insulinย sensitivity after Roux-en-Y gastric bypass in a rat model ofย obesityย is partially mediated via hypothalamicย insulinย action
  1917. Improvement of heart rate variability after decreasedย insulinย resistance after sleeve gastrectomy for morbidlyย obesityย patients
  1918. Improvement of hyperandrogenism andย insulinย resistance in females with severeย obesityย after weight loss through bariatric surgery
  1919. Improvement ofย insulinย resistance afterย obesityย surgery: a comparison of gastric banding and bypass procedures
  1920. Improvement ofย insulinย sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects withย obesity
  1921. Improvement of left ventricular function by lifestyle intervention inย obesity: contributions of weight loss and reducedย insulinย resistance
  1922. Improvement ofย obesity-linked skeletal muscleย insulinย resistance by strength and endurance training
  1923. Improvingย obesityย andย insulinย Resistance by Targeting Skeletal Muscle MKP-1
  1924. In addition toย insulinย resistance andย obesity, brachial-ankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese-a population-based study โ€ฆ
  1925. In addition toย insulinย resistance andย obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a โ€ฆ
  1926. In addition toย obesityย andย insulinย resistance, microalbuminuria and diminishedย insulinย secretion are linked with the metabolic syndrome in community-dwelling โ€ฆ
  1927. IN FOCUS: Pioglitazone protects against thrombosis in a mouse model ofย obesityย andย insulinย resistance
  1928. In normoglycaemic siblings of type 2 diabetic patients,ย obesityย accounts for decreasedย insulinย sensitivity but not for hypertension.
  1929. In patients with coronary artery disease the NCEP-defined metabolic syndrome,ย insulinย resistance andย obesityย are all associated with decreased adiponectin โ€ฆ
  1930. In the article entitled โ€œIncreased Susceptibility toย insulinย Re-sistance Associated with Abdominalย obesityย in Aging Rats,โ€
  1931. in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci Withย insulinย Release,ย insulinย Sensitivity, andย obesityย in a Population-Based Sample โ€ฆ
  1932. In Vivo Changes in Central and Peripheralย insulinย Sensitivity in a Large Animal Model ofย obesity
  1933. In vivo kinetics of islet compensation and dysfunction in a mouse model of diet-inducedย obesityย andย insulinย resistance
  1934. In-silico study of the immune systems associated genes in case of type-2 diabetes withย insulinย action and resistance and inย obesity
  1935. Inactivation of class II PI3K-C2ฮฑ induces leptin resistance, age-dependentย insulinย resistance andย obesityย in male mice
  1936. Inactivation ofย insulinย in Livers from Mice with Goldthioglueoseย obesity.
  1937. Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads toย insulinย hypersensitivity and resistance to diet-inducedย obesity
  1938. Inactivation of PKCฮธ leads to increased susceptibility toย obesityย and dietaryย insulinย resistance in mice
  1939. Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-inducedย insulinย resistance but does not preventย obesity
  1940. Inadequacy of Vitamin D Nutritional Status in Individuals with Metabolically Unhealthyย obesityย Phenotype: The Relevance ofย insulinย Resistance
  1941. Incidence ofย obesityย does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: role of leptin,ย insulin, and IGF-1
  1942. Incidence of type II diabetes in Mexican Americans predicted by fastingย insulinย and glucose levels,ย obesity, and body-fat distribution
  1943. Increase inย insulinย secretion with age: its clinical importance in evaluating abnormal secretions focused on diabetes type II andย obesity
  1944. Increaseย insulinย sensitivity by PTP1B deletion abolishedย obesityโ€induced hypertension in mice
  1945. Increased 4E-BP1 expression protects against diet-inducedย obesityย andย insulinย resistance in male mice
  1946. Increased abdominalย obesity,ย insulinย and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-ฮฒ1 gene
  1947. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model ofย insulin-resistantย obesityย and diabetes mellitus
  1948. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement inย obesity-linkedย insulinย resistance
  1949. Increased adipocyte O2 consumption triggers HIF-1ฮฑ, causing inflammation andย insulinย resistance inย obesity
  1950. Increased adipocyte S-nitrosylation targets anti-lipolytic action ofย insulin: relevance to adipose tissue dysfunction inย obesity
  1951. Increased adipose tissue expression of ILโ€18R and its ligand ILโ€18 associates with inflammation andย insulinย resistance inย obesity
  1952. Increased adipose tissue expression of tumor necrosis factor-alpha in humanย obesityย andย insulinย resistance.
  1953. Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated withย insulin, IGF-I, and leptin, but not with measures ofย obesity
  1954. Increased binding ofย insulinย to mononuclear blood cells following gastric bypass for morbidย obesity
  1955. Increased body mass index increase andย insulinย resistance parameters in dyslipidemia. Risk and positive correlation in essentialย obesity
  1956. Increased C-jun N terminal kinase (JNK) activity may linkย insulinย resistance and inflammation in human centralย obesity
  1957. INCREASED EXPRESSION OF IL-18R AND IL-18 IN THE ADIPOSE TISSUE IS ASSOCIATED WITHย insulinย RESISTANCE (HOMA-IR) INย obesity
  1958. Increased expression of triggering receptor expressed on myeloid cellsโ€1 in the population withย obesityย andย insulinย resistance
  1959. Increased fat mass compensates forย insulinย resistance in abdominalย obesityย and type 2 diabetes: a positron-emitting tomography study
  1960. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads toย obesityย withoutย insulinย resistance
  1961. Increased food intake leads toย obesityย andย insulinย resistance in the tg2576 Alzheimerโ€™s disease mouse model
  1962. Increased hepatic PDGF-AA signaling mediates liverย insulinย resistance inย obesity-associated type 2 diabetes
  1963. Increasedย insulinย requirement may contribute to risk ofย obesityย in children and young people with Type 1 Diabetes Mellitus
  1964. Increasedย insulinย resistance compounded by reducedย insulinย sensitivity drives theโ€ Fat Aussieโ€(Alms1foz/foz) model of Alstrรถm syndrome towardsย obesityย and type 2 โ€ฆ
  1965. Increasedย insulinย resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained byย obesity
  1966. Increasedย insulinย sensitivity andย obesityย resistance in mice lacking the protein tyrosine phosphatase-1B gene
  1967. Increasedย insulinย Sensitivity by High-Altitude Hypoxia in Mice with High-Fat Diet-Inducedย obesityย Is Associated with Activated AMPK Signaling and Subsequently โ€ฆ
  1968. Increasedย insulinย translation from anย insulinย splice-variant overexpressed in diabetes,ย obesity, andย insulinย resistance
  1969. Increased maternalย insulinย resistance promotes placental growth and decreases placental efficiency in pregnancies withย obesityย and gestational diabetes mellitus
  1970. Increased mitochondrial oxidative phosphorylation in the liver is associated withย obesityย andย insulinย resistance
  1971. Increased muscle blood supply and transendothelial nutrient andย insulinย transport induced by food intake and exercise: effect ofย obesityย and ageing
  1972. Increasedย obesityย resistance andย insulinย sensitivity in mice lacking the isocitrate dehydrogenase 2 gene
  1973. Increased oxidative stress precedes the onset of high-fat dietโ€“inducedย insulinย resistance andย obesity
  1974. Increased serum dihomo-ฮณ-linolenic acid levels are associated withย obesity, body fat accumulation, andย insulinย resistance in Japanese patients with type 2 diabetes
  1975. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia inย obesity, independently ofย insulinย resistance
  1976. Increased serum resistin in adults with prader-willi syndrome is related toย obesityย and not toย insulinย resistance
  1977. Increased Susceptibility toย insulinย Resistance Associated with Abdominalย obesityย in Aging Rats**
  1978. Increasing peripheralย insulinย sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure inย obesity
  1979. Incretin hormone secretion in women with polycystic ovary syndrome: roles ofย obesity,ย insulinย sensitivity, and treatment with metformin
  1980. Independent effects ofย obesityย andย insulinย resistance on postprandial thermogenesis in men.
  1981. Independent relationships ofย obesityย andย insulinย resistance with serum proinsulinย level in prepubertal children with normal glucose tolerance
  1982. Independent tissue contributors toย obesity-associatedย insulinย resistance
  1983. Indices ofย insulinย Resistance in Children with Simpleย obesity.
  1984. Indices ofย insulinย resistance in paediatricย obesity
  1985. Indices ofย obesity, dyslipidemia, andย insulinย resistance in apparently healthy Caribbean subjects
  1986. Indomethacin treatment prevents high fat diet-inducedย obesityย andย insulinย resistance but not glucose intolerance in C57BL/6J mice
  1987. Induction of adipose and hepatic SWELL1 expression is required for maintaining systemicย insulin-sensitivity inย obesity
  1988. Induction ofย obesityย andย insulinย Resistance in Mice using a Modified Diet
  1989. Inflamed Host: Serine/Threonine Phosphorylation Signaling Pathway that Linksย obesityย andย insulinย Resistance and Worse Prognosis for COVID-19
  1990. Inflammasome is a central player in the induction ofย obesityย andย insulinย resistance
  1991. Inflammation andย insulin/IGF-1 resistance as the possible link betweenย obesityย and neurodegeneration
  1992. Inflammation andย obesity: STAMPing outย insulinย resistance?
  1993. Inflammation and oxidative stress: the molecular connectivity betweenย insulinย resistance,ย obesity, and Alzheimerโ€™s disease
  1994. Inflammation and the IKK ฮฒ/I ฮบ B/NF-ฮบ B axis inย obesity-and diet-inducedย insulinย resistance
  1995. Inflammation but notย obesityย orย insulinย resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
  1996. Inflammation inย obesityย is a common link between defects in fatty acid metabolism andย insulinย resistance
  1997. Inflammation is not a contributing factor in the development ofย insulinย resistance in diet inducedย obesityย in rats
  1998. Inflammation-induced microvascularย insulinย resistance is an early event in diet-inducedย obesity
  1999. Inflammationโ€mediatedย obesityย andย insulinย resistance as targets for nutraceuticals
  2000. Inflammation,ย insulinย resistance, andย obesity
  2001. Inflammation: the link betweenย insulinย resistance,ย obesityย and diabetes
  2002. Inflammatory and metabolic role of Kupffer cells in diet-inducedย obesityย andย insulinย resistance
  2003. Inflammatory biomarkers associated withย obesityย andย insulinย resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein
  2004. Inflammatory Cross-Talk Between Short Sleep Duration andย obesityย in Development ofย insulinย Resistance: Narrative Review
  2005. Inflammatory mediators andย insulinย resistance inย obesity: role of nuclear receptor signaling in macrophages
  2006. Inflammatory Responses toย obesityย andย insulinย Resistance
  2007. Inflammatory responses underlying the microvascular dysfunction associated withย obesityย andย insulinย resistance
  2008. Influence of a mini-trampoline rebound exercise program onย insulinย resistance, lipid profile and centralย obesityย in individuals with type 2 diabetes.
  2009. Influence of acupuncture onย insulinย resistance in simpleย obesityย patients
  2010. Influence of Acupuncture on Leptin,ย insulin-resistance and Adiponectin of Type 2 Diabeticย obesityย Rats [J]
  2011. Influence of catgut implantation at acupoints on leptin andย insulinย resistance in simpleย obesityย rats
  2012. Influence of Diet and Exercise Comprehensive Correction on Plasmaย insulinย inย obesityย Complicated with Menopausal Syndrome Patients
  2013. Influence of dietary protein upon the development ofย obesity,ย insulinย resistance (IR) and energy metabolism (EM) in malnourished mice fed a high fat diet (HFD)
  2014. Influence of duration ofย obesityย on theย insulinย resistance of obese non-diabetic patients
  2015. Influence of electronic acupuncture on serum leptin andย insulinย of rats with simpleย obesity
  2016. Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters andย insulinย resistance in women withย obesity
  2017. Influence ofย insulinย resistance on renal function in patients with abdominalย obesity.
  2018. Influence ofย insulin, sympathetic nervous system activity, andย obesityย on blood pressure: the Normative Aging Study.
  2019. Influence of maternalย obesityย onย insulinย sensitivity and secretion in offspring
  2020. Influence of morbidย obesityย andย insulinย resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver
  2021. Influence of morbidย obesityย and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution
  2022. Influence of nutritional state andย obesityย on pituitary control ofย insulinย secretion
  2023. Influence ofย obesityย and family history of type 2 diabetes mellitus on serum ferritin andย insulinย levels in young adults
  2024. Influence ofย obesityย andย insulinย resistance on left atrial size in children
  2025. Influence ofย obesityย andย insulinย resistance on scavenger receptor CD36 expression on monocytes in young women
  2026. Influence ofย obesityย andย insulinย sensitivity onย insulinย signaling genes in human omental and subcutaneous adipose tissue
  2027. Influence ofย obesityย andย insulinย sensitivity on phospholipid transfer protein activity
  2028. Influence ofย obesityย in the miRNome landscape: miR-4454, a-tissue-specific regulator ofย insulinย response
  2029. Influence ofย obesityย in the miRNome: miR-4454, a key regulator ofย insulinย response via splicing modulation in prostate
  2030. Influence ofย obesityย on first-phaseย insulinย secretion in individuals with different glucose tolerance
  2031. Influence ofย obesityย onย insulinย and C-peptide levels in elderly diabetic patients [J]
  2032. Influence ofย obesityย onย insulinโ€mediated dilation in the human microcirculation
  2033. Influence ofย obesityย on the antilipolytic effect ofย insulinย in isolated human fat cells obtained before and after glucose ingestion.
  2034. Influence ofย obesityย on the relationship betweenย insulinย and triglyceride levels in endogenous hypertriglyceridemia
  2035. Influence ofย obesityย to glucose tolerance,ย insulin, blood lipid and fribrinogen level in middle-aged and elderly men
  2036. Influence of reversibleย obesityย on eating behavior, blood glucose, andย insulinย in the rat
  2037. Influence of risk factors onย insulinย resistance in patients with overweight andย obesity.
  2038. Influence of Various Diets on Diurnal Levels of Plasma Glucose,ย insulin, and Lipids inย obesityย andย insulin-Independent Diabetics
  2039. Influence of weight reduction on plasma high-density-lipoprotein cholesterol concentrations in severeย obesity: interrelationships with plasmaย insulinย levels
  2040. Inherentย insulinย sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extremeย obesity
  2041. Inhibition of 11ฮฒ-hydroxysteroid dehydrogenase type 1 amelioratesย obesity-relatedย insulinย resistance
  2042. Inhibition of 72 kDa inositol polyphosphate 5-phosphatase E improvesย insulinย signal transduction in diet-inducedย obesity
  2043. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, andย obesity-inducedย insulinย resistance
  2044. Inhibition of cyclooxygenases attenuates diet-inducedย obesityย and compensatory increased glucose-stimulatedย insulinย secretion in C57BL/6J mice
  2045. Inhibition of Hepatic Glucocorticoid Availability in Response to the Development of Diet Inducedย obesityย andย insulinย Resistance in Mice.
  2046. Inhibition ofย insulinย receptor signaling by TNF: potential role inย obesityย and non-insulin-dependent diabetes mellitus
  2047. Inhibition ofย obesity-induced hepatic ER stress by earlyย insulinย therapy in obese diabetic rats
  2048. Inhibition of P2Y6 signaling in AgRP neurons reduces food intake and improves systemicย insulinย sensitivity inย obesity
  2049. Inhibition of platelet-collagen interaction: an in vivo action ofย insulinย abolished byย insulinย resistance inย obesity
  2050. Inhibition of Stearoyl-CoA Desaturase 1 (SCD1) dissociatesย insulinย resistance andย obesityย from atherosclerosis
  2051. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy forย obesity,ย insulinย resistance and type-2 diabetes mellitus
  2052. Innate immune pathway linksย obesityย toย insulinย resistance
  2053. Inorganic nitrite improves components of the metabolic syndrome independent of weight change in a murine model ofย obesityย andย insulinย resistance
  2054. iNOS promotes hypothalamicย insulinย resistance associated with deregulation of energy balance andย obesityย in rodents
  2055. Insights intoย obesityย andย insulinย resistance from the study of extreme human phenotypes
  2056. Insights into the role of macrophage migration inhibitory factor inย obesityย andย insulinย resistance
  2057. Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 inย obesityย andย insulinย resistance
  2058. insulinย access to skeletal muscle is impaired during the early stages of dietโ€inducedย obesity
  2059. insulinย access to skeletal muscle is preserved inย obesityย induced by polyunsaturated diet
  2060. insulinย action and resistance inย obesityย and noninsulin-dependent type II diabetes mellitus
  2061. insulinย action and resistance inย obesityย and type 2 diabetes
  2062. insulinย action in brown adipose tissue is compromised during diet-inducedย obesity
  2063. insulinย action in morbidย obesity: a focus on muscle and adipose tissue
  2064. insulinย action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepaticย insulinย resistance andย obesity
  2065. insulinย action in the brain and how this may cause/exacerbateย obesityย or diabetes
  2066. insulinย Action on Endothelial Cells Limits Leukocyte-Endothelial Interaction through CXCR4 and Counteracts Intestinal Tumor Formation inย obesity
  2067. insulinย and blood pressure inย obesity.
  2068. insulinย AND CYCLICALย obesityย IN THE DORMOUSE, GLIS GLIS.
  2069. insulinย and glucose transporter gene expression inย obesityย and diabetes
  2070. insulinย and growth hormone balance: implications forย obesity
  2071. insulinย and humanย obesity.
  2072. insulinย and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation inย obesity
  2073. insulinย and hypertension: lessons fromย obesity
  2074. insulinย and hypertension: relationship toย obesityย and glucose intolerance in Pima Indians
  2075. insulinย and IGFs inย obesity-related breast cancer
  2076. insulinย and leptin action: roles in diabetes andย obesity.
  2077. insulinย and leptin relations inย obesity: a multimedia approach
  2078. insulinย andย obesityย in the Zucker genetically obese rat โ€œfattyโ€
  2079. insulinย andย obesityย transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state
  2080. insulinย as a factor of increased androgen production in women withย obesityย and polycystic ovaries
  2081. insulinย attenuates cardiac dysfunction in a rodent model of diet inducedย obesityย andย insulinย resistance
  2082. insulinย based combination treatments of patients withย obesityย and type 2 diabetes
  2083. insulinย binding and action in isolated rat hepatocytes: effect ofย obesityย and fasting
  2084. insulinย binding to monocytes andย insulinย action in humanย obesity, starvation, and refeeding
  2085. insulinย clearance inย obesity
  2086. insulinย deficiency: a possible link betweenย obesityย and cognitive function
  2087. insulinย Degradation by Adipose Humanย obesity
  2088. insulinย degradation by adipose tissue is increased in humanย obesity
  2089. insulinย degradation by adipose tissue is increased in humanย obesity
  2090. insulinย dependent diabetes mellitus: the affect ofย obesityย on blood glucose control
  2091. insulinย downregulates M 2-muscarinic receptors in adult rat atrial cardiomyocytes: a link betweenย obesityย and cardiovascular complications
  2092. insulinย dysregulation in a population of Finnhorses and associated phenotypic markers ofย obesity
  2093. insulinย dysregulation in horses with inducedย obesity
  2094. insulinย gene variable number of tandem repeats (INS VNTR) genotype and metabolic syndrome in childhoodย obesity
  2095. insulinย hypoglycemia, a functional test of the state of the hypothalamo-hypophyseo-adrenal system inย obesity
  2096. insulinย impairs regulatory T cell function: implications forย obesityย (P1020)
  2097. insulinย inhibits IL-10โ€“mediated regulatory T cell function: implications forย obesity
  2098. insulinย levels during pregnancy orย obesityย in normoglycemic women with a positive history of diabetes mellitus
  2099. insulinย measurement is also inappropriate in paediatricย obesity
  2100. insulinย metabolism in hypothalamicย obesity
  2101. insulinย normalization as an approach to the pharmacological treatment ofย obesity
  2102. insulinย production and resistance in different models of diet-inducedย obesityย and metabolic syndrome
  2103. insulinย receptor binding andย insulinย action in human fat cells: effects ofย obesityย and fasting
  2104. insulinย receptor binding inย obesity: a reassessment
  2105. insulinย receptor deficiency in genetic and acquiredย obesity
  2106. insulinย receptor kinase activity in muscles and white adipose tissue during course of VMHย obesity
  2107. insulinย receptor substrateโ€1 inhibits highโ€fat dietโ€inducedย obesityย by browning of white adipose tissue through miRโ€503
  2108. insulinย receptor variants andย obesity-related cancers in the Framingham Heart Study
  2109. insulinย receptor: role in the resistance of humanย obesityย toย insulin
  2110. insulinย receptors in adipose tissue of rats with monosodium glutamate-inducedย obesity
  2111. insulinย reduces reaction of follicular granulosa cell to FSH stimulation inย obesity-related infertility women during IVF
  2112. insulinย reduces reaction of follicular granulosa cells to FSH stimulation in women withย obesity-related infertility during IVF
  2113. insulinย regulation of glucose and lipid metabolism in massiveย obesity
  2114. insulinย regulation of monoamine signaling: pathway toย obesity
  2115. insulinย relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein responseโ€dependentย insulinย resistance as a cause ofย obesityโ€associated โ€ฆ
  2116. insulinย release in response to oral glucose inย obesity: The effect of reduction of body weight
  2117. insulinย Resistance & Inflammatory Markers inย obesity.
  2118. insulinย Resistance Affects bothย insulinย and Exercise Stimulated Glucose Uptake inย obesityย Independent of Glucose Delivery. In vivo Studies Using [[sup. 15] O]-[H. sub โ€ฆ
  2119. insulinย resistance and cardiovascular risk marker evaluation in morbidย obesityย 12 months after bariatric surgery compared to weight-matched controls
  2120. insulinย resistance and changes in plasma concentration of TNFฮฑ, IGF1, and NEFA in dogs during weight gain andย obesity
  2121. insulinย RESISTANCE AND COMPENSATORY HYPERinsulinEMIA: THE LINCHPIN BETWEENย obesityย AND CARDIOVASCULAR
  2122. insulinย Resistance and Glucose Metabolism in Childhoodย obesity
  2123. insulinย Resistance and High TNF [Alpha] Concentrations Precedeย obesityย in Rats Fed High Carbohydrate Diet during Suckling Period
  2124. insulinย resistance and hunger in childhoodย obesity: a patient and physicianโ€™s perspective
  2125. insulinย resistance and hypersecretion inย obesity. European Group for the Study ofย insulinย Resistance (EGIR).
  2126. insulinย resistance and impaired glucose tolerance in overweight/obese adolescents attending anย obesityย clinic in Belgium
  2127. insulinย Resistance and Inflammation: Links Betweenย obesityย and Cardiovascular Disease
  2128. insulinย Resistance and its Relevance with Age, Sex, Season andย obesityย in Darehshori Horse Breed
  2129. insulinย resistance and low metabolic rate: do they causeย obesity?
  2130. insulinย resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus andย obesity
  2131. insulinย resistance and metabolic disorders in women with morbidย obesity
  2132. insulinย resistance and metabolic syndrome in children withย obesity
  2133. insulinย resistance and neurodegeneration: roles ofย obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis
  2134. insulinย resistance and not BMI is the major determinant of early vascular impairment in patients with morbidย obesity
  2135. insulinย resistance andย obesity
  2136. insulinย resistance andย obesity
  2137. insulinย resistance andย obesityย affect lipid profile in the salivary glands
  2138. insulinย resistance andย obesityย affect monocyte-derived dendritic cell phenotype and function
  2139. insulinย resistance andย obesityย among infertile women with different polycystic ovary syndrome phenotypes
  2140. insulinย resistance andย obesityย in a mouse model of systemic lupus erythematosus
  2141. insulinย resistance andย obesityย in childhood
  2142. insulinย Resistance andย obesityย in Lupus
  2143. insulinย Resistance andย obesityย in Mexican Youth
  2144. insulinย resistance andย obesityโ€related factors in Praderโ€“Willi syndrome: Comparison with obese subjects
  2145. insulinย resistance andย obesity, and their association with depression in relatively young people
  2146. insulinย resistance andย obesity, and their association with depression in relatively young people: findings from a large UK birth cohort
  2147. insulinย resistance andย obesity: how do they affect tau pathology?
  2148. insulinย resistance andย obesity: resistin, a hormone secreted by adipose tissue
  2149. insulinย resistance and parentalย obesityย as predictors to response to therapeutic life style change in obese children and adolescents 10โ€“18 years old
  2150. insulinย Resistance and Systemic Inflammation in Patients with Osteoarthrosis Associated withย obesity: The Effectiveness of Symptomatic Slow-Acting Drugs
  2151. insulinย resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population withย obesity
  2152. insulinย resistance and the metabolic syndrome in obese children referred to anย obesityย center
  2153. insulinย resistance and the persistence ofย obesityย from childhood into adulthood
  2154. insulinย resistance and the renin-angiotensin-aldosterone system in metabolic syndrome andย obesity-related hypertension
  2155. insulinย resistance and the severity of coronary artery disease based onย obesityย status in stable-angina patients: A cross-sectional analysis
  2156. insulinย resistance and truncalย obesityย as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with โ€ฆ
  2157. insulinย resistance and upper-bodyย obesityย in polycystic ovary syndrome
  2158. insulinย resistance and visceral fatย obesityย in hyperlipidemia
  2159. insulinย resistance as a characteristic of hypertension with overweight/obesityย in Shanghai Chinese
  2160. insulinย resistance as common molecular denominator linkingย obesityย to Alzheimerโ€™s disease
  2161. insulinย resistance as key factor for linking modulation of gut microbiome to health claims and dietary recommendations to tackleย obesity
  2162. insulinย resistance associated toย obesity: the link TNF-alpha
  2163. insulinย resistance associates with hepatic lobular inflammation in subjects withย obesity
  2164. insulinย resistance contributes toย obesity-related proteinuria
  2165. insulinย resistance contribution to pathogenesis of cardiac remodeling in patients with hypertension in combination withย obesityย and type 2 diabetes
  2166. insulinย resistance due toย obesity
  2167. insulinย Resistance for Adolescents withย obesityย in Latvia
  2168. insulinย resistance in aging is related to abdominalย obesity
  2169. insulinย Resistance in Aging ls Related to Abdominalย obesity
  2170. insulinย resistance in childhoodย obesity
  2171. insulinย resistance in childhoodย obesity.
  2172. insulinย Resistance in Children and Adolescents with Exogen-Constitutionalย obesity
  2173. insulinย resistance in children and adolescents with type 1 diabetes mellitus: relation toย obesity
  2174. insulinย resistance in children and teenagers with exogenous constitutiveย obesity
  2175. insulinย resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominalย obesity
  2176. insulinย resistance in kidney disease: is there a distinct role separate from that of diabetes orย obesity
  2177. insulinย resistance in Mexican Americansโ€”A precursor toย obesityย and diabetes?
  2178. insulinย resistance in morbidย obesity: reversal with intramyocellular fat depletion
  2179. insulinย resistance inย obesity
  2180. insulinย resistance inย obesityย and hypertension: an important link with cardiovascular disease
  2181. insulinย resistance inย obesityย and its molecular control
  2182. insulinย resistance inย obesityย and metabolic syndrome: is there a connection with platelet l-arginine transport?
  2183. insulinย resistance inย obesityย and noninsulinย dependent diabetes mellitus.
  2184. insulinย resistance inย obesityย and polycystic ovary syndrome: systematic review and meta-analysis of observational studies
  2185. insulinย resistance inย obesityย as analyzed by the response of glucose kinetics to glucagon infusion
  2186. insulinย resistance inย obesityย as the underlying cause for the metabolic syndrome
  2187. insulinย resistance inย obesityย can be reliably identified from fasting plasmaย insulin
  2188. insulinย resistance inย obesityย is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose andย insulin
  2189. insulinย resistance inย obesity, type II diabetes and stress
  2190. insulinย resistance inย obesity: a critical analysis at enzyme level. A review.
  2191. insulinย resistance inย obesity: an overview of fundamental alterations
  2192. insulinย resistance inย obesity: body-weight or energy balance?
  2193. insulinย resistance inย obesity: metabolic mechanisms and measurement methods
  2194. insulinย resistance inย obesity: pathogenesis and effects
  2195. insulinย resistance inย obesity: Targeting the Molecular Mechanisms of Metabolic Disease
  2196. insulinย resistance in patients with stroke is related to visceral fatย obesityย and adipocytokines
  2197. insulinย Resistance in Pima Indians: A Combined Effect of Genetic Predisposition andย obesityโ€related Skeletal Muscle Cell Hypertrophy
  2198. insulinย Resistance In Semi-Urban South Western Nigeria And Itโ€™s Relationship With Indices Ofย obesity
  2199. insulinย resistance in the defense againstย obesity
  2200. #VALUE!
  2201. insulinย resistance in type 2 diabetes andย obesity: implications for endothelial function
  2202. insulinย resistance in type 2 diabetes: association with truncalย obesity, impaired fitness, and atypical malonyl coenzyme A regulation
  2203. insulinย resistance in very low birth weight infants progresses during childhood without aggravation ofย obesityย or dyslipidaemia
  2204. insulinย resistance in visceralย obesity
  2205. insulinย resistance in women with polycystic ovary syndrome contributed to cardiovascular disease risk factors independent ofย obesity.
  2206. insulinย resistance induced by hydrocortisone is increased in patients with abdominalย obesity
  2207. insulinย resistance is a characteristic feature of primary hypertension independent ofย obesity
  2208. insulinย Resistance Is a Late Manifestation of Ovariectomy in Mice That Occurs in the Absence ofย obesityย but Is Associated With Adipose Tissue Inflammation
  2209. insulinย resistance is associated with arterial stiffness independent ofย obesityย in male adolescents
  2210. insulinย resistance is associated with C-reactive protein independent of abdominalย obesityย in nondiabetic Taiwanese
  2211. insulinย resistance is associated with gut permeability without the direct influence ofย obesityย in young adults
  2212. insulinย resistance measured by QUICKI andย obesityย in type 2 diabetic patients
  2213. insulinย resistance measured by the triglyceride-glucose index and risk ofย obesity-related cancers: An epidemiological investigation in more than 500,000 individuals.
  2214. insulinย resistance might linkย obesityย and congestive heart failure
  2215. insulinย resistance modifies the association betweenย obesityย and current asthma in adults
  2216. insulinย Resistance Modifies the Association Betweenย obesityย and Current Asthma in Adults
  2217. insulinย resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow inย obesity.
  2218. insulinย resistance of human adipose tissue inย obesityย measured with [18F] FDG and PET
  2219. insulinย resistance pathogenesis in metabolicย obesity
  2220. insulinย resistance study in diabetes mellitus type II and its correlation withย obesity
  2221. insulinย resistance syndrome (metabolic syndrome) andย obesityย in Asian Indians: evidence and implications
  2222. insulinย resistance syndrome and Alzheimerโ€™s disease: age-andย obesity-related effects on memory, amyloid, and inflammation
  2223. insulinย resistance syndrome andย obesity
  2224. insulinย RESISTANCE SYNDROME IN PAEDIATRICย obesity.
  2225. insulinย resistance syndrome includingย obesity, premature pubarche and polycystic ovary syndrome
  2226. insulinย resistance versusย insulinย secretion in the hypertension ofย obesity.
  2227. insulinย resistance via modification of PGC1ฮฑ function identifying a possible preventive role of vitamin D analogues in chronic inflammatory state ofย obesity. A double โ€ฆ
  2228. insulinย resistance with acanthosis nigricans: the roles ofย obesityย and androgen excess
  2229. insulinย resistance withoutย obesityย induced by cotton pellet granuloma in mice
  2230. insulinย resistanceโ€“a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), androidย obesity, essential โ€ฆ
  2231. insulinย Resistance-associated Impairment Of Preadipocyte Differentiation In Human Abdominalย obesity
  2232. insulinย resistance, atherogenic dyslipidemia and other atherogenic factors in simpleย obesityย andย obesityย with Acanthosis nigricans (an) in childhood
  2233. insulinย resistance, beta-cell function, and glucose tolerance in Brazilian adolescents withย obesityย or risk factors for type 2 diabetes mellitus
  2234. insulinย resistance, centralย obesity, and risk of colorectal adenomas
  2235. insulinย resistance, endothelial function, fibrinolytic activity, and markers ofย obesityย in children
  2236. insulinย resistance, glucose regulation,ย obesityย and mood: A review of the literature.
  2237. insulinย resistance, glucose regulation,ย obesity, and mood.
  2238. insulinย resistance, hyperinsulinemia, and blood pressure: role of age andย obesity
  2239. insulinย resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent ofย obesity
  2240. insulinย resistance, hyperinsulinemia, and LH: relative roles in peripubertalย obesity-associated hyperandrogenemia
  2241. insulinย Resistance, Hyperinsulinemia, and LH: Relative Roles in Peripubertalย obesity-Associated Hyperandrogenemia
  2242. insulinย resistance, hyperinsulinemia, andย obesity-associated hypertension.
  2243. insulinย resistance, impaired postprandial lipid metabolism and abdominalย obesity
  2244. insulinย resistance, inflammation, andย obesity: role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism
  2245. insulinย resistance,ย insulinย response, andย obesityย as indicators of metabolic risk
  2246. insulinย resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominalย obesity
  2247. insulinย resistance,ย obesityย and breast cancer risk
  2248. insulinย resistance,ย obesityย and diabetes: the connection
  2249. insulinย resistance,ย obesityย and hypertension
  2250. insulinย resistance,ย obesityย and hypertension: an overview
  2251. insulinย resistance,ย obesityย and hypertension: is the link waist circumference?
  2252. insulinย resistance,ย obesityย and hypovitaminosis D adversely affect pregnancy utcome: Can Supplemental vitamin D cut this risk?
  2253. insulinย resistance,ย obesityย and lipotoxicity
  2254. insulinย resistance,ย obesityย and the metabolic syndrome.
  2255. insulinย resistance,ย obesityย and the metabolic syndrome. Is there a therapeutic role for endothelin-1 antagonists?
  2256. insulinย resistance,ย obesityย indices and lipid profile in Nigerian patients with type 2 diabetes mellitus
  2257. insulinย resistance,ย obesity, and liver cancer
  2258. insulinย resistance,ย obesity, and metabolic syndrome among non-diabetic pre-and post-menopausal women in North Taiwan
  2259. insulinย Resistance,ย obesity, Body Fat Distribution, and Risk of Cardiovascular Disease
  2260. insulinย resistance,ย obesity, hypertension, and renal sodium transport
  2261. insulinย resistance,ย obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age< or= 14 years, 13 with โ€ฆ
  2262. insulinย resistance,ย obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions
  2263. insulinย resistance,ย obesity, metabolic syndrome, and lifestyle modification
  2264. insulinย resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatricย obesity
  2265. insulinย resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatricย obesity
  2266. insulinย resistance, subclinical left ventricular remodeling, and theย obesityย paradox: MESA (Multi-Ethnic Study of Atherosclerosis)
  2267. insulinย resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population withย obesity
  2268. insulinย RESISTANCE, TUMOR NECROSIS FACTOR-ALPHA INย obesity-ASSOCIATED HYPERTENSION: PP. 34.367
  2269. insulinย resistance, ฮฒ-cell function, and glucose tolerance in Brazilian adolescents withย obesityย or risk factors for type 2 diabetes mellitus
  2270. insulinย resistance: a multifaceted syndrome responsible for NIDDM,ย obesity, hypertension, dyslipidaemia and atherosclerosis
  2271. insulinย resistance: a multifaceted syndrome responsible for NIDDM,ย obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
  2272. insulinย resistance: interactions betweenย obesityย and a common variant ofย insulinย receptor substrate-1
  2273. insulinย resistance: Lessons from animal models ofย obesity
  2274. insulinย resistance: receptor and post-binding defects in humanย obesityย and non-insulin-dependent diabetes mellitus
  2275. insulinย Resistance: The Linchpin Betweenย obesityย andย obesity-Related Metabolic Abnormalities
  2276. insulinย resistance: the link betweenย obesityย and cardiovascular disease
  2277. insulinย resistance: the metabolic link between non-insulin-dependent diabetes mellitus,ย obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular โ€ฆ
  2278. insulinย response to a rapid intravenous injection of dextrose in patients with anorexia nervosa andย obesity
  2279. insulinย response to a spontaneously ingested standard meal during the development ofย obesityย in GTG-injected mice.
  2280. insulinย response to an intravenous glucose load during development ofย obesityย in gold thioglucose-injected mice
  2281. insulinย response to glucagon: the opposing effects of diabetes andย obesity
  2282. insulinย response to high intensity interval training versus resistive training in post menopusalย obesity
  2283. insulinย responsiveness in vitro of diaphragm and adipose tissue from weanling rats with hypothalamicย obesity
  2284. insulinย responsiveness of adipose tissue lipoprotein lipase is delayed but preserved inย obesity
  2285. insulinย secretion and body composition inย obesity
  2286. insulinย secretion and carbohydrate tolerance in childhoodย obesity
  2287. insulinย secretion in childhoodย obesity
  2288. insulinย secretion in experimentalย obesity
  2289. insulinย secretion in humanย obesity: effects of prolonged fasting and refeeding.
  2290. insulinย secretion in hypothalamicย obesity: Diurnal variation and the effect of naloxone
  2291. insulinย secretion inย obesity
  2292. insulinย secretion inย obesityย after exercise
  2293. insulinย secretion inย obesityย and diabetes: an illustrative case
  2294. insulinย secretion,ย insulinย resistance, andย obesity
  2295. insulinย secretion,ย obesity, and potential behavioral influences: results from theย insulinย Resistance Atherosclerosis Study (IRAS)
  2296. insulinย secretion, peripheralย insulinย sensitivity andย insulin-receptor binding in subjects with different degrees ofย obesity
  2297. insulinย sensitive and resistantย obesityย in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
  2298. insulinย sensitivity affects propensity toย obesityย in an ethnic-specific manner: results from two controlled weight loss intervention studies
  2299. insulinย sensitivity and abdominalย obesityย in African-American, Hispanic, and non-Hispanic white men and women: theย insulinย Resistance and Atherosclerosis Study
  2300. insulinย sensitivity and carbohydrate metabolism of rats with hypothalamicย obesity
  2301. insulinย sensitivity and secretion in children and adolescents with hypothalamicย obesityย following treatment for craniopharyngioma
  2302. insulinย sensitivity decreases withย obesity, and lean cats with lowย insulinย sensitivity are at greatest risk of glucose intolerance with weight gain
  2303. insulinย sensitivity deteriorates after short-term lifestyle intervention in theย insulinย sensitive phenotype ofย obesity
  2304. insulinย sensitivity from preschool to school age in patients with severeย obesity
  2305. insulinย sensitivity in anorexia nervosa: a mirror image ofย obesity?
  2306. insulinย sensitivity in Chinese: Inter-relations withย obesityย and other components of the metabolic syndrome.
  2307. insulinย sensitivity M ratio and IRI/G ratio in patients with hypertension andย obesity
  2308. insulinย sensitivity of adipocytes from inbred mouse strains resistant or sensitive to diet-inducedย obesity
  2309. insulinย sensitivity of the body in experimental hypothalamicย obesity
  2310. insulinย sensitivity predictions in individuals withย obesityย and type II diabetes mellitus using mathematical model of theย insulinย signal transduction pathway
  2311. insulinย sensitivity regulates cholesterol metabolism to a greater extent thanย obesity: lessons from the METSIM Study
  2312. insulinย Sensitization and Antiโ€obesityย Effects of Astragalus Polysaccharide on High Fat Dietโ€fed C57BL/6J Mice
  2313. insulinย signal transduction and glucose transport in human adipocytes: effects ofย obesityย and low calorie diet
  2314. insulinย status and vascular responses to weight loss inย obesity
  2315. insulinย suppresses TNF-dependent early osteoarthritic changes associated withย obesityย and type 2 diabetes
  2316. insulinย translates unfavourable lifestyle intoย obesity
  2317. insulinย Treatment, Type 2 Diabetes andย obesity
  2318. insulinย up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk andย obesity?
  2319. insulin-andย obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations
  2320. insulin-dependent activation of MCH neurons impairs locomotor activity andย insulinย sensitivity inย obesity
  2321. insulin-dependent metabolism of branched-chain amino acids inย obesity
  2322. insulin-Induced Free IGF-I Suppression is Lost inย obesity
  2323. insulin-induced hexokinase II expression is reduced inย obesityย and NIDDM.
  2324. insulin-induced vasodilatation and endothelial function inย obesity/insulinย resistance. Effects of troglitazone
  2325. insulin-like growth factor 1 related to chronic low-grade inflammation in patients withย obesityย and early change of its levels after laparoscopic sleeve gastrectomy
  2326. insulin-like growth factor 2/H19 methylation at birth and risk of overweight andย obesityย in children
  2327. insulin-like growth factor and its dynamics in babies born from mothers withย obesity
  2328. insulin-like growth factor binding protein-1, non-alcoholic fatty liver disease, and its relationship with fructose consumption in children withย obesity
  2329. insulin-like growth factor binding protein-3 (IGFBP-3) enhancesย obesity-related breast tumorigenesis
  2330. insulin-like growth factor binding protein-3 linksย obesityย and breast cancer progression
  2331. insulin-like growth factor binding protein-I levels are strongly associated withย insulinย sensitivity andย obesityย in early pubertal children
  2332. insulin-like growth factor-I response to a single bolus of growth hormone is increased inย obesity
  2333. insulin-mediated sympathetic stimulation: role in the pathogenesis ofย obesity-related hypertension (or, howย insulinย affects blood pressure, and why)
  2334. insulin-mediated sympathoexcitation inย obesityย and type 2 diabetes
  2335. insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or withoutย obesity
  2336. insulin-receptor interaction on liver cell membranes and isolated adipocytes of rats in experimentalย obesity
  2337. insulin-regulated aminopeptidase in adipocyte is Cys-specific and affected byย obesity
  2338. insulin-sensitiveย obesity
  2339. insulin-Sensitiveย obesity
  2340. insulin-sensitiveย obesityย in humansโ€“a โ€˜favorable fatโ€™phenotype?
  2341. insulin-Sensitiveย obesity: Prospective and Interventional Studies
  2342. insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects inย obesityย and type II diabetes
  2343. insulin-stimulated protein kinase C ฮป/ฮถ activity is reduced in skeletal muscle of humans withย obesityย and type 2 diabetes: reversal with weight reduction
  2344. insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated withย obesity
  2345. insulinโ€like growth factor type I receptor gene expression andย obesityย in esophageal adenocarcinoma
  2346. insulin, androgens, andย obesityย in women with and without polycystic ovary syndrome: a heterogeneous group of disorders
  2347. insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting inย obesity
  2348. insulin, central dopamine D2 receptors, and monetary reward discounting inย obesity
  2349. insulin, ghrelin and early return of hunger in women withย obesityย and polycystic ovary syndrome
  2350. insulin,ย insulinย resistance,ย obesity, and cancer
  2351. insulin, Leptin and Ghrelin inย obesityย with and without Hypertension.
  2352. insulin,ย obesity, and triglyceride interrelationships in sixteen children with familial hypertriglyceridemia.
  2353. Integrated concentrations of growth hormone,ย insulin, C-peptide and prolactin in humanย obesity
  2354. Interacting epidemics? Sleep curtailment,ย insulinย resistance, andย obesity
  2355. Interaction between corticosterone andย insulinย inย obesity: regulation of lard intake and fat stores
  2356. Interaction between theย obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA onย insulinย sensitivity
  2357. Interaction connecting Leptin-obesityโ€“insulinย dependent diabetes mellitus
  2358. Interaction ofย insulin-like growth factor-I andย insulinย resistance-related genetic variants withย obesityย and lifestyle factors on postmenopausal breast cancer risk
  2359. Interaction of sex steroid hormones andย obesityย onย insulinย resistance and type 2 diabetes in men: the Third National Health and Nutrition Examination Survey
  2360. Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscleย insulinย resistance inย obesityย and type 2 diabetes: studies with โ€ฆ
  2361. Interactions amongย insulinย resistance, inflammation factors,ย obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational โ€ฆ
  2362. Interactions between glucocorticoid metabolism and inflammation inย obesityย andย insulinย resistance.
  2363. Interactions betweenย insulinย and glucocorticoids in the maintenance of geneticย obesity
  2364. Interactions ofย obesityย and glucose-stimulatedย insulinย secretion in familial hypertriglyceridemia
  2365. Interactions ofย obesity, and glucose andย insulinย levels in hypertriglyceridemia
  2366. INTERACTIVE EFFECTS OFย obesityย AND OVARIAN STEROIDS ONย insulinย PHYSIOLOGY IN CATTLE AND SHEEP.
  2367. Intercellular adhesion molecule 1, ICAM-1, in polycystic ovary syndrome: relationship toย insulinย resistance orย obesity
  2368. Intercellular adhesion molecule-1 concentration is genetically correlated withย insulinย resistance,ย obesity, and HDL concentration in Mexican Americans
  2369. Interferon activated gene 202b (Ifi202b) promotes Zfp432 expression and suppresses the thermogenic gene program resulting inย obesityย andย insulinย resistance
  2370. Interferon regulatory factor 7 deficiency prevents diet-inducedย obesityย andย insulinย resistance
  2371. Interferon tau alleviatesย obesity-induced adipose tissue inflammation andย insulinย resistance by regulating macrophage polarization
  2372. Interleukin-1 receptor antagonist is upregulated during diet-inducedย obesityย and regulatesย insulinย sensitivity in rodents
  2373. Interleukin-18 in plasma and adipose tissue: effects ofย obesity,ย insulinย resistance, and weight loss
  2374. Interleukin-6 depletion selectively improves hepaticย insulinย action inย obesity
  2375. Interleukin-6 induces impairment in human subcutaneous adipogenesis inย obesity-associatedย insulinย resistance
  2376. Interleukin-6 signaling promotes alternative macrophage activation to limitย obesity-associatedย insulinย resistance and endotoxemia
  2377. INTERLEUKINโ€10 DEFICIENCY LIMITS THE DEVELOPMENT OFย obesityย ANDย insulinย RESISTANCE PRODUCED BY A HIGH FAT DIET
  2378. Intermedin/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-inducedย obesityย andย insulinย resistance in mice
  2379. Intermittent hypoxia and diet-inducedย obesity: effects on oxidative status, sympathetic tone, plasma glucose andย insulinย levels, and arterial pressure
  2380. Intermuscular and perimuscular fat expansion inย obesityย correlates with skeletal muscle T cell and macrophage infiltration andย insulinย resistance
  2381. Interplay between gut microbiota and p66Shc affectsย obesityโ€associatedย insulinย resistance
  2382. Interplay of anย obesity-based genetic risk score with dietary and endocrine factors onย insulinย resistance
  2383. Intertissue communication in the pathogenesis ofย insulinย resistance inย obesityย and type 2 diabetes
  2384. Intestinal FABP2 A54T Polymorphism: Association withย insulinย Resistance andย obesityย in Women
  2385. Intestinal FXR agonism promotes adipose tissue browning and reducesย obesityย andย insulinย resistance
  2386. Intestinal Microbiota and Bacterial Translocation: Impact of Diet,ย obesityย andย insulinย Resistance
  2387. Intestinal microbiota contributes to energy balance, metabolic inflammation, andย insulinย resistance inย obesity
  2388. Intestinal Microbiota,ย obesityย andย insulinย Resistanceโ€”What Are the Relationships?
  2389. Intestinal PPARฮด protects against diet-inducedย obesity,ย insulinย resistance and dyslipidemia
  2390. Intestine-targeted DGAT1 inhibition improvesย obesityย andย insulinย resistance without skin aberrations in mice
  2391. Intra-Placental Gene Transfer of Humanย insulin-Like Growth Factor-1 Preventsย obesityย in an Intra-Uterine Growth Restricted Model Exposed to High Fat Diet โ€ฆ
  2392. Intra-Placental Gene Transfer of Humanย insulin-Like Growth Factor-1 Reprograms Fetal Predisposition toย obesityย in Intra-uterine Growth Restriction
  2393. Intracellular hyperinsulinism: a metabolic characteristic ofย obesityย with and without type 2 diabetes: intracellularย insulinย inย obesityย and Type 2 diabetes
  2394. Intracellular lipid accumulation andย insulinย sensitivity in muscle and liver: Fighting against โ€œintracellularย obesityโ€
  2395. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympatheticโ€mediatedย obesityย andย insulinย resistance
  2396. Intracerebroventricular infusions of 3-OHB andย insulinย in a rat model of dietaryย obesity
  2397. Intramuscular lipid metabolism,ย insulinย action, andย obesity
  2398. Intramyocitic lipid accumulation and SREBP-1c expression are related toย insulinย resistance and cardiovascular risk in morbidย obesity
  2399. Intranasal targeting of hypothalamic PTP1B and TCPTP reinstates leptin andย insulinย sensitivity and promotes weight loss inย obesity
  2400. Intrauterine influences onย obesityย andย insulinย resistance in pre-pubertal children.
  2401. Inverse relationship of the CMKLR1 relative expression and chemerin serum levels inย obesityย with dysmetabolic phenotype andย insulinย resistance
  2402. Investigating the onset ofย insulinย resistance and non-alcoholic fatty liver disease inย obesity-induced cardiac dysfunction
  2403. Investigating the role of Class-1 Phosphoinositide 3 Kinases (PI3Ks) inย insulinย signaling andย obesity
  2404. Investigating the role ofย insulin-like growth factor binding protein-2 (IGFBP-2) in childhoodย obesityย and Type 2 Diabetes
  2405. Investigating the Wnt/ฮฒ-catenin Pathway in Conventional Dendritic cells inย obesity-Induced Tissue Inflammation andย insulinย Resistance
  2406. Investigation of DNA Methylation inย obesityย and its Underlyingย insulinย Resistance
  2407. Investigation of Relationship between Leptin andย insulinย Resistance inย obesityย [J]
  2408. Investigation of the association betweenย obesityย andย insulin-induced gene 1 polymorphism at 7q36. 3 region in Uygur population in Xinjiang, China
  2409. Investigation of the relationship between genetic and environmental risk factors associated withย obesityย andย insulinย resistance in South African patients with non โ€ฆ
  2410. Investigation on the relationships among blood zinc, copper,ย insulinย and thyroid hormones in non-insulinย dependent diabetes mellitus andย obesity
  2411. Involvement of adipocytokines in pathogenesis ofย insulinย resistance,ย obesity, and metabolic syndrome
  2412. Involvement of protein kinase C in human skeletal muscleย insulinย resistance andย obesity.
  2413. Involvement of protein phosphatase 5 (pp5) in diet-inducedย obesityย andย insulinย resistance
  2414. Inward Glucose Transfer Accounts forย insulinโ€Dependent Increase in Brain Glucose Metabolism Associated with Dietโ€Inducedย obesity
  2415. Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion andย insulinย sensitivity duringย obesity
  2416. iRhom2 serves as a facilitator inย obesityย by enhancing adipose inflammation andย insulinย resistance
  2417. Irisin is expressed and produced by human muscle and adipose tissue in association withย obesityย andย insulinย resistance
  2418. Iron andย obesityย status-associatedย insulinย resistance influence circulating fibroblast-growth factor-23 concentrations
  2419. IRS-1-mediated inhibition ofย insulinย receptor tyrosine kinase activity in TNF-ฮฑ-andย obesity-inducedย insulinย resistance
  2420. Is Absence of Carbohydrate Metabolism Disorders in Patients with Prolonged History ofย obesityย due to Lowย insulinย Resistance or Preservedย insulinย Secretion?
  2421. Is Exposure to Bisphenolโ€A and Phthalates Associated withย obesity, Metabolic Disturbances andย insulinย Resistance among US adults?
  2422. Isย insulinย the link between hypertension andย obesity?
  2423. Isย insulin-dependent diabetes andย obesityย a predisposition for endometrial and pancreatic carcinoma?
  2424. Isย insulin-like growth factor 1 a determinant of renal haemodynamics inย obesityย hypertension?
  2425. #VALUE!
  2426. Is leptin the link betweenย obesityย andย insulinย resistance?
  2427. Isย obesityย an absolute evil? Increase in adipose tissue does not always decreaseย insulinย sensitivity
  2428. Isย obesity-relatedย insulinย status the cause of blunted growth hormone secretion in turnerโ€™s syndrome?
  2429. Is salivary gland function altered in noninsulin-dependent diabetes mellitus andย obesityโ€“insulinย resistance?
  2430. #VALUE!
  2431. Is there a relationship between leptin andย insulinย sensitivity independent ofย obesity? A population-based study in the Indian Ocean nation of Mauritius
  2432. Islet adaptation toย obesityย andย insulinย resistance in WNIN/GR-Ob rats
  2433. Isletย insulinย secretion, ฮฒ-cell mass, and energy balance in a polygenic mouse model of type 2 diabetes withย obesity
  2434. Jaboticaba peel powder and jaboticaba peel aqueous extract reducesย obesity,ย insulinย resistance and hepatic fat accumulation in rats
  2435. Jejunal T cell inflammation in humanย obesityย correlates with decreased enterocyteย insulinย signaling
  2436. JNK activation of BIM promotes hepatic oxidative stress, steatosis, andย insulinย resistance inย obesity
  2437. JNK at the crossroad ofย obesity,ย insulinย resistance, and cell stress response
  2438. JNK expression by macrophages promotesย obesity-inducedย insulinย resistance and inflammation
  2439. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation andย insulinย resistance without affectingย obesity
  2440. Joint Effects ofย obesityย and Vitamin D Deficiency onย insulinย Resistance and Type 2 Diabetes
  2441. Joint effects ofย obesityย and vitamin D insufficiency onย insulinย resistance and type 2 diabetes: results from the NHANES 2001โ€“2006
  2442. #VALUE!
  2443. Ketone body kinetics in humans: the effects ofย insulin-dependent diabetes,ย obesity, and starvation.
  2444. Kinetics of in vivo muscleย insulin-mediated glucose uptake in humanย obesity
  2445. Kinome profiling reveals abnormal activity of kinases in skeletal muscle from adults withย obesityย andย insulinย resistance
  2446. KLF10 Deficiency in CD4+ T Cells Triggersย obesity,ย insulinย Resistance, and Fatty Liver
  2447. Knockdown of ANT2 reduces adipocyte hypoxia and improvesย insulinย resistance inย obesity
  2448. Korean diet preventsย obesityย and amelioratesย insulinย resistance in mice fed a high-fat diet
  2449. KSR2 mutations are associated withย obesity,ย insulinย resistance, and impaired cellular fuel oxidation
  2450. L-PGDS-produced PGD 2 in premature, but not in mature, adipocytes increasesย obesityย andย insulinย resistance
  2451. L-pGDs-produced pGD2 in premature, but not in mature, adipocytes increasesย obesityย andย insulinย resistance
  2452. L-PGDS-produced PGD2 in premature, but not in mature, adipocytes increasesย obesityย andย insulinย resistance
  2453. Labrador tea (Rhododendron groenlandicum) attenuatesย insulinย resistance in a diet-inducedย obesityย mouse model
  2454. Lack of association between apelin,ย insulinย resistance, cardiovascular risk factors, andย obesityย in children: a longitudinal analysis
  2455. Lack of association between endothelial nitric oxide synthase glu298Asp variation, visceralย obesityย andย insulinย related phenotypes in Turkish type 2 diabetic โ€ฆ
  2456. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism withย obesityย andย insulinย resistance in two aboriginal populations from Chile
  2457. Lack of dietary regulation of jejunal glycolytic enzymes and disaccharidases inย obesity: the role ofย insulin
  2458. Lack of overt FGF21 resistance in two mouse models ofย obesityย andย insulinย resistance
  2459. Lack of Uncoupling Protein 3 Protects from Highโ€Fat Dietโ€Inducedย obesity, Systemic Inflammation andย insulinย Resistance in Rats
  2460. Lactate generation following glucose ingestion: relation toย obesity, carbohydrate tolerance andย insulinย sensitivity.
  2461. Lactobacillus plantarum strain Ln4 attenuates diet-inducedย obesity,ย insulinย resistance, and changes in hepatic mRNA levels associated with glucose and lipid โ€ฆ
  2462. Laparoscopic sleeve gastrectomy improves body composition and alleviatesย insulinย resistance inย obesityย related acanthosis nigricans
  2463. Large effects on body mass index andย insulinย resistance of fat mass andย obesityย associated gene (FTO) variants in patients with polycystic ovary syndrome โ€ฆ
  2464. Latent inflammation and defect in adipocyte renewal as a mechanism ofย obesity-associatedย insulinย resistance
  2465. Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation,ย insulinย Resistance, and Non-Alcoholic Fatty Liver Disease inย obesity
  2466. Lean muscle mass in classic or ovulatory PCOS: association with centralย obesityย andย insulinย resistance
  2467. Lecithin cholesterol acyltransferase deficiency protects from diet-inducedย insulinย resistance andย obesityโ€”novel insights from mouse models
  2468. Lecithin cholesterol acyltransferase null mice are protected from diet-inducedย obesityย andย insulinย resistance in a gender-specific manner through multiple โ€ฆ
  2469. LECT2 functions as a hepatokine that linksย obesityย to skeletal muscleย insulinย resistance
  2470. LECT2 functions as a hepatokine that linksย obesityย to skeletal muscleย insulinย resistance
  2471. Leisure time and occupational physical activity in relation toย obesityย andย insulinย resistance: a population-based study from the Skaraborg Project in Sweden
  2472. Lemon Balm Extract ALS-L1023 Regulatesย obesityย and Improvesย insulinย Sensitivity via Activation of Hepatic PPARฮฑ in High-Fat Diet-Fed Obese C57BL/6J Mice
  2473. Leptin andย insulinย resistance in patients with osteoarthritis combined withย obesityย and the dynamics of their levels on the background of treatment with symptomatic โ€ฆ
  2474. Leptin and its relation toย obesityย andย insulinย in the SHR/N-corpulent rat, a model of type II diabetes mellitus
  2475. Leptin in relation to hypertension: The role ofย obesityย in theย insulinย resistance atherosclerosis study (IRAS)
  2476. Leptin Indicatesย obesityย andย insulinย Resistance in Men
  2477. Leptin-to-adiponectin ratio is related to low grade inflammation andย insulinย resistance independent ofย obesityย in non-diabetic Taiwanese: a cross-sectional โ€ฆ
  2478. Leptin, adiponectin, and their ratio as markers ofย insulinย resistance and cardiometabolic risk in childhoodย obesity
  2479. Leptin,ย insulin, andย obesityโ€related Phenotypes: Genetic Influences on Levels and Longitudinal Changes
  2480. Letter regarding article,โ€œAssociations ofย obesityย and circulatingย insulinย and glucose with breast cancer risk: a Mendelian randomization analysisโ€
  2481. Leucocyte sodium pump activity after meals orย insulinย in normal and obese subjects: cause for increased energetic efficiency inย obesity?
  2482. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained byย obesityย andย insulinย resistance
  2483. Level of beta endorphins andย insulinย in blood of obese subjects. Effect of surgical treatment forย obesityย on higher exchange parameters
  2484. Levels of C3 in patients with severe, morbid and extremeย obesity: its relationship toย insulinย resistance and different cardiovascular risk factors
  2485. Lifestyle modification in the management ofย insulinย resistance states in overweight/obesity: the role of exercise training
  2486. Lifestyle, anthropometric, andย obesity-related physiologic determinants ofย insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey โ€ฆ
  2487. Lifestyle,ย obesity, andย insulinย resistance
  2488. Limited contribution ofย insulinย resistance and metabolic parameters toย obesity-associated increases in ambulatory blood pressure in a black African โ€ฆ
  2489. Linagliptin improvesย insulinย sensitivity and hepatic steatosis in diet-inducedย obesity
  2490. Link between omentinโ€1,ย obesityย andย insulinย resistance in children: Findings from a longitudinal intervention study
  2491. Link between theย obesityย andย insulinย resistance with lipid profile in women polycystic ovary syndrome
  2492. Linking gut microbiota and inflammation toย obesityย andย insulinย resistance
  2493. Linking maternalย obesityย to earlyย insulinย resistance
  2494. Links between body mass index, total body fat, cholesterol, highโ€density lipoprotein, andย insulinย sensitivity in patients withย obesityย related to depression, anger, and โ€ฆ
  2495. Links between inflammation andย insulinย resistance in children with morbidย obesityย and metabolic syndrome
  2496. Links betweenย obesity-induced brainย insulinย resistance, brain mitochondrial dysfunction, and dementia
  2497. Lipid induced macrophage inflammation: implications forย obesityย inducedย insulinย resistance
  2498. Lipid partitioning, incomplete fatty acid oxidation, andย insulinย signal transduction in primary human muscle cells: effects of severeย obesity, fatty acid incubation, and โ€ฆ
  2499. Lipid-adjusting Therapy can Enforceย insulinย Sensitivity of Type 2 Diabetes Mellitus Patients withย obesityย [J]
  2500. Lipidomics reveals associations of phospholipids withย obesityย andย insulinย resistance in young adults
  2501. Lipocalin-2 deficiency attenuatesย insulinย resistance associated with aging andย obesity
  2502. Lipocalin-2 is an inflammatory marker closely associated withย obesity,ย insulinย resistance, and hyperglycemia in humans
  2503. Lipolysis in lipid turnover, cancer cachexia, andย obesity-inducedย insulinย resistance
  2504. Lipopolysaccharide-binding protein plasma levels as a biomarker ofย obesity-relatedย insulinย resistance in adolescents
  2505. Lipoprotein abnormalities in hirsute women II. Compensatory responses ofย insulinย resistance and dehydroepiandrosterone sulfate withย obesity
  2506. Lipoproteinย insulinย resistance score in nondiabetic patients withย obesityย after bariatric surgery
  2507. Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated withย obesity
  2508. Liquid sucrose consumption promotesย obesityย and impairs glucose tolerance without altering circulatingย insulinย levels
  2509. Lisofylline mitigates cardiac inflammation in a mouse model ofย obesityย through improvingย insulinย secretion and activating cardiac AMPK signaling pathway
  2510. Liver and muscle in morbidย obesity: the interplay of fatty liver andย insulinย resistance
  2511. Liver attenuation, pericardial adipose tissue,ย obesity, andย insulinย resistance: the Multiโ€Ethnic Study of Atherosclerosis (MESA)
  2512. Liver fibrosis andย insulinย resistance in patients with hypertension, associated withย obesity
  2513. Liverย insulinย receptor tyrosine kinase activity in a rat model of type II diabetes mellitus andย obesity
  2514. Liver macrophages inhibit the endogenous antioxidant response inย obesity-associatedย insulinย resistance
  2515. Liver-specificย insulinย receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-inducedย obesity
  2516. Liverโ€specific suppressor of cytokine signalingโ€3 deletion in mice enhances hepaticย insulinย sensitivity and lipogenesis resulting in fatty liver andย obesityย 1
  2517. LncRNA TUG1 reduces inflammation and enhancesย insulinย sensitivity in white adipose tissue by regulating miR-204/SIRT1 axis inย obesityย mice
  2518. LNK deficiency decreasesย obesity-inducedย insulinย resistance by regulating GLUT4 through the PI3K-Akt-AS160 pathway in adipose tissue
  2519. Localization ofย insulin-2 (Ins-2) and theย obesityย mutant tubby (tub) to distinct regions of mouse chromosome 7
  2520. Long non-coding RNA Meg3 deficiency impairs glucose homeostasis andย insulinย signaling by inducing cellular senescence of hepatic endothelium inย obesity
  2521. Long term but not short term exposure toย obesityย related microbiota promotes hostย insulinย resistance
  2522. Long-term changes in carbohydrate tolerance,ย insulinย secretion and action in African-American patients withย obesityย and history of hyperglycemic crises
  2523. Long-term consumption of Platycodi radix amelioratesย obesityย andย insulinย resistance via the activation of AMPK pathways
  2524. Long-term dysbiosis promotesย insulinย resistance duringย obesityย despite rapid diet-induced changes in the gut microbiome of mice
  2525. Long-term Fenretinide treatment prevents high-fat diet-inducedย obesity,ย insulinย resistance, and hepatic steatosis
  2526. Long-Term Ingestion of Monosodium L-Glutamate Did Not Induceย obesity, Dyslipidemia orย insulinย Resistance: A Two-Generation Study in Mice
  2527. Long-term metformin treatment in adolescents withย obesityย andย insulinย resistance, results of an open label extension study
  2528. Long-term normalization ofย insulinย sensitivity following biliopancreatic diversion forย obesity
  2529. Longโ€Term ฮฒโ€galactoโ€oligosaccharides Supplementation Decreases the Development ofย obesityย andย insulinย Resistance in Mice Fed a Westernโ€Type Diet
  2530. Longitudinal study of depressive symptoms and progression ofย insulinย resistance in youth at risk for adultย obesity
  2531. Loss of Epac2 results in prematureย obesityย andย insulinย resistance
  2532. Loss of estrogen receptor ฮฑ signaling leads toย insulinย resistance andย obesityย in young and adult female mice
  2533. Loss of FoxOs in muscle reveals sex-based differences inย insulinย sensitivity but mitigates diet-inducedย obesity
  2534. Loss of fractalkine-CX3CR1 signaling exacerbatesย obesity-induced adipose tissue inflammation andย insulinย resistance through M1 dominant shift in macrophages
  2535. Loss of function mutation in toll-like receptor-4 does not offer protection againstย obesityย andย insulinย resistance induced by a diet high in trans fat in mice
  2536. Loss of growth hormoneโ€“mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results inย insulinย sensitivity withย obesity
  2537. Loss of hepatic CEACAM1: a unifying mechanism linkingย insulinย resistance toย obesityย and non-alcoholic fatty liver disease
  2538. Loss ofย insulinย response to ingested amino acids after jejunoileal bypass surgery for morbidย obesity
  2539. Loss of intestinal GATA4 prevents diet-inducedย obesityย and promotesย insulinย sensitivity in mice
  2540. Loss of iRhom2 accelerates fat gain andย insulinย resistance in diet-inducedย obesityย despite reduced adipose tissue inflammation
  2541. Loss of Kupffer cells in diet-inducedย obesityย is associated with increased hepatic steatosis, STAT3 signaling, and further decreases inย insulinย signaling
  2542. Loss of Mbd2 Protects Mice Against High-Fat Dietโ€“Inducedย obesityย andย insulinย Resistance by Regulating the Homeostasis of Energy Storage and Expenditure
  2543. Loss of mitochondrial protease ClpP protects mice from dietโ€inducedย obesityย andย insulinย resistance
  2544. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Inducedย obesityย andย insulinย Resistance despite Long-Chain Acylcarnitine Accumulation
  2545. Loss of nucleobindin-2 causesย insulinย resistance inย obesityย without impacting satiety or adiposity
  2546. Loss of prion protein is associated with the development ofย insulinย resistance andย obesity
  2547. Loss of protein kinase Cฮฒ function protects mice against dietโ€inducedย obesityย and development of hepatic steatosis andย insulinย resistance
  2548. Loss of regulator of G protein signaling 5 exacerbatesย obesity, hepatic steatosis, inflammation andย insulinย resistance
  2549. Loss of TDAG51 results in mature-onsetย obesity, hepatic steatosis, andย insulinย resistance by regulating lipogenesis
  2550. Loss of transcriptional repression by BCL6 confersย insulinย sensitivity in the setting ofย obesity
  2551. Loss of transglutaminase 2 sensitizes for diet-inducedย obesity-related inflammation andย insulinย resistance due to enhanced macrophage c-Src signaling
  2552. Loss of Uncoupling Protein 3 Attenuates Western Dietโ€“Inducedย obesity, Systemic Inflammation, andย insulinย Resistance in Rats
  2553. Loss-of-function mutation in myostatin reduces tumor necrosis factor ฮฑ production and protects liver againstย obesity-inducedย insulinย resistance
  2554. Loss-of-function mutation in Toll-like receptor 4 prevents diet-inducedย obesityย andย insulinย resistance
  2555. Low 25โ€hydroxyvitamin D does not affectย insulinย sensitivity inย obesityย after bariatric surgery
  2556. Low advanced Glycation end product diet improves the centralย obesity,ย insulinย resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a โ€ฆ
  2557. #VALUE!
  2558. Low clusterin levels in high-density lipoprotein associate withย insulinย resistance,ย obesity, and dyslipoproteinemia
  2559. Low concentrations ofย insulin-like growth factor-I in abdominalย obesity.
  2560. Low dose organochlorine pesticides and polychlorinated biphenyls predictย obesity, dyslipidemia, andย insulinย resistance among people free of diabetes
  2561. Low doses of cocoa extract supplementation ameliorate diet-inducedย obesityย andย insulinย resistance in rats
  2562. Lowย insulin-like growth factor-1 level inย obesityย nephropathy: a new risk factor?
  2563. Low intrinsic aerobic fitness increases susceptibility to OVXโ€inducedย obesityย andย insulinย resistance in the absence of adipose tissue inflammation (1028.3)
  2564. Low number ofย insulinย receptors but high receptor protein content in adipose tissue of rats with monosodium glutamate-inducedย obesity
  2565. Low serum 25-hydroxyvitamin D concentrations are associated withย insulinย resistance andย obesityย in women with polycystic ovary syndrome
  2566. Low serum adiponectin concentrations are associated withย insulinย sensitivity independent ofย obesityย in Sudanese subjects with type 2 diabetes mellitus
  2567. Low-calorie sweeteners augment tissue-specificย insulinย sensitivity in a large animal model ofย obesity
  2568. Low-density lipoprotein particle size, centralย obesity, cardiovascular fitness, andย insulinย resistance syndrome markers in obese youths
  2569. Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility toย insulinย resistance andย obesity
  2570. Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus andย obesityย treated withย insulin: a randomized trial
  2571. Low-grade inflammation,ย obesity, andย insulinย resistance in adolescents
  2572. Low-molecular-weight acid phosphatase (ACP1),ย obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus
  2573. Low-Molecular-Weight Acid Phosphatase (ACPI),ย obesity, and Blood Lipid Levels in Subjects with Non-insulin-Dependent Diabetes Mellitus
  2574. Lowโ€dose diet supplement of a natural flavonoid, luteolin, ameliorates dietโ€inducedย obesityย andย insulinย resistance in mice
  2575. Lower circulating B12 is associated with higherย obesityย andย insulinย resistance during pregnancy in a non-diabetic white British population
  2576. Lower cortisol levels after oral glucose in subjects withย insulinย resistance and abdominalย obesity
  2577. Lower Leg Fat Depots Are Associated with Albuminuria Independently ofย obesity,ย insulinย Resistance, and Metabolic Syndrome (Korea National Health and โ€ฆ
  2578. Lower NLRP3 inflammasome activity in NAGโ€1 transgenic mice is linked to a resistance toย obesityย and increasedย insulinย sensitivity
  2579. Lower serum magnesium concentration is associated with diabetes,ย insulinย resistance, andย obesityย in South Asian and white Canadian women but not men
  2580. Lowering body weight in obese mice with diastolic heart failure improves cardiacย insulinย sensitivity and function: implications for theย obesityย paradox
  2581. Lowering effects of a preparation containing fibres and lactulose on glucose andย insulinย levels inย obesity.
  2582. Lowering saturated fat and increasing vegetable and fruit intake may increaseย insulinย sensitivity 2 years later in children with a family history ofย obesity
  2583. LTB4 causes macrophageโ€“mediated inflammation and directly inducesย insulinย resistance inย obesity
  2584. Luteolin attenuates hepatic steatosis andย insulinย resistance through the interplay between the liver and adipose tissue in mice with diet-inducedย obesity
  2585. Luteolin reducesย obesity-associatedย insulinย resistance in mice by activating AMPKฮฑ1 signalling in adipose tissue macrophages
  2586. #VALUE!
  2587. Lycopene Alleviatesย obesityโ€Induced Inflammation andย insulinย Resistance by Regulating M1/M2 Status of Macrophages
  2588. Lysophosphatidic acid inhibitsย insulinย signaling in primary rat hepatocytes via the LPA3 receptor subtype and is increased inย obesity
  2589. Lysophosphatidic acid signaling inย obesityย andย insulinย resistance
  2590. Lysophosphatidic Acid Signaling inย obesityย andย insulinย Resistance
  2591. Lysosomal Nitrosative Stress Contributes to Hepaticย insulinย Resistance inย obesity
  2592. M2 macrophages infusion amelioratesย obesityย andย insulinย resistance by remodeling inflammatory/macrophagesโ€™ homeostasis in obese mice
  2593. Macronutrient-mediated inflammation and oxidative stress: relevance toย insulinย resistance,ย obesity, and atherogenesis
  2594. Macrophage cannabinoid 1 receptor promotesย obesity-inducedย insulinย resistance and inflammation
  2595. Macrophage function inย obesity-induced inflammation andย insulinย resistance
  2596. Macrophage gene expression in adipose tissue is associated withย insulinย sensitivity and serum lipid levels independent ofย obesity
  2597. Macrophage HIF-2ฮฑ ameliorates adipose tissue inflammation andย insulinย resistance inย obesity
  2598. Macrophage lamin A/C regulates inflammation and the development ofย obesity-inducedย insulinย resistance
  2599. Macrophage migration inhibitory factor: critical role inย obesity,ย insulinย resistance, and associated comorbidities
  2600. Macrophage TNF-ฮฑ contributes toย insulinย resistance and hepatic steatosis in diet-inducedย obesity
  2601. Macrophage VLDLR mediatesย obesity-inducedย insulinย resistance with adipose tissue inflammation
  2602. Macrophage-specific de novo synthesis of ceramide is dispensable for inflammasome-driven inflammation andย insulinย resistance inย obesity
  2603. Macrophages and adipocytes in humanย obesity: adipose tissue gene expression andย insulinย sensitivity during calorie restriction and weight stabilization
  2604. Macrophages inย obesityย andย insulinย resistance
  2605. Macrophages, inflammation, adipose tissue,ย obesityย andย insulinย resistance
  2606. Making of a unique birth control vaccine against hCG with additional potential of therapy of advanced stage cancers and prevention ofย obesityย andย insulinย resistance
  2607. Mammalian life-span determinant p66shcA mediatesย obesity-inducedย insulinย resistance
  2608. Management ofย obesityย in NIDDM (non-insulin-dependent diabetes mellitus).
  2609. Management ofย obesityย in non-insulin-dependent diabetes mellitus
  2610. Management ofย obesity,ย insulinย resistance and type 2 diabetes in children: consensus and controversy
  2611. Managingย obesityย and glycemic control inย insulin-using patients: clinical relevance and practice recommendations
  2612. Manganese [III] tetrakis [5, 10, 15, 20]-benzoic acid porphyrin reduces adiposity and improvesย insulinย action in mice with pre-existingย obesity
  2613. Map4k4 impairs energy metabolism in endothelial cells and promotesย insulinย resistance inย obesity
  2614. Marked resistance of the ability ofย insulinย to decrease arterial stiffness characterizes humanย obesity.
  2615. Markers of capacity to utilize fatty acids in human skeletal muscle: relation toย insulinย resistance andย obesityย and effects of weight loss
  2616. Markers of Iron Status as Predictors, Effect Modifiers and Outcomes in an RCT of Growth Hormone and Rosiglitazone forย obesityย andย insulinย Resistance in Adults โ€ฆ
  2617. Mass spectrometry for measuring protein secretion fromย insulinย sensitive tissues duringย obesity
  2618. Maternal adipokines andย insulinย as biomarkers of pregnancies complicated by overweight andย obesity
  2619. Maternal diet-inducedย obesityย during suckling period programs offspring obese phenotype and hypothalamic leptin/insulinย resistance
  2620. Maternal dietโ€inducedย obesityย alters muscle mitochondrial function in offspring without changingย insulinย sensitivity
  2621. Maternal endotoxemia results inย obesityย andย insulinย resistance in adult male offspring
  2622. Maternal exercise attenuates the lower skeletal muscle glucose uptake andย insulinย secretion caused by paternalย obesityย in female adult rat offspring
  2623. Maternal folate status andย obesity/insulinย resistance in the offspring: a systematic review
  2624. Maternal lipids are associated with newborn adiposity, independent of GDM status,ย obesityย andย insulinย resistance: a prospective observational cohort study
  2625. Maternalย obesityย Affects the Glucose-insulinย Axis During the First Trimester of Human Pregnancy
  2626. Maternalย obesityย and Excessive Gestational Weight Gain Alter the Maternal-Fetalย insulin-Like Growth Factor Axis
  2627. Maternalย obesityย and western-style diet impair fetal and juvenile offspring skeletal muscleย insulin-stimulated glucose transport in nonhuman primates
  2628. Maternalย obesityย associates with foetoplacental vascular dysfunction involving endoplasmic reticulum stress and alteredย insulinย vascular reactivity
  2629. Maternalย obesityย at conception andย insulinย sensitivity in late gestation alters placental structure but not fetal biometry at birth in the horse
  2630. Maternalย obesityย causes fetal hypothalamicย insulinย resistance and disrupts development of hypothalamic feeding pathways
  2631. Maternalย obesityย has sexโ€dependent effects onย insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring
  2632. Maternalย obesityย in ewes results in reduced fetal pancreatic ฮฒ-cell numbers in late gestation and decreased circulatingย insulinย concentration at term
  2633. Maternalย obesityย increasesย insulinย resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age
  2634. Maternalย obesityย leads to an inflammatory response andย insulinย resistance in ovarian tissuse
  2635. Maternalย obesityย results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with antiโ€inflammatory andย insulinโ€sensitizing properties
  2636. Maternalย obesity-impairedย insulinย signaling in sheep and induced lipid accumulation and fibrosis in skeletal muscle of offspring
  2637. Maternal pregravidย obesityย changes gene expression profiles toward greater inflammation and reducedย insulinย sensitivity in umbilical cord
  2638. Maternal prepregnancyย obesityย andย insulinย treatment during pregnancy are independently associated with delayed lactogenesis in women with recent gestational โ€ฆ
  2639. Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and inducesย obesityย andย insulinย resistance in adult offspring
  2640. Maternally inherited diabetes with deafness andย obesity: body weight reduction response to treatment withย insulinย analogues
  2641. Mature-onsetย obesityย andย insulinย resistance in mice deficient in the signaling adapter p62
  2642. Maturity-onset diabetes of the young: recent findings indicateย insulinย resistance/obesityย are not factors
  2643. Maximum stimulation ofย insulinย secretion in children with chemical diabetes andย obesity.
  2644. McArdleโ€™s disease withย insulinย resistance caused byย obesity
  2645. MCP-1 contributes to macrophage infiltration into adipose tissue,ย insulinย resistance, and hepatic steatosis inย obesity
  2646. Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis ofย obesity-relatedย insulinย โ€ฆ
  2647. Measurement ofย obesityย by anthropometry and bioelectric impedance analysis: correlation with fasting lipids andย insulinย resistance in an Asian population.
  2648. Mechanism of action of magnesium lithospermate B against aging andย obesity-induced ER stress,ย insulinย resistance, and inflammsome formation in the liver
  2649. Mechanism of ER stress and inflammation for hepaticย insulinย resistance inย obesity
  2650. Mechanism of hyperglycaemia coexistence with hypertension:ย obesityย interaction withย insulinย resistance approach.
  2651. Mechanism ofย insulin-resistance in the adipose cell in the aging-rat model ofย obesity
  2652. #VALUE!
  2653. Mechanism of programmedย obesity: altered centralย insulinย sensitivity in growth-restricted juvenile female rats
  2654. Mechanism of the postreceptor defect inย insulinย action in humanย obesity. Decrease in glucose transport system activity.
  2655. Mechanism Research of Reducingย obesity-Inducedย insulinย Resistance in the White Adipose Tissue by Knockdown of Neuropeptide Y Expression in the Dorsomedial โ€ฆ
  2656. Mechanism, treatment, and evaluation ofย obesity-inducedย insulinย resistance and type 2 diabetes
  2657. Mechanisms inย obesity-related hypertension: role ofย insulinย and catecholamines
  2658. Mechanisms linkingย obesityย toย insulinย resistance and type 2 diabetes
  2659. Mechanisms linking the adipocyte renin angiotensin system toย obesity, inflammation andย insulinย resistance
  2660. Mechanisms mediating beneficial effects of Eicosapentaenoic Acid (EPA) inย insulinย resistance andย obesity: Studies in muscle
  2661. Mechanisms of agouti-inducedย obesity: Effects on adipocyte metabolism and interaction withย insulin.
  2662. Mechanisms of cardiovascular diseases development inย obesityย andย insulinย resistance: focus on atherothrombosis
  2663. Mechanisms of coronary dysfunction inย obesityย andย insulinย resistance
  2664. Mechanisms ofย insulinย action and identification of defects leading toย insulinย resistance in maternalย obesityย and gestational diabetes
  2665. Mechanisms ofย insulinย Resistance at the Crossroad ofย obesityย with Associated Metabolic Abnormalities and Cognitive Dysfunction
  2666. Mechanisms ofย insulinย resistance in humanย obesity: evidence for receptor and postreceptor defects.
  2667. Mechanisms ofย insulinย resistance inย obesity
  2668. Mechanisms ofย insulinย resistance inย obesity
  2669. Mechanisms ofย insulinย resistance inย obesityย and noninsulin-dependent (type II) diabetes
  2670. Mechanisms of macrophage activation inย obesity-inducedย insulinย resistance
  2671. Mechanisms ofย obesity-associatedย insulinย resistance: many choices on the menu
  2672. Mechanisms ofย obesity-induced inflammation andย insulinย resistance: insights into the emerging role of nutritional strategies
  2673. Mechanisms of the kinetic defect inย insulinย action inย obesityย and NIDDM
  2674. Mechanisms underlyingย obesity-relatedย insulinย resistance
  2675. Mechanistic links betweenย obesity,ย insulin, and cancer
  2676. Mediating effects of inflammatory biomarkers onย insulinย resistance associated withย obesity
  2677. Mediators of cytokine-inducedย insulinย resistance inย obesityย and other inflammatory settings
  2678. Mediators of Impaired Adipogenesis inย obesity-Associatedย insulinย Resistance and T2DM
  2679. MEDITERRANEAN DIET ADHERENCE. WHICH RELATIONSHIP WITHย obesityย ANDย insulinย RESISTANCE
  2680. Melanin-concentrating hormone overexpression in transgenic mice leads toย obesityย andย insulinย resistance
  2681. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model ofย insulinย resistance andย obesity.
  2682. #VALUE!
  2683. Merchanism ofย obesity-related hypertension: fromย insulinย to leptin
  2684. Mesenteric fat lipolysis mediatesย obesity-associated hepatic steatosis andย insulinย resistance
  2685. META060 protects against diet-inducedย obesityย andย insulinย resistance in a high-fatโ€“diet fed mouse
  2686. METABOLIC CHANGES ASSOCIATED WITHย obesityย AND THE ROLE OFย insulin
  2687. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in theย insulinย resistance ofย obesity
  2688. Metabolic concomitants of hypophagia during recovery fromย insulin-inducedย obesityย in rats
  2689. Metabolic consequences ofย obesityย andย insulinย resistance in polycystic ovary syndrome: diagnostic and methodological challenges
  2690. Metabolic disturbances inย obesityย versus sleep apnoea: the importance of visceralย obesityย andย insulinย resistance
  2691. Metabolic dysregulation of theย insulinโ€“glucose axis and risk ofย obesity-related cancers in the Framingham heart study-offspring cohort (1971โ€“2008)
  2692. Metabolic endotoxemia initiatesย obesityย andย insulinย resistance
  2693. Metabolic factors in theย insulinย resistance in humanย obesity
  2694. Metabolic fluxes in skeletal muscle in relation toย obesityย andย insulinย resistance
  2695. Metabolic inflammation andย insulinย resistance inย obesity
  2696. Metabolic inflammation: connectingย obesityย andย insulinย resistance
  2697. Metabolic origin ofย insulinย resistance inย obesityย with and without type 2 (non-insulin-dependent) diabetes mellitus
  2698. Metabolic perturbations in Welsh Ponies withย insulinย dysregulation,ย obesity, and laminitis
  2699. Metabolic predispositions to laminitis in horses and ponies:ย obesity,ย insulinย resistance and metabolic syndromes
  2700. Metabolic profiling of tissue-specificย insulinย resistance in humanย obesity: results from the diogenes study and the Maastricht study
  2701. Metabolic signature ofย obesity-associatedย insulinย resistance and type 2 diabetes
  2702. Metabolic syndrome andย insulinย resistance are associated with chronic kidney disease in nondiabetic adults with abdominalย obesity
  2703. Metabolic syndrome andย insulinย resistance in subjects with morbidย obesity
  2704. Metabolic syndrome in humans and horses: The relationship betweenย obesityย andย insulinย resistance
  2705. Metabolic syndrome, centralย obesityย andย insulinย resistance are associated with adverse pathological features in postmenopausal breast cancer
  2706. Metabolic syndrome: relationship betweenย obesity,ย insulinย resistance and systemic hypertension in small animals.
  2707. Metabolically activated macrophages inย obesityย andย insulinย resistance
  2708. Metabolism of sphingolipids in experimentalย obesityย andย insulinย resistance
  2709. Metformin decreases blood pressure andย obesityย in OLETF rats via improvement ofย insulinย resistance
  2710. Metformin decreases food consumption and induces weight loss in subjects withย obesityย with type II nonโ€insulinโ€dependent diabetes
  2711. Metformin reduces weight, centripetalย obesity,ย insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index โ€ฆ
  2712. Methionine-restricted C57BL/6J mice are resistant to diet-inducedย obesityย andย insulinย resistance but have low bone density
  2713. MGAT2 deficiency ameliorates high-fat diet-inducedย obesityย andย insulinย resistance by inhibiting intestinal fat absorption in mice
  2714. MGL1 promotes adipose tissue inflammation andย insulinย resistance by regulating 7/4hi monocytes inย obesityMGL1 andย obesity-induced inflammation
  2715. Mice deficient for the Sam68 RNA binding protein are protected from dietaryย obesityย andย insulinย resistance
  2716. Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-inducedย obesityย andย insulinย resistance
  2717. Mice Expressing Humanย insulinย Receptors In Skeletal Muscle Are Resistant To The Development Ofย obesity
  2718. Mice expressing reduced levels of hepatic glucose-6-phosphatase-ฮฑ activity do not develop age-relatedย insulinย resistance orย obesity
  2719. Mice heterozygous for tumor necrosis factor-ฮฑ converting enzyme are protected fromย obesity-inducedย insulinย resistance and diabetes
  2720. Mice lacking dipeptidyl peptidase IV are protected againstย obesityย andย insulinย resistance
  2721. Mice Lacking OPA1 in Adipose Tissue Are Resistant to Diet-Inducedย obesityย andย insulinย Resistance
  2722. Mice lacking sialyltransferase ST3Gal-II develop late-onsetย obesityย andย insulinย resistance
  2723. Mice with a targeted deletion of the type 2 deiodinase areย insulinย resistant and susceptible to diet inducedย obesity
  2724. Mice with a targeted deletion of the type 2 deiodinase areย insulinย resistant and susceptible to diet inducedย obesity
  2725. Microarray gene expression profiling inย obesityย andย insulinย resistance
  2726. MicroRNA-125a-3p expression in abdominal adipose tissues is associated withย insulinย signalling gene expressions in morbidย obesity: observations in Taiwanese
  2727. microRNA-dependent control of MODY gene expression contributes toย obesity-associatedย insulinย resistance
  2728. MicroRNAs inย insulinย resistance andย obesity
  2729. Microvascular dysfunction as a link betweenย obesity,ย insulinย resistance and hypertension
  2730. Microvascular dysfunction inย obesity: a potential mechanism in the pathogenesis ofย obesity-associatedย insulinย resistance and hypertension
  2731. Microvascular dysfunction: a potential mechanism in the pathogenesis ofย obesityโ€associatedย insulinย resistance and hypertension
  2732. Microvascular dysfunction: an emerging pathway in the pathogenesis ofย obesity-relatedย insulinย resistance
  2733. Microvascular dysfunction: Potential role in the pathogenesis ofย obesity-associated hypertension andย insulinย resistance
  2734. Microvascularย insulinย resistance in skeletal muscle and brain occurs early in the development of juvenileย obesityย in pigs
  2735. Mid-upper arm circumference as a simple tool for identifying centralย obesityย andย insulinย resistance in type 2 diabetes
  2736. Midkine, a potential link betweenย obesityย andย insulinย resistance
  2737. Mifepristone promotes adiponectin production and improvesย insulinย sensitivity in a mouse model of diet-induced-obesity
  2738. Mild suppression of hyperinsulinemia to treatย obesityย andย insulinย resistance
  2739. Mind over metabolism: the cephalic phase in relation to non-insulin-dependent diabetes andย obesity
  2740. Mindin/Spondin 2 inhibits hepatic steatosis,ย insulinย resistance, andย obesityย via interaction with peroxisome proliferator-activated receptor ฮฑ in mice
  2741. Mineralocorticoids and cardiovascular disease in females withย insulinย resistance andย obesity
  2742. Minor diplotypes of FMO3 might protect children and adolescents fromย obesityย andย insulinย resistance
  2743. MiR-130b promotesย obesityย associated adipose tissue inflammation andย insulinย resistance in diabetes mice through alleviating M2 macrophage polarization via โ€ฆ
  2744. miR-150 regulatesย obesity-associatedย insulinย resistance by controlling B cell functions
  2745. miR-26b is decreased inย obesityย and is associated withย insulinย resistance and visfatin levels
  2746. miR-30a remodels subcutaneous adipose tissue inflammation to improveย insulinย sensitivity inย obesity
  2747. MiR-377 promotes white adipose tissue inflammation and decreasesย insulinย sensitivity inย obesityย via suppression of sirtuin-1 (SIRT1)
  2748. miR-483-5p associates withย obesityย andย insulinย resistance and independently associates with new onset diabetes mellitus and cardiovascular disease
  2749. miRNA signatures ofย insulinย resistance inย obesity
  2750. Mitochondrial DNA content and function, childhoodย obesity, andย insulinย resistance
  2751. Mitochondrial dysfunction in the pathogenesis ofย insulinย resistance associated withย obesity, diabetes, and aging
  2752. Mitochondrial oxidative stress and inflammation: an slalom toย obesityย andย insulinย resistance
  2753. Mitochondrial uncoupler BAM15 reverses diet-inducedย obesityย andย insulinย resistance in mice
  2754. Mitogen-Activated Protein Kinases, Inhibitory-ฮบB Kinase, andย insulinย Signaling in Human Omental Versus Subcutaneous Adipose Tissue inย obesity
  2755. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preservesย insulinย sensitivity inย obesity
  2756. Model of high-fat diet-inducedย obesityย associated toย insulinย resistance and glucose intolerance
  2757. Moderate caloric restriction in lactating rats protects offspring againstย obesityย andย insulinย resistance in later life
  2758. Moderate Lactate Administration Activates Adipose Tissue Macrophage PKA-AMPKฮฑ1 Pathway to Alleviateย obesity-Associatedย insulinย Resistance in Mice
  2759. Moderate weight reduction in an outpatientย obesityย intervention program significantly reducesย insulinย resistance and risk factors for cardiovascular disease in โ€ฆ
  2760. Moderating role of cognitive ability on theย obesity: inflammation:ย insulinย resistance triplet
  2761. Modified glucagon test allowing simultaneous estimation ofย insulinย secretion andย insulinย sensitivity: application toย obesity,ย insulin-dependent diabetes mellitus, and โ€ฆ
  2762. Modulation of cell-mediated immunity to prevent high-fat diet-inducedย obesityย andย insulinย resistance
  2763. Modulation of cell-mediated immunity to suppress high fat diet-inducedย obesityย andย insulinย resistance
  2764. Modulation of endothelial cell migration by ER stress andย insulinย resistance: a role during maternalย obesity?
  2765. Modulation of heat shock factor 1 activity through silencing of Ser303/Ser307 phosphorylation supports a metabolic program leading to age-relatedย obesityย andย insulinย โ€ฆ
  2766. Modulation of HSF1 Activity Through Silencing of Ser303/Ser307 Phosphorylation Supports A Metabolic Program Leading to Age-relatedย obesityย andย insulinย โ€ฆ
  2767. Modulation ofย obesityย andย insulinย Resistance by the Redox Enzyme and Adaptor Protein p66Shc
  2768. Molecular analysis of the mouse agouti gene and the role of dominant agouti-locus mutations inย obesityย andย insulinย resistance
  2769. Molecular Aspects ofย obesityย andย insulinย Resistance in Metabolic Syndrome and Neurological Disorders
  2770. Molecular aspects of the link betweenย obesity,ย insulinย resistance and breast cancer.
  2771. Molecular Basis of Inflammation andย insulinย Resistance inย obesity
  2772. Molecular interactions between inflammation andย insulinย resistance inย obesity.
  2773. Molecular investigation of genetic factors associated withย insulinย resistance andย obesityย in a South African population
  2774. Molecular mechanism ofย insulinย resistance andย obesity
  2775. Molecular mechanism ofย insulinย resistance in humanย obesity
  2776. Molecular mechanism ofย insulinย resistance inย obesityย and type 2 diabetes
  2777. Molecular mechanisms involved inย obesity-associatedย insulinย resistance: therapeutical approach
  2778. Molecular mechanisms mediating the beneficial metabolic effects of [Arg4] tigerinin-1R in mice with diet-inducedย obesityย andย insulinย resistance
  2779. Molecular mechanisms ofย insulinย action in human skeletal muscle and adipose tissue: Implications for diabetes andย obesity
  2780. Molecular mechanisms ofย insulinย resistance inย obesity
  2781. Molecular mechanisms ofย insulinย resistance inย obesityย and type 2 diabetes mellitus
  2782. Molecular mechanisms ofย insulinย resistance,ย obesityย and metabolic syndrome
  2783. Molecular mechanisms underlyingย obesity-induced hypothalamic inflammation andย insulinย resistance: pivotal role of resistin/TLR4 pathways
  2784. Molecular pathways linking adipose innervation toย insulinย action inย obesityย and diabetes mellitus
  2785. Molecular pathways linking adipose innervation toย insulinย sensitivity inย obesityย and type 2 diabetes
  2786. Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association withย obesity, plasma glucose, orย insulin
  2787. Monocyte chemoattractant protein 1 inย obesityย andย insulinย resistance
  2788. Monocyte chemoattractant proteinโ€1 inย obesityย and type 2 diabetes.ย insulinย sensitivity study
  2789. Monomeric tartrate resistant acid phosphatase inducesย insulinย sensitiveย obesity
  2790. Monomeric Tartrate Resistant Acid Phosphatase Inducesย insulinย Sensitiveย obesity
  2791. Monounsaturated fatty acidโ€“enriched high-fat diets impede adipose NLRP3 inflammasomeโ€“mediated IL-1ฮฒ secretion andย insulinย resistance despiteย obesity
  2792. Morbidย obesityย is associated with hepatic inflammation independent of liver fat content andย insulinย sensitivity
  2793. Moringa olifeira Lam. stimulates activation of theย insulin-dependent akt pathway. Antidiabetic effect in a diet-inducedย obesityย (DIO) mouse model
  2794. Morning circadian misalignment is associated withย insulinย resistance in girls withย obesityย and polycystic ovarian syndrome
  2795. MR Spectroscopy inย obesityย and its Complications: Diabetes andย insulinย Resistance
  2796. mRNA expression of diacylglycerol kinase isoforms inย insulinโ€sensitive tissues: effects ofย obesityย andย insulinย resistance
  2797. MRP14 enhances the ability of macrophage to recruit T cells and promotesย obesity-inducedย insulinย resistance
  2798. Mucosa-associated microbiota in the jejunum of patients with morbidย obesity: alterations in states ofย insulinย resistance and metformin treatment
  2799. Multiple abnormalities of myocardialย insulinย signaling in a porcine model of diet-inducedย obesity
  2800. Multiple Abnormalities of Myocardialย insulinย Signaling in Pigs with Diet-Inducedย obesity
  2801. Multiple endocrine abnormalities of the growth hormone andย insulin-like growth factor axis in prepubertal children with exogenousย obesity: effect of short-and long โ€ฆ
  2802. Multiple Sclerosis andย obesity.ย insulinย Impairs IL-10-Mediated Regulatory T Cell Function (P1. 372)
  2803. Munc18c in adipose tissue is downregulated inย obesityย and is associated withย insulin
  2804. Muramyl dipeptide-based postbiotics mitigateย obesity-inducedย insulinย resistance via IRF4
  2805. Muscleย insulinย Resistance in Youth withย obesityย and Normoglycemia is Associated with Altered Fat Metabolism
  2806. Muscle microvascular dysfunction in centralย obesityย is related to muscleย insulinย insensitivity but is not reversed by high-dose statin treatment
  2807. Muscle mitochondrial oxidative phosphorylation activity, but not content, is altered with abdominalย obesityย in sedentary men: synergism with changes inย insulinย โ€ฆ
  2808. Muscular resistance, hypertrophy and strength training equally reduce adiposity, inflammation andย insulinย resistance in mice with diet-inducedย obesity
  2809. Myeloid cell TRAF3 promotes metabolic inflammation,ย insulinย resistance, and hepatic steatosis inย obesity
  2810. Myeloid cell-restrictedย insulinย receptor deficiency protects againstย obesity-induced inflammation and systemicย insulinย resistance
  2811. Myeloid RAGE Downregulates Lipid Metabolism in Obese Adipose Tissue and Increases Whole-Bodyย obesityย andย insulinย Resistance
  2812. Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improvesย insulinย sensitivity, and suppresses diet-inducedย obesity
  2813. Myeloperoxidase deletion prevents high-fat dietโ€“inducedย obesityย andย insulinย resistance
  2814. Myeloperoxidase: a therapeutic target for preventingย insulinย resistance and the metabolic sequelae ofย obesity?
  2815. Myocardial metabolism and cardiac performance inย obesityย andย insulinย resistance
  2816. Myocardial structure, function and ischaemic tolerance in a rodent model ofย obesityย withย insulinย resistance
  2817. Myostatin as a Potential Therapeutic Target forย obesityย andย insulinย Resistance
  2818. Myostatin blockade with a form of the ActRIIB receptor has potent antiโ€obesityย andย insulinย sensitizing actions
  2819. Myostatin knockout mice are protected from high-fat diet inducedย obesityย andย insulinย resistance.
  2820. Myricanol modulates skeletal muscleโ€“adipose tissue crosstalk to alleviate highโ€fat dietโ€inducedย obesityย andย insulinย resistance
  2821. Myricetin-induced brown adipose tissue activation preventsย obesityย andย insulinย resistance in db/db mice
  2822. N-3 long chain polyunsaturated fatty acids: a nutritional tool to preventย insulinย resistance associated to type 2 diabetes andย obesity?
  2823. N-stearoylethanolamine restores pancreas lipid composition inย obesity-inducedย insulinย resistant rats
  2824. Na+-sensitive elevation in blood pressure is ENaC independent in diet-inducedย obesityย andย insulinย resistance
  2825. NADPH Oxidase and (-)-Epicatechin in the Modulation ofย obesity-Associatedย insulinย Resistance
  2826. NDUFAB1 protects againstย obesityย andย insulinย resistance by enhancing mitochondrial metabolism
  2827. Neck and wrist circumferences propose a reliable approach to qualifyย obesityย andย insulinย resistance
  2828. Nedd4 haploinsufficient mice display moderateย insulinย resistance, enhanced lipolysis, and protection against high-fat diet-inducedย obesity
  2829. Negative regulation of hepatic fat mass andย obesityย associated (Fto) gene expression byย insulin
  2830. Neonates from women with pregestational maternalย obesityย show reduced umbilical vein endothelial response toย insulin
  2831. Nesfatin-1 in childhood and adolescentย obesityย and its association with food intake, body composition andย insulinย resistance
  2832. NESFATINEMIA ANDย insulinย RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION ANDย obesity
  2833. Netrin-1 promotes adipose tissue macrophage retention andย insulinย resistance inย obesity
  2834. Netrin-1 Promotes Macrophage Accumulation andย insulinย Resistance inย obesity
  2835. Networking pathways unveils association betweenย obesityย and non-insulinย dependent diabetes mellitus
  2836. Neural correlates of stress-and food cueโ€“induced food craving inย obesity: association withย insulinย levels
  2837. Neuroendocrine factors regulating blood glucose, plasma FFA andย insulinย in the development ofย obesity
  2838. NEUROENDOCRINE MODEL OFย obesityย WORSENย insulinย RESISTANCE OF SPONTANEOUSLY HYPERTENSIVE RATS: A NEW MODEL OF TYPE 2 โ€ฆ
  2839. Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance,ย insulinย resistance, and visceralย obesity
  2840. Neuropeptide Y1 receptor in immune cells regulates inflammation andย insulinย resistance associated with diet-inducedย obesity
  2841. Neutralization of osteopontin inhibitsย obesity-induced inflammation andย insulinย resistance
  2842. Neutrophil elastase is a key player in inflammation,ย obesity, andย insulinย resistance
  2843. New developments in diabetesย obesityย andย insulinย resistance.
  2844. New insights into adipose tissue VEGF-A actions in the control ofย obesityย andย insulinย resistance
  2845. New insights into the role of serum amyloid A (SAA) onย obesityย andย insulinย resistance
  2846. New insights into TNFฮฑ/PTP1B and PPARรŽยณ pathway through RNF213-a link between inflammation,ย obesity,ย insulinย resistance, and Moyamoya disease.
  2847. New insights into TNFฮฑ/PTP1B and PPARฮณ pathway through RNF213-a link between inflammation,ย obesity,ย insulinย resistance, and Moyamoya disease
  2848. Newly identified set ofย obesityโ€related genotypes and abdominal fat influence the risk ofย insulinย resistance in a Korean population
  2849. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppressesย obesity-related non-alcoholic fatty liver disease and hepaticย insulinย resistance through the โ€ฆ
  2850. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations withย insulinย resistance andย obesity
  2851. NK cells in human visceral adipose tissue contribute toย obesityโ€associatedย insulinย resistance through lowโ€grade inflammation
  2852. NK cells induce hepatic ER stress to promoteย insulinย resistance inย obesityย through osteopontin production
  2853. NK cells linkย obesity-induced adipose stress to inflammation andย insulinย resistance
  2854. NK cells linkย obesity-induced adipose tissue stress to inflammation andย insulinย resistance
  2855. NLRP3 inflammasome regulatesย obesityย induced systemic inflammation andย insulinย signaling (117.4)
  2856. No acute effect of physiologicalย insulinย increase on dehydroepiandrosterone sulfate in women withย obesityย and/or polycystic ovarian disease
  2857. No decrease in free IGFโ€I with increasingย insulinย inย obesityโ€relatedย insulinย resistance
  2858. No evidence for a role of adipose tissue-derived serum amyloid a in the development ofย insulinย resistance orย obesity-related inflammation in hsaa1+ โ€ฆ
  2859. No evidence for involvement of the calpain-10 genehigh-riskโ€™haplotype combination for non-insulin-dependent diabetes mellitus in early onsetย obesity
  2860. No evidence of attenuation of placentalย insulin-stimulated Akt phosphorylation and amino acid transport in maternalย obesityย and gestational diabetes mellitus
  2861. No need to sweat: is dieting enough to alleviateย insulinย resistance inย obesity?
  2862. No specific effect of fluoxetine treatment on fasting glucose,ย insulin, lipid levels, and blood pressure in healthy men with abdominalย obesity
  2863. NO to Lysosomes: A Signal forย insulinย Resistance inย obesity
  2864. NO toย obesity: does nitric oxide regulate fat oxidation andย insulinย sensitivity?
  2865. Nobiletin improvesย obesityย andย insulinย resistance in high-fat diet-induced obese mice
  2866. Non-alcoholic steatohepatitis: association withย obesityย andย insulinย resistance, and influence of weight loss
  2867. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects withย obesity/insulinย resistance?
  2868. Non-insulin-dependent (Type II) diabetes mellitus andย obesityย in Asians in UK-scope for future studies
  2869. Non-insulin-dependent diabetes andย obesityย in the black and Hispanic population: culturally sensitive management
  2870. Non-insulin-dependent diabetes mellitus and visceralย obesity: Italian epidemiologic study and analysis of risk factors
  2871. Non-insulin-dependent diabetes mellitus in the elderly: influence ofย obesityย and physical inactivity
  2872. Non-invasive evaluation of endothelial dysfunction in uncomplicatedย obesity: relationship withย insulinย resistance
  2873. Nonโ€alcoholic fatty liver disease and its association withย obesity,ย insulinย resistance and increased serum levels of Cโ€reactive protein in Hispanics
  2874. Nonerythropoietic erythropoietin-derived peptide suppresses adipogenesis, inflammation,ย obesityย andย insulinย resistance
  2875. Nonirritative lesions of VMH: effects on plasmaย insulin,ย obesity, and hyperreactivity
  2876. Norathyriol reversesย obesity-and high-fat-diet-inducedย insulinย resistance in mice through inhibition of PTP1B
  2877. Normal weightย obesityย is associated with metabolic syndrome andย insulinย resistance in young adults from a middle-income country
  2878. #VALUE!
  2879. Normalization ofย obesity-associatedย insulinย resistance through immunotherapy
  2880. NOV/CCN3: a new adipocytokine involved inย obesity-associatedย insulinย resistance
  2881. Novel curcumin derivative CNB-001 mitigatesย obesity-associatedย insulinย resistance
  2882. Novel measures of inflammation andย insulinย resistance are related toย obesityย and fitness in a diverse sample of 11โ€“14 year olds: The HEALTHY Study
  2883. Novel mechanisms ofย insulinย resistance and weight gain in diet inducedย obesity
  2884. Novel pharmacological approaches to combatย obesityย andย insulinย resistance: targeting skeletal muscle with โ€˜exercise mimeticsโ€™
  2885. Novel phosphorylation of PPARฮณ amelioratesย obesity-induced adipose tissue inflammation and improvesย insulinย sensitivity
  2886. NTproBNP inย insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
  2887. Nuclear factor-ฮบB (NF-ฮบB) expression in high fat diet-inducedย obesityย andย insulinย resistance in rats.
  2888. Nuclear orphan receptor TAK1/TR4-deficient mice are protected againstย obesity-linked inflammation, hepatic steatosis, andย insulinย resistance
  2889. Nuclear receptors as targets for drug development: molecular mechanisms for regulation ofย obesityย andย insulinย resistance by peroxisome proliferator-activated โ€ฆ
  2890. Nucleic acid-targeting pathways promote inflammation inย obesity-relatedย insulinย resistance
  2891. Nutritional and endocrine modulation of intracellular calcium: implications inย obesity,ย insulinย resistance and hypertension
  2892. Nutritional modulation of gut microbiota in the context ofย obesityย andย insulinย resistance: Potential interest of prebiotics
  2893. Nutritional strategy to prevent fatty liver andย insulinย resistance independent ofย obesityย by reducing glucose-dependentย insulinotropic polypeptide responses in mice
  2894. NYGGF4 as a new therapeutic target forย obesity-associatedย insulinย resistance
  2895. O-1: The leptin-insulinย axis: Interactions in the development ofย obesityย and diabetes
  2896. Obes Surg.: Metabolic syndrome andย insulinย resistance in subjects with morbidย obesity
  2897. obesityย accelerates cognitive decline by aggravating mitochondrial dysfunction,ย insulinย resistance and synaptic dysfunction under estrogen-deprived conditions
  2898. obesityย affects myocardial vasoreactivity and coronary flow response toย insulin
  2899. obesityย Alters Aortic Vasorelaxation Mediated byย insulinย andย insulinโ€like Growth Factorโ€1
  2900. obesityย Amplifies the Sympathoexcitatory Response toย insulinย in Male, but not Female, Rats: Role of Neuropeptide Y Inputs into the Paraventricular Nucleus
  2901. obesityย and adipose tissue distribution in men: relation to sex steroids andย insulin
  2902. obesityย and alcohol modulate the effect of apolipoprotein E polymorphism on lipids andย insulin
  2903. obesityย and arterial hypertension. Relation betweenย insulinย secretion, peripheralย insulinย resistance and pressure indices
  2904. obesityย and autonomic neuropathy in non-insulin-dependent diabetes mellitus
  2905. obesityย and cancer risk: the role of theย insulinโ€“IGF axis
  2906. obesityย and cancer, a case forย insulinย signaling
  2907. obesityย and chronic leptin resistance fosterย insulinย resistance: An analytical overview
  2908. obesityย and diabetes: pathophysiology ofย obesity-induced hyperglycemia andย insulinย resistance
  2909. obesityย and diet affect glucose dynamics andย insulinย sensitivity in Thoroughbred geldings
  2910. obesityย and fatty acids in the etiology ofย insulinย resistance
  2911. obesityย and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women
  2912. obesityย and high blood pressure: a clinical phenotype for theย insulinย resistance syndrome in African Americans
  2913. obesityย and hypertestosteronaemia are independently and synergistically associated with elevatedย insulinย concentrations and dyslipidaemia in pre-menopausal โ€ฆ
  2914. obesityย and incidence of diabetes: Effect of absence of metabolic syndrome,ย insulinย resistance, inflammation and fatty liver
  2915. obesityย andย insulinย levels
  2916. obesityย andย insulinย resistance
  2917. obesityย andย insulinย resistance
  2918. obesityย andย insulinย resistance
  2919. obesityย andย insulinย resistance
  2920. obesityย andย insulinย Resistance
  2921. obesityย andย insulinย resistance (IR) negativley impact cumulus oocyte complex (COC) quality
  2922. obesityย andย insulinย Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
  2923. obesityย andย insulinย resistance after chemotherapy in patients with acute lymphoblastic leukemia
  2924. obesityย andย insulinย resistance among adolescents from Chiapas
  2925. obesityย andย insulinย resistance among infertile women with polycystic ovarian syndrome
  2926. obesityย andย insulinย resistance are associated with reduced activity in core memory regions of the brain
  2927. obesityย andย insulinย resistance are inversely associated with serum and adipose tissue carotenoid concentrations in adults
  2928. obesityย andย insulinย resistance are significant predictors of serum leptin levels
  2929. obesityย andย insulinย resistance are the central issues in prevention of and care for comorbidities
  2930. obesityย andย insulinย Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome.
  2931. obesityย andย insulinย resistance as risk factors for chronic kidney disease
  2932. obesityย andย insulinย resistance associated with lower plasma vitamin B12 in PCOS
  2933. obesityย andย insulinย resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome
  2934. obesityย andย insulinย Resistance in Adolescents
  2935. obesityย andย insulinย Resistance in Adolescents
  2936. obesityย andย insulinย resistance in adolescents: impact of renin angiotensin system
  2937. obesityย andย insulinย resistance in apparently healthy Korean men
  2938. obesityย andย insulinย resistance in breast cancerโ€“chemoprevention strategies with a focus on metformin
  2939. obesityย andย insulinย resistance in childhood
  2940. obesityย andย insulinย Resistance in Childhood
  2941. obesityย andย insulinย resistance in childhood and adolescence
  2942. obesityย andย insulinย resistance in children
  2943. obesityย andย insulinย resistance in children
  2944. obesityย andย insulinย resistance in children.
  2945. obesityย andย insulinย resistance in human growth hormone transgenic rats
  2946. obesityย andย insulinย resistance in humans: a dose-response study
  2947. obesityย andย insulinย resistance in nonalcoholic fatty liver
  2948. obesityย andย insulinย resistance in patients with non-alcoholic fatty liver disease diagnosed by non invasive diagnostic methods
  2949. obesityย andย insulinย resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy
  2950. obesityย andย insulinย resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.
  2951. obesityย andย insulinย resistance in resistant hypertension: implications for the kidney
  2952. obesityย andย insulinย resistance in Swedish subjects
  2953. obesityย andย insulinย resistance in the obese-hyperglycemic mouse (obob)
  2954. obesityย andย insulinย resistance in women with polycystic ovary syndrome
  2955. obesityย andย insulinย resistance increase plasma viscosity in young women with polycystic ovary syndrome
  2956. obesityย andย insulinย resistance increases sensitivity to sepsis-induced hepatotoxicity
  2957. obesityย andย insulinย resistance induce early development of diastolic dysfunction in young female mice fed a Western diet
  2958. obesityย andย insulinย resistance is associated with lower atp binding cassette transporter A1 (Abca1) expression in visceral adipose tissue
  2959. obesityย andย insulinย resistance promote atherosclerosis through an IFNฮณ-regulated macrophage protein network
  2960. obesityย andย insulinย Resistance Rates in a Population Under 40 Years Old Who Admitted to a Family Medicine Outpatient Clinic
  2961. obesityย andย insulinย resistance screening tools in American adolescents: National Health and Nutrition Examination Survey (NHANES) 1999 to 2010
  2962. obesityย andย insulinย Resistance Status: The Impact of Using Different International Growth Standards in Romanian Children.
  2963. obesityย andย insulinย resistance syndrome
  2964. obesityย andย insulinย resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects
  2965. obesityย andย insulinย Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women
  2966. obesityย andย insulinย resistance, risk factors for gingivitis in children?
  2967. obesityย andย insulinย Resistance: A Review of Molecular Interactions
  2968. obesityย andย insulinย resistance: An abridged molecular correlation
  2969. obesityย andย insulinย resistance: an ongoing saga
  2970. obesityย andย insulinย resistance: associations with chronic inflammation, genetic and epigenetic factors
  2971. obesityย andย insulinย resistance: effects on cardiac structure, function, and substrate metabolism
  2972. obesityย andย insulinย resistance: is it due to body fat, energy balance, or gut factors?
  2973. obesityย andย insulinย resistance: lessons learned from the Pima Indians
  2974. obesityย andย insulinย Resistance: Management in Diabetes.
  2975. obesityย andย insulinย resistance:โ€œwindowโ€ to myocardial dysfunction
  2976. obesityย andย insulinย secretion in fasting high school students
  2977. obesityย andย insulinย sensitivity effects on cardiovascular risk factors: Comparisons of obese dysglycemic youth and adults
  2978. obesityย andย insulin-like growth factor-I in African Americans and whites
  2979. obesityย and intestinal epithelial deletion of theย insulinย receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon
  2980. obesityย and its metabolic complications: the role of adipokines and the relationship betweenย obesity, inflammation,ย insulinย resistance, dyslipidemia and nonalcoholic โ€ฆ
  2981. obesityย and menstrual irregularity: associations with SHBG, testosterone, andย insulin
  2982. obesityย and metabolic dysfunction severely influence prostate cell function: role ofย insulinย and IGF 1
  2983. obesityย and non-insulinย dependent diabetes mellitus. 22-23 April 1998, The Royal Society, London, UK.
  2984. obesityย and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma
  2985. obesityย and non-insulin-dependent diabetes mellitus. Considerations on an epidemiological study
  2986. obesityย and Plasma Levels ofย insulinย and Growth Hormone
  2987. obesityย and sex influenceย insulinย resistance and total and multimer adiponectin levels in adult neutered domestic shorthair client-owned cats
  2988. #VALUE!
  2989. obesityย and the development ofย insulinย resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study
  2990. obesityย and theย insulinย resistance syndrome
  2991. obesityย and theย insulinย resistance syndrome
  2992. obesityย and the Risk of Recurrent Vascular Events in Patients with Ischemic Stroke: Insights from theย insulinย Resistance Intervention after Stroke (IRIS) Trial
  2993. obesityย and the use ofย insulin: a study of patients with type 2 diabetes in the UK
  2994. obesityย and type 2 diabetes impairย insulin-induced suppression of glycogenolysis as well as gluconeogenesis
  2995. obesityย and type 2 diabetes mellitus (T2DM) have been associated with increased levels of circulating branched-chain amino acids (BCAAs) that may be โ€ฆ
  2996. obesityย and Type 2 Diabetes Mellitus: Adipocytokines as Markers ofย insulinย Resistance
  2997. obesityย as a risk factor for developing non-insulinย dependent diabetes mellitusโ€“obesityย andย insulinย resistance
  2998. obesityย as a risk factor for non-insulin-dependent diabetes mellitus in Korea.
  2999. obesityย as associated factors forย insulin, Fasting blood sugar, and Hemoglobin A1c in Korean adults
  3000. obesityย associatedย insulinย resistance occurs in hypopituitary subjects
  3001. obesityย attenuates the contribution of African admixture to theย insulinย secretory profile in peripubertal children: a longitudinal analysis
  3002. obesityย bluntsย insulin-mediated microvascular recruitment in human forearm muscle
  3003. obesityย does not aggravate osteoporosis or osteoblasticย insulinย resistance in orchiectomized rats
  3004. obesityย Does Not Equalย insulinย Resistance
  3005. obesityย does not influence the unique pharmacological properties of different biphasicย insulinย aspart preparations in patients with type 2 diabetes
  3006. obesityย does not modulateย insulinย secretion in Indian patients with non-insulin-dependent diabetes in the young
  3007. obesityย Effect on Homeostasis Model Assessment ofย insulinย Resistance (HOMA-IR) Value in Various Metabolic Syndrome (MS) Components
  3008. obesityย genes andย insulinย resistance
  3009. obesityย hypertension, salt sensitivity andย insulinย resistance.
  3010. obesityย Improves Myocardial Ischaemic Tolerance and โ€˜RISKโ€™Signalling in Middle-agedย insulin-insensitive Rats
  3011. obesityย improves myocardial ischaemic tolerance and RISK signalling inย insulin-insensitive rats
  3012. obesityย inย insulinย receptor substrateโ€2โ€“deficient mice: disrupted control of arcuate nucleus neuropeptides
  3013. obesityย in MENX rats is accompanied by high circulating levels of ghrelin and improvedย insulinย sensitivity
  3014. obesityย in Osborne-Mendel and S 5B/Pl rats: effects of sucrose solutions, castration, and treatment with estradiol orย insulin
  3015. obesityย in polycystic ovary syndrome:ย insulinย sensitizing therapy
  3016. obesityย in relation to inflammatory biomarkers, adiponectin gene variability, andย insulinย resistance among middle-aged Egyptian women
  3017. obesityย in Spanish schoolchildren: relationship with lipid profile andย insulinย resistance
  3018. #VALUE!
  3019. obesityย increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic โ€ฆ
  3020. obesityย Increases the Risk of Developingย insulinย Resistance and Promote Metabolic Syndrome: A Study among Obese and On-Obese Non-Diabetic Subjects
  3021. obesityย independently predicts responders to biphasicย insulinย 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from otherย insulinย regimens: a โ€ฆ
  3022. obesityย induced by a high-fat diet is associated with reduced brainย insulinย transport in dogs.
  3023. obesityย induced by a high-fat diet is associated with reduced brainย insulinย transport in dogs.(Abstracts: recently published abstracts)
  3024. obesityย induced by high-fat diet promotesย insulinย resistance in the ovary
  3025. obesityย induced infertility rescued by ovarian theca cellspecific knockout of theย insulinย receptor.
  3026. obesityย inducedย insulinย resistance and oxidative stress in mice fed a high fat diet
  3027. obesityย induced-insulinย resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia
  3028. obesityย Influence onย insulinย Activity and Resting Metabolic Rate in Type 2 Diabetes
  3029. obesityย is a critical risk factor for worsening of glucose tolerance in a family with the mutantย insulinย receptor
  3030. obesityย is associated with activated andย insulinย resistant immune cells
  3031. obesityย is associated with altered metabolic and reproductive activity in the mare: effects of metformin onย insulinย sensitivity and reproductive cyclicity
  3032. obesityย is associated with impairedย insulin-mediated potassium uptake
  3033. obesityย is associated with increased basal and postprandial ฮฒ-cellย insulinย secretion even in the absence ofย insulinย resistance
  3034. obesityย is associated with increased seminalย insulinย and leptin alongside reduced fertility parameters in a controlled male cohort
  3035. obesityย is associated withย insulinย resistance and components of the metabolic syndrome in Lebanese adolescents
  3036. obesityย is associated withย insulinย resistance but not skeletal muscle dysfunction or all-cause mortality
  3037. obesityย is the main determinant ofย insulinย resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients
  3038. obesityย is the major cause of alterations inย insulinย secretion and calcium fluxes by isolated islets from aged rats
  3039. obesityย is the major factor determiningย insulinย sensitivity and androgen production in women with anovulary cycles
  3040. obesityย leads to impairments in the morphology and organization of human skeletal muscle lipid droplets and mitochondrial networks, which are resolved with gastric โ€ฆ
  3041. obesityย May Connectย insulinย Resistance to Decreased Neuronal Viability in Human Diabetic Brain
  3042. obesityย may have more pronounced effect on the occurrence ofย insulinย resistance than hypertension
  3043. obesityย mediates the association between Mediterranean diet consumption andย insulinย resistance and inflammation in US adults
  3044. obesityย modifies the association between serum 25-hydroxyvitamin D andย insulinย resistance in Korean general population without increased fasting glucose levels
  3045. obesityย modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes andย insulinย sensitivity
  3046. obesityย Modulates the Association among APOE Genotype,ย insulin, and Glucose in Men
  3047. obesityย potentiates development of fatty liver andย insulinย resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice
  3048. obesityย preventive function of novel edible mushroom, Basidiomycetes-X (Echigoshirayukidake): Manipulations ofย insulinย resistance and lipid metabolism
  3049. obesityย provides a permissive milieu in inflammation-associated carcinogenesis: analysis ofย insulinย and IGF pathways
  3050. obesityย rather than severity of sleep-disordered breathing as the major determinant ofย insulinย resistance and altered lipidemia in snoring children
  3051. obesityย Related toย insulinย Response and Counterregulatory Hormones in NIDDM Patients
  3052. obesityย resistance and enhancedย insulinย sensitivity in Ahnak-/-mice fed a high fat diet are related to impaired adipogenesis and increased energy expenditure
  3053. obesityย status affects the relationship between protein intake andย insulinย sensitivity in late pregnancy
  3054. obesityย status influences the relationship among serum osteocalcin, iron stores andย insulinย sensitivity
  3055. obesityย type and clustering ofย insulinย resistance-associated cardiovascular risk factors in middle-aged men and women
  3056. obesityย withย insulinย resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker Fatty rats
  3057. obesityย withย insulinย resistance: experimental insights
  3058. obesityโ€”insulinย resistanceโ€“type 2 diabetes mellitus
  3059. obesity-associated extracellular and ultrastructural changes in adipocytes: Impact onย insulinย sensitivity
  3060. obesity-associated family with sequence similarity 13, member A (FAM13A) is dispensable for adipose development andย insulinย sensitivity
  3061. obesity-associated gingival vascular inflammation andย insulinย resistance
  3062. obesity-Associated Inflammation And Its Role Inย insulinย Resistance
  3063. obesity-associatedย insulinย resistance adversely affects skin function
  3064. obesity-associatedย insulinย resistance in skeletal muscle: role of lipid accumulation and physical inactivity
  3065. obesity-associatedย insulinย resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels
  3066. obesity-associated interleukin-6 contributes to hepaticย insulinย resistance in mice
  3067. obesity-associated intestinalย insulinย resistance is ameliorated after bariatric surgery
  3068. obesity-associated, but notย obesity-independent, tumors respond toย insulinย by increasing mitochondrial glucose oxidation
  3069. obesity-associated, but notย obesity-independent, tumors respond toย insulinย by increasing mitochondrial glucose oxidation
  3070. obesity-induced adipose tissue inflammation andย insulinย resistance
  3071. obesity-induced Brainย insulinย Resistance Exacerbates TBI Outcome
  3072. obesity-induced DNA hypermethylation of the adiponectin gene mediatesย insulinย resistance
  3073. obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation andย insulinย resistance
  3074. obesity-induced infertility and hyperandrogenism are corrected by deletion of theย insulinย receptor in the ovarian theca cell
  3075. obesity-Induced Inflammation andย insulinย Resistance
  3076. obesity-induced inflammation andย insulinย resistance
  3077. obesity-induced inflammation andย insulinย resistance: A mini-review on T-cells
  3078. obesity-inducedย insulinย resistance and hyperglycemia: etiologic factors and molecular mechanisms
  3079. obesity-Inducedย insulinย Resistance in Human Skeletal Muscle Is Characterised by
  3080. obesity-inducedย insulinย resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase
  3081. obesity-inducedย insulinย resistance via changes in the DNA methylation profile ofย insulinย pathway genes
  3082. obesity-inducedย insulinย resistance via changes in the DNA methylation profile ofย insulinย pathway genes
  3083. obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairsย insulinย signalling
  3084. obesity-induced mouse benign prostatic hyperplasia (BPH) is improved by treatment with resveratrol: implication of oxidative stress,ย insulinย sensitivity and neuronal โ€ฆ
  3085. obesity-induced overexpression of miR-802 impairsย insulinย transcription and secretion
  3086. obesity-induced overexpression of miRNA-143 inhibitsย insulin-stimulated AKT activation and impairs glucose metabolism
  3087. obesity-induced p53 activation inย insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats
  3088. obesity-induced reduced expression of the lncRNA ROIT impairsย insulinย transcription by downregulation of Nkx6. 1 methylation
  3089. obesity-inducing hypothalamic knife cuts: effects on lipolysis and bloodย insulinย levels
  3090. obesity-linkedย insulinย resistance in childrenโ€“an emerging problem: The EarlyBird Study (31)
  3091. obesity-Linkedย insulinย Resistance: Is Interleukin-6 a Friend or Foe?
  3092. obesity-linked PPARฮณ S273 phosphorylation promotesย insulinย resistance through Growth Differentiation Factor 3
  3093. obesity-prone rats have preexisting defects in their counterregulatory response toย insulin-induced hypoglycemia
  3094. obesity-related changes in the vascular actions ofย insulin
  3095. obesity-related diseases and syndromes:ย insulinย resistance, type 2 diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, and metabolic โ€ฆ
  3096. obesity-related dyslipidemia associated with FAAH, independent ofย insulinย response, in multigenerational families of Northern European descent
  3097. obesity-related hypertension and theย insulinย resistance syndrome.
  3098. obesity-Related Hypertension and the Role ofย insulinย and Leptin in High-Fatโ€“Fed Rabbits
  3099. obesity-related hypertension: role of the sympathetic nervous system,ย insulin, and leptin
  3100. obesity-related hypoxia via miR-128 decreasesย insulin-receptor expression in human and mouse adipose tissue promoting systemicย insulinย resistance
  3101. obesity-relatedย insulinย resistance in adolescents: a systematic review and meta-analysis of observational studies
  3102. obesity-relatedย insulinย resistance is reversible after weight loss
  3103. obesity-relatedย insulinย resistance: implications for the surgical patient
  3104. obesity-relatedย insulinย resistance: implications for the surgical patient
  3105. obesity-related lipid profile and alteredย insulinย incretion in adolescents with polycystic ovary syndrome
  3106. obesity-related thyroiditis in childhood: relationship withย insulinย resistance
  3107. obesity-Related Vascular Functional Change is Associated withย insulinย Resistance in Children
  3108. obesity-stroke paradox exists inย insulin-resistant patients but notย insulinย sensitive patients
  3109. obesityโ€inducedย insulinย resistance and hepatic steatosis are alleviated by ฯ‰โ€3 fatty acids: a role for resolvins and protectins
  3110. obesityโ€inducedย insulinย resistance and macrophage infiltration of the adipose tissue: A vicious cycle
  3111. obesityโ€induced miRโ€15b is linked causally to the development ofย insulinย resistance through the repression of theย insulinย receptor in hepatocytes
  3112. obesityโ€“insulinย targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice
  3113. obesity, abdominalย obesity, andย insulinย resistance
  3114. obesity, acanthosis nigricans,ย insulinย resistance, and hyperandrogenemia: pediatric perspective and natural history
  3115. obesity, adipocytokines, andย insulinย resistance in breast cancer
  3116. obesity, adipogenesis andย insulinย resistance
  3117. obesity, adipogenesis andย insulinย resistance
  3118. obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).
  3119. obesity, and notย insulinย resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women
  3120. obesity, bioactive lipids, and adipose tissue inflammation inย insulinย resistance
  3121. obesity, Body Composition andย insulinย Resistance in Women with and without Bipolar Disorder
  3122. obesity, body fat distribution and other risk factors of non-insulin-dependent diabetes mellitus in different ethnic groups living in East Anglia
  3123. obesity, body fat distribution,ย insulinย resistance and link with type 2 diabetes mellitus
  3124. obesity, body fat distribution,ย insulinย sensitivity and islet ฮฒ-cell function as explanations for metabolic diversity
  3125. obesity, diabetes andย insulinย resistance. Alterations ofย insulinย signalling
  3126. obesity, diabetes, andย insulinย resistance: implications from molecular biology, epidemiology, and experimental studies in humans and animals. Synopsis of the โ€ฆ
  3127. obesity, Dyslipidemia andย insulinย Resistance in Survivors of Childhood Cancer
  3128. obesity, ectopic lipids, andย insulinย resistance Tissue-specific defects in nutrient handling
  3129. obesity, fasting plasmaย insulin, and cโ€reactive protein levels in healthy children
  3130. obesity, free fatty acids, andย insulinย resistance
  3131. obesity, hyperinsulinemia, and portal blood flow: a theoretic study of the effects of increased portal blood flow upon fasting peripheralย insulinย concentrations
  3132. obesity, HYPERinsulinEMIA, THEย insulinย ANDย insulin-LIKE GROWTH FACTOR 1 RECEPTORS, AND RISK OF COLORECTAL CANCER
  3133. obesity, hyperlipidemia and non-insulin-dependent diabetes: A unified theory
  3134. obesity, hypertension andย insulinย resistance
  3135. obesity, hypertension andย insulinย resistance in childhoodโ€“a pilot study
  3136. obesity, HYPERTENSION ANDย insulinย RESISTANCE IN CHILDHOOD.
  3137. obesity, hypertension, andย insulinย resistance
  3138. obesity, independent ofย insulinย resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese
  3139. obesity, inflammation andย insulinย resistance: role of gp 130 receptor ligands
  3140. obesity, inflammation, andย insulinย resistance
  3141. obesity, inflammation, andย insulinย resistance
  3142. obesity, inflammation, andย insulinย resistance
  3143. obesity, inflammation, andย insulinย resistanceโ€“a mini-review
  3144. obesity,ย insulinย and chemoresistance in colon cancer
  3145. obesity,ย insulinย and hypertension
  3146. obesity,ย insulinย and triglycerides
  3147. obesity,ย insulinย resistance and assisted conception
  3148. obesity,ย insulinย resistance and breast cancer outcomes
  3149. obesity,ย insulinย resistance and cancer risk
  3150. obesity,ย insulinย Resistance and Cancer: The PI3K connection
  3151. obesity,ย insulinย resistance and comorbidities? Mechanisms of association
  3152. obesity,ย insulinย resistance and diabetes in the sand rat exposed to a hypercaloric diet; possible protective effect for IL1-ฮฒ
  3153. obesity,ย insulinย resistance and diabetesโ€”a worldwide epidemic
  3154. obesity,ย insulinย resistance and diabetes: sex differences and role of oestrogen receptors
  3155. obesity,ย insulinย resistance and endometrial cancer risk
  3156. obesity,ย insulinย Resistance and Exercise [J]
  3157. obesity,ย insulinย resistance and hepatic perfusion
  3158. obesity,ย insulinย resistance and increase in adipokines levels: importance of the diet and physical activity
  3159. obesity,ย insulinย Resistance andย insulin.
  3160. obesity,ย insulinย resistance and isolated low highโ€densityโ€lipoprotein cholesterol in Chinese subjects
  3161. obesity,ย insulinย resistance and kidney disease risk: insights into the relationship
  3162. obesity,ย insulinย resistance and lifestyle factors: implications for prostate cancer screening
  3163. obesity,ย insulinย Resistance and Loss of Dipping are Associated With Pulse Wave Velocity in Prepubertal Children
  3164. obesity,ย insulinย resistance and oxidative stress: implication for breast carcinogenesis.
  3165. obesity,ย insulinย Resistance and Pediatric Bone
  3166. obesity,ย insulinย Resistance and Placental Dysfunction ฤ€ Foetal Growth
  3167. obesity,ย insulinย resistance and Polycystic ovary syndrome
  3168. obesity,ย insulinย resistance and pregnancy outcome
  3169. obesity,ย insulinย resistance and skeletal muscle characteristics
  3170. obesity,ย insulinย resistance and the implication of thiazolidinediones
  3171. obesity,ย insulinย resistance and the prevalence of atopy and asthma in US adults
  3172. obesity,ย insulinย resistance and type 2 diabetes: risk factors for breast cancer
  3173. obesity,ย insulinย Resistance Pathway Factors, and Colon Cancer
  3174. obesity,ย insulinย resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets
  3175. obesity,ย insulinย resistance, adiponectin, and PPAR-ฮณ gene expression in broiler chicks fed diets supplemented with fat and green tea (Camellia sinensis) extract
  3176. obesity,ย insulinย resistance, and Alzheimerโ€™s disease
  3177. obesity,ย insulinย resistance, and cancer prognosis: implications for practice for providing care among cancer survivors
  3178. obesity,ย insulinย resistance, and capillary recruitment
  3179. obesity,ย insulinย resistance, and cardiovascular disease
  3180. obesity,ย insulinย resistance, and colorectal cancer: could miRNA dysregulation play a role?
  3181. obesity,ย insulinย resistance, and HCV: implications for pathogenesis
  3182. obesity,ย insulinย resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women
  3183. obesity,ย insulinย resistance, and incident small vessel disease on magnetic resonance imaging: atherosclerosis risk in communities study
  3184. obesity,ย insulinย resistance, and inflammaging
  3185. obesity,ย insulinย resistance, and its link to non-insulin-dependent diabetes mellitus
  3186. obesity,ย insulinย resistance, and metabolic syndrome: a study in WNIN/Ob rats from a pancreatic perspective
  3187. obesity,ย insulinย resistance, and microvascular adaptation
  3188. obesity,ย insulinย resistance, and microvessel density
  3189. obesity,ย insulinย resistance, and nocturnal systolic blood pressure
  3190. obesity,ย insulinย resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease
  3191. obesity,ย insulinย resistance, and renal function
  3192. obesity,ย insulinย resistance, and skeletal muscle nitric
  3193. obesity,ย insulinย resistance, and skeletal muscle nitric oxide synthase
  3194. obesity,ย insulinย resistance, and skeletal muscle nitric oxide synthase
  3195. obesity,ย insulinย resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks
  3196. obesity,ย insulinย resistance, and the pathway to type 2 diabetes
  3197. obesity,ย insulinย resistance, and the renal circulation
  3198. obesity,ย insulinย resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population
  3199. obesity,ย insulinย resistance, and the risk of colonic adenoma
  3200. obesity,ย insulinย resistance, and type 1 diabetes mellitus
  3201. obesity,ย insulinย resistance, and type 2 diabetes in children and adolescents
  3202. obesity,ย insulinย resistance, and type 2 diabetes: associations and therapeutic implications
  3203. obesity,ย insulinย resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension โ€ฆ
  3204. obesity,ย insulinย resistance, hypertension and sleep in the child
  3205. obesity,ย insulinย resistance, NASH and hepatocellular carcinoma
  3206. obesity,ย insulinย resistance, oxidative stress, and inflammation in mouse models of the metabolic syndrome and atherosclerosis
  3207. obesity,ย insulinย resistance, type 2 diabetes and free fatty acids
  3208. obesity,ย insulinย resistance, ฮฒ-cell autoimmunity, and the changing clinical epidemiology of childhood diabetes
  3209. obesity,ย insulinย secretion andย insulinย action: reinterpreting the disposition index
  3210. obesity,ย insulin, and colon cancer.
  3211. obesity,ย insulin, and hypertension: why outliers count
  3212. obesity,ย insulin, sex steroids and ovulation
  3213. obesity, leptin resistance, and the effects ofย insulinย reduction
  3214. obesity, metabolic syndrome, andย insulinย dynamics in children after craniopharyngioma surgery
  3215. obesity, metabolic syndrome, andย insulinย resistance in urban high school students of minority race/ethnicity
  3216. obesity, NIDDM, Adipogenesis andย insulinย Resistance-IBCโ€™s Ninth International Conference.
  3217. obesity, non-insulin-dependent diabetes mellitus and age, but not estrogen, were associated with changes of (delta) 6 and (delta) 5 desaturase enzyme activity โ€ฆ
  3218. obesity, occupational work and parental history as risk factors for non-insulin-dependent diabetes mellitus
  3219. #VALUE!
  3220. obesity, oxidative stress, and their effect on serum heme oxygenase-1 concentrations andย insulinย in children aged 3 to 5 years in a pediatric hospital of the Ministry of โ€ฆ
  3221. obesity, plasma high sensitivity C-reactive protein levels andย insulinย resistance status among school children in Taiwan
  3222. obesity, syndrome X, and diabetes: the role of HISS-dependentย insulinย resistance altered by sucrose, an antioxidant cocktail, and age
  3223. obesity, type 2 diabetes, and cancer: theย insulinย and IGF connection
  3224. obesity, Type 2 Diabetes, and Cancer: Theย insulinย andย insulin-Like Growth Factor Connection.
  3225. obesity, type 2 diabetes, and impairedย insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1
  3226. obesity, weight change, fastingย insulin, proinsulin, C-peptide, andย insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo โ€ฆ
  3227. obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks onย insulinย resistance and androgen levels
  3228. obesity: Adipogenesis andย insulinย Resistance.
  3229. obesity: changes in lipid metabolism and the role ofย insulin
  3230. obesity/insulinย resistance is associated with endothelial dysfunction. Implications for the syndrome ofย insulinย resistance.
  3231. obesity/insulinย resistance rather than liver fat increases coagulation factor activities and expression in humans
  3232. #VALUE!
  3233. Obstructive sleep apnea andย insulinย resistance in children withย obesity
  3234. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless ofย obesity/insulinย โ€ฆ
  3235. Obstructive sleep apnea,ย insulinย resistance, and steatohepatitis in severeย obesity
  3236. OGTT,ย insulinย Releasing Test and Changes of Plasma Lipids inย obesity
  3237. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and preventsย insulinย resistance andย obesityย induced by a high โ€ฆ
  3238. Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and preventsย insulinย resistance andย obesityย induced by a high โ€ฆ
  3239. Omega-3 index,ย obesityย andย insulinย resistance in children
  3240. Omega-3 PUFA and probiotics as a single formulation forย insulinย resistance andย obesity: Evidence from animals to randomized clinical studies
  3241. Omental adipose tissue fibrosis andย insulinย resistance in severeย obesity
  3242. On the paradoxย insulinย resistance/insulinย hypersensitivity andย obesity: two tales of the same history
  3243. On the pathogenesis of type II diabetes with special reference to diminishedย insulinย response andย obesity: a 5-12 year follow-up study of subjects with borderline โ€ฆ
  3244. #VALUE!
  3245. OPA 1 deficiency promotes secretion of FGF 21 from muscle that preventsย obesityย andย insulinย resistance
  3246. Operative risk factors in the metabolic syndrome: Is it lipids and high blood pressure or are there direct vascular effects ofย insulinย resistance andย obesity?
  3247. Optimal waist circumference cutoff value based onย insulinย resistance and visceralย obesityย in Koreans with type 2 diabetes
  3248. OR-43: A neuroendocrine model ofย obesityย worsenย insulinย resistance of spontaneously hypertensive rats: a new model of type 2 diabetes
  3249. OR01-3 microRNA-34a-mediated FGF21 resistance in the adipose tissue contributes toย insulinย resistance and hypoadiponectinemia in diet-inducedย obesity
  3250. OR26-03 Lower Serum Myostatin Levels Are Associated with Higherย insulinย Sensitivity in Adults with Overweight/obesity
  3251. Oral administration of alkylglycerols differentially modulates high-fat diet-inducedย obesityย andย insulinย resistance in mice
  3252. Oral glutamine supplementation reducesย obesity, pro-inflammatory markers, and improvesย insulinย sensitivity in DIO wistar rats and reduces waist circumference in โ€ฆ
  3253. Oral hormonal therapy with ethinylestradiolโ€“levonorgestrel improvesย insulinย resistance,ย obesity, and glycogen synthase kinase-3 independent of circulating โ€ฆ
  3254. Organophosphorus pesticide chlorpyrifos intake promotesย obesityย andย insulinย resistance through impacting gut and gut microbiota
  3255. Original Research Article Correlation betweenย insulinย resistance and metabolic syndrome inย obesityย adolescents
  3256. Osteocalcin reverses endoplasmic reticulum stress and improves impairedย insulinย sensitivity secondary to diet-inducedย obesityย through nuclear factor-ฮบB signaling โ€ฆ
  3257. Osteopontin mediatesย obesity-induced adipose tissue macrophage infiltration andย insulinย resistance in mice
  3258. Osteoprotegerin andย insulinย resistance in childhoodย obesity: a new interplay?
  3259. Osteoprotegerin in relation toย insulinย resistance and blood lipids in sub-Saharan African women with and without abdominalย obesity
  3260. Over Expression of theย insulinย Like Growth Factor Type 1 Receptors in Endothelial Cells Protects Against the Development ofย obesity
  3261. Over-nutrition,ย obesityย andย insulinย resistance in the development of ฮฒ-cell dysfunction
  3262. Overactivation of the adipose tissue renin angiotensin system contributes toย insulinย resistance in highโ€fat dietโ€inducedย obesity
  3263. Overall and abdominalย obesityย withย insulinย sensitivity and secretion in a Han Chinese population: a Mendelian randomisation study
  3264. Overall and centralย obesityย withย insulinย sensitivity and secretion in a Han Chinese population: a Mendelian randomization analysis
  3265. Overcoming metabolic syndrome in severeย obesity: adiponectin as a marker ofย insulinย sensitivity and HDL-cholesterol improvements after gastric bypass
  3266. Overexpression of 11ฮฒ-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquiredย obesityย and features ofย insulinย resistance: studies in young โ€ฆ
  3267. Overexpression of C-type natriuretic peptide in endothelial cells protects againstย insulinย resistance and inflammation during diet-inducedย obesity
  3268. Overexpression of cโ€myc in the liver preventsย obesityย andย insulinย resistance
  3269. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation andย insulinย resistance inย obesity
  3270. Overexpression of interleukin-15 in mice promotes resistance to diet-inducedย obesity, increasedย insulinย sensitivity, and markers of oxidative skeletal muscle โ€ฆ
  3271. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-inducedย obesity, fatty liver andย insulinย resistance
  3272. Overexpression of the A1 adenosine receptor in adipose tissue protects mice fromย obesityโ€relatedย insulinย resistance
  3273. Overfeeding-inducedย obesityย in rats:ย insulinย sensitivity and autonomic regulation of metabolism
  3274. Overview: low density lipoprotein subclass phenotype B as a biochemical marker for visceralย obesityย andย insulinย resistance
  3275. Overweight andย obesityย in infants of mothers with long-termย insulin-dependent diabetes or gestational diabetes
  3276. Overweight,ย obesityย and features of metabolic syndrome in children with diabetes treated withย insulinย pump therapy
  3277. Overweight,ย obesity, and their associations withย insulinย resistance and ฮฒ-cell function among Chinese: a cross-sectional study in China
  3278. OX40 promotesย obesity-induced adipose inflammation andย insulinย resistance
  3279. Oxidative modifications of mitochondrial complex II are associated withย insulinย resistance of visceral fat inย obesity
  3280. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation andย obesity-linkedย insulinย resistance
  3281. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation andย obesity-linkedย insulinย resistance.
  3282. Oxidative stress is associated with Cโ€reactive protein in nondiabetic postmenopausal women, independent ofย obesityย andย insulinย resistance
  3283. Oxidized LDL is associated with metabolic syndrome traits independently of centralย obesityย andย insulinย resistance
  3284. #VALUE!
  3285. P-135:ย obesity,ย insulinย resistance, cardiac structure, and renin-angiotensin system genes in essential hypertension
  3286. P-138: Bmi-independent inflammation in omental adipose tissue associated withย insulinย resistance in morbidย obesity
  3287. P-443: Preliminary results of topiramate in an experimental model ofย obesity,ย insulinย resistance and hypertension (obese Zucker rats)
  3288. P-495: Relationships between endogenousย insulinย secretion andย insulinย resistance and blood pressure inย obesity
  3289. P-572: Clinical study on the role of leptin andย insulinย resistance in the pathogenesis ofย obesityย related hypertension
  3290. P-77: Risk of cardiovascular morbidity is correalted withย insulinย resistance, but not withย obesityย in a bariatric surgical population
  3291. p-Coumaric Acid Enriched-Peanut Sprout Improves High Fat Diet-Inducedย obesityย andย insulinย Resistance by Inhibiting Macrophage Recruitment
  3292. P-selectin glycoprotein ligand-1 deficiency is protective againstย obesity-relatedย insulinย resistance
  3293. Pโ€selectin deficiency protects against highโ€fat dietโ€inducedย obesityย andย insulinย resistance (641.1)
  3294. P2-03-01: Genetic Reduction of Circulatingย insulin-Like Growth Factor (IGF)-1 Differentially Impacts the Effects of Diet-Inducedย obesityย and Calorie Restriction on โ€ฆ
  3295. P20 Study ofย insulinย cardiovascular resistance in an animal model of childhoodย obesityย by over-feeding during lactation
  3296. P2X7 Receptor in the Management of Energy Homeostasis: Implications forย obesity, Dyslipidemia, andย insulinย Resistance
  3297. P5. 64 Effect of morbidย obesityย in skeletal muscle and its association withย insulinย resistance
  3298. P5299 Epicardialย obesityย as a significant predictor of leptino andย insulinย resistance
  3299. P649 A possible role for the ATM protein in the myocardial pathology associated withย obesityย andย insulinย resistance.
  3300. p66 (ShcA): linking mammalian longevity withย obesity-inducedย insulinย resistance
  3301. p66ShcA: linking mammalian longevity withย obesity-inducedย insulinย resistance
  3302. P704ย obesityย andย insulinย resistance are not associated with endothelial dysfunction in rat aortas.
  3303. PAI-1,ย obesity, andย insulinย resistance
  3304. PAI-1,ย obesity,ย insulinย resistance and risk of cardiovascular events
  3305. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia inducedย obesityย and inflammation mediatedย insulinย resistance via MAPK/NOX3-JNK pathway
  3306. Pancreastatin inhibitor PSTi8 protects theย obesityย associated skeletal muscleย insulinย resistance in diet induced streptozotocin-treated diabetic mice
  3307. Pancreastatin-dependent inflammatory signaling mediatesย obesity-inducedย insulinย resistance
  3308. Pancreatic acinar cell-specific overexpression of group 1B phospholipase A 2 exacerbates diet-inducedย obesityย andย insulinย resistance in mice
  3309. Pancreatic beta-cellย insulinย signaling in genetic and dietary models ofย obesityย andย insulinย resistance
  3310. Pancreatic ฮฒ-cell adaptive plasticity inย obesityย increasesย insulinย production but adversely affects secretory function
  3311. Parathyroid hormone andย insulinย resistance in distinct phenotypes of severeย obesity: a cross-sectional analysis in middle-aged men and premenopausal women
  3312. Parathyroid Hormone andย insulinย Resistance in Distinct Phenotypes of Severeย obesity: A Cross-Sectional Analysis in Middle-Aged Men and Premenopausal Women
  3313. Parthenolide Reversesย obesity-Inducedย insulinย Resistance [J]
  3314. Partial reversal ofย obesity-inducedย insulinย resistance owing to anti-inflammatory immunomodulatory potential of flaxseed oil
  3315. Partly replacing meat protein with soy protein altersย insulinย resistance and blood lipids in postmenopausal women with abdominalย obesity
  3316. Past and currentย obesityย in Koreans with non-insulin-dependent diabetes mellitus
  3317. Past and Presentย obesity, Parameters of Body Fat and Blood Pressure in Korean Patients with Non-insulinย Dependent Diabetes Mellitus (NIDDM)
  3318. Pathogenesis and clinical features ofย obesityย andย insulinย resistance
  3319. Pathogenesis ofย insulinย resistance and glucose intolerance in childhoodย obesity
  3320. Pathogenesis ofย insulinย resistance in metabolicย obesity
  3321. PATHOGENESIS OFย insulinย RESISTANCE IN PREGNANT WOMEN WITHย obesityย PATOGENEZAย insulinOOPORNOลšCI U KOBIET CIฤ˜ลปARNYCH Z โ€ฆ
  3322. Pathogenetic Relationship Betweenย insulinย Resistance,ย insulinย Secretion and Impaired Glucose Tolerance in Patients Withย obesity
  3323. Pathogenic role of inflammatory cytokines inย obesity: fromย insulinย resistance to diabetes mellitus
  3324. Pathologic Remodeling of Myocardial Cardiolipin in a Porcine Model of Diet-Inducedย obesityย andย insulinย Resistance
  3325. Pathomechanism ofย insulinย resistance in men with centralย obesity: correlation of GGT, GPx, hs-CRP and plasma total cysteine
  3326. Pathophysiological connections between gallstone disease,ย insulinย resistance, andย obesity
  3327. Pathophysiology and Management of Dyslipidemias Associated withย obesity, Type 2 Diabetes, and Otherย insulin-Resistant States
  3328. Pathophysiology in Animal models of Diet-Inducedย obesity: A critical Role forย insulinย Resistance
  3329. Pathophysiology of diabetes mellitus type 2: roles ofย obesity,ย insulinย resistance and ฮฒ-cell dysfunction
  3330. Pathophysiology ofย obesity-inducedย insulinย resistance and type 2 diabetes mellitus
  3331. Pathophysiology ofย obesity-related hypertension: role ofย insulinย and the sympathetic nervous system.
  3332. Pathways involved in lipid-inducedย insulinย resistance inย obesity
  3333. Pattern ofย obesityย andย insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
  3334. Pattern of plasma lipids andย insulinย blood levels in male patients with non-insulin-dependent diabetes mellitus and moderateย obesity
  3335. Patterns of glycemia during theย insulinย resistance of pregnancy:ย obesity, gestational diabetes and relationship to neonatal adiposity
  3336. PBI-4547 Improves Glucose Metabolism andย insulinย Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model ofย obesityย and Metabolic Syndrome
  3337. PC4 CONSEQUENCE OF CARBOHYDRATE AND FAT CONTENT OF WEANING DIET ON DEVELOPMENT OFย obesity, BLOODย insulin, LEPTIN AND LIPIDS โ€ฆ
  3338. PCOS andย obesity:ย insulinย resistance might be a common etiology for the development of type I endometrial carcinoma
  3339. PDK4 augments ERโ€“mitochondria contact to dampen skeletal muscleย insulinย signaling duringย obesity
  3340. Peculiarities of asthma andย insulinย resistance depending on the types ofย obesity
  3341. Peculiarities of cardiovascular syndrome in children and adolescents withย obesityย in dependence of level ofย insulinย resistance
  3342. Pediatricย obesityย andย insulinย resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification
  3343. Percentage fractions of urinary di (2-ethylhexyl) phthalate metabolites: Association withย obesityย andย insulinย resistance in Korean girls
  3344. Perforin is a novel immune regulator ofย obesity-relatedย insulinย resistance
  3345. Pericardial fat,ย insulinย resistance, and left ventricular structure and function in morbidย obesity
  3346. Perinatal growth failure: the road toย obesity,ย insulinย resistance and cardiovascular disease in adults
  3347. Peripheral hyperinsulinemia of simpleย obesity: pancreatic hypersecretion or impairedย insulinย metabolism?
  3348. Peripheralย insulinย Resistance Accounts for Endothelial Dysfunction inย obesity
  3349. Peripheral sgp130-mediated trans-signaling blockade inducesย obesityย andย insulinย resistance in mice via PPARฮฑ suppression
  3350. Peroxisomal-mitochondrial oxidation in a rodent model ofย obesity-associatedย insulinย resistance
  3351. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects ofย obesity, weight loss, and regulation byย insulinย and glucocorticoids.
  3352. Peroxisome proliferator-activated receptor y2 Pro115Gln and G972Rย insulinย substrate receptor-1 variants inย obesityย andย insulinย resistance
  3353. Peroxisome proliferator-activated receptors (PPARs) inย obesityย andย insulinย resistance development
  3354. Persistent adipose tissueย insulinย responsiveness during fasting of weanling rats with hypothalamicย obesity
  3355. Personalized dietary management of overweight andย obesityย based on measures ofย insulinย and glucose
  3356. PERTURBATION IN IMMUNE-METABOLIC FUNCTION ASSOCIATED WITHย obesityย INDUCEDย insulinย RESISTANCE IN HUMANS
  3357. PGRN is a key adipokine mediating high fat diet-inducedย insulinย resistance andย obesityย through IL-6 in adipose tissue
  3358. Pharmacokinetics ofย insulinย aspart inย obesity, renal impairment, or hepatic impairment
  3359. Pharmacological effects of palmitoylethanolamide on hypertension,ย insulin-resistance andย obesityย in murine models
  3360. Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increasesย insulinย sensitivity in diet-inducedย obesity
  3361. Pharmacological Inhibition of NLRP3 Inflammasome by Parthenolide Improvesย obesity-Inducedย insulinย Resistance in Diet-Induced Obese Mice
  3362. Pharmacological Strategies forย insulinย Sensitivity inย obesityย and Cancer: Thiazolidinediones and Metformin
  3363. Pharmacological targeting of ฮฑ3ฮฒ4 nicotinic receptors improves peripheralย insulinย sensitivity in mice with diet-inducedย obesity
  3364. Pharmacological treatment ofย insulinย resistance inย obesity.
  3365. Pharyngeal collapsibility during sleep is elevated inย insulin-resistant females with morbidย obesity
  3366. Phenotypic characterisation of human amylin transgenic mice: altered hormone signalling in the brain underlyingย obesityย andย insulinย resistance
  3367. Phenotypic characterization ofย insulin-resistant andย insulin-sensitiveย obesity
  3368. Phlorizin amelioratesย obesity-associated endotoxemia andย insulinย resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
  3369. Phosphatidylinositol-4-phosphate-5-kinase ฮฑ deficiency alters dynamics of glucose-stimulatedย insulinย release to improve glucohomeostasis and decreaseย obesityย in โ€ฆ
  3370. PHOSPHO1 is a skeletal regulator ofย insulinย resistance andย obesity
  3371. PHOSPHO1, a novel skeletal regulator ofย insulinย resistance andย obesity
  3372. Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet inducedย obesityย andย insulinย resistance
  3373. Phospholipid Transfer Protein Deficiency Attenuates High-Fat Dietโ€“Inducedย obesityย andย insulinย Resistance
  3374. Phosphorylation status of fetuin-A is critical for inhibition ofย insulinย action and is correlated withย obesityย andย insulinย resistance
  3375. Physical activity energy expenditure is associated with 2-hย insulinย independently ofย obesityย among Inuit in Greenland
  3376. Physical activity impactsย insulinย sensitivity post metabolic bariatric surgery in adolescents with severeย obesity
  3377. Physical activity, eating patterns, andย insulinย resistance inย obesity
  3378. Physical activity, fitness and cardiovascular disease risk in adults: interactions withย insulinย resistance andย obesity
  3379. Physical and Metabolic Characteristics of p62 Knockout Mouse: A New Animal Model ofย obesity/insulinย Resistance
  3380. Physical inactivity andย obesityย underlie theย insulinย resistance of aging
  3381. Physical inactivity andย obesity: links withย insulinย resistance and type 2 diabetes mellitus
  3382. Physical Training in Humanย obesityย II. Effects on Plasmaย insulinย in Glucose-Intolerant Subjects without Marked Hyperinsulinemia
  3383. Physical training in hyperplasticย obesity. V. Effects of atropine on plasmaย insulin.
  3384. Physiological patterns of intestinal microbiota. The role of dysbacteriosis inย obesity,ย insulinย resistance, diabetes and metabolic syndrome
  3385. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age,ย obesity, gonadal function, and โ€ฆ
  3386. Physiopathology and Possible Etiology of Hormonal Dysregulations andย insulinย Resistance in Obese Rats: a Potential Model for Some Humanย obesity
  3387. Phytosterols do not change susceptibility toย obesity,ย insulinย resistance, and diabetes induced by a high-fat diet in mice
  3388. PI3Kฮณ activity in leukocytes promotes adipose tissue inflammation and early-onsetย insulinย resistance duringย obesity
  3389. PI3Kฮณ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotesย obesityย andย insulinย resistance
  3390. Pigment epithelium-derived factor contributes toย insulinย resistance inย obesity
  3391. Pituitary lesions,ย obesity, and mesenteric Lipomas inย insulin-resistant horses
  3392. PKCฮฒ-induced Selective IRS1 Dysfunction andย insulinย Resistance in Renal Glomeruli of Rodent Models of Diabetes andย obesity
  3393. Plasma Active Ghrelin Level in Patients with Type 2 Diabetes Mellitus and its Interrelationship withย insulinย resistance, Hypertension, Dyslipidemia andย obesity
  3394. Plasma adiponectin levels are related toย obesity, inflammation, blood lipids andย insulinย in type 2 diabetic and non-diabetic Trinidadians
  3395. Plasma aldosterone, plasma lipoproteins,ย obesityย andย insulinย resistance in humans
  3396. Plasma amino acid levels andย insulinย secretion inย obesity
  3397. Plasma amino acids andย insulinย levels inย obesity: response to carbohydrate intake and tryptophan supplements
  3398. Plasma B-cell tropin,ย insulinย secretion andย obesity
  3399. Plasma cell glycoprotein-1, interleukin-6 and tumor necrosis factor-alfa as candidate genes forย insulinย resistance,ย obesityย and type 2 diabetes (PC-1 โ€ฆ
  3400. Plasma cell membrane glycoprotein 1 (PC-1): a marker ofย insulinย resistance inย obesity, uremia and diabetes mellitus.
  3401. Plasma concentrations ofย insulinย and free fatty acids in dietary-inducedย obesityย of Wistar-rats before and after glucose stimulation.
  3402. Plasma CTRP-3 concentrations in Chinese patients withย obesityย and type II diabetes negatively correlate withย insulinย resistance
  3403. Plasma free fatty acids do not provide the link betweenย obesityย andย insulinย resistance or ฮฒโ€cell dysfunction: results of the Reading, Imperial, Surrey, Cambridge, Kings โ€ฆ
  3404. Plasma ghrelin,ย obesity, and the polycystic ovary syndrome: correlation withย insulinย resistance and androgen levels
  3405. Plasma high-density lipoprotein cholesterol but not apolipoprotein AI is a good correlate of the visceralย obesityโ€”insulinย resistance dyslipidemic syndrome
  3406. Plasmaย insulinย A-chain inย obesityย and diabetes
  3407. Plasmaย insulinย and growth hormone levels inย obesityย and diabetes
  3408. Plasmaย insulinย changes inย obesityย with or without abnormal glucose tolerance
  3409. Plasmaย insulinย in patients with coronary sclerosis and inย obesity.
  3410. Plasmaย insulinย levels during pregnancy, inย obesityย and potential diabetes
  3411. Plasmaย insulin, growth hormone, cortisol, and centralย obesityย among young Chinese type 2 diabetic patients.
  3412. Plasmaย insulin, leptin, and soluble TNF receptors levels in relation toย obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men
  3413. Plasma islet amyloid polypeptide levels inย obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus
  3414. Plasma Leptin andย insulinย Resistance Correlation withย obesityย in Pre Pubertal Children.
  3415. Plasma leptin concentration,ย obesity, andย insulinย resistance in healthy Korean population
  3416. Plasma leptin concentrations andย obesityย in relation toย insulinย resistance syndrome components among school children in Taiwanโ€”The Taipei Children Heart Study
  3417. Plasma leptin levels: interaction ofย obesityย with a common variant ofย insulinย receptor substrate-1
  3418. Plasma Leptin,ย insulinย Resistance, andย obesityย Index of Type 2 Diabetics and Normal Subjects among Koreans.
  3419. Plasma levels of ghrelin, des-acyl ghrelin and LEAP2 in children withย obesity: correlation with age andย insulinย resistance
  3420. Plasma levels ofย insulinย and leptin in patients with morbidย obesityย and anorexia nervosa after weight loss or gain, respectively
  3421. Plasma lipid profiling of tissue-specificย insulinย resistance in humanย obesity
  3422. Plasma PAF acetylhydrolase in non-insulinย dependent diabetes mellitus andย obesity: effect of hyperinsulinemia and lovastatin treatment
  3423. Plasma phospholipid transfer protein activity is independently determined byย obesityย andย insulinย resistance in non-diabetic subjects
  3424. Plasma plasminogen activator inhibitor 1,ย insulinย resistance and androidย obesity
  3425. Plasma procalcitonin is associated withย obesity,ย insulinย resistance, and the metabolic syndrome
  3426. Plasma profiles of glucose,ย insulinย and lipids in the male WBN/Kob-Leprfa rat, a new model of type 2 diabetes withย obesity
  3427. Plasma progranulin concentrations are increased in patients with type 2 diabetes andย obesityย and correlated withย insulinย resistance
  3428. Plasma PTX3 protein levels inversely correlate withย insulinย secretion andย obesity, whereas visceral adipose tissue PTX3 gene expression is increased inย obesity
  3429. Plasma retinol-binding protein 4 andย insulinย resistance in overweight andย obesity: effect of weight loss
  3430. Plasma SFRP5 levels are decreased in Chinese subjects withย obesityย and type 2 diabetes and negatively correlated with parameters ofย insulinย resistance
  3431. Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol inย insulinย resistance andย obesity
  3432. Plasma tocopherols and carotenes are decreased in spanish children and adolescents withย insulinย resistance, independently ofย obesity
  3433. Plasma visfatin concentrations in childhoodย obesity: relationships withย insulinย resistance and anthropometric measurements indices
  3434. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction,ย insulinย and leptin, and inย obesityย and diabetes
  3435. Plasminogen activator inhibitorโ€1, inflammation,ย obesity,ย insulinย resistance and vascular risk
  3436. Platelet resistance to nitrates inย obesityย and obese NIDDM, and normal platelet sensitivity to bothย insulinย and nitrates in lean NIDDM
  3437. Platelet-endothelial interactions in atherosclerosis-prone arteries in a non-human primate model ofย obesityย andย insulinย resistance
  3438. Plenary 3 Role of inflammation in the etiology ofย obesityย inducedย insulinย resistance and Type 2 diabetes
  3439. PLTP Deficiency Attenuates High Fat Diet Inducedย obesityย andย insulinย Resistance
  3440. POCU1b, the n-Butanol Soluble Fraction of Polygoni Cuspidati Rhizoma et Radix, Attenuatesย obesity, Non-Alcoholic Fatty Liver, andย insulinย Resistance via Inhibitions โ€ฆ
  3441. Polycystic ovarian syndrome: correlation between hyperandrogenism,ย insulinย resistance andย obesity
  3442. Polycystic ovaries,ย obesityย andย insulinย resistance in women with epilepsy
  3443. Polycystic ovary syndrome and antiโ€Mรผllerian hormone: role ofย insulinย resistance, androgens,ย obesityย and gonadotrophins
  3444. Polycystic Ovary Syndrome is Associated withย insulinย Resistance Independent ofย obesity, Vitamin D Status and Inflammatory Activation
  3445. Polycystic ovary syndrome,ย insulinย resistance, andย obesity: navigating the pathophysiologic labyrinth
  3446. Polycystic Ovary Syndrome,ย obesityย andย insulinย Resistance
  3447. Polycystic ovary syndrome:ย obesity,ย insulinย resistance, hyperandrogenism.
  3448. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated withย obesity, leptin levels, andย insulinย resistance in young subjects and diet-treated โ€ฆ
  3449. Polymorphisms in inflammatory pathway markers and their association withย obesityย andย insulinย resistance in populations of the African diaspora
  3450. Polymorphisms in the adiponutrin gene are associated with increasedย insulinย secretion andย obesity
  3451. Polymorphisms near SOCS3 are associated withย obesityย and glucose homeostasis traits in Hispanic Americans from theย insulinย Resistance Atherosclerosis Family โ€ฆ
  3452. Polyunsaturated fatty acids attenuate diet inducedย obesityย andย insulinย resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle
  3453. Pomegranate seed oil prevents diet inducedย obesityย andย insulinย resistance in mice
  3454. Pomegranate seed oil, a rich source of punicic acid, prevents diet-inducedย obesityย andย insulinย resistance in mice
  3455. Poor vitamin D status may contribute to high risk forย insulinย resistance,ย obesity, and cardiovascular disease in Asian Indians
  3456. Populus balsamifera extract and its active component salicortin reduceย obesityย and attenuateย insulinย resistance in a diet-induced obese mouse model
  3457. Populus balsamifera L.(Salicaceae) mitigates the development ofย obesityย and improvesย insulinย sensitivity in a diet-induced obese mouse model
  3458. Positive association between musclin andย insulinย resistance inย obesity: evidence of a human study and an animal experiment
  3459. Positive association ofย obesityย andย insulinย resistance with bone mineral density in Tunisian postmenopausal women
  3460. Possible criteria forย obesityย based onย insulinย resistance in Japanese college athletes
  3461. Possible role of cytosolic free calcium concentrations in mediatingย insulinย resistance ofย obesityย and hyperinsulinemia.
  3462. Possible role of pancreaticย insulinย and glucagon in the hyperlipidemia andย obesityย of obese strain of chicken
  3463. Possible Treatment Options forย insulinย Resistance inย obesityย via Branched-Chain Amino Acid Pathway
  3464. Postmenopausal hypertension, abdominalย obesity, apolipoprotein andย insulinย resistance
  3465. Postnatal deficiency of essential fatty acids in mice results in resistance to diet-inducedย obesityย and low plasmaย insulinย during adulthood
  3466. Postnatal environment overrides genetic and prenatal factors influencing offspringย obesityย andย insulinย resistance
  3467. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes inย obesityย and non-insulin-dependent diabetes mellitus
  3468. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently ofย obesityย and whole-bodyย insulinย resistance
  3469. Postprandial Dyslipidemia and Intestinal Dysfunction in Adolescents withย obesityย andย insulinย Resistance
  3470. Postprandial oscillatory patterns of blood glucose andย insulinย in NIDDM: Abnormal diurnalย insulinย secretion patterns and glucose homeostasis independent ofย obesity
  3471. Postprandial triglyceridaemia is modulated byย insulinย resistance but not by grade ofย obesityย in abdominal and morbid obese subjects
  3472. Potential cellular and genetic mechanisms forย insulinย resistance in the common disorders of diabetes andย obesity
  3473. Potential epigenetic biomarkers ofย obesity-relatedย insulinย resistance in human whole-blood
  3474. Potential involvement of adipocyteย insulinย resistance inย obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression
  3475. Potential Mechanism (s) ofย obesity-Inducedย insulinย Resistance in Skeletal Muscle: The Role of Exercise
  3476. Potential Role Of Endoplasmic Reticulum Redox Changes In Endoplasmic Reticulum Stress And Impaired Protein Folding Inย obesity-Associatedย insulinย Resistance
  3477. Potential Role ofย insulinย Growth-Factor-Binding Protein 2 as Therapeutic Target forย obesity-Relatedย insulinย Resistance
  3478. Potential role of regulatory T cells in reversingย obesity-linkedย insulinย resistance and diabetic nephropathy
  3479. Potential Roles of Adipocyte Extracellular Vesicleโ€“Derived miRNAs inย obesity-Mediatedย insulinย Resistance
  3480. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women withย obesityย andย insulinย resistance
  3481. PP. 28.18:ย insulinย RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND ABDOMINALย obesityย DEPENDING ON ACE AND PPAR-GAMMA2 โ€ฆ
  3482. PP180. Maternal plasma endotoxin increases significantly across pregnancy with no association withย obesity, inflammation, orย insulinย sensitivity
  3483. PPAR-ฮณ2 Pro12Ala variant is associated with greaterย insulinย sensitivity in childhoodย obesity
  3484. PPAR-ฮณ2 Pro12Ala variant,ย insulinย resistance and plasma long-chain polyunsaturated fatty acids in childhoodย obesity
  3485. PPARฮณ2 protects againstย obesityย by means of a mechanism that mediatesย insulinย resistance
  3486. Praliciguat, a clinical-stage sGC stimulator, improved glucose tolerance andย insulinย sensitivity and lowered triglycerides in a mouse diet-inducedย obesityย model
  3487. PRAS40 prevents development of diabetic cardiomyopathy and improves hepaticย insulinย sensitivity inย obesity
  3488. Pre-sarcopenia is associated with renal hyperfiltration independent ofย obesityย orย insulinย resistance: Nationwide Surveys (KNHANES 2008โ€“2011)
  3489. Prediagnosis smoking,ย obesity,ย insulinย resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study
  3490. Predictive models ofย insulinย resistance derived from simple morphometric and biochemical indices related toย obesityย and the metabolic syndrome in baboons
  3491. Predictive Models ofย insulinย Resistance Derived from Simple Morphometric and Metabolic Measurements Related toย obesityย in Baboons.
  3492. Predictors ofย insulinย resistance in children versus adolescents withย obesity
  3493. Predictors ofย insulinย Resistance in Indonesian Adolescents withย obesity
  3494. Predictors ofย insulinย resistance inย obesityย and type 2 diabetes mellitusโ€”The role of magnesium
  3495. Predictors ofย insulinย resistance in patients withย obesity: a pilot study
  3496. Predisposition toย insulinย resistance andย obesityย due to staple consumption of rice: Amylose content versus germination status
  3497. Predominance ofย insulinย Resistance Over Beta-Cell Dysfunction as a Diabetes Risk Factor in Chinese Adults: Impact ofย obesityย in a Nationwide Prospective Study
  3498. Predominant role ofย obesity/insulinย resistance in oxidative stress development
  3499. Pregnancy,ย obesityย andย insulinย resistance: maternal overnutrition and the target windows of fetal development
  3500. Preliminary evidence forย obesityย and elevations in fastingย insulinย mediating associations between cortisol awakening response and hippocampal volumes and frontal โ€ฆ
  3501. Preliminary evidence forย obesity-associatedย insulinย resistance in adolescents without elevations of inflammatory cytokines
  3502. Preoperative revelation ofย insulinย resistance as a criterion of debulking necessity in patients withย obesity
  3503. Preperitoneal fat thickness in childhoodย obesity: association with serumย insulinย concentration
  3504. Preserved endothelial function in humanย obesityย in the absence ofย insulinย resistance
  3505. Pressure overload exacerbatesย insulinย resistance inย obesityย and type 2 diabetes
  3506. Preteenย insulinย levels interact with caloric intake to predict increases inย obesityย at ages 18 to 19 years: a 10-year prospective study of black and white girls
  3507. Prevalence and clinical characteristics of children and adolescents with metabolically healthyย obesity: Role ofย insulinย sensitivity
  3508. Prevalence and correlates ofย obesityย inย insulinย dependent diabetic patients.
  3509. Prevalence and Regional Differences ofย obesityย in Young Women Latentย obesityย andย insulinย Resistance
  3510. Prevalence and treatment of depression are differentially associated withย insulinย resistance andย obesity
  3511. Prevalence of Atherogenic Index and Its Relationship to Abdominalย obesity, Hypertension andย insulinย Resitance in Obese Pediatric Patients of South Bronx
  3512. Prevalence ofย insulinย Resistance and Impaired Glucose Tolerance among Children and Adolescents withย obesity.
  3513. Prevalence ofย insulinย resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents withย obesity
  3514. Prevalence ofย insulinย Resistance and its Association withย obesityย and Alcoholism in Male Medical Students of Bhopal
  3515. Prevalence ofย insulinย resistance in urban Indian school going children with overweight/obesity: A cross-sectional study
  3516. Prevalence of male secondary hypogonadism in moderate to severeย obesityย and its relationship withย insulinย resistance and excess body weight
  3517. Prevalence ofย obesityย in Korean Adultย insulin-Dependent Diabetic Patients
  3518. Prevalence ofย obesityย in Korean non-insulin-dependent diabetic patients
  3519. Prevalence ofย obesity, Dyslipidemia, andย insulinย Resistance in Childhood Cancer Survivors
  3520. Prevalence ofย obesity, hyperlipemia andย insulinย resistance in children with suprasellar brain tumors
  3521. Prevalence of theย insulinย resistance syndrome inย obesity
  3522. Preventing high fat diet-inducedย obesityย and improvingย insulinย sensitivity through neuregulin 4 gene transfer
  3523. Prevention and treatment ofย obesity,ย insulinย resistance, and diabetes by bile acidโ€“binding resin
  3524. Prevention ofย obesityย andย insulinย resistance by estrogens requires ERฮฑ activation function-2 (ERฮฑAF-2), whereas ERฮฑAF-1 is dispensable
  3525. Prevention ofย obesityย andย insulinย resistance by glucokinase expression in skeletal muscle of transgenic mice
  3526. Prevention ofย obesityย andย insulinย resistance in mice lacking plasminogen activator inhibitor 1
  3527. Preventive effects of Salvia officinalis leaf extract onย insulinย resistance and inflammation in a model of high fat diet-inducedย obesityย in mice that responds to โ€ฆ
  3528. Preventive effects of salvia officinalis leaf extract onย insulinย resistance and inflammation, in high fat diet-induced-obesityย mice model
  3529. Preventive effects of salvia officinalis leaf extract onย insulinย resistance and inflammation, in high fat diet-induced-obesityย mice model
  3530. Pro-inflammatory adipocytokines, oxidative stress,ย insulin, Zn and Cu: interrelations withย obesityย in Egyptian non-diabetic obese children and adolescents
  3531. Pro-inflammatory CD11c+ CD206+ adipose tissue macrophages are associated withย insulinย resistance in humanย obesity
  3532. Probiotic and omega-3 polyunsaturated fatty acids supplementation reducesย insulinย resistance, improves glycemia andย obesityย parameters in individuals with type 2 โ€ฆ
  3533. Probiotics improveย obesity-associated dyslipidemia andย insulinย resistance in high-fat diet-fed rats
  3534. Profound peripheralย insulinย resistance, independent ofย obesity, in polycystic ovary syndrome
  3535. Programmed cell death-4 deficiency prevents diet-inducedย obesity, adipose tissue inflammation, andย insulinย resistance
  3536. Programming of fetalย insulinย resistance in pregnancies with maternalย obesityย by ER stress and inflammation
  3537. Programming of infant neurodevelopment by maternalย obesity: potential role of maternal inflammation andย insulinย resistance
  3538. Progress and controversies: treatingย obesityย andย insulinย resistance in the context of hypertension
  3539. Progress in the Study of the Association between Adipocyte Fatty Acid Binding Protein and PTEN and Their Correlation withย obesityย andย insulinย Resistance
  3540. Progression ofย obesity-inducedย insulinย resistance in response to a high-fat diet is delayed in IL-1 receptor type I-knock-out mice
  3541. Progressive defect ofย insulinย action on glycogen synthase inย obesityย and diabetes
  3542. Progressiveย obesityย alters ovarianย insulin, phosphatidylinositol-3 kinase, and chemical metabolism signaling pathways and potentiates ovotoxicity induced by โ€ฆ
  3543. Prohibitin-induced,ย obesity-associatedย insulinย resistance and accompanying low-grade inflammation causes NASH and HCC
  3544. Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences inย obesity,ย insulinย resistance, and metabolic dysregulation
  3545. Promising Effect of Irisin in Reduction ofย obesityย Andย insulinย Resistance: A Review
  3546. Properly timed injections of cortisol and prolactin produce long-term reductions inย obesity, hyperinsulinaemia andย insulinย resistance in the Syrian hamster โ€ฆ
  3547. Proteasome dysfunction associated to oxidative stress and proteotoxicity in adipocytes compromisesย insulinย sensitivity in humanย obesity
  3548. Proteasome dysfunction mediatesย obesity-induced endoplasmic reticulum stress andย insulinย resistance in the liver
  3549. Protection against diet-inducedย obesityย andย obesityโ€“ relatedย insulinย resistance in Group 1B PLA2-deficient mice
  3550. Protection from dietโ€inducedย obesityย andย insulinย resistance in mice lacking CCL19โ€CCR7 signaling
  3551. Protection fromย obesityย andย insulinย resistance in mice overexpressing human apolipoprotein C1
  3552. Protection Fromย obesityย and Systemicย insulinย Resistance by Hepatocyte Growth Factor in Mice
  3553. Protection fromย obesity-inducedย insulinย resistance in mice lacking TNF-ฮฑ function
  3554. Protective role for B-1b B cells and IgM inย obesity-associated inflammation, glucose intolerance, andย insulinย resistance
  3555. Protein inhibitor of activated STAT 1 (PIAS1) protects againstย obesity-inducedย insulinย resistance by inhibiting inflammation cascade in adipose tissue
  3556. Protein kinases: mechanisms and downstream targets in inflammation-mediatedย obesityย andย insulinย resistance
  3557. Protein oxidation inย obesityย andย insulinย resistance
  3558. Protein-restriction diet during the suckling phase programs rat metabolism againstย obesityย andย insulinย resistance exacerbation induced by a high-fat diet in adulthood
  3559. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus,ย obesityย and related states ofย insulinย resistance
  3560. Proteomic analysis of malignant and benign endometrium according toย obesityย andย insulin-resistance status using Reverse Phase Protein Array
  3561. Proteomic and biochemical analysis of adipose protein carbonylation inย obesityย linkedย insulinย resistance
  3562. PS1-1. TLR-3 is highly expressed in human adipocytes, but deficiency of TLR3 does not protect againstย obesity-induced inflammation andย insulinย resistance in mice
  3563. PS15-78. Increased adipose tissue oxygen tension inย obesityย is accompanied byย insulinย resistance, impaired adipose tissue capillarisation and inflammation
  3564. PS19-89. Absence of JNK1 protects mice against age-inducedย obesityย andย insulinย resistance
  3565. PS2-9. Effect of B-and T-cell deficiency onย obesity-induced inflammation andย insulinย resistance
  3566. PS8-44. FcR-ฮณ-chain-/-mice are protected against diet-inducedย obesityย and diet-inducedย insulinย resistance
  3567. PS8-45.ย insulinย resistance in 4-5 year old children with overweight andย obesity
  3568. PTEN Mutations as a Cause of Constitutiveย insulinย Sensitivity andย obesity
  3569. PTEN mutations as a cause of constitutiveย insulinย sensitivity andย obesityย in human beings
  3570. PTEN mutations increaseย insulinย sensitivity andย obesity
  3571. PTEN targeting: the search for novelย insulinย sensitisers provides new insight intoย obesityย research
  3572. PTPRT regulates high-fat diet-inducedย obesityย andย insulinย resistance
  3573. Puโ€™erh tea extract-mediated protection against hepatosteatosis andย insulinย resistance in mice with diet-inducedย obesityย is associated with the induction of de novo โ€ฆ
  3574. Purified Betacyanins from Hylocereus undatus Peel Ameliorateย obesityย andย insulinย Resistance in High-Fat-Diet-Fed Mice
  3575. PWD/PhJ and WSB/EiJ mice are resistant to diet-inducedย obesityย but have abnormalย insulinย secretion
  3576. PXR ablation alleviates diet-induced and geneticย obesityย andย insulinย resistance in mice
  3577. Pyruvate attenuate lipid metabolic disorders andย insulinย resistance inย obesityย induced in rats
  3578. PYY (3โ€“36) reduces food intake and body weight and improvesย insulinย sensitivity in rodent models of diet-inducedย obesity
  3579. QTL mapping of genes controlling plasmaย insulinย and leptin concentrations: metabolic effect ofย obesityย QTLs identified in an F2 intercross between C57BL/6J and โ€ฆ
  3580. Quantifying mediating effects of endogenous estrogen andย insulinย in the relation betweenย obesity, alcohol consumption, and breast cancer
  3581. Quantitative trait loci forย obesityย andย insulinย resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese โ€ฆ
  3582. Quantitative variation inย obesity-related traits andย insulinย precursors linked to the OB gene region on human chromosome 7.
  3583. Race affects the association ofย obesityย measures withย insulinย sensitivity
  3584. Race, Childhoodย insulin, Childhood Caloric Intake, and Class 3ย obesityย at Age 24: 14โ€Year Prospective Study of Schoolgirls
  3585. Racial differences in peripheralย insulinย sensitivity and mitochondrial capacity in the absence ofย obesity
  3586. Radiologic evidence that hypothalamic gliosis is associated withย obesityย andย insulinย resistance in humans
  3587. Randomized, controlled trial of metformin forย obesityย andย insulinย resistance in children and adolescents: improvement in body composition and fastingย insulin
  3588. Rapid development of cardiac dysfunction in a canine model ofย insulinย resistance and moderateย obesity
  3589. Raspberry alleviatesย obesity-induced inflammation andย insulinย resistance in skeletal muscle through activation of AMP-activated protein kinase (AMPK) ฮฑ1
  3590. #VALUE!
  3591. Re: Maternal lipids are associated with newborn adiposity independent of GDM status,ย obesityย andย insulinย resistance: a prospective observational cohort study โ€ฆ
  3592. Recent advances inย obesity-induced inflammation andย insulinย resistance
  3593. Recent advances in the relationship betweenย obesity, inflammation, andย insulinย resistance
  3594. Recessive Inheritance ofย obesityย in Familial Nonโ€”insulin-Dependent Diabetes Mellitus, and Lack of Linkage to Nine Candidate Genes
  3595. Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors inย obesityย andย insulinย resistance
  3596. Red pitaya betacyanins protects from dietโ€inducedย obesity, liver steatosis andย insulinย resistance in association with modulation of gut microbiota in mice
  3597. Red wine polyphenols do not improveย obesityโ€associatedย insulinย resistance: A randomized controlled trial
  3598. Redistribution of substrates to adipose tissue promotesย obesityย in mice with selectiveย insulinย resistance in muscle
  3599. Reduced [Beta]-cell Compensation toย insulinย Resistance Associated withย obesityย in Familial Type 2 Diabetes
  3600. Reduced access toย insulin-sensitive tissues in dogs withย obesityย secondary to increased fat intake
  3601. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development ofย insulinย resistance withย obesity
  3602. Reduced anorexic effects ofย insulinย inย obesity-prone rats fed a moderate-fat diet
  3603. Reduced beta-cell compensation to theย insulinย resistance associated withย obesityย in members of caucasian familial type 2 diabetic kindreds.
  3604. Reduced biliverdin reductase-A levels are associated with early alterations ofย insulinย signaling inย obesity
  3605. Reduced Cardiolipin Synthesis Protects Against the Development ofย obesityย andย insulinย Resistance
  3606. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently ofย obesity, lipid indices and serumย insulinย levels: a cross โ€ฆ
  3607. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents withย obesityย andย insulinย resistance
  3608. Reduced gluteal expression of adipogenic and lipogenic genes in black South African women is associated withย obesity-relatedย insulinย resistance
  3609. Reduced heart rate variability correlates withย insulinย resistance but not with measures ofย obesityย in population undergoing laparoscopic Roux-en-Y gastric bypass
  3610. Reduced hepaticย insulinย clearance in rats with dietary-inducedย obesity
  3611. Reduced hepaticย insulinย extraction inย obesity: relationship with plasmaย insulinย levels
  3612. Reducedย insulinย suppression of glucose appearance is related to susceptibility to dietaryย obesityย in rats
  3613. Reduced plasma visfatin/pre-B cell colony-enhancing factor inย obesityย is not related toย insulinย resistance in humans
  3614. Reduced Socs3 expression in adipose tissue protects female mice againstย obesity-inducedย insulinย resistance
  3615. Reduced tyrosine kinase activity of theย insulinย receptor inย obesity-diabetes. Central role of tumor necrosis factor-alpha.
  3616. Reduction in adiposity, ฮฒ-cell function,ย insulinย sensitivity, and cardiovascular risk factors: a prospective study among Japanese withย obesity
  3617. Reduction in BACE1 decreases body weight, protects against diet-inducedย obesityย and enhancesย insulinย sensitivity in mice
  3618. Reduction in endotoxemia, oxidative and inflammatory stress, andย insulinย resistance after Roux-en-Y gastric bypass surgery in patients with morbidย obesityย and type 2 โ€ฆ
  3619. Reductions in adipose tissue mitochondrial content in high fat dietโ€inducedย obesityย and lean models ofย insulinย resistance
  3620. Reevaluation of fatty acids,ย obesity, andย insulinย resistance
  3621. Regular alcohol consumption improvesย insulinย resistance in healthy Japanese men independent ofย obesity
  3622. Regulated membrane transport of free fatty acids in adipocytes: role inย obesityย and non-insulinย dependent diabetes mellitus.
  3623. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-inducedย obesityย andย insulinย resistance
  3624. Regulation of Autotaxin and its Role inย obesity-Induced Tissueย insulinย Resistance
  3625. Regulation of Bโ€type natriuretic peptide synthesis byย insulinย inย obesityย in male mice
  3626. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth toย insulinย resistance andย obesity
  3627. Regulation of HIF-1ฮฑ activity in adipose tissue byย obesity-associated factors: adipogenesis,ย insulin, and hypoxia
  3628. Regulation of human adipose tissue gene expression in relation toย obesityย andย insulinย resistance
  3629. Regulation of human adipose tissue gene expression in relation toย obesityย andย insulinย resistance
  3630. Regulation of human vascular redox state inย obesityย andย insulinย resistance
  3631. Regulation ofย insulinย degrading enzyme activity byย obesity-associated factors and pioglitazone in liver of diet-induced obese mice
  3632. Regulation ofย insulin-response element binding protein-1 inย obesityย and diabetes: potential role in impairedย insulin-induced gene transcription
  3633. Regulation of mouse hepatic genes in response to diet inducedย obesity,ย insulinย resistance and fasting induced weight reduction
  3634. Regulation of Nephron Afferent Arteriole Resistance inย obesity: Role ofย insulinย and Connecting Tubule Glomerular Feedback
  3635. REGULATION OFย obesityย ANDย insulinย RESISTANCE BY FOENICULUM VULGARE AND ANETHUM GRAVEOLENS EXTRACT IN HIGH-FAT DIET-INDUCED โ€ฆ
  3636. Regulation ofย obesityย andย insulinย resistance by hypoxia-inducible factors
  3637. Regulation ofย obesityย andย insulinย resistance by nitric oxide
  3638. Regulation ofย obesity-relatedย insulinย resistance with gut anti-inflammatory agents
  3639. Regulatory function of interferon regulatory factor 3 inย obesity, inflammation andย insulinย resistance (HUM7P. 287)
  3640. Regulatory role of CD40 inย obesity-inducedย insulinย resistance
  3641. Relating smoking,ย obesity,ย insulinย resistance and ovarian biomarker changes to the final menstrual period (FMP)
  3642. Relation between abdominalย obesity,ย insulinย resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in โ€ฆ
  3643. Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in androidย obesityย and the phenomenon ofย insulinย resistance syndromes
  3644. Relation betweenย obesityย in young adulthood and risk of non-insulin-dependent diabetes mellitus
  3645. Relation of centralย obesityย andย insulinย resistance with high diabetes prevalence and cardiovascular risk in South Asians
  3646. Relation of Chemerin toย insulinย Resistance, Inflammation andย obesityย in Egyptian Type II Diabetics
  3647. Relation of circulating oxidized LDL toย obesityย andย insulinย resistance in children
  3648. Relation of circulating resistin toย insulinย resistance in type 2 diabetes andย obesity: a systematic review and meta-analysis
  3649. Relation of depot-specific adipose inflammation toย insulinย resistance in humanย obesity
  3650. Relation ofย insulinย resistance to left ventricular hypertrophy and diastolic dysfunction inย obesity
  3651. Relation ofย obesityย and Chronic Inflammation,ย insulinย Resistance
  3652. Relation ofย obesityย toย insulinย secretion and clearance in adolescents: the Bogalusa Heart Study.
  3653. Relation of plasma kisspeptin levels withย obesityย andย insulinย resistance in polycystic ovary syndrome
  3654. Relation of the degree ofย obesityย in childhood to adipose tissueย insulinย resistance
  3655. Relation of the white blood cell count toย obesityย andย insulinย resistance: effect of race and gender
  3656. Relation of triglyceride stores in skeletal muscle cells to centralย obesityย andย insulinย sensitivity in European and South Asian men
  3657. Relations betweenย obesity,ย insulinย resistance, and 25-hydroxyvitamin D
  3658. Relationship amongย obesity, blood lipids andย insulinย resistance in Bangladeshi adults
  3659. Relationship amongย obesity,ย insulinย resistance, and hyperinsulinemia in the polycystic ovary syndrome
  3660. Relationship among resistance to theย insulinย andย obesityย in Zacatecas population
  3661. Relationship among serum adiponectin level,ย obesityย andย insulinย resistance.
  3662. Relationship between adiponectin,ย obesityย andย insulinย resistance
  3663. Relationship between alteration of serum leptin level andย insulinย resistance in simpleย obesityย patients
  3664. Relationship between beta~ 3-AR gene andย obesity, type 2 diabetes,ย insulinย resistance in Chiness Hans population
  3665. Relationship between Body Mass Index andย insulinย Resistance and Beta Cell Function byย obesityย Type in Obese Middle-Aged Men
  3666. Relationship between degree ofย obesityย and in vivoย insulinย action in man
  3667. Relationship between expression of resistin andย insulinย resistance in diet-inducedย obesityย andย obesityย resistant rats [J]
  3668. Relationship between Fat Distribution and Leptin-insulin: Needle-Knife Treatment for Simpleย obesity-A Clinical Study.
  3669. Relationship between generalized and upper bodyย obesityย toย insulinย resistance in Asian Indian men
  3670. Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severeย obesity
  3671. Relationship between immunoreactiveย insulinย and plasma somatomedin-C/insulin-like growth factor-I concentration in childhoodย obesity
  3672. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus andย obesity.
  3673. Relationship betweenย insulinย and somatotropin inย obesity.
  3674. Relationship betweenย insulinย Resistance and Blood Lipids Level in Children with Simpleย obesityย [J]
  3675. Relationship betweenย insulinย resistance and free fatty acids in children with simpleย obesityย [J]
  3676. Relationship betweenย insulinย resistance and serum high sensitivity C-reactive protein, blood lipids level in adult with simpleย obesityย [J]
  3677. Relationship betweenย insulinย resistance and serum levels of adiponectin and resistin with childhoodย obesity
  3678. Relationship betweenย insulinย Resistance and Tumor Necrosis Factor-alpha in Children with Simpleย obesity
  3679. Relationship betweenย insulinย resistance, incidence of fatty liver and serum ferritin level in adults with simpleย obesity
  3680. Relationship betweenย insulinย resistance, inflammation and liver cell apoptosis in patients with severeย obesity
  3681. Relationship betweenย insulinย resistance,ย insulinย secretion andย insulinย metabolism in simpleย obesity.
  3682. Relationship betweenย insulinย Resistance,ย obesityย and Lipid Profile in Diabetic Women with Polycystic Ovarian Syndromes (POS)
  3683. Relationship betweenย insulinย resistance,ย obesityย and serum prostate-specific antigen levels in healthy men
  3684. Relationship betweenย insulinย sensitivity and degree ofย obesityย in mild hypertension
  3685. Relationship betweenย insulinย sensitivity,ย obesity, body fat distribution and ฮฒ-endorphinaemia in obese women
  3686. Relationship betweenย insulin-sensitiveย obesityย and retinal microvascular abnormalities.
  3687. Relationship between Intra-abdominalย obesityย andย insulinย Resistance
  3688. Relationship between leptin level, index ofย insulinย resistance and the main indicators of carbohydrate and lipid metabolism in patients with varying degrees ofย obesity
  3689. Relationship between Metabolic Syndrome, Metabolic Syndrome Score,ย insulinย Resistance and Beta Cell Function in Korean Adults withย obesity
  3690. Relationship betweenย obesityย and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins
  3691. Relationship betweenย obesityย andย insulinย and lipoprotein metabolism in postmenopausal women
  3692. Relationship betweenย obesityย and maximalย insulin-stimulated glucose uptake in vivo and in vitro in man
  3693. Relationship betweenย obesityย and maximalย insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians.
  3694. Relationship betweenย obesityย and related indicators withย insulinย resistance among the residents over 50-year-old in Wuxi area
  3695. Relationship betweenย obesityย and serunย insulinย and C-peptide levels in long-term female psychiatric inpatients [J]
  3696. Relationship betweenย obesityย and the increased risk of major complications in nonโ€insulinโ€dependent diabetes mellitus
  3697. Relationship betweenย obesity-associated non-ovulation menstruation dysfunction andย insulinย resistance
  3698. Relationship betweenย obesity, IL-17 and IL-23 andย insulinย resistance
  3699. Relationship betweenย obesity, inflammation andย insulinย resistance: new concepts
  3700. Relationship betweenย obesity,ย insulinย resistance and adipokines in morbidly obese women
  3701. Relationship betweenย obesity,ย insulinย resistance, and coronary heart disease risk
  3702. Relationship betweenย obesity, metabolic syndrome andย insulinย resistance in children [J]
  3703. Relationship between plasma membrane glycoprotein gene andย obesity, type 2 diabetes mellitus,ย insulinย resistance in Chinese population
  3704. Relationship between plasma membrane glycoprotein geneandย obesity,ย insulinย resistance
  3705. Relationship between plasma progranulin andย insulinย resistance in patients with type 2 diabetes mellitus andย obesity
  3706. Relationship between preclinical abnormalities of global and regional left ventricular function andย insulinย resistance in severeย obesity: a Color Doppler Imaging Study
  3707. Relationship between serum adiponectin,ย obesityย andย insulinย resistance in nonalcoholic fatty liver disease
  3708. Relationship between Serum Leptin Level and RAAS,ย insulinย Sensitivity in Patients withย obesity-related Hypertension
  3709. Relationship between serum levels of 1-84 parathormone (PTH1-84) andย obesity, HOMAย insulin-sensitivity or beta-cells function (HOMA-B) in type 2 diabetic patients
  3710. Relationship between serum lipoprotein ratios andย insulinย resistance inย obesity
  3711. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men withย obesity
  3712. Relationship between serum tumor necrosis factor-aandย insulinย in theย obesity
  3713. Relationship between Simpleย obesityย and Risk Factors ofย insulinย Resistance Syndrome in Children [J]
  3714. Relationship between skeletal muscleย insulinย resistance,ย insulin-mediated glucose disposal, andย insulinย binding. Effects ofย obesityย and body fat topography.
  3715. Relationship between sub-clinical abnormalities of global and regional left ventricular function andย insulinย resistance in severeย obesity: a color Doppler imaging study โ€ฆ
  3716. Relationship between the plasma resistin,ย obesityย andย insulinย resistance in nonalcoholic fatty liver disease patients.
  3717. Relationship between TNF-ฮฑ,ย obesityย andย insulinย Resistant in Patients with Type โ…ก Diabetes Mellitus
  3718. Relationship between urinary sodium-creatinine ratios andย insulinย resistance in Korean children and adolescents withย obesity
  3719. Relationship between visceralย obesityย andย insulinย resistance in SD rats induced by high fat diets
  3720. #VALUE!
  3721. #VALUE!
  3722. Relationship of abdominalย obesityย measured by DXA and waist circumference withย insulinย sensitivity in Hispanic and nonโ€Hispanic white individuals: The San Luis โ€ฆ
  3723. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones andย insulinย sensitivity in humanย obesity
  3724. RELATIONSHIP OF HUMAN SERUM LEPTIN WITHย insulinย SERUM LIPIDS ANDย obesityย [J]
  3725. Relationship ofย insulinย sensitivity and left ventricular mass in uncomplicatedย obesity
  3726. Relationship of Internalized Racism to Abdominalย obesityย and Blood Pressure in Black Women: Implications for theย insulinย Resistance Syndrome in African Americans
  3727. Relationship of islet function toย insulinย action in humanย obesity
  3728. Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins,ย obesity, anaย insulinย Resistance in Japanese Men
  3729. Relationship of monocyte chemoattractant protein 1 (MCP-1) withย insulinย resistance and body mass index, but not with thermogenetic hormones inย obesity
  3730. Relationship ofย obesityย andย insulinย resistance with the cerebrovascular reactivity: a case control study
  3731. Relationship ofย obesityย and physical activity with C-peptide, leptin, andย insulin-like growth factors in breast cancer survivors
  3732. Relationship ofย obesityย to adipose tissueย insulinย resistance
  3733. Relationship ofย obesityย toย insulinย resistance in Egyptian women: role of leptin
  3734. Relationship ofย obesityย withย insulinย resistance in polycystic ovarian syndrome
  3735. Relationship of plasmaย insulinย concentration andย insulinย sensitivity to blood pressure. Is it modified byย obesity?
  3736. Relationship of proinsulinย andย insulinย with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact ofย obesityโ€“clinical โ€ฆ
  3737. Relationship of serum CXCL5 withย obesityย andย insulinย resistance
  3738. Relationship of serum resistin withย insulinย resistance andย obesity
  3739. Relationships among autonomic dysfunction, obstructive sleep apnea, andย insulinย resistance in childhoodย obesity
  3740. Relationships among B-endorphin (B-EP),ย insulinย and atrial natriuretic peptide (ANP) in patients with simpleย obesity
  3741. Relationships among inflammatory cytokines,ย obesity, andย insulinย sensitivity in the horse,
  3742. Relationships amongย insulinย resistance,ย obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk
  3743. Relationships Among Left Ventricular Geometry, Arterial-Ventricular Stiffening andย insulinย Resistance in Childhoodย obesity
  3744. Relationships amongย obesity, inflammation, andย insulinย resistance in African Americans and West Africans
  3745. Relationships amongย obesity, inflammation, andย insulinย resistance in African Americans and West Africans.
  3746. #VALUE!
  3747. Relationships between diet,ย obesityย andย insulinย dysregulation in horses and ponies
  3748. Relationships between glycaemic abnormalities,ย obesityย andย insulinย resistance in nondiabetic Polynesians of New Caledonia
  3749. Relationships between HDL2-C subfractions andย obesityย in non-insulin-dependent diabetics
  3750. Relationships between metabolic clearance rate ofย insulinย and body mass index in a female population ranging from anorexia nervosa to severeย obesity.
  3751. Relationships betweenย obesity, body composition and continuous glucose monitoring parameters in subjects with type 2 diabetes onย insulinย therapy
  3752. Relationships between Parameters ofย insulinย Sensitivity,ย obesityย and Liver Aminotransferases in Patients with Nonalcoholic Fatty Liver Disease
  3753. Relationships between Plasma Carnitine, Free Fat Acid Levels andย insulinย Resisitance in Children with Simpleย obesity
  3754. Relationships between Plasma Carnitine, Free Fat Acid Levels andย insulinย Resisitance in Children with Simpleย obesityย [J]
  3755. Relationships between sarcopenicย obesityย andย insulinย resistance, inflammation, and vitamin D status: the K orean S arcopenic O besity S tudy
  3756. Relationships of body composition and liver fat content withย insulinย resistance inย obesityโ€matched adolescents and adults
  3757. Relationships ofย obesityย indices to serumย insulinย and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM).
  3758. Relationships of Serum Leptin, Tumor Necrosis Factor-? andย insulinย Resistance in Simpleย obesityย Children
  3759. Relationships of Serum Leptin, Tumor Necrosis Factor-alpha andย insulinย Resistance in Simpleย obesityย Children
  3760. Relationships of the systolic blood pressure response during exercise withย insulinย resistance,ย obesity, and endurance fitness in men with type 2 diabetes mellitus
  3761. Relative adipose tissue failure in Alstrรถm syndrome drivesย obesity-inducedย insulinย resistance
  3762. Relative contribution ofย obesityย and body fat distribution to alterations in glucoseย insulinย homeostasis: predictive values of selected indices in premenopausal women
  3763. Relative impact ofย insulinย resistance andย obesityย on cardiovascular risk factors in polycystic ovary syndrome
  3764. Relative importance and conjoint effects ofย obesityย and physical inactivity for the development ofย insulinย resistance
  3765. REMOVED:ย insulinย resistance andย obesityย in childhood and long term consequences during aging
  3766. Renal hemodynamics in Otsuka Long-Evans Tokushima fatty rat, a model rat of spontaneous non-insulin-dependent diabetes mellitus withย obesity
  3767. Renalย insulinย sensitizing effect of exenatide in a high-fat dietย obesityย rat model
  3768. Renin-angiotensin system blockers protect pancreatic islets against diet-inducedย obesityย andย insulinย resistance in mice
  3769. Replication data for: Modest weight loss improves leptin to adiponectin ratio and inducesย insulinย and leptin resensitivization in individuals withย obesity.
  3770. Reply to Letter:โ€œConcerning the Article Assessment of Different Bariatric Surgeries in the Treatment ofย obesityย andย insulinย Resistance in Miceโ€
  3771. Reproductive tissues maintainย insulinย sensitivity in diet-inducedย obesity
  3772. Reprogrammed functional brown adipocytes ameliorateย insulinย resistance and dyslipidemia in diet-inducedย obesityย and type 2 diabetes
  3773. Requirement of JIP1-mediated c-Jun N-terminal kinase activation forย obesity-inducedย insulinย resistance
  3774. Rescue ofย obesity-induced infertility in female mice due to a pituitary-specific knockout of theย insulinย receptor
  3775. Rescue ofย obesityโ€induced infertility in female mice due to an ovarian theca cellโ€specific knockout of theย insulinย receptor
  3776. Research data supportingโ€ย obesityย andย insulinย Resistance are Associated with Reduced Activity in Core Memory Regions of the Brainโ€
  3777. Research for the Relationship betweenย obesity, blood sugar,ย insulinย and Type 2 Diabetes in Kunming
  3778. RESEARCH IN EFFECTS OF FAT DISTRIBUTION ONย insulinย SECRETION ANDย insulinย RESISTANCE IN METABOLICย obesityย NORMAL-WEIGHT
  3779. Research Methodology of Aerobic Compared to Resistance Training to Reduceย insulinย Resistance inย obesity
  3780. Research on Character of Glucose and Lipid Metabolism andย insulinย Sensitivity in Simpleย obesityย Children
  3781. RESEARCH ON THE RELATIONSHIP BETWEENย insulinย RESISTANCE AND SUSCEPTIBILITY OFย obesity
  3782. RESEARCH ON THE RELATIONSHIP OF SERUM TUMOR NECROTIC FACTOR ANDย insulinย LEVEL IN PATIENTS WITHย obesity
  3783. Research progress in aberrant sphingolipid metabolism andย obesityย andย obesity-mediatedย insulinย resistance
  3784. Research progress of Ghrelin andย obesity,ย insulinย resistance and type 2 diabetes mellitus
  3785. Research progress of mechanism of vitamin D in regulatingย obesityย andย insulinย resistance on children
  3786. Research Progress of Relationship between Estrogen Decrease and Abdominalย obesityย andย insulinย Resistance [J]
  3787. Research Progress of the Omega-3 Fatty Acids in the Treatment ofย insulinย Resistance,ย obesity, Diabetes
  3788. Research Progress on Pathogenesis ofย obesity-Inducedย insulinย Resistance and Its Therapeutic Targets: PPARฮฑ/ฮณ
  3789. Resistance of adipose tissue lipoprotein lipase toย insulinย action in rats fed anย obesity-promoting diet
  3790. Resistance to Diet-Inducedย obesityย and Improvedย insulinย Sensitivity in Mice With a Regulator of G Protein Signalingโ€“Insensitive G184S Gnai2 Allele
  3791. Resistance to diet-inducedย obesityย and improvedย insulinย sensitivity in mice with an RGS insensitive G184S Gnai2 allele
  3792. Resistance to diet-inducedย obesity: food intake, pancreatic sympathetic tone, andย insulin
  3793. Resistance to high-fat diet-inducedย obesityย andย insulinย resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency
  3794. Resistance to high-fat dietโ€“inducedย obesityย but exacerbatedย insulinย resistance in mice overexpressing Preadipocyte Factor-1 (Pref-1): a new model of partial โ€ฆ
Related Posts

Inflammation & Depression

Antiaging effects of coffee

Methionine Restriction

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping